Guangdong Haid Group Co. Ltd.2025 Annual ReportSection 1 Important Tips Table of Contents and Interpretation
The board of directors directors and senior management of the company
guarantee that the contents of the annual report are true accurate and complete
and there are no false records misleading statements or major omissions and
bear individual and joint legal liabilities.Xue Hua the person in charge of the company Yang Shaolin the person in
charge of accounting work and Yang Shaolin the person in charge of the
accounting organization (accounting officer) hereby confirm that the financial
report in this annual report is true accurate and complete.All directors attended the board meeting at which the report was considered.Forward-looking statements such as the company's future plans covered in
this report do not constitute a material commitment of the company to any
investors and related parties. Investors are advised to be aware of investment risks.
1. The risk of abnormal weather affecting the periodic fluctuations of the
feed industry
The feed industry mainly serves the downstream aquaculture industry.When natural factors such as high temperature extreme cold rain typhoon and
other natural factors change abnormally during the breeding process there may
be large fluctuations in the nu
mber of breeding stocks and storage ponds and even large-scale outbreaks
of diseases which will affect the demand for feed and there will be a risk of
1phased or regional demand fluctuations. For example continuous rainfall will
reduce the dissolved oxygen saturation of the water body deteriorate the water
quality affect the feeding of aquatic animals cause farmers to passively reduce
feeding and some aquatic products will not adapt to the drastic changes in the
environment and even die which will affect the short-term aquatic feed demand;
Floods caused by heavy rainfall in the region in the short term will lead to the loss
of aquatic products and livestock and poultry breeding which will affect the
normal feed demand. After floods animal epidemics are prone to occur and occur
frequently which will also adversely affect the production and operation of feed
enterprises.Risk response measures: (1) The company is currently deploying factories
and developing local markets in major breeding regions such as South China
Central China East China and North China as well as overseas markets such as
Southeast Asia Latin America and Africa. The expansion of the regional layout
can effectively deal with the risks of abnormal weather and natural disasters in
local areas; (2) Continuously improve the service ability of farmers through the
joint empowerment of feed seedlings and animal protection provide scientific
breeding plans and provide corresponding guidance from the company's
technical personnel to improve farmers' anti-risk ability and breeding
competitiveness and reduce the adverse effects caused by abnormal weather
influences.
22. Risks brought by breeding diseases to the company's production and
operation
With environmental changes and the development of large-scale breeding
animal diseases will also occur from time to time. For example the "African swine
fever virus" that began to break out nationwide in August 2018 and the diseases
such as "blue-ear virus" in pigs "EMS disease" in shrimp farming and "H7N9
virus" in poultry have appeared in recent years. The occurrence of diseases will
lead to a reduction in the production and stock of farmed animals which will
directly inhibit the scale of breeding and reduce the demand for feed in the short
term; The prevalence of major animal diseases can also easily affect consumer
psychology leading to shrinking terminal demand causing the aquaculture
industry to fall into a staged downturn affecting feed demand. At the same time
the outbreak of regional epidemics will bring about major adjustments in the
breeding structure and stock in some areas which will affect the demand for feed
in the region.Risk response measures: (1) The company's feed varieties cover livestock
and poultry feeds such as pig feed chicken feed and duck and goose feed and
aquatic feeds such as fish feed and shrimp feed. The variety is complete and the
structure is balanced which can effectively deal with the disease risk of a single
breeding species. At the same time the company is currently deploying factories
and developing local markets in major domestic breeding regions and overseas
markets such as Southeast Asia Latin America and Africa. The expansion of the
3regional layout can effectively deal with the risk of epidemic outbreaks in local
areas; (2) The company has established a strict disease prevention and control
system in the production process of feed products and at the same time it uses its
technical advantages and professional capabilities to implement the prevention
and control of breeding diseases from the source.
3. The risk of major raw materials price fluctuations
The feed ingredients are mainly various bulk agricultural products mainly
corn and soybeans (soybean meal). In recent years the domestic and international
agricultural product markets have been closely linked. Climate change changes
in planting area and harvest changes in purchasing storage and subsidy policies
changes in import and export policies political games in various countries
international trade relations shipping conditions and other logistics capacity and
cost fluctuations and exchange rate changes in major grain-producing countries
may bring large fluctuations in agricultural product prices which in turn will
have a certain impact on feed and breeding costs. With the strengthening of the
internationalization of agricultural product trade the factors of agricultural
product price change are becoming more and more complex and the price
fluctuation is also intensified. If the company fails to grasp the changes in the feed
raw material market in a timely manner and do a good job in the strategic
management and risk control of procurement in a timely manner it may face the
risk of rising comprehensive procurement costs.
4Risk response measures: (1) The company divides raw material varieties and
implements a combination of centralized procurement of bulk varieties and local
procurement of regional varieties which not only ensures the advantages of large-
scale procurement of bulk raw materials but also strives to obtain the localized
advantages of rapid response to regional procurement; (2) The company
continues to invest in the construction of the raw material procurement research
system. The professional raw material information research department team is
relatively mature. It conducts strategic procurement through real-time tracking
research and judgment of the market trend of domestic and foreign bulk raw
materials and conducts position risk management on bulk raw materials through
tools such as futures hedging and raw material trading which can effectively
control procurement risks; (3) The company has a relatively rich accumulation of
research and development of animal nutrition and feed formula technology. It has
a large R&D team and invests a lot of money in research and development every
year. It focuses on animal nutrition requirements feed formula technology breed
breeding and excellent germplasm breeding healthy breeding mode and other
research directions. It has a deep understanding of animal nutrition requirements
and a relatively high technical level of comprehensive utilization of raw materials.Therefore when the price of raw materials fluctuates It can control reasonable
feed nutrition level and formula cost by quickly adjusting the formula.
4. Risks of environmental protection laws and policies on the scale structure
and regional adjustment of the aquaculture industry
5In recent years the state has introduced a series of environmental protection
regulations such as the new Environmental Protection Law the Regulations on
Pollution Prevention and Control of Large-scale Livestock and Poultry Breeding
the Action Plan for Water Pollution Prevention and Control and the Guiding
Opinions on Promoting the Adjustment and Optimization of Pig Breeding Layout
in Southern Water Network Areas. According to the regulations and policies of
the central government no-breeding zones and restricted-breeding zones have
been set up all over the country. The implementation of the environmental
protection policy will not only further accelerate the withdrawal of retail pig
farmers reduce the unqualified environmental protection and small-scale
backward production capacity continue to expand the production capacity of
large-scale farmers and continuously improve the scale and structure of breeding;
in addition the establishment of no-breeding areas and restricted-breeding areas
will also adjust the production capacity of pig breeding in various regions and
across the country. The scale structure of breeding and the regional adjustment
of production capacity will definitely have a profound impact on the existing
production capacity layout market share pricing power and business model of
the feed industry. The impact of environmental protection policies on the pig
breeding and feed industries has put the existing dominant companies in the
market at risk of reshuffling.Risk response measures: (1) The company continues to improve its service
capabilities for farmers. In addition to feed products it has a layout in the
6industrial chain of animal protection vaccines finance etc. which is highly sticky
to large-scale farmers; (2) The company's feed varieties cover livestock and
aquatic products and the product line is rich and the production lines of pig feed
chicken feed duck feed and pellet fish feed can be used universally. By adjusting
the production capacity in various places the company can quickly switch the
production capacity layout and adjust the industry change; (3) The company
adopts various models to accelerate the production capacity layout in areas with
abundant resources and strong environmental carrying capacity and seize the
market share of new breeding areas; (4) The company continues to increase R&D
investment and the research results in key technologies of microbial fermented
feed key technologies of feed antibiotic substitutes and key technologies of
functional health feed have been effectively applied leading the progress and
development of the industry.
5. The risk of exchange rate fluctuations
The global procurement of feed raw materials has become the norm and the
company's overseas investment and overseas business scale are also rapidly
expanding. The scale of cross-border fund settlement and overseas asset stock
have increased significantly. It involves the currency types of many relevant
countries and the exchange rate fluctuation factors of each currency are different
and the exchange rate fluctuation of any currency may have a certain impact on
the business settlement cost and asset stock value in the region.
7Risk response measures: (1) According to the business scale business model
and settlement characteristics of each region and country the company carefully
selects the settlement currency based on the principle of strict control of exchange
rate risk and strives to achieve a relatively balanced regional capital inflow and
outflow through the structural arrangement of financing sources and financing
varieties and control exchange rate risk; (2) The expansion of two-way
fluctuations in the RMB exchange rate has become the new normal. The company
further enhances its awareness of foreign exchange risk management arranges
settlement models according to procurement and sales strategies and the cyclical
characteristics of import and export business and flexibly uses financial
instruments such as forward foreign exchange settlement and sales swaps and
foreign exchange options to lock in exchange rate risks control procurement and
sales costs and control risks that may arise from exchange rate fluctuations.The profit distribution plan approved by the board of directors of the
company is: based on the total share capital of the repurchased shares deducted
from the share registration date when the distribution plan is implemented in the
future a cash dividend of 11 yuan (including tax) will be distributed to all
shareholders for every 10 shares and 0 bonus shares (including tax) will be
distributed and the common reserve fund will not be converted into share capital.Any discrepancy between the mantissa of the total and the mantissa of the
listed values in this report is due to rounding.
8Content
Section 1 Important Tips Table of Contents and Int... 1
Section 2 Company Profile and Main Financial Indic.. 12
Section 3 Management Discussion and Analysis ....... 17
Section 4 Corporate Governance Environment and Soc.. 51
Section 5 Important Matters ........................ 89
Section 6 Changes in Shares and Shareholders ...... 119
Section 7 Bond Related Information ................ 128
Section 8 Financial Report ........................ 129
9Reference file directory
(1) Financial statements with the signatures and seals of the person in charge of
the company the person in charge of accounting work and the person in charge of
the accounting organization (accounting officer).
(2) The original audit report with the seal of the accounting firm and the signature
and seal of the certified public accountant.
(3) The originals of all company documents and announcements that have been
publicly disclosed during the reporting period.
(4) Annual reports published in other securities markets.
10Paraphrase
Paraphrase Depend on Paraphrase content
The company the company the group
the Haid Group Depend on Guangdong Haid Group Co. Ltd.Haid Holdings Depend on Haid International Holdings Limited
Board of directors Depend on Guangdong Haid Group Co. Ltd. Board of Directors
Shareholders' meeting Depend on Guangdong Haid Group Co. Ltd. Shareholders' Meeting
The Companies Act Depend on "Company Law of the People's Republic of China"
Securities Act Depend on "Securities Law of the People's Republic of China"
Articles of Association Depend on "Articles of Association of Guangdong Haid Group Co. Ltd."
Yuan Depend on RMB Yuan
Reporting period current period current
year Depend on January 1 2025 to December 31 2025
Last year same period last year Depend on January 1 2024 to December 31 2024
End of period Depend on December 31 2025
Beginning beginning of the year Depend on January 1 2025
China Securities Regulatory Commission Depend on China Securities Regulatory Commission
11Section 2 Company Profile and Main Financial Indicators
I. Company information
Stock abbreviation Haid Group Stock code 002311
Stock abbreviation before the change
(if any) No
Stock exchange Shenzhen Stock Exchange
Chinese name of the company Guangdong Haid Group Co. Ltd.Chinese abbreviation of the company Haid Group
Foreign name of the company (if any) Guangdong Haid Group Co. Limited
Abbreviation of the company's foreign
name (if any) HAID GROUP
Legal representative of the company Xue Hua
Registered address 701 Block 2 No. 42 Wanbo Fourth Road Nancun Town Panyu District Guangzhou City Guangdong Province
Postal code of registered address 511445
Historical changes of the company's
registered address There was no change of registered address during the reporting period
Office address Building 1 Haida Science Park No. 8 Longtai Street Hualong Town Panyu District Guangzhou City Guangdong Province
Postal code of office address 511434
Company URL www.haid.com.cn
E-mail zqbgs@haid.com.cn
II. Contact person and contact information
Board secretary Securities Affairs Representative
Name Huang Zhijian Yang Huafang Li Tanhang
Building 1 Haida Science Park No. 8 Building 1 Haida Science Park No. 8
Contact address Longtai Street Hualong Town Panyu Longtai Street Hualong Town Panyu District Guangzhou City Guangdong District Guangzhou City Guangdong
Province Province
Telephone 8620-39388960 8620-39388960
Fax 8620-39388958 8620-39388958
E-mail zqbgs@haid.com.cn zqbgs@haid.com.cn
III. Information Disclosure and Preparation Location
The stock exchange website where the company discloses its
annual report Shenzhen Stock Exchange http://www.szse.cn
The name and website of the media where the company "Securities Times" "China Securities Journal" "Securities
discloses its annual report Daily" "Shanghai Securities News" and www.cninfo.com.cn
Where the company's annual report is prepared Corporate Securities and Investment Center
12IV. Registration Changes
Unified Social Credit Code No change
Changes in the company's main business since its listing (if
any) No change
Changes in previous controlling shareholders (if any) No change
V. Other relevant information
Accounting firm hired by the company
Accounting firm name Grant Thornton Zhitong Certified Public Accountants LLP
Office address of accounting firm Floor 5 Scitech Plaza No. 22 Jianguomenwai Street Chaoyang District Beijing
Name of Signing Accountant Li Xujia Qiu Shuntong
Sponsor institutions engaged by the company to perform continuous supervision duties during the
reporting period
□Applicable □Not Applicable
Financial consultants hired by the company to perform continuous supervision duties during the
reporting period
□ Applicable □Not Applicable
VI. Key Accounting Data and Financial Indicators
Whether the company needs to retrospectively adjust or restate the accounting data of previous
years
□ Yes □No
Increase or decrease
2025 2024 this year over the 2023
previous year
Operating income (yuan) 128468230914.96 114601056662.29 12.10% 116117168742.97
Net profit attributable to
shareholders of listed 4280330734.08 4503995518.39 -4.97% 2741256374.98
companies (yuan)
Net profit attributable to
shareholders of the listed
company after deducting 4279400457.60 4539064747.56 -5.72% 2541491959.42
non-recurring gains and
losses (yuan)
Net cash flow from
operating activities (yuan) 6260377323.22 7996255375.05 -21.71% 12698374699.54
13Basic earnings per share
(yuan/share) 2.58 2.71 -4.80% 1.66
Diluted earnings per share
(yuan/share) 2.57 2.70 -4.81% 1.66
Weighted average return
on equity 17.42% 20.88% -3.46% 14.53%
Increase or decrease
End of 2025 End of 2024 at the end of this year compared to the end End of 2023
of the previous year
Total assets (yuan) 47590711885.11 48140586659.70 -1.14% 44746735775.61
Net assets attributable to
shareholders of listed 24248840877.02 23905302719.55 1.44% 19647107064.19
companies (yuan)
The lower of the company's net profit before and after deducting non-recurring gains and losses in
the last three fiscal years is negative and the audit report of the most recent year shows that the
company's ability to continue operations is uncertain
□ Yes □No
During the reporting period the company's total audited profit net profit and net profit after
deducting non-recurring gains and losses whichever is lower is negative
□ Yes □No
VII. Differences in accounting data under domestic and foreign accounting standards
1. Differences in net profit and net assets in financial reports disclosed in accordance with
international accounting standards and Chinese accounting standards at the same time
□ Applicable □Not Applicable
During the reporting period there was no difference in net profit and net assets in the financial
reports disclosed in accordance with international accounting standards and in accordance with
Chinese accounting standards.
2. Differences in net profit and net assets in financial reports disclosed in accordance with
overseas accounting standards and Chinese accounting standards at the same time
□ Applicable □Not Applicable
During the reporting period there was no difference in net profit and net assets in the financial
14reports disclosed in accordance with overseas accounting standards and in accordance with Chinese
accounting standards.VIII. Main financial indicators by quarter
Unit: Yuan
First quarter Second quarter Third quarter Fourth quarter
Operating income 25628943274.11 33201951864.77 37263255284.21 32374080491.87
Net profit attributable
to shareholders of 1282349455.39 1356191468.82 1503886685.05 137903124.82
listed companies
Net profit attributable
to shareholders of the
listed company after
deducting non- 1280674503.11 1373567608.71 1522907946.68 102250399.10
recurring gains and
losses
Net cash flow from
operating activities -2249832645.97 5297922728.51 1969342736.63 1242944504.05
Whether the above financial indicators or their total numbers are materially different from the
relevant financial indicators of the company's disclosed quarterly reports and semi-annual reports
□ Yes □No
IX. Items and amounts of non-recurring gains and losses
□Applicable □ Not applicable
Unit: Yuan
Projects 2025 Amount 2024 Amount 2023 Amount Description
Gains and losses on disposal of illiquid assets
(including the write-off portion of the -36158599.44 -59464676.78 9004677.06
provision for asset impairment)
Government subsidies included in the current
profit and loss (except for government
subsidies that are closely related to the
company's normal business operations
comply with national policies and regulations 70422837.99 88405109.35 59119428.77
are enjoyed according to determined
standards and have a continuous impact on
the company's profit and loss)
In addition to the effective hedging business
related to the company's normal business
operations the gains and losses from changes
in fair value arising from the holding of
financial assets and financial liabilities by -126235785.00 -58602433.58 147165591.84
non-financial enterprises and the gains and
losses arising from the disposal of financial
assets and financial liabilities
Gains and losses from external entrusted loans 326833.38
Reversal of provision for impairment of 49219466.84 34087704.91 14802077.94
15receivables that have been separately tested
for impairment
Other non-operating revenue and expenditure
other than the above-mentioned items 2661719.15 -3065353.75 -8642137.95
Less: Income tax impact amount -43336092.77 19665499.65 9966547.74
Amount of impact on minority
shareholders’ equity (after tax) 2315455.83 16764079.67 12045507.74
Total 930276.48 -35069229.17 199764415.56 --
Details of other profit and loss items that meet the definition of non-recurring profit and loss:
□ Applicable □Not Applicable
The company does not have other specific circumstances of profit and loss items that meet the
definition of non-recurring profit and loss.Explanation of the situation of defining the non-recurring profit and loss items listed in the
"Explanatory Announcement No. 1 on Information Disclosure of Companies Offering Securities to
the Public — Non-recurring Profit and Loss" as recurring profit and loss items
□ Applicable □Not Applicable
The company does not define the non-recurring gains and losses listed in the "Explanatory
Announcement No. 1 on Information Disclosure of Companies Offering Securities to the Public —
Non-recurring Gains and Losses" as recurring gains and losses.
16Section 3 Management Discussion and Analysis
I. The main business of the company during the reporting period
The company's industrial chain business layout is based on providing overall solutions for
animal breeding. The main products include feed high-quality animal seedlings animal protection
live pigs aquatic products etc. The business operation has covered all business links such as research
and development design production sales and service of various products. Specifically the
company's products include animal feed such as chickens ducks geese pigs fish shrimp and crabs
ruminants live pigs shrimp fish and other farmed species shrimp fry fish fry and other seedling
species livestock and poultry water-produced fresh products and prepared dishes as well as
biological products veterinary drugs vaccines and other animal protection products required in the
process of livestock and aquaculture.
(1) Synergized feed seedlings and animal health solutions create value for farmers
Feed seedlings and animal protection are the company's core business and its operating income
accounts for more than 80% of the company. After more than 20 years of development the feed
business has accumulated a wide range of customer resources. By providing customers with high-
quality animal seedlings cost-effective and strong feed products in the market and relying on the
breeding technology service system to drive the development of animal protection products such as
vaccines veterinary drugs and biological products the complete set of breeding solutions can help
customers succeed in breeding. While achieving healthy breeding customers can control breeding
costs and gain competitive advantages in terminal products.
(2) On the basis of specialization the breeding business realizes a light-asset low-risk breeding
model
On the basis of the high-quality development of feed seedlings and animal protection business
the company conducts model exploration in the breeding link. In terms of livestock and poultry
breeding the company is currently mainly engaged in pig breeding with continuous improvement in
breeding professional capabilities continuous optimization of breeding costs and controllable risks.In aquaculture the company uses its own high-quality seedlings feed and animal protection products
to focus on the factory farming of shrimp which the company has overall advantages. In the breeding
17business the company controls the scale of breeding builds teams reduces costs improves the
system and is building core competitiveness.
2. Main business model
(1) Business Models for Feed Breeding and Animal Health Segments
The company's feed business is the company's core business. The operation management mainly
adopts the business model of centralized procurement of raw materials distribution of production
sales of products and technical services. 1) For bulk raw materials such as agricultural products the
centralized procurement model of "group + regional center" combined with hedging can obtain better
procurement advantages and risk control; 2) The production link aims to be closest to the market
convenient in logistics and rich in resources and carry out multi-site production in the breeding area.At present the factories are mainly distributed in more than 200 cities in Asia Africa and Latin
America; 3) The company focuses on localized service marketing and fully establishes distribution
channels to efficiently solve the capital and transportation needs of farmers. At the same time the
company directly goes deep into farmers to provide breeding technical services by setting up technical
and service teams in breeding areas forming sales and services channels and functions of farmers.Complementary and synergistic; 4) High-quality animal seedlings biological products veterinary
drugs and vaccines have become indispensable products and tools in the process of providing
breeding technical services for the company and constitute a package of overall breeding solutions.
(2) Operating Model of the Farming Business
The company's pig breeding business basically adopts the "company + family farm" model.The "company + family farm" model means that the company provides family farmers with
seedlings feed vaccines and other necessary products for breeding. After the main technical
requirements of the breeding process are agreed the family farmers complete the breeding process
and the company recycles the finished products for external sales. The company's aquatic product
breeding and processing business is still in its infancy. The main species of aquatic product
breeding is prawns. With the company's high-quality seedlings feed animal protection and
technical advantages standardized and factory farming is carried out.
18II. Industry situation of the company during the reporting period
Based on the insight and layout of the global feed industry the company is driven by scientific
research and development and technical services operates efficiently focuses on customer needs
seizes opportunities at different stages of industrial development in various regions and transforms
R&D investment industrialization and scale advantages into high-quality growth momentum; the
company's total feed sales volume achieved a record-high in 2025.China as the largest region in the global feed industry is also the fastest growing region in the
world in the past three decades. In 2025 the total feed output has exceeded 340 million tons an
increase of 8.6% year-on-year and its scale ranks first in the world. The feed preparation technology
and the development of upstream and downstream industries are also world-leading. At present the
competition in China's feed industry has shifted from the single-dimensional competition of feed
products to the multi-dimensional comprehensive competition of seedlings animal protection feed
and breeding technical services and high-quality development has become the core main line of the
industry to break through. Industry integration continues to accelerate. Leading companies have
occupied a leading position in the market by virtue of their scale advantages procurement advantages
raw material substitution and formula innovation technologies. However small and medium-sized
enterprises lacking core competitiveness are affected by raw material price fluctuations and the
mismatch of downstream aquaculture product price cycles. The operating pressure continues to
increase and the living space is constantly being squeezed. The solidification of the downstream
aquaculture structure has further intensified the situation of stock competition. Free-range farmers
continue to withdraw from the market. Moderately large-scale family farms and breeding companies
have become the main force of breeding. Their requirements for the quality of feed products
customization level and supporting services have been significantly improved. The focus of
competition in the stock market has fully shifted to value enhancement and efficiency optimization.Asia (excluding East Asia) is the fastest growing sub-region. Feed production in 2025 is about
170 million tons and the compound growth rate from 2026 to 2030 is expected to be about 4.9%.
The region's population is growing rapidly the urbanization rate continues to increase and the per
capita disposable income is steadily increasing. According to the OECD-FAO Agricultural Outlook
2021-2030 from 2018 to 2020 animal protein will account for only 13% of the total protein supply
19in Southeast Asia which is far lower than the average level in China and the world. The supply of
animal protein in Southeast Asia will continue to grow thereby expanding the feed market capacity.Relying on the vast market space huge consumer population abundant breeding resources and
continuously improving economic development potential this area has become a key layout area for
global high-quality feed companies bringing together local multinational feed companies in
Southeast Asia and well-known European and American manufacturers. Due to the relatively low
overall economic strength and industrialization level of various countries the unstable supply of raw
materials the weak overall competitiveness of local small-scale feed manufacturers and the lack of
room for large-scale development the industry is currently mainly competition among multinational
companies still focusing on the product strength of feed products themselves and relying on product
quality to gain a competitive advantage.The African region also maintained a strong growth trend. The feed output in 2025 has exceeded
60 million tons and the compound annual growth rate from 2026 to 2030 is expected to be about
4.1%. As the region with the fastest population growth in the world Africa has an annual population
growth rate of over 2.5% but its per capita consumption of animal protein is less than one-third of
the global average. In some regions the per capita supply of animal protein has even declined slightly
due to rapid population growth. The contradiction between protein supply and demand is very
prominent. This imbalance between supply and demand urgently needs to improve breeding
efficiency and increase animal protein supply through the development of feed industry. In addition
Africa's vast arable land resources provide a large amount of feed raw materials and the feed industry
has broad development space in this region.The Latin American region also showed a solid growth trend. The total feed production in 2025
will reach 210 million tons and the compound annual growth rate from 2026 to 2030 is expected to
be about 3.9%. Latin America has unique natural advantages: abundant feed ingredients provide
sufficient raw material supply for feed enterprises; rich water resources rapid growth of aquaculture
industry; superior geographical location close to developed countries in Europe and America
convenient for meat protein export. There are many feed manufacturers in the region mainly
European and American feed companies and local companies. Sufficient and relatively cheap raw
materials ensure the cost advantage of animal breeding in the region. If feed upgrades and innovations
product supporting services and breeding model upgrades can be achieved the breeding efficiency
20and advantages will be greatly improved and the feed efficiency will have a large room for
improvement.The growth rate of other regions such as North America and Europe is relatively flat. It is
estimated that the compound annual growth rate from 2026 to 2030 will be less than 2%. The overall
development characteristics are optimized. The profitability of feed in these regions is relatively
stable but the technology and industry are relatively solidified and the innovation is insufficient.There is still a large room for improvement in technical services operational efficiency and cost
control. North America is the second largest feed production region in the world with a total feed
output of about 290 million tons in 2025. The United States accounts for most of the production in
this region. It is also the second largest feed producer in the world with a high degree of vertical
integration. The total feed output in Europe in 2025 is about 270 million tons showing a trend of
regional differentiation. Among them Russia and Spain are among the top ten feed producers in the
world with feed output exceeding 30 million tons.Company Operation Overview
2025 marks the beginning of the company's management structure reform with a focus on
specialisation and refined management. In the face of rapid changes in the industry mainly customers
the company starts from customer needs and builds specialized product divisions at the group level:
shrimp special general water pig industry and poultry industry divisions. From the original
independent operations between subsidiaries and the business links of seedling-material-medicine to
the coordinated operation of product lines and industrial chains within the group; from the original
extensive management (the group only vertically manages finance procurement and technology) to
refined management (including the technical service content breeding solutions precise product
positioning product development and operation cycle refined production process management team
assessment management etc.) of each product line managed by the group; The core capabilities that
were originally scattered in various regions centers subsidiaries and business links were moved to
the shared center at the group level and the process was solidified and promoted.The company has established the operation requirements of "standardization scale
intensification specialization and platformization". Among them standardization and
standardization of operation process and product quality large-scale amplification of resource
aggregation efficiency intensive reduction of operating costs specialization to strengthen technology
21R&D and service capabilities and platformization to achieve resource integration and business lines
are synergistically linked. After the initial adjustment and operation of the management structure in
2025 the company's various businesses have been implemented with high quality:
1. The feed business at home and abroad is growing rapidly and the globalization strategy
has entered a new stage
The company takes product leadership operational excellence and customer intimacy as the
core strategy to drive global development and drive the company's high-quality growth. It always
adheres to customer-centricity. Based on the professional ability of investing in R&D and excellent
products the company provides customers with a "seedling-material-medicine" overall technical
service plan through the establishment of a process-driven efficient organization and the formation
of leading product capabilities and service capabilities creating excess value and empowering
customers for long-term development.During the reporting period the company achieved a sales volume of 32.08 million tons of feed
(including approximately 2.22 million tons of internal aquaculture consumption) a year-on-year
increase of approximately 21%. Among them the external sales volume was 29.86 million tons and
the absolute value of the external sales volume greatly exceeded the full-year target for 2025. The
market share continued to increase and the global leading position was further consolidated. In terms
of varieties (including domestic and overseas markets): 14.7 million tons of poultry feed an increase
of about 16% year-on-year; 7.7 million tons of pig feed an increase of about 37% year-on-year; 6.96
million tons of aquatic feed an increase of about 19% year-on-year; and 500000 tons of ruminant
feed and other categories.Domestic feed business
In the face of the fierce industry competition environment brought about by the large production
capacity of the domestic breeding and feed industry and the changes in consumer demand the
company timely adjusted the group management structure improved team specialization product
standardization and process efficiency effectively drove the growth of feed sales enlarged the scale
advantage and continuously improved the internal operation efficiency and built the basic operation
advantage with higher capacity utilization rate and lower cost and further built the core competitive
advantage of product leadership and customer intimacy on this basis.
22In 2025 the domestic feed export sales volume was 26.4 million tons a year-on-year increase
of about 20% far exceeding the industry growth rate. It is one of the few leading enterprises that can
maintain stable growth. Poultry feed increased by 14% year-on-year. The company closely follows
the needs and pain points of breeding strengthens product competitiveness through unified standards
and synergy of resources; at the same time it builds core benchmark factories with high operating
efficiency and good cost control (such as laying hen feed and laying duck feed factories) and builds
differentiated competitive advantages in products operations and services so as to meet the
diversified product needs of food enterprises and market terminals enhance the overall value of
breeding varieties empower the development of the industry and steadily expand market share. Pig
feed increased by 37% year-on-year and the company actively followed the trend of the breeding
industry: First optimize the customer structure focus on high-quality products team transformation
and professional service system and focus on developing pig family farms and large-scale farms with
breeding advantages and strong vitality and consolidate the development foundation in the next few
years; The second is to actively develop professional pig breeding group customers and provide them
with various services from raw material procurement formulation technology feed production
quality monitoring to disease prevention and treatment. The overall output is the comprehensive
service system of its managed feed factory. During the reporting period the feed sales of such
customers increased significantly; aquatic feed increased by 12% year-on-year. General water feed
special water fish feed shrimp and crab feed all achieved good year-on-year growth. According to
the breeding trends breeding models and changes in customer needs of different species the company
accurately matched products and invested resources. The sales of tilapia feed carp feed California
perch feed and prawn feed increased year-on-year. The company builds an overall solution for
seedlings materials medicines and breeding management guidance around the needs of farmers
creates value for farmers and forms multiple core competitiveness in its own industrial chain. At
present this model has achieved initial results in vannamei white shrimp and has gradually appeared
in tilapia and carp and will gradually be extended to other aquatic products.Overseas feed business
Relying on the foundation of competitive advantages in technology service and procurement
the company continued to increase its overseas layout accelerated the construction and expansion of
feed production capacity in Southeast Asia Africa and Latin America and strengthened the
23supporting layout of seedlings and animal protection to match the future competition needs of
customers and the market in advance. The company's overseas feed sales volume and profitability
have grown rapidly.In 2025 the sales volume of feed in overseas regions was 3.46 million tons a year-on-year
increase of about 47% and the sales volume of aquatic products poultry pig feed and other feeds all
increased by more than 40%. Among them aquatic feed helps farmers achieve higher survival rates
and improve production efficiency by virtue of its excellent product strength and strong breeding
technology service system. At the same time it develops seed matching layout around the two major
varieties of global circulation and consumption-vannamei prawn and tilapia and continues to build
core competition barriers to promote the accelerated growth of aquatic feed sales; the advantages of
poultry feed products are also obvious and it is also forming a significant competitive advantage in
combination with seedlings which drives a rapid increase in sales; Sales of pig feed and other feeds
also increased steadily.The company's overseas feed business has developed at a high growth rate and its global layout
has achieved remarkable results. The company will continue to promote overseas market expansion
and production capacity construction and build global competition barriers and provide a solid
foundation for the long-term development of overseas business by building innovation-led
technology research and development capabilities industry-leading technical service capabilities
cost-leading global procurement capabilities and providing integrated seedling-material-
pharmaceutical solutions and replicable transnational localized operating systems.
2. Continuous research and development of seedlings and animal protection business and
actively develop new categories
During the reporting period the company's seedling business achieved operating income of 1.44
billion yuan. In terms of shrimp breeding it constitutes a germplasm resource bank with high genetic
diversity and has a number of specialized shrimp breeding centers expansion and testing bases to
ensure the strong competitiveness of the company's shrimp seedling products. The company
continued to adhere to and invest in the fish fry industry broke through the traditional breeding model
and introduced indoor factory breeding; the company has achieved important phased results in the
field of spineless fish and through the deep integration of production education and research it has
promoted the transformation of the achievements of the spineless Wuchang fish and grass carp
24varieties and promoted the industrial upgrading and promotion; the company has made great
breakthroughs in the breeding breeding and breeding of tilapia varieties and it is expected to rapidly
form industrial advantages in the next few years; It is the first to realize the large-scale development
of unisexual seedlings in raw fish yellow catfish and other varieties. From a geographical point of
view the company has invested in the construction of aquatic and poultry seedling farms in Vietnam
Indonesia Ecuador and other countries starting an international strategic layout.The overall operating income of the animal insurance business was 890 million yuan. Relying
on a strong independent research and development system and continuous innovation capabilities
the company intensively cultivates in the field of animal protection closely meets market demand
promotes iterative product upgrades and focuses on creating various high value-added animal
protection products. At the same time the company has deeply integrated the core technologies
related to functional materials and health materials into the feed business system realized the
synergistic empowerment of animal protection technology and feed business and continued to
improve the ability to escort farmers.
3. The professional ability is improved and the downstream aquaculture develops steadily
In 2025 the profit of the company's pig breeding business decreased by more than 900 million
yuan year-on-year mainly due to the following factors: * The pig market situation was complicated
throughout the year and the price of pigs continued to decline and it has been lower than the breeding
cost since September; * More than 40% of the piglets in the company's pig breeding were purchased
from outside and the high piglet price in 2025 further squeezed the company's pig breeding profit. In
the future the company will continue to focus on the capacity building of the pig breeding team and
the innovation of the asset-light model and focus on exploring and implementing the operation model
of "company + family farm locking profits and hedging risks" creating a light-asset low-risk and
stable pig breeding model reasonably controlling the pace of production and operation and
controlling the overall breeding risk.In terms of aquaculture the company's current main breeding species are special aquatic
products such as prawns. Factory shrimp farming has the advantages of safety controllability and
stable quality compared with traditional farming mode through factory scientific design circulating
water system biological feed technology and strict biological prevention and control and can form a
dislocation competition with traditional products in terms of time to market and product specifications.
25The company appropriately controls the scale of raw fish farming and continuously improves the
professional level of farming.
4. Future Outlook
Looking forward to the future the company has a clear strategy and clear goals: as the first core
business the feed business will continue to focus on core capacity building and large-scale expansion.The medium-term goal is to reach 51.5 million tons of sales in 2030; steadily increase domestic
capacity utilization and market share and accelerate the deployment of overseas feed business.Seedlings and animal protection businesses are both the company's core businesses and are an
important foundation for intensive animal farming with significant technical barriers and industrial
value. The company will continue to increase resource investment and research and development
efforts to seize the technological heights and industrial commanding heights and build core
competitive advantages. At the same time the company actively explores the asset-light pig raising
model and factory-based shrimp farming business insisting on forming unique competitiveness and
core advantages and becoming one of the company's main businesses in the future.The company will closely focus on its strategic goals unswervingly practice the core path of
operational excellence product leadership customer intimacy and global development gradually
and steadily promote the adjustment of management structure achieve its own high-quality growth
empower industry upgrades and continue to create value for society.III. Analysis of core competitiveness
The company's products and services are laid out around the needs of breeding. The core
competitiveness is reflected in the ability to create value for customers. The comprehensive
performance is the outstanding single product strength driven by research and development the
matching ability of high-quality seedlings and animal protection and the breeding technical service
ability directly to the terminal to build the output capacity of the overall breeding solution.
1. R&D-driven feed product strength is the company's most important competitive advantage
The company conducts research on basic forward-looking and key common issues in the seven
R&D directions of "animal genetics and breeding animal nutrition and feed veterinary medicine and
biopharmaceuticals microbial engineering biochemical engineering protein engineering and
26healthy breeding" and continuously improves the three-level R&D system to comprehensively and
effectively support drive and serve the needs of the rapid development of the group. The company
has a relatively rich technical research reserve and a huge R&D team. It invests a lot of money in
R&D every year. R&D personnel include animal nutrition veterinary breeding breeding mode
bioengineering biochemistry machinery and other multi-disciplinary talents. The transformation of
R&D results is fast and the investment supporting strategy can be clear and fast. Landed. For example
for feed formula technology through more than 20 years of continuous research and development
the company has established a huge animal nutrition demand database and reserves a variety of raw
material formula technologies. Every year thousands of sets of comparative experimental results are
added to the animal core nutrition demand and raw material utilization database to transform the
technology into productivity. Therefore the company has a strong ability to continuously optimize
product formulations and can quickly adjust formulations when raw material prices fluctuate to gain
a cost competitive advantage. At the same time the optimization and upgrading of products driven
by scientific and technological research and development can not only adapt to changes in the
breeding environment and changes in breeding models but also lead the progress of breeding
technology and the upgrading of breeding models.On the basis of a strong R&D system and continuous technological innovation the company's
various series of products are committed to creating product capabilities that are significantly ahead
of competitors. While high-end products are priced at high prices they all have obvious advantages
in the ultimate pursuit of animal survival rate growth effect and growth efficiency and their brand
effect is outstanding. On the basis of ensuring leading production efficiency mid-end products are
priced close to competitors' products and pursue outstanding product cost-effectiveness. Therefore
when the overall breeding efficiency of the industry is good the company's customers can obtain
significantly higher income than similar farmers; and when the industry's breeding efficiency declines
or even the whole industry loses money the company's customers can lose less or even no loss.
2. High-quality seedling animal protection solves the pain points of farmers
In the breeding industry chain seedlings are the "core chips" the link with the highest technical
threshold and the greatest potential for value mining. The company has the world's leading
technological advantages resource reserves and industrialization scale in the field of aquatic breeding.It is the first to build an integrated commercial breeding system for breeding reproduction and
27promotion in the industry. It is among the first batch of 20 "China Aquatic Seed Industry Integrated
Advantage Enterprises" and has been selected as a national seed industry formation enterprise. The
company has technologically advanced shrimp fry and freshwater fish fry breeding technology and
has cultivated a number of new varieties with fast production speed and strong disease resistance and
stress resistance. There are 9 new national aquatic species: Litopenaeus vannamei "Haixingnong No.
2" Litopenaeus vannamei "Haixingnong No. 3" Litopenaeus vannamei "Haijingzhou No. 1" Tilapia
"Bairong No. 1" Hybrid Channa "Xiongbi No. 1" Tuantou "Huahai No. 1" Changzhu hybrid
mandarin catfish hybrid yellow croaker "Baixiong No. 1" grass carp "Husu No. 1".The company's animal protection vaccine is guided by distinctive technology and research and
development and is empowered by a complete service system and mature breeding plan. It has strong
market competitiveness and excellent market reputation and solves the pain points of breeding for
farmers all over the country. High-quality aquatic animal protection and livestock and poultry animal
protection products can help farmers improve the breeding environment prevent and control diseases
of farmed animals reduce disease losses realize healthy safe and controllable breeding process
reduce breeding costs and improve breeding efficiency.
3. The breeding technology service system is an important starting point for the company to
create value for customers continuously acquire new customers and improve customer viscosity
In 2006 the company took the lead in the industry to provide comprehensive technical services
to farmers and positioned the company as a service-oriented enterprise that provides farmers with
overall breeding solutions. The company provides farmers with product and technical service support
for the whole breeding process such as "seedling-stocking mode-environmental control-disease
control-feed-market information" to ensure that farmers can use the most advanced breeding
technology so as to ensure the success and profitability of farmers. The company has the most
experienced and passionate technical service team in the industry; and has accumulated a variety of
advanced breeding models based on local characteristics; it has hundreds of efficient service stations
in the national breeding intensive areas which can provide technical services for tens of thousands
of farmers at the same time. The company's relatively complete service system in the industry can
give full play to the advantages of product strength and provide technical services throughout the
breeding process which can effectively amplify customer benefits and increase customer stickiness.
28The company's breeding technical services started from aquaculture services. After more than
ten years of talent team building and platform building the process and concept of the breeding
technical service system have penetrated into all aspects of product technology research and
development market and operation driving the company's aquatic feed and animal protection
business development to highlight the effect and the process and ideas have been gradually promoted
to pig breeding and have achieved obvious results. Comprehensive breeding technical services have
become an important brand label of the company and it is an important starting point for the company
to create value for customers acquire customers and improve customer stickiness.IV. Main business analysis
1. Overview
Please refer to the relevant content of "II. The industry in which the company operates during the
reporting period".
2. Revenue and Cost
(1) Composition of operating income
Unit: Yuan
2025 2024 Year-on-year
Amount Proportion of Proportion of
increase or
operating income Amount operating income decrease
Total operating
income 128468230914.96 100% 114601056662.29 100% 12.10%
By industry
Feed industry 110509308067.35 86.02% 95774577643.37 83.57% 15.38%
Breeding industry 17958922847.61 13.98% 18826479018.92 16.43% -4.61%
Sub-product
Feed 105257615986.92 81.93% 91202471546.02 79.58% 15.41%
Animal health
products 891050510.76 0.69% 845785008.00 0.74% 5.35%
Agricultural
products 17958922847.61 13.98% 18826479018.92 16.43% -4.61%
Trading business 4124515406.60 3.21% 3435411501.16 3.00% 20.06%
Other business 236126163.07 0.19% 290909588.19 0.25% -18.83%
By regions
South China 68610857366.39 53.41% 67393687661.28 58.81% 1.81%
29East China 18139504851.76 14.12% 16343599813.21 14.26% 10.99%
North China 29197174546.67 22.73% 27435014704.38 23.94% 6.42%
Central China 34662098357.55 26.98% 30865136138.53 26.93% 12.30%
Overseas area 16636118527.14 12.95% 14339378668.54 12.51% 16.02%
Combined offset -38777522734.55 -30.19% -41775760323.65 -36.45% -7.18%
(2) The situation of industries products regions and sales models that account for more than
10% of the company's operating income or operating profit
□Applicable □ Not applicable
Unit: Yuan
Increase or Operating Gross profit
decrease in costs margin
operating increased or increased or
Operating income Operating cost Gross margin income over decreased decreased
the same compared to compared
period of the the same with the same
previous year period last period last year year
By industry
Feed industry 110509308067.35 99686866392.64 9.79% 15.38% 15.57% -0.15%
Breeding
industry 17958922847.61 15506477221.90 13.66% -4.61% 0.79% -4.62%
Sub-product
Feed 105257615986.92 95075398107.81 9.67% 15.41% 15.50% -0.07%
Animal
protection 891050510.76 485883904.63 45.47% 5.35% 32.02% -11.01%
products
Agricultural
products 17958922847.61 15506477221.90 13.66% -4.61% 0.79% -4.62%
Trading
business 4124515406.60 4016901743.07 2.61% 20.06% 17.69% 1.96%
By regions
South China 68610857366.39 62411244649.22 9.04% 1.81% 3.22% -1.24%
East China 18139504851.76 17030498113.15 6.11% 10.99% 10.99% -0.01%
North China 29197174546.67 27759517038.81 4.92% 6.42% 6.41% 0.01%
Central China 34662098357.55 33106730999.13 4.49% 12.30% 14.75% -2.03%
Overseas area 16636118527.14 14051934824.02 15.53% 16.02% 13.13% 2.15%
If the statistical caliber of the company's main business data is adjusted during the reporting period
the company's main business data adjusted according to the caliber at the end of the reporting
period in the most recent year
□ Applicable □Not Applicable
30(3) Whether the company's physical sales income is greater than the labor income
□Yes □ No
Industry Year-on-year
classification Projects Unit 2025 2024 increase or decrease
Sales volume 10000 tons 3208.70 2652.42 20.97%
Feed industry Production volume 10000 tons 3209.38 2656.50 20.81%
Inventory 10000 tons 30.88 30.20 2.25%
Explanation of the reasons why the relevant data has changed by more than 30% year-on-year
□ Applicable □Not Applicable
(4) The performance of major sales contracts and major procurement contracts signed by the
company as of the reporting period
□ Applicable □Not Applicable
(5) Composition of operating costs
Industry and Product Classification
Unit: Yuan
20252024
Industry Year-on-year
classification Projects increase or Amount Proportion of Amount Proportion of operating cost operating cost decrease
Feed industry Material cost 95309297182.93 95.61% 82300277709.15 95.42% 15.81%
Feed industry Labor cost 1178085174.41 1.18% 1059264120.40 1.23% 11.22%
Feed industry Manufacturing expenses 2834764084.00 2.84% 2532650682.13 2.94% 11.93%
Contract
Feed industry performance 256037314.17 0.26% 204940960.99 0.24% 24.93%
cost
Feed industry other 108682637.13 0.11% 157822034.39 0.18% -31.14%
Total feed
industry 99686866392.64 100.00% 86254955507.06 100.00% 15.57%
Breeding
industry Material cost 12447511886.17 80.27% 12710121419.04 82.62% -2.07%
Breeding
industry Labor cost 2050256772.73 13.22% 1781888643.36 11.58% 15.06%
Breeding Manufacturing
industry expenses 966246302.52 6.23% 856521390.67 5.57% 12.81%
Breeding Contract
industry performance 42462260.48 0.27% 36090528.04 0.23% 17.65% cost
Total breeding
industry 15506477221.90 100.00% 15384621981.11 100.00% 0.79%
Unit: Yuan
3120252024
Product Year-on-year
categories Projects Amount Proportion of Amount Proportion of
increase or
operating cost operating cost decrease
Feed Material cost 90886399632.48 95.59% 78583692155.91 95.47% 15.66%
Feed Labor cost 1153007050.12 1.21% 1040158185.91 1.26% 10.85%
Feed Manufacturing expenses 2797772533.08 2.94% 2502195525.44 3.04% 11.81%
Contract
Feed performance 238218892.13 0.25% 189937237.48 0.23% 25.42%
cost
Total feed 95075398107.81 100.00% 82315983104.74 100.00% 15.50%
Animal
protection Material cost 405995807.38 83.56% 303482482.82 82.46% 33.78%
products
Animal
protection Labor cost 25078124.29 5.16% 19105934.49 5.19% 31.26%
products
Animal
protection Manufacturing 36991550.92 7.61% 30455156.69 8.27% 21.46%
products expenses
Animal Contract
protection performance 17818422.04 3.67% 15003723.51 4.08% 18.76%
products cost
Total animal
insurance 485883904.63 100.00% 368047297.51 100.00% 32.02%
products
Agricultural
products Material cost 12447511886.17 80.27% 12710121419.04 82.62% -2.07%
Agricultural
products Labor cost 2050256772.73 13.22% 1781888643.36 11.58% 15.06%
Agricultural Manufacturing
products expenses 966246302.52 6.23% 856521390.67 5.57% 12.81%
Agricultural Contract
products performance 42462260.48 0.27% 36090528.04 0.23% 17.65% cost
Total
agricultural 15506477221.90 100.00% 15384621981.11 100.00% 0.79%
products
Trade industry Cost of sales 4016901743.07 100.00% 3413103070.42 100.00% 17.69%
other Cost of sales 108682637.13 100.00% 157822034.39 100.00% -31.14%
Description
No.
(6) Whether the scope of consolidation has changed during the reporting period
□Yes □ No
The company included 611 subsidiaries in the consolidated financial statements this year an
increase of 64 and a decrease of 27 over the previous year. For details please refer to Note VII in
Section VIII "Financial Reports". Interests in other entities.
32(7) Significant changes or adjustments in the company's business products or services during
the reporting period
□ Applicable □Not Applicable
(8) Major sales customers and major suppliers
The company's main sales customers
The total sales amount of the top five customers (yuan) 3143410697.38
The proportion of the total sales amount of the top five
customers to the total annual sales 2.45%
The proportion of related party sales in the top five customer
sales to the total annual sales 0.00%
The company's top 5 customer profiles
Serial number Customer name Sales (yuan) % of total annual sales
1 First place 699546515.58 0.54%
2 Second place 628927408.60 0.49%
3 Third place 618579129.10 0.48%
4 Fourth place 603361556.29 0.47%
5 Fifth place 592996087.81 0.46%
Total -- 3143410697.38 2.45%
Other descriptions of major customers
□ Applicable □Not Applicable
The company's main suppliers
The total purchase amount of the top five suppliers (yuan) 17797622925.28
The proportion of the total purchase amount of the top five
suppliers to the total annual purchase amount 15.75%
The proportion of related party purchases in the total annual
purchases of the top five suppliers 0.00%
The company's top 5 suppliers
Serial number Supplier name Purchase amount (yuan) Percentage of total annual purchases
1 First place 7309992105.26 6.51%
2 Second place 3084798177.87 2.70%
3 Third place 2848434791.51 2.53%
4 Fourth place 2586784391.89 2.27%
5 Fifth place 1967613458.75 1.74%
Total -- 17797622925.28 15.75%
Other descriptions of major suppliers
33□ Applicable □Not Applicable
During the reporting period the company's trading business income accounted for more than 10%
of its operating income
□ Applicable □Not Applicable
3. Fees
Unit: Yuan
Year-on-year
2025 2024 increase or Description of major changes
decrease
A year-on-year increase of 8.84% was mainly
Selling 2838918272.58 2608350800.44 8.84% due to the expansion of the company's sales expense volume the increase in sales and service
personnel and the increase in salary levels.Administration A year-on-year increase of 16.07% was mainly
expense 3699769055.55 3187514888.49 16.07% due to the increase in salary levels and the increase in office-related expenses.Finance A year-on-year decrease of 31.03% was
expense 254979226.98 369711343.72 -31.03% mainly due to the decrease in financing scale and the decrease in financing costs.A year-on-year increase of 8.53% was mainly
R&D expenses 933395251.56 860035315.34 8.53% due to the increase in the company's R&D personnel the increase in salary levels and the
increase in related consulting services.
4. R&D investment
□Applicable □ Not applicable
Main R&D Expected impact on the
project name Project purpose Project progress Goals to be achieved company's future development
The cost of feed has been
Determine the precise significantly reduced
Construction and nutritional requirements Nutrition is more precise feed cost the cost of breeding by
maintenance of of multiple aquatic farmers has been
precision Precision products in various
is saved feed waste is avoided the
breeding modes environment is protected feed
significantly reduced
nutrition database Nutrition different growth stages digestion and absorption are more
and the growth
for various complete and growth performance performance of aquatic
aquatic products different breeding stages and different breeding is greatly improved.products has been
higher which promotes
environments. the green development
of the breeding industry.Immune enhancers have In view of common diseases of Establishment of Development Focusing on the core
disease-resistant of functional been developed to
livestock and poultry immune
enhancers can significantly concept of creating value
nutrition system feed and improve the resistance of for customers we will
for livestock and functional pigs and poultry to
improve disease resistance and improve the efficiency of
poultry additives bacterial and viral
provide a strong guarantee for the
healthy and efficient production of breeding and enhance diseases. livestock and poultry breeding. the product strength.Constructing an Provide high- It has been awarded a Complete the systematic work of Relying on the whole
integrated shrimp quality stable number of national seed industry selection and industry chain of
and fish fry shrimp and fish aquatic new varieties breeding germplasm resource aquaculture we will give
34breeding system fry and continues to promote protection and germplasm family full play to the
the genetic breeding establishment. advantages of the three-
research of other body linkage of "feed +
varieties. seedlings + animal
protection" to promote
the green and high-
quality development of
aquaculture.The research on the Choose raw materials that are easy
nutritional value to digest and absorb nutrients which are more in line with the
Establishment of evaluation nutritional pulverization and relaxation of the
nutritional system requirements feeding mode feed processing gastrointestinal tract of piglets and Create the quality of for teaching Precision and other aspects of all-round balanced nutrition so teaching materials and trough material Nutrition different raw materials that piglets are healthier and have create industry and nursery has been completed and a higher survival rate; better benchmarks. material the effect has been intestinal development less
verified in the breeding diarrhea; better feed palatability
terminal. better nutrient absorption better balance and faster growth.Company R&D personnel
2025 2024 Change ratio
Number of R&D personnel
(person) 4208 3860 9.02%
The proportion of R&D
personnel 9.53% 9.23% 0.30%
Educational structure of R&D personnel
Undergraduate 1139 1012 12.55%
Master 1012 922 9.76%
PhD 135 137 -1.46%
Age composition of R&D personnel
Under 30 2235 2057 8.65%
30 ~ 40 years old 1290 1206 6.97%
40 ~ 50 years old 449 391 14.83%
Over 50 years old 234 206 13.59%
The company's R&D investment
2025 2024 Change ratio
R & D investment amount (yuan) 971317029.77 911811476.92 6.53%
R & D investment as a percentage of operating income 0.76% 0.80% -0.04%
Amount of capitalized R&D investment (yuan) 37921778.21 51776161.58 -26.76%
Capitalized R&D investment as a percentage of R&D
investment 3.90% 5.68% -1.78%
The reasons and impacts of major changes in the composition of the company's R&D personnel
□ Applicable □Not Applicable
Reasons for the significant change in the proportion of total R&D investment in operating income
compared with the previous year
35□ Applicable □Not Applicable
Reasons for the substantial change in the capitalization rate of R&D investment and its rationality
□ Applicable □Not Applicable
5. Cash flow
Unit: Yuan
Year-on-year
Projects 2025 2024 increase or
decrease
Subtotal of cash inflow from operating
activities 130437396701.31 117807433617.72 10.72%
Subtotal of cash outflows from operating
activities 124177019378.09 109811178242.67 13.08%
Net cash flow from operating activities 6260377323.22 7996255375.05 -21.71%
Subtotal of cash inflows from investing
activities 19112912102.13 17400060753.23 9.84%
Subtotal of cash outflows from investing
activities 20454523514.82 23805566731.01 -14.08%
Net cash flows from investing activities -1341611412.69 -6405505977.78 79.06%
Subtotal of cash inflows from financing
activities 5273318177.53 7750505656.53 -31.96%
Subtotal of cash outflows from financing
activities 10449217959.41 11360973044.88 -8.03%
Net cash flows from financing activities -5175899781.88 -3610467388.35 -43.36%
Cash and cash equivalents -328369011.91 -2040303927.96 83.91%
Description of the main influencing factors for the significant year-on-year changes in relevant data
□Applicable □ Not applicable
1. The net cash flow from operating activities decreased by 21.71% compared with the same period
of the previous year mainly due to the increase in cash paid by the company for purchasing goods
and accepting labor services as well as the expansion of the company's sales volume and the
increase in the level of compensation and benefits for employees that is the increase in cash paid to
and for employees.
2. The net cash flow from investing activities increased by 79.06% compared with the same period
of the previous year mainly due to the increase in cash received by the company to recover
investment in the current period and the decrease in the scale of wealth management.
3. The net cash flow from financing activities decreased by 43.36% compared with the same period
of the previous year which was mainly due to the increase in the cash paid by the company for the
36distribution of dividends in the current period.
Explanation of the reasons for the significant difference between the net cash flow generated by the
company's operating activities during the reporting period and the net profit for the year
□ Applicable □Not Applicable
V. Analysis of non-main business
□ Applicable □Not Applicable
VI. Analysis of Assets and Liabilities
1. Major changes in asset composition
Unit: Yuan
End of 2025 Early 2025 Proportion
% of % of increase Description of major changes
Amount total Amount total or
assets assets decrease
The proportion of total assets at
the end of the period decreased
by 0.5% compared with the
beginning of the period and the
Monetary fund 3202836313.58 6.73% 3478256875.63 7.23% -0.50% amount at the end of the period
decreased by 7.92% compared
with the beginning of the period
mainly due to cash dividends and
share repurchase.The proportion of total assets at
the end of the period increased by
1.84 percentage points compared
with the beginning of the period
and the amount at the end of the
Accounts period increased by 40.12%
Receivable 2978763231.09 6.26% 2125872345.43 4.42% 1.84% compared with the beginning of the period mainly due to the
expansion of the company's
business scale and the
corresponding increase in
accounts receivable from
customers.Contract assets 0.00 0.00% 0.00 0.00% 0.00% Not applicable
The proportion of total assets at
the end of the period increased by
0.44 percentage points from the
Inventory 11371777008.15 23.89% 11290384103.30 23.45% 0.44% beginning of the period and the
amount at the end of the period
was basically the same as that at
the beginning of the period.Investment 47197067.54 0.10% 92624790.99 0.19% -0.09% The proportion of total assets at the end of the period decreased
37End of 2025 Early 2025 Proportion
% of % of increase Description of major changes
Amount total Amount total or
assets assets decrease
real estate by 0.09 percentage points from
the beginning of the period and
the amount at the end of the
period decreased by 49.04% from
the beginning of the period
mainly due to the completion of
the sale of the land held by the
company to be sold during the
period.The proportion of total assets at
the end of the period increased
slightly by 0.06 percentage points
from the beginning of the period
Long‐term and the amount at the end of the
equity 305960124.82 0.64% 280217892.86 0.58% 0.06% period increased by 9.19% from
investment the beginning of the period
mainly due to the increase in
investment income recognized by
associates under the equity
method.The proportion of total assets at
the end of the period increased by
0.57 percentage points from the
Fixed assets 17007956953.83 35.74% 16930687726.99 35.17% 0.57% beginning of the period and the
amount at the end of the period
was basically the same as that at
the beginning of the period.The proportion of total assets at
the end of the period increased by
0.38 percentage points compared
with the beginning of the period
Construction and the amount at the end of the
in progress 603959168.05 1.27% 426719987.46 0.89% 0.38% period increased by 41.54% compared with the beginning of
the period mainly due to the
increase in supporting projects of
the company's feed projects
under construction.The proportion of total assets at
the end of the period increased by
Right-of-use 0.24 percentage points from the
asset 2848775741.09 5.99% 2769825756.21 5.75% 0.24% beginning of the period and the amount at the end of the period
was basically the same as that at
the beginning of the period.The proportion of total assets at
the end of the period increased by
1.93 percentage points compared
with the beginning of the period
Short-term and the amount at the end of the
loan 1163647077.79 2.45% 251739887.29 0.52% 1.93% period increased by 362.24% compared with the beginning of
the period mainly due to the
adjustment of the company's
long-term/short-term loan
structure in the current period.The proportion of total assets at
the end of the period increased by
Contract 0.74 percentage points compared
liabilities 2581711607.32 5.42% 2251063282.58 4.68% 0.74% with the beginning of the period
and the amount at the end of the
period increased by 14.69%
38End of 2025 Early 2025 Proportion
% of % of increase or Description of major changes Amount total Amount total
assets assets decrease
compared with the beginning of
the period mainly due to the
expansion of the company's sales
volume and the increase in
advance receipts.The proportion of total assets at
the end of the period decreased
by 3.16 percentage points
compared with the beginning of
the period and the amount at the
Long-term 249637310.50 0.52% 1769821334.89 3.68% -3.16% end of the period decreased by loan 85.89% compared with the
beginning of the period mainly
due to the early repayment of
some long-term bank loans and
the transfer of long-term loans
due within one year.The proportion of total assets at
the end of the period increased by
0.34 percentage points from the
beginning of the period and the
Lease
liabilities 2155819284.66 4.53% 2015568878.94 4.19% 0.34%
amount at the end of the period
increased by 6.96% from the
beginning of the period mainly
due to the expansion of the
company's business scale and the
addition of leasing business.The proportion of total assets at
the end of the period decreased
by 5.24 percentage points
compared with the beginning of
Trading the period and the amount at the
financial 2118734927.43 4.45% 4662427829.82 9.69% -5.24% end of the period decreased by
assets 54.56% compared with the
beginning of the period mainly
due to the recovery of the
company's idle funds and wealth
management.The proportion of total assets at
the end of the period increased by
0.58 percentage points compared
with the beginning of the period
Advance 898028973.32 1.89% 628293443.54 1.31% 0.58% and the amount at the end of the payment period increased by 42.93%
compared with the beginning of
the period mainly due to the
increase in the company's
prepayments for raw materials.The proportion of total assets at
the end of the period increased by
0.11 percentage points compared
with the beginning of the period
Long-term and the amount at the end of the
receivables 218462655.69 0.46% 169130714.29 0.35% 0.11% period increased by 29.17% compared with the beginning of
the period mainly because the
company increased the long-term
receivables of financial leases
and leases in the current period.The proportion of total assets at
Goodwill 391322506.75 0.82% 245178825.99 0.51% 0.31% the end of the period increased by
0.31 percentage points from the
39End of 2025 Early 2025 Proportion
% of % of increase Description of major changes
Amount total Amount total or
assets assets decrease
beginning of the period and the
amount at the end of the period
increased by 59.61% from the
beginning of the period mainly
due to the increase in the
company's equity acquisition
business not under the same
control in the current period.The proportion of total assets at
the end of the period increased by
0.27 percentage points compared
with the beginning of the period
and the amount at the end of the
Long-term period increased by 41.23%
deferred 417290154.13 0.88% 295462632.97 0.61% 0.27% compared with the beginning of
expenses the period mainly due to the
increase in the company's
expenditure on office decoration
and production facilities
improvement in the current
period.The proportion of total assets at
the end of the period increased by
0.64 percentage points compared
with the beginning of the period
and the amount at the end of the
Deferred Tax period increased by 40.7%
Assets 1022909749.23 2.15% 726995506.26 1.51% 0.64% compared with the beginning of the period mainly due to the
increase in deferred assets
recognized by the company's
lease liabilities asset impairment
reserves and credit impairment
reserves in the current period.The proportion of total assets at
the end of the period increased by
0.3 percentage points compared
with the beginning of the period
and the amount at the end of the
Other non- 307915733.10 0.65% 167343863.72 0.35% 0.30% period increased by 84% current assets compared with the beginning of
the period mainly due to the
increase in the company's
advance payment for equipment
and construction in the current
period.The proportion of total assets at
the end of the period increased by
1.21 percentage points from the
beginning of the period and the
amount at the end of the period
Other payables 1519032906.76 3.19% 952217282.62 1.98% 1.21% increased by 59.53% from the beginning of the period mainly
due to the increase in the equity
transfer payment payable by the
company for the acquisition of
minority shareholders' equity in
the current period.Non-current The proportion of total assets at
liabilities due 512564985.67 1.08% 1229927887.97 2.55% -1.47% the end of the period decreased within one by 1.47 percentage points
year compared with the beginning of
40End of 2025 Early 2025 Proportion
% of % of increase or Description of major changes Amount total Amount total
assets assets decrease
the period and the amount at the
end of the period decreased by
58.33% compared with the
beginning of the period mainly
due to the decrease of the
company's long-term loans due
within one year in the current
period.The proportion of total assets at
the end of the period increased by
1.21 percentage points from the
beginning of the period and the
Treasury stock 870133667.50 1.83% 300081705.48 0.62% 1.21% amount at the end of the period
increased by 189.97% from the
beginning of the period mainly
due to the company's repurchase
of shares in the current period.The proportion of total assets at
the end of the period decreased
by 1.39 percentage points from
the beginning of the period and
the amount at the end of the
Other period decreased by 187.17%
comprehensive -310781746.53 -0.65% 356509145.52 0.74% -1.39% from the beginning of the period
income mainly because the company's
cash flow hedging reserves
included in other comprehensive
income in the previous period
were transferred to profit and loss
in the current period.Overseas assets account for a relatively high proportion
□ Applicable □Not Applicable
2. Assets and liabilities measured at fair value
□Applicable □ Not applicable
Unit: ten thousand yuan
Gains and
losses from Changes in Impairment
Beginning changes in cumulative provision Purchase Amount sold
Projects of the fair value fair value for the amount in in the Other Ending
period for the included in current the current current changes number
current equity period period period
period
Financial assets
1.
Transactional
financial
assets
(excluding 35805.96 -12427.20 8962.48 48.81 39.98 10302.47
derivative
financial
assets)
41Gains and
losses from Changes in Impairment
Beginning changes in cumulative provision Purchase Amount sold
Projects of the fair value fair value for the amount in in the Other Ending
period for the included in current the current current changes number
current equity period period period
period
5. Other non-
current
financial 23838.06 658.00 90.00 24585.74
assets
Subtotal of
financial 59644.02 -11769.20 8962.48 0.00 138.81 39.98 0.00 34888.21
assets
Other [Note] 430436.82 -450.44 1166600.00 1400688.82 201571.02
Total of the
above 490080.84 -12219.64 8962.48 0.00 1166738.81 1400728.80 0.00 236459.23
Financial
liabilities 7739.03 9520.45 -6259.67 6497.03
Note: Others are wealth management products.Other changes
No.Whether the measurement attributes of the company's main assets have changed significantly
during the reporting period
□Yes □No
3. Restricted asset rights as of the end of the reporting period
As of the end of the reporting period the company still had restricted assets of RMB
375431932.40 which were mainly land reclamation deposits guarantee deposits futures account
funds fixed assets mortgaged by loans etc.VII. Analysis of investment status
1. Overall situation
□Applicable □ Not applicable
Investment in the reporting period (yuan) Investment in the same period last year (yuan) Range of change
3336532557.693136747295.936.37%
422. Significant equity investments obtained during the reporting period
□ Applicable □Not Applicable
3. Major non-equity investments in progress during the reporting period
□ Applicable □Not Applicable
4. Financial asset investment
(1) Securities investment
□Applicable □ Not applicable
Unit: Yuan
Gains
and
losses Chang
Accou Book from es in
Purch Profit
Abbre value chang cumul ase
Amou
nt and Book Types
of Securi viatio
Initial nting at the es in ative amou sold loss value Accou Sourc
securi ties n of
invest measu nt in for at the nting
Code securi ment remen
begin fair fair
ning value value the
in the
curren the end of subjec
e of
ties cost t curren report the ts funds ties model of the for includ t period the ed in t ing period
curren equity period
period period
t
period
Dome Aono
stic ng Fair Tradi Incom
and 60336 Biolo 8605 value
e
overse gical measu 3622 1286 0.00 4880 3998 1559 6064
ng
3.SH 86.44 94.22 31.10 57.92 49.99 52.57 54.72 financ
from
as Techn remen ial debt
stocks ology t assets repay
[Note] Group ment
Other securities
investments held at the 0.00 -- 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -- --
end of the period
Total 8605 -- 3622 1286 0.00 4880 3998 1559 606486.44 94.22 31.10 57.92 49.99 52.57 54.72 -- --
Note: According to the "Reorganization Plan of Fujian Aonong Biological Technology Group
Incorporation Ltd." approved by the court the company has transferred the shares of Aonong
Biological Technology Group (603363.SH) to offset the company's receivables.
(2) Derivatives investment
□Applicable □ Not applicable
431) Derivative investments for hedging purposes during the reporting period
□Applicable □ Not applicable
Unit: ten thousand yuan
The
proportion
of the
Gains and investment
Amount losses Changes in Amount Amount amount at
Derivatives Initial at the from Amount the end of
investment investment beginning changes in
cumulative purchased sold during
fair value fair value during the the
at the end the period
type amount of the included in reporting reporting of the to the
period for the current equity period period
period company's
net assets at
period the end of
the
reporting
period
Futures
company 0 59768.13 -3494.31 2740.42 479440.13 486109.7 43985.34 1.81%
Commercial
Bank 0 0 584.17 -37.61 0 0 0 0.00%
Total 0 59768.13 -2910.14 2702.81 479440.13 486109.7 43985.34 1.81%
The
accounting
policies and
specific
principles of
accounting for
hedging
business According to the relevant provisions of the Ministry of Finance's "Accounting Standards for Business Enterprises
during the No. 22 — Recognition and Measurement of Financial Instruments" "Accounting Standards for Business
reporting Enterprises No. 23 — Transfer of Financial Assets" "Accounting Standards for Business Enterprises No. 24 —
period and an Hedging Accounting" "Accounting Standards for Business Enterprises No. 37 — Presentation of Financial
explanation of Instruments" and their guidelines the company conducts corresponding accounting and processing for the
whether there hedging business carried out. There was no significant change in the accounting policies and accounting of the
have been company's hedging business during the reporting period compared with the previous reporting period.significant
changes
compared with
the previous
reporting
period
Explanation of In order to avoid the fluctuation of the market price of raw materials such as corn and meal and the fluctuation
actual profit risk of expected future cash flow caused by the expected sales of live pigs the company has carried out commodity
and loss during futures hedging business; in order to avoid the operating risks brought by foreign exchange rate fluctuations to
the reporting the company it has carried out foreign exchange hedging business. During the reporting period the actual profit
period and loss of the company's commodity and foreign exchange hedging derivative contracts and spot profits and losses totaled -185 million yuan.The company's commodity futures hedging futures are mainly corn meal and other raw materials related to
production and operation and live pigs and inventory-related commodities. Through the change of the value of
Description of hedging instruments the risk of changes in the value of the hedged item is effectively hedged and the expected
hedging effect risk management goal is basically achieved. The company's foreign exchange hedging business means that the company's overseas bank loan financing business and overseas procurement business face the risk of exchange
rate fluctuations. By carrying out forward foreign exchange settlement and sales and currency swaps the company
locks in exchange rate costs and effectively hedges uncertain risks arising from exchange rate fluctuations.Sources of
Funds for
Derivatives Own funds
Investment
44The
proportion
of the
Gains and investment
Amount losses from Changes in Amount Amount
amount at
Derivatives Initial at the cumulative purchased sold during Amount the end of
investment investment beginning changes in fair value during the the at the end the period
type amount of the fair value for the included in reporting reporting
of the to the
period period company's current equity period period net assets at
period the end of
the
reporting
period
1. Match the hedging business with the company's production and operation strictly control the futures and
options positions conduct foreign exchange hedging transactions in strict accordance with the company's
predicted foreign exchange collection period foreign exchange payment period and amount and reasonably use
futures options the above product portfolio foreign exchange hedging and other tools to lock the company's feed
Risk analysis raw materials and other related product costs and expenses.of derivative 2. Strictly control the capital scale of hedging rationally plan and use margin issue operation instructions in strict
positions accordance with the company's futures trading management system and conduct operations after approval
during the according to regulations. The company will rationally allocate funds for hedging business.reporting 3. According to the "Guidelines for Self-Regulatory Supervision of Listed Companies on the Shenzhen Stock
period and Exchange No. 7 — Transactions and Related Party Transactions" and other relevant regulations the company has
description of formulated the "Commodity Hedging Business Management System" "Futures Management Measures" and
control "Live Pig Futures Business Operation Management Measures" and other systems which clearly stipulate the
measures approval authority internal review process and risk handling procedures for hedging business. The company has
(including but established a dedicated commodity hedging operation team a commodity hedging business operation monitoring
not limited to team and corresponding business processes which are controlled by the implementation of authorization and post
market risk containment as well as internal auditing and other measures.liquidity risk 4. The company has formulated the foreign exchange hedging business management system which clearly
credit risk stipulates the company's foreign exchange hedging business quota product scope approval authority internal
operational review process responsible department and responsible person information isolation measures internal risk
risk legal risk reporting system and risk handling procedures etc. The system meets the relevant requirements of the regulatory
etc.) authorities and meets the needs of actual operation and the risk control measures formulated are practical and
effective.
5. The company's risk control department regularly and irregularly inspects the hedging transaction business
supervises the hedging transaction business personnel to implement risk management policies and risk
management work procedures and prevent operational risks in the business in a timely manner.In the case of
changes in the
market price or
the fair value
of the product
during the
reporting
period of the
invested The company's commodity hedging transactions are traded on the futures exchange with great market
derivatives the transparency and very active transactions. The transaction price and the settlement unit price of the day can fully
analysis of the reflect the fair value of the derivatives; the foreign exchange hedging transactions are measured at the fair value
fair value of of the date when the contract between the company and the commercial bank is signed and the subsequent
the derivatives measurement of its fair value is based on the closing valuation notice of each commercial bank.shall disclose
the specific
methods used
and the setting
of relevant
assumptions
and parameters
Litigation-
related
circumstances Not applicable
(if applicable)
Announcement
of the Board of July 25 2025
45The
proportion
of the
Gains and investment
Amount losses from Changes in Amount Amount
amount at
Derivatives Initial at the cumulative purchased sold during Amount the end of
investment investment beginning changes in fair value fair value during the the
at the end the period
type amount of the included in reporting reporting of the to the
period for the period company's current equity period period net assets at
period the end of
the
reporting
period
Directors for
Derivatives
Investment
Approval
Disclosure
Date (if any)
Derivatives
Investment
Approval
Shareholders'
Meeting August 14 2025
Announcement
Disclosure
Date (if any)
2) Derivatives investment for speculative purposes during the reporting period
□ Applicable □Not Applicable
During the reporting period the company did not invest in derivatives for speculative purposes.VIII. Major Asset and Equity Sale
1. Sale of major assets
□ Applicable □Not Applicable
The company did not sell any major assets during the reporting period.
2. Sale of major equity
□ Applicable □Not Applicable
46IX. Analysis of major holding companies
□ Applicable □Not Applicable
During the reporting period the company did not have any important information on holding
companies that should be disclosed.X .structured entities controlled by the company
□ Applicable □Not Applicable
XI. Prospects for the company's future development
Please refer to the relevant content of "II. The industry in which the company operates during the
reporting period".XII. Reception of research communication interviews and other activities during the
reporting period
□Applicable □ Not applicable
The main
content of
Reception Reception Reception the Reception Reception object discussion Basic Information Index time location object type and the of the Survey
information
provided
The survey results are
Company published on
January Shanghai other Mechanism UBS Securities production www.cninfo.com.cn and 16 2025 Danshuiquan etc and the interactive website of
operation the Shenzhen Stock
Exchange's website
The survey results are
Company published on
February Gf Securities Cathay production www.cninfo.com.cn and
28 2025 Shanghai other Mechanism Pacific Fund etc and the interactive website of
operation the Shenzhen Stock
Exchange's website
The survey results are
Company published on
March 07
2025 Wuhan other Mechanism
Changjiang Securities production www.cninfo.com.cn and
Penghua Fund etc and the interactive website of
operation the Shenzhen Stock
Exchange's website
47The main
content of
Reception Reception Reception Reception
the
time location object type Reception object discussion
Basic Information Index
and the of the Survey
information
provided
The survey results are
Company published on
March 14 Shenzhen other Mechanism Huatai Securities GF production www.cninfo.com.cn and 2025 Fund etc and the interactive website of
operation the Shenzhen Stock
Exchange's website
Interpretation
of the The survey results are published on
April 22 Company meeting Telephone
company's
2025 communication Mechanism
Gf Securities E Fund annual www.cninfo.com.cn and
room etc results and the interactive website of
first quarter the Shenzhen Stock
results Exchange's website
The
company's The survey results are
Online Investors participating production published on
April 25 p5w.net communication other in the
and
2025 on network "Panorama · Roadshow operation
www.cninfo.com.cn and
the interactive website of
platform World" interaction and the company's the Shenzhen Stock
development Exchange's website
strategy
The survey results are
May 13 Company Gf Securities Invesco
Company published on
meeting Field research Mechanism Great Wall Fund production www.cninfo.com.cn and 2025 room Harvest Fund etc and the interactive website of operation the Shenzhen Stock
Exchange's website
The survey results are
May 28 Hangzhou
Company published on
2025 Shanghai other Mechanism
Gf Securities Huatai production www.cninfo.com.cn and
Ningbo Bai Rui Fund etc and the interactive website of operation the Shenzhen Stock
Exchange's website
The survey results are
Company published on
June 13 Chengdu other Mechanism Gf Securities Huatai production www.cninfo.com.cn and 2025 Shanghai Bai Rui Fund etc and the interactive website of
operation the Shenzhen Stock
Exchange's website
Interpretation The survey results are
July 29 Company
published on
meeting Telephone Gf Securities E Fund
of the
2025 communication Mechanism etc company's
www.cninfo.com.cn and
room semi-annual the interactive website of
results the Shenzhen Stock Exchange's website
The survey results are
Company published on
August China Universal Fund production www.cninfo.com.cn and
28 2025 Shanghai other Mechanism Suzaku Fund etc and the interactive website of
operation the Shenzhen Stock
Exchange's website
The survey results are
Online Investors participating Company published on
September communication in the production www.cninfo.com.cn and
19 2025 p5w.net on network other "Panorama · Roadshow and the interactive website of
platform World" interaction operation the Shenzhen Stock
Exchange's website
October Company Telephone Mechanism Gf Securities E Fund Interpretation The survey results are
48The main
content of
Reception Reception Reception the Reception Reception object discussion Basic Information Index time location object type and the of the Survey
information
provided
19 2025 meeting communication etc of the published on
room company's www.cninfo.com.cn and
third quarter the interactive website of
results the Shenzhen Stock
Exchange's website
XIII. Formulation and implementation of market value management system and valuation
enhancement plan
Whether the company has established a market value management system.□Yes □ No
Has the company disclosed its valuation enhancement plan
□Yes □No
The Company formulated the Market Value Management System in December 2024 and revised
it at the first meeting of the seventh board of directors on June 16 2025. The main purpose of market
value management is to enhance the company's transparency through fully compliant information
disclosure guide the company's market value and intrinsic value to converge and at the same time
use capital operation equity management investor relationship management and other means to fully
realize the company's value establish a stable and high-quality investor base and obtain long-term
market support.XIV. Implementation of the "Quality and Return Double Improvement" Action Plan
Has the company disclosed the announcement of the action plan for "double improvement of
quality and return"
□Yes □ No
In order to thoroughly implement the important instructions of "To activate the capital market
and boost investor confidence" put forward by the Political Bureau of the Central Committee meeting
and "To vigorously improve the quality and investment value of listed companies and to take more
49effective and effective measures to stabilize the market and stabilize confidence" put forward by the
executive meeting of the State Council the company has always practiced the concept of high-quality
sustainable development while sticking to its original intention and taking root in agricultural
development and has continuously improved the company's operational development quality
investment value and sustainable development level. In order to safeguard the interests of all
shareholders of the company enhance investor confidence and promote the stable development of
the capital market the company formulated the action plan for "Double Improvement of Quality and
Return" on March 7 2024. For details please refer to the "Announcement on Promoting the Action
Plan for" Double Improvement of Quality and Return "disclosed in the company's designated
information disclosure media (Announcement No.: 2024-017). For the implementation and progress
of the action plan please refer to the relevant announcements disclosed in the company's designated
information disclosure media "Securities Times" "China Securities Journal" "Shanghai Securities
News" "Securities Daily" and www.cninfo.com.cn (http://www.cninfo.com.cn).
50Section 4 Corporate Governance Environment and Society
I. The basic situation of corporate governance
1. The establishment of the company system
From the company's listing to the end of the reporting period the company has continuously
improved the company's internal corporate governance structure optimized the internal control
environment improved the internal management system and standardized the operation of the
company in strict accordance with the "Company Law" "Securities Law" "Shenzhen Stock
Exchange Stock Listing Rules" "Shenzhen Stock Exchange Self-Regulatory Supervision Guidelines
No. 1 — Standardized Operation of Listed Companies on the Main Board" and other relevant laws
regulations normative documents and articles of association Efforts to improve the level of corporate
governance. The actual situation of corporate governance complies with the requirements of the
relevant normative documents of the China Securities Regulatory Commission and the Shenzhen
Stock Exchange on the governance of listed companies.
2. About shareholders and shareholders meeting
During the reporting period the company strictly followed the "Company Law" "Articles of
Association" "Rules of Procedures for Shareholders' Meetings" and other laws and regulations and
the requirements of the internal control system to standardize the convening convening and voting
procedures of shareholders' meetings ensure that all shareholders enjoy equal status fully exercise
their rights and ensure the legality of the meeting and voting procedures by hiring lawyers to witness
and safeguard the legitimate rights and interests of the company and shareholders. A total of five
shareholder meetings will be held in 2025 all of which will be convened by the board of directors;
the convening convening and voting procedures of the shareholder meeting have been witnessed by
witnessing lawyers and all are legal and valid.
3. About directors and the board of directors
The company elects and appoints directors in strict accordance with the "Company Law"
"Articles of Association" "Rules of Procedure of the Board of Directors" and "Independent Director
System". The selection and appointment procedures of directors are open fair and just and the
51composition and number of directors meet the requirements of laws and regulations. During the
reporting period the company implemented the general election of the board of directors. The
members of the seventh board of directors of the company were nominated and recommended in
accordance with relevant regulations reviewed by the board of directors and elected by the
cumulative voting system. There are currently 7 directors including 3 independent directors.Independent directors account for more than one-third of all directors and their qualifications meet
the relevant requirements of the "Administrative Measures for Independent Directors of Listed
Companies".All directors of the company perform their duties in strict accordance with relevant laws
regulations and normative documents attend all board meetings and carry out related work in a
serious and responsible manner and strictly abide by the directors' statements and commitments.Independent directors strictly follow the relevant requirements of independence conduct self-
examination on independence every year and the board of directors of the company evaluates the
independence of incumbent independent directors and issues special opinions.The board of directors has an audit committee and a strategy committee and each committee can
perform its functions in accordance with its working rules and make due contributions to the
standardization of corporate governance. The board of directors can carry out its work in strict
accordance with relevant laws and regulations. All directors of the company are honest trustworthy
diligent and responsible attend board meetings and shareholders' meetings conscientiously actively
participate in relevant training and are familiar with relevant laws and regulations.
4. About the internal audit system
The company has established a sound internal audit system and set up an internal audit
department to conduct effective internal supervision over the company's daily operations.
5. About stakeholders
The company fully respects and safeguards the legitimate rights and interests of stakeholders
realizes the coordination and balance of the interests of society shareholders the company
employees etc. treats suppliers and customers with integrity earnestly trains every employee
52adheres to the principle of mutual benefit and win-win with stakeholders and jointly promotes the
company's sustainable healthy and rapid development.
6. Information disclosure and transparency
The company strictly complies with the relevant laws and regulations and the requirements of
the company's "Information Disclosure System" and "Investor Relations Management System" to
disclose information truthfully accurately completely and in a timely manner to ensure that all
shareholders have equal opportunities to obtain information.The chairman of the board assumes primary responsibility for the management of the company's
information disclosure affairs. The company appoints the secretary of the board of directors to be
responsible for organizing and coordinating the management of the company's information disclosure
affairs and investor relations. The Securities and Investment Center is the executive department of
information disclosure affairs and investor relations management. The company pays attention to
communication with investors and strengthens communication with investors through various
methods such as telephone email and investor relations interactive platform.The company's information disclosure work has been assessed by the Shenzhen Stock Exchange
as the highest level A (excellent) for 15 consecutive years from 2010 to 2024.
7. About investor relations management
The company has always attached great importance to the management of investor relations and
carried out relevant work in accordance with the requirements of the "Investor Relations Management
System" and other systems. It implemented investor relations management in various forms such as
the Shenzhen Stock Exchange's investor relations interactive platform investor hotline and receiving
investor visits strengthened communication with investors and fully guaranteed the majority of
investors' right to know.Corporate governance is a systematic and long-term project that requires continuous
improvement. After the company is successfully listed it is willing to accept the supervision of all
parties adhere to the scientific development concept continuously improve the corporate governance
system strengthen the practice of various laws and regulations promote the healthy development of
the company and improve the overall competitiveness.
538. About inside information management
According to the "Company Law" "Securities Law" "Shenzhen Stock Exchange Stock Listing
Rules" and other relevant laws and regulations and the relevant provisions of the "Articles of
Association" the company has formulated the "Registration Management System for Insiders with
Inside Information". In strict accordance with the requirements of the relevant system the company
does a good job in the registration and filing of insider information and can truthfully record and
disclose the report transmission preparation resolution disclosure and other links of insider
information before the disclosure of insider information and the list of insiders and the progress of
major events. Memorandum. During the reporting period the company did not have any insider
information illegally buying or selling the company's stock and no relevant personnel were suspected
of insider trading and were subject to regulatory measures and administrative penalties by the
regulatory authorities.Are there any significant differences between the actual status of corporate governance and laws
administrative regulations and the regulations on corporate governance of listed companies issued by
the China Securities Regulatory Commission
□Yes □No
There is no major difference between the actual status of corporate governance and laws
administrative regulations and the regulations on listed company governance issued by the China
Securities Regulatory Commission.II. The company's independence from the controlling shareholder and actual controller in
guaranteeing the company's assets personnel finance organization business etc
The company has independent and complete business and independent operation capabilities
and is completely independent of the controlling shareholder in terms of assets personnel finance
organization and business.
1. In terms of assets the company has a clear property rights relationship with the controlling
shareholder has independent land use rights housing property rights and independently registers
builds accounts accounts and manages the company's assets. The controlling shareholder has no
54non-operating occupation dominates the company's assets or interferes with the company's operation
and management of the assets.
2. In terms of personnel the company has established an independent personnel system. The
controlling shareholders exercise their rights and undertake corresponding obligations in accordance
with the law. There is no occurrence of affecting the appointment and removal of personnel of listed
companies or restricting the performance of duties by directors senior managers or other personnel
of listed companies by exercising shareholder rights other than those stipulated by laws and
regulations.
3. In terms of finance the company has a complete and independent financial institution
equipped with sufficient full-time financial personnel established an independent accounting system
and financial management system independently opened bank accounts independently paid taxes
independently allocated funds and made independent financial decisions. There is no situation where
the controlling shareholder interferes with the financial management of the company.
4. In terms of organization various functional departments within the company's board of
directors can operate independently and there is no subordinate relationship with the internal
organization of the controlling shareholder and there is no direct or indirect interference in the
company's decision-making and business activities by the controlling shareholder beyond the
shareholders' meeting.
5. In terms of business the controlling shareholder has an independent and complete business
structure and has the business ability to face the market independently and operate independently.There is no competition with the company in terms of business scope business nature customer
targets product substitutability etc.; there is no situation in which the controlling position of the
company is used to seek business opportunities belonging to the company; there is no situation in
which major decisions about the listed company are directly made on behalf of the shareholders
meeting and the board of directors and interfere with the normal decision-making procedures of the
listed company.
55III. Horizontal competition
□ Applicable □Not Applicable
IV. Directors and Senior Management
1. Basic information
The
Numbe The numb
r of numb er of
shares er of share
Numbe
r of Reaso
held at share s s held reduc Other shares
ns for
Employ Term Term the chang held at the
Name Sex Age Position ment start end beginni
in the ed in increa
status date date ng of curre the
es the end
nt curre (share of the
se or
the perio nt s) period
decrea
period se of
(shares d perio
(shares shares
) (shar d
)
es) (shar
es)
June June
Chairman Incumbent 06 15 Xue Male 56 2007 2028 Hua Incumbe May June
President nt 25 15 2010 2028
Co-
Chairman Incumbe June June
Xu of the nt 06 15
Yingzhu Male 58 Board 2007 2028
o Vice- Incumbe June June
President nt 16 15 2025 2028
Employee
Representa Incumbe Februar June
tive nt y 03 15
Director 2021 2028
Qian Male 59 Vice- Incumbe July 16 June 25570 25570Xueqiao President nt 2019 15 0 0 2028
Chief Incumbe January June
engineer nt 22 15 2008 2028
June June
Director Incumbe
Shen nt
1615
Male 48 2025 2028 Dong Septem June
Supervisor Outgoing ber 14 16
20232025
Yin Independe Incumbe June June
Zhan Male 61 nt director nt 16 15 2025 2028
Tan Jin Male 61 Independe Incumbe
June June
Song nt director nt 16 15 2025 2028
Li Male 63 Independe Incumbe June June Chunho nt director nt 16 15
56The
Numbe The numb
r of numb er of
shares er of share
Numbe Reaso
held at share s
r of ns for
Employ Term Term the s held reduc
Other shares the
Name Sex Ag Position ment start end beginni in the ed in
chang held at
e curre the es the end
increa
status date date ng of se or
the nt curre
(share of the
s) period decrea
period perio nt se of
(shares d perio
(shares
) shares
) (shar d es) (shar
es)
u 2025 2028
Gui Male 70 Independe Outgoing July 16
January
Jianfang nt director 2019 09 2025
He Independe July 16 June
Jianguo Male 64 nt director Outgoing 2019 16 2025
Liu Male 60 Independe Outgoing July 16
June
Yunguo nt director 2019 16 2025
Gao Fema Independe January June
Zexia le 44 nt director Outgoing 09 16 2025 2025
Director Outgoing July 16
June
2019 16 Cheng Male 46 2025 Qi 52500 52500 Vice- Incumbe July 16 June
President nt 2019 15 2028
Liu
Guoxian Male 57 Vice- Incumbe July 16
June 15207
President nt 2019 15 0
15207
g 2028 0
Vice- Incumbe July 16 June
Yang President nt 2019
15
Male 52 2028 33090 33090Shaolin Financial Incumbe October June 0 0
Controller nt 22 15 2012 2028
Chen June June
Mingzh Male 61 Vice- Incumbe 06 15
ong President nt 2007 2028
Jiang Male 58 Vice- Incumbe July 16
June
Xiewu President nt 2019 15 50180 50180 2028
Mi June
Guoche Male 54 Vice- Incumbe July 16 18210 18210
ng President nt 2019
15
202800
Chen
Zhongz Male 56 Vice- Incumbe July 16
June
15 14157President nt 2019 0
14157
hu 2028 0
Huo Februar June
Quanwe Male 51 Vice- IncumbePresident nt y 05 15 n 2024 2028
Zhang Februar Novem
Guijun Male 52
Vice-
President Outgoing y 05 ber 26 2024 2025
Lu Male 49 Vice- Incumbe
Februar June
Xuezhi President nt y 05 15 52260 52260 2024 2028
Hou June June
Huaping Male 52 Vice- Incumbe
[Note] President nt
1615
20252028
57The
Numbe The numb
r of numb er of
shares er of share
Numbe Reaso
held at share s
r of
Other shares ns for
Ag Employ Term Term the
s held reduc chang held at the
Name Sex e Position ment start end beginni
in the ed in es the end increa
status date date ng of curre the se or
the nt curre
(share of the decrea
period perio nt
s) period
d perio (shares
se of
(shares shares
) (shar d
)
es) (shar
es)
Yang Vice- August Novem
Jiantao Male 57 President Outgoing 19 ber 26 2022 2025
Wang Fema Vice- Incumbe August June
Jing le 47 President nt 19 15 8700 8700 2022 2028
Vice- Incumbe July 26 June 15
Huang President nt 2012 Male 48 2028 41224 41224Zhijian Board Incumbe July 26 June 4 4
secretary nt 2012 15 2028
Wang Novem June
Hua Male 39 Supervisor Outgoing ber 16 16 2020 2025
Mu June
Yongfan Female 37 Supervisor Outgoing
July 16
g 2019
16
2025
Total -- -- -- -- -- -- 16382 0 0 0 1638224 24 --
Note: The number of shares held by Mr. Hou Huaping at the beginning of the period refers to the
shareholding situation on the day the company appointed him as vice president (June 16 2025).Whether there were any resignations of directors and senior management during the reporting
period
□Yes □ No
For details please refer to "Changes in Directors and Senior Management of the Company" in this
section.Changes in the company's directors and senior management
□Applicable □ Not applicable
Name Position held Type Date Reason
Gui Jianfang Independent director Outgoing January 09 2025 Personal reasons
Cheng Qi Director Resignation at the end of the term June 16 2025 Change of term
He Jianguo Independent director Resignation at the end of the term June 16 2025 Change of term
58Name Position held Type Date Reason
Liu Yunguo Independent director Resignation at the end of the term June 16 2025 Change of term
Gao Zexia Independent director Resignation at the end of the term June 16 2025 Change of term
Shen Dong Supervisor Resignation at the end of the term June 16 2025 Change of term
Wang Hua Supervisor Resignation at the end of the term June 16 2025 Change of term
Mu Yongfang Supervisor Resignation at the end of the term June 16 2025 Change of term
Zhang Guijun Vice-President Dismissal November 26 2025 Job transfer
Yang Jiantao Vice-President Dismissal November 26 2025 Job transfer
2. Employment
The professional background main work experience and current main responsibilities of the
company's current directors and senior managers
(1) Director
Mr. Xue Hua born in 1970 master degree engineer. In 1992 he graduated from the Fisheries
College of Huazhong Agricultural University majoring in special aquaculture; in 1995 he received
a master's degree in zoology from the School of Life Sciences Sun Yat-sen University. He has
successively served as the vice chairman of Guangdong Rural Revitalization Promotion Association
the vice chairman of Guangdong Feed Industry Association the vice chairman of Guangdong
Agricultural Industrialization Leading Enterprise Association the vice chairman of Guangdong High-
tech Enterprise Association the vice chairman of the 16th Executive Committee of Guangzhou
Federation of Industry and Commerce the vice chairman of Guangzhou Charity Association the
honorary chairman of Guangzhou Feed Industry Association and the executive vice chairman of
Guangzhou Guangdong-Hong Kong-Macao Greater Bay Area Enterprise Integrity and Compliance
Management Association. It has successively won the titles of "Leading Figure of Chinese Feed
Enterprises" "Thirty Outstanding Entrepreneurs in China" and "Top Ten Economic Figures in
Guangdong". One of the founders of the company he is currently the chairman and president of the
company and the executive director of Guangzhou Haihao Investment Co. Ltd. the controlling
shareholder of the company. Mr. Xue Hua holds 39.75% of the equity of Guangzhou Haihao
Investment Co. Ltd. the controlling shareholder of the company and is the actual controller of the
company.
59Mr. Xu Yingzhuo born in 1968 is an animal pastor. In 1991 he graduated from South China
Agricultural University majoring in animal husbandry with a bachelor's degree and later obtained a
master's degree in business administration from HEC Business School in Paris. One of the founders
of the company he is currently the co-chairman and vice president of the company.Mr. Qian Xueqiao born in 1967 holds a doctorate degree. He has presided over or participated
in the Hubei Provincial Natural Science Foundation project "Development and Utilization of Feather
Protein in Fishery Feed" the development project of the State Key Laboratory of Freshwater Ecology
and Biotechnology "Effects of Nutritional Levels and Nutritional History on Fish Growth and
Activities Research on Feeding Behavior and Chemical Sensation of Allogeneic Crucian Carp
Research on Utilization of Plant Protein by Major Freshwater Farmed Fish" The National Natural
Science Foundation of China project "Comparative Nutritional Energy Research on Feed Protein
Requirements for Carnivorous Fish and Omnivorous Fish" and the Ministry of Agriculture's 948
project "Artificial Propagation and Large-scale Breeding of Keynose Sturgeon" etc. have published
more than 20 papers three of which have been published in international journals and included in
SCI. The company is mainly engaged in aquatic animal nutrition and feed science research and the
development of new feed additives. He has been the chief engineer of the company since 2008 the
vice president of the company since 2019 and the director of the company since 2021. He is currently
the employee representative director of the company.Mr. Shen Dong born in 1978 holds a master's degree and graduated from Sun Yat-sen
University majoring in law. Joined the company in 2021 served as a supervisor of the company from
2023 to 2025 and has been a director of the company since 2025.
Mr. Yin Zhan born in 1965 has a PhD in Zoology from the National University of Singapore
a professor at the Fisheries College of Ocean University of China and a professor at the Shenzhen
Research Institute of Ocean University of China. He used to be the director of the Institute of
Hydrobiology Chinese Academy of Sciences and the director of the State Key Laboratory of
Freshwater Ecology and Biotechnology. He was funded by the Outstanding Youth Fund of the
National Natural Science Foundation of China. He has been selected as a leader of the innovation
team in the key field of "Fish Biology and Biotechnology" of the Ministry of Science and Technology
a national expert on outstanding contributions to young and middle-aged people and the "Ten
Thousand Talents Program" of the Organization Department of the Central Committee. He is
60currently the vice chairman of the Chinese Society of Oceans and Limnology as well as the deputy
editor-in-chief and editorial board member of 5 SCI journals including Engineering. He has long been
engaged in the research of animal molecular developmental biology and fish endocrine regulation.He has presided over 2 national key research and development projects and 2 key projects of the
National Natural Science Foundation of China. He has published nearly 70 first or corresponding
author articles in international academic journals such as Nat. Med. PNAS Science Bulletin
Engineering etc. and has been cited more than 3000 times by SCI source articles. He won 1 first
prize of the 2022 Ministry of Education Natural Science Award (ranked third by individuals) and 5
Chinese invention patents were authorized. Currently serving as an independent director of the
company.Mr. Tan Jinsong born in 1965 Han nationality member of the Communist Party of China
doctor of management (accounting) is currently a professor at the School of Management of Sun
Yat-Sen University director of the Modern Accounting and Finance Research Center of Sun Yat-Sen
University vice president of Guangdong Institute of Certified Public Accountants president of
Guangzhou Internal Audit Association chairman of the Independent Board Committee of Guangdong
Association of Listed Companies chairman of the Audit Committee of Listed Companies of
Guangdong Association of Listed Companies etc.; He is currently an independent director of the
company and an independent director of the domestic Jsti Group (300284. SZ).Mr. Li Chunhou born in 1963 holds a Bachelor of Science degree in Zoology from Sun Yat-
sen University a national outstanding aquatic science and technology worker and a second-level
researcher. He has long been engaged in fishery resource conservation fishery ecological
environment protection and circulating aquaculture research and won the second prize of National
Marine Innovation Achievement the third prize of Shennong Chinese Agricultural Science and
Technology the first prize of Guangdong Science and Technology the second prize of Guangdong
Science and Technology and the third prize of Guangdong Science and Technology. He is currently
a researcher at the South China Sea Fisheries Research Institute of the Chinese Academy of Fishery
Sciences an executive director of the Chinese Fisheries Society a chairman of the Fisheries
Resources and Environment Branch of the Chinese Fisheries Society a member of the National
Fisheries Standardization Technical Committee a chairman of the Fisheries Resources Sub-
Technical Committee a vice chairman of the Marine Ecological Security Professional Committee of
61the Chinese Society of Environmental Sciences a vice chairman of the Guangdong Provincial Union
of Field Science Observation and Research Stations and a director of the Guangzhou Representative
Office of the China Fisheries Circulation and Processing Association. Currently serving as an
independent director of the company.
(2) Senior management
Mr. Cheng Qi born in 1980 holds a master's degree. He graduated from Huazhong University
of Science and Technology in 2002 with a major in automation; from 2005 to 2008 he studied at Sun
Yat-sen University with a master's degree in world economics; from 2013 to 2015 he studied at China
Europe International Business School with an EMBA and obtained a master's degree in business
administration. From 2002 to 2010 he served as process engineer operation manager supply chain
manager and technical director in Guangzhou Procter & Gamble & Gamble Co. Ltd. From 2010 to
2017 he served as operation director of East Asia Pacific and global supply chain director in Esol
Packaging Co. Ltd. He joined the company in 2017 served as a director of the company from 2019
to 2025 and has been the company's vice president since 2019.Mr. Liu Guoxiang born in 1969 bachelor degree graduated from Huazhong Agricultural
University in 1992 majoring in special aquatic products. He joined the company in 2004 and has
been the company's vice president since 2019.Mr. Yang Shaolin born in 1974 graduated from Sun Yat-sen University majoring in business
administration with a master's degree EMBA of China Europe International Business School senior
accountant certified public accountant and certified tax agent. From 2008 to 2012 he served as
Executive Director Chief Financial Officer and Joint Secretary of KEE Holdings Limited
(HK.02011). He was selected into the high-tech enterprise evaluation expert database of the
Guangdong Provincial Department of Science and Technology and served as the vice president of
the Guangdong Association of Management Accountants. Since June 2016 he has served as an off-
campus tutor for the Master of Accounting in the School of Management of Sun Yat-Sen University.Since January 2026 he has served as an off-campus industry tutor for MBA MPAcc and Maud of
Sun Yat-Sen University. Since 2021 he has been a master tutor for accounting in Guangdong
University of Foreign Studies. He joined the company in 2012 and has been the company's chief
financial officer since 2012 and has been the company's vice president since 2019.
62Mr. Chen Mingzhong born in 1965 master degree. He is currently the vice president of
Guangzhou Agricultural Leading Enterprise Association the vice president of the Standing
Committee of Guangzhou Panyu District Federation of Industry and Commerce the vice president
of Guangzhou Sanhui (Guangzhou Federation of Industrial Economics etc.) and the executive vice
president of Nancun General Chamber of Commerce in Panyu District Guangzhou. He was awarded
the honorary title of "Excellent Entrepreneur of Caring for Employees in Panyu District Guangzhou".He joined the company in 2004 and has been the company's vice president since 2007.Mr. Jiang Xiewu born in 1968 bachelor degree aquaculture engineer the first batch of rural
craftsman professionals in Guangdong Province (senior title). In 1992 he graduated from the
Fisheries College of Huazhong Agricultural University majoring in special aquatic products. He
served as the vice president of China Fisheries Association the executive president of the first council
of the Aquatic Seedling Branch of China Fisheries Association and the honorary president of
Weifang Fisheries Association. He joined the company in 2004 served as a director of the company
from 2007 to 2016 and served as the company's vice president from 2010 to 2016 and since 2019.Mr. Mi Guocheng born in 1972 bachelor degree graduated from Southwest Agricultural
University majoring in freshwater fishery. He joined the company in 2010 and has been the company's
vice president since 2019.Mr. Chen Zhongzhu born in 1970 holds a master's degree. He joined the company in 2004 and
has been the company's vice president since 2019.Mr. Huo Quanwen born in 1974 is studying for an MBA from Cheung Kong Graduate School
of Business. He joined the company in 2012 and has been the company's vice president since 2024.Mr. Lu Xuezhi born in 1977 holds a master's degree from China Europe International Business
School. He joined the company in 2010 and has been the company's vice president since 2024.Mr. Hou Huaping born in 1974 bachelor degree graduated from Guangdong Ocean University.He joined the company in 2004 and has been its vice president since 2025.Ms. Wang Jing born in 1979 graduated from the University of Science and Technology of
China majoring in management science in 2001. From 2006 to 2008 she studied MBA at Cheung
Kong Graduate School of Business and obtained a master's degree in business administration. From
2001 to 2006 he successively worked in IFLYTEK Co. Ltd. Shenzhen Bohua Consulting Co. Ltd.
63and Tencent Technology Co. Ltd. From the beginning of 2008 to 2010 he worked as a consultant in
IBM China. He joined the company in 2012 and has been the company's vice president since 2022.Mr. Huang Zhijian born in 1978 accountant bachelor degree. He joined the company in 2004
and has been the company's vice president and secretary of the company's board of directors since
2012.
The controlling shareholder and actual controller serve as the chairman and general manager of the
listed company at the same time
□Applicable □ Not applicable
The actual controller of the company Mr. Xue Hua is one of the founders of the company. He
also serves as the director of Guangzhou Haihao Investment Co. Ltd. the controlling shareholder of
the company and the chairman and president of the company. He has rich experience in corporate
management and industry resources. The controlling shareholder of the company is only an
investment platform company and has not carried out substantial business operations. It will not
distract Mr. Xue Hua from performing his duties in the company nor will it affect his diligence and
due diligence in the company. In addition Mr. Xue Hua serves as the chairman and president of the
company at the same time which can ensure the company's efficient and unified development strategy
and business decision-making. His appointment is a reasonable arrangement for the company's
current business development and complies with the relevant provisions of the Company Law and
the Articles of Association. The company has formulated relevant internal control systems such as
the Articles of Association the Working Rules of the President and the Management System of
Related Parties and Related Party Transactions which reasonably and clearly stipulate the functions
and powers of the board of directors and the president ensure standardized corporate governance and
independent operation and effectively safeguard the legitimate rights and interests of all shareholders
especially small and medium shareholders.Serving in shareholder units
□Applicable □ Not applicable
Whether to receive
Name of Name of Positions held in remuneration
incumbent shareholder unit shareholder units Term start date Term end date allowance in the
shareholder unit
64Guangzhou
Xue Hua Haihao Investment Director September 27 2006 No Co. Ltd
Guangzhou
Xu Yingzhuo Haihao Investment Manager December 01 March 19 2025 Yes
Co. Ltd 2021
Guangzhou
Qian Xueqiao Haihao Investment Supervisor December 01
Co. Ltd 2021
No
Description of the Mr. Xu Yingzhuo continued to engage in other work in the shareholder unit after he resigned as the manager
position in the of the shareholder unit on March 19 2025; Mr. Xu Yingzhuo was appointed as the vice president of the
shareholder unit company in June 2025. After taking office he did not hold any position in the shareholder unit and did not receive remuneration allowance.Serving in other units
□Applicable □ Not applicable
Whether to
Name of receive
incumbent Other unit names
Positions held
in other units Term start date Term end date remuneration allowance in
other units
Guangdong Airport City
Investment Co. Ltd Director January 21 2015 No
Guangzhou Huading
Xue Hua Investment Holdings Co. Supervisor May 19 2022 No
Ltd
Guangzhou Huayu
Investment Co. Ltd Director December 14 2021 No
Guangdong Haihaowan
Development Co. Ltd Chairman April 22 2020 No
Guangzhou Yanling
Investment Development Executive
Xu Co. Ltd Director
June 02 2021 No
Yingzhuo Guangzhou Yuyi Investment
Development Co. Ltd Supervisor June 04 2021 No
Guangzhou Yansheng
Investment Holdings Co. Executive Director June 08 2021 No Ltd
Guangzhou Huayu
Qian Investment Co. Ltd Supervisor December 14 2021 No
Xueqiao Guangzhou Qingyuan Executive
Investment Co. Ltd Director February 25 2022 No
School of Fisheries Ocean
University of China Professor November 28 2024 Yes Yin Zhan Shenzhen Research Institute
of Ocean University of China Professor November 28 2024 Yes
Sun Yat-sen University Professor June 01 2002 Yes
COSCO Shipping
Tan Jin Specialized Carriers Co. Independent December 06 2018 September 25
Song Ltd. director 2025
Yes
Jsti Group Independent director January 16 2026 Yes
Liu Guangzhou Qingyuan
Guoxiang Investment Co. Ltd Supervisor February 25 2022 No
Sun Yat-sen University Master's Off-campus Tutor June 05 2016 June 05 2028 Yes
Guangdong University of
Yang Foreign Studies Master Tutor January 01 2025 January 01 2030 No
Shaolin Guangdong Association of
Management Accountants Vice President October 01 2021 October 01 2027 No
Sun Yat-sen University Off-campus industry mentor January 17 2026 December 31 2028 Yes
65Jiang Guangzhou Haishengyuan Executive
Xiewu Investment Co. Ltd Director January 27 2022 No
Executive
Linyi Jiajun Management Director
Consulting Co. Ltd General April 26 2020 No
Huo Manager
Quanwen Executive
Linyi Haiding Management Director
Consulting Co. Ltd General April 29 2015 No
Manager
Description
of
employment Not applicable.in other
units
Punishment by securities regulatory authorities of the company's current and resigned directors and
senior executives in the past three years during the reporting period
□ Applicable □Not Applicable
3. Remuneration of directors and senior management
Decision-making procedures basis for determination and actual payment of remuneration for
directors and senior executives
The company has formulated the "Remuneration and Appraisal Management System for
Directors and Senior Managers" in accordance with national laws and regulations and in light of its
own actual conditions. As the highest authority of the company the shareholders' meeting is
responsible for reviewing and approving the implementation change and termination of the
remuneration system. The company has formulated the "Remuneration Plan for Directors and Senior
Management": independent directors adopt an annual allowance system with an allowance standard
of 180000 yuan per year; non-independent directors do not receive director allowances from the
company and non-independent directors who concurrently hold senior management or core positions
are paid according to the salary standard of senior management or core positions; the remuneration
of directors and senior management who concurrently hold core positions consists of basic salary
performance salary and medium and long-term incentives.Remuneration of directors and senior management during the reporting period
Unit: ten thousand yuan
Total pre-tax Whether to get
Name Sex Age Position Employment compensation paid from the status received from the company's
company affiliates
66Xue Hua Male 56 Chairman President Incumbent 406.09 No
Xu Yingzhuo Male 58 Co-Chairman Vice President Incumbent 51.64 Yes
Employee Representative
Qian Xueqiao Male 59 Director Vice President Incumbent 210.29 No
Chief Engineer
Director Incumbent
Shen Dong Male 48 179.38 No
Supervisor Outgoing
Yin Zhan Male 61 Independent director Incumbent 9.75 No
Tan Jin Song Male 61 Independent director Incumbent 9.75 No
Li Chunhou Male 63 Independent director Incumbent 9.75 No
Gui Jianfang Male 70 Independent director Outgoing 0.39 No
He Jianguo Male 64 Independent director Outgoing 8.25 No
Liu Yunguo Male 60 Independent director Outgoing 8.25 No
Gao Zexia Female 44 Independent director Outgoing 7.86 No
Cheng Qi Male 46 Vice-President Incumbent 221.67 No
Liu Guoxiang Male 57 Vice-President Incumbent 197.94 No
Yang Shaolin Male 52 Vice President Chief Financial Officer Incumbent 456.5 No
Chen
Mingzhong Male 61 Vice-President Incumbent 62.49 No
Jiang Xiewu Male 58 Vice-President Incumbent 198.99 No
Mi Guocheng Male 54 Vice-President Incumbent 196.94 No
Chen
Zhongzhu Male 56 Vice-President Incumbent 179.87 No
Huo Quanwen Male 51 Vice-President Incumbent 247.78 No
Zhang Guijun Male 52 Vice-President Outgoing 119.44 No
Lu Xuezhi Male 49 Vice-President Incumbent 167.67 No
Hou Huaping Male 52 Vice-President Incumbent 87.51 No
Yang Jiantao Male 57 Vice-President Outgoing 79.62 No
Wang Jing Female 47 Vice-President Incumbent 216.39 No
Huang Zhijian Male 48 Vice President Secretary of the Board Incumbent 194.67 No
Wang Hua Male 39 Supervisor Outgoing 39.73 No
Mu Yongfang Female 37 Supervisor Outgoing 25.54 No
Total -- -- -- -- 3594.15 --
Note: 1. The remuneration amount of new and outgoing directors supervisors and senior executives
during the reporting period is the amount of remuneration they received during their tenure during
the reporting period. For the term of office of each director supervisor and senior management during
the reporting period please refer to "IV. 1 Basic Information" in this chapter.
2. The above table does not include the total amount of operating profit sharing and special bonuses
paid and distributed by the 16 vice presidents of the company in 2025 totaling RMB 94607200.
3. Mr. Xu Yingzhuo will not receive remuneration from affiliated companies from June 17 2025.
67It is decided in accordance with the company's "Directors and
The assessment basis for the actual remuneration of all Senior Management Remuneration and Appraisal Management
directors and senior management at the end of the reporting System" and related systems combined with the company's
period performance realization and the contribution of the employees
to the company's operation and management.The completion of the assessment of the actual remuneration of
all directors and senior management at the end of the reporting Finished
period
Deferred payment arrangements for the actual remuneration of
all directors and senior management at the end of the reporting No
period
Stop payment recourse for all directors and senior management
actually received remuneration at the end of the reporting No
period
Other information
□ Applicable □Not Applicable
V. Directors' performance of duties during the reporting period
1. Directors' attendance at the board of directors and shareholders' meeting
Directors' attendance at the board of directors and shareholders' meeting
The number of
times you
should Number of Number Whether to fail to
Director's participate in
On-site Participation in of
the board of attendance the Board of
entrusted absences attend board Number of
name at the board Directors by attendance from the meetings in shareholders' directors of directors Correspondence at the board board of person for two meetings during the of directors directors consecutive times reporting
period
Xue Hua 7 7 0 0 0 No 4
Xu
Yingzhuo 7 4 3 0 0 No 3
Qian
Xueqiao 7 4 3 0 0 No 2
Shen Dong 5 4 1 0 0 No 2
Yin Zhan 5 1 4 0 0 No 3
Tan Jin
Song 5 1 4 0 0 No 3
Li
Chunhou 5 4 1 0 0 No 3
Cheng Qi 2 2 0 0 0 No 2
He Jianguo 2 1 1 0 0 No 2
Liu
Yunguo 2 1 1 0 0 No 3
Gao Zexia 2 1 1 0 0 No 3
Gui
Jianfang 0 0 0 0 0 No 2
Explanation of failing to attend the board of directors in person for two consecutive times
68During the reporting period there was no situation in which the company failed to attend the
board of directors in person for two consecutive times.
2. Directors' objections to the company's related matters
Whether the directors raise objections to the company's related matters
□Yes □No
During the reporting period the directors did not raise any objections to the company's relevant
matters.
3. Other explanations for directors to perform their duties
Whether the directors' recommendations on the company have been adopted
□Yes □ No
Directors' statement on whether the company's proposal was adopted or not adopted
During the reporting period all directors of the company carried out their work in strict
accordance with the "Company Law" "Shenzhen Stock Exchange Stock Listing Rules" and other
laws and regulations as well as the "Articles of Association" "Rules of Procedures of the
Shareholders' Meeting" "Rules of Procedures of the Board of Directors" and other company systems.They were faithful diligent and responsible. According to the actual situation of the company they
put forward relevant opinions on the company's major governance and business decisions. After full
communication and discussion they reached a consensus. And resolutely supervise and promote the
implementation of the resolutions of the board of directors ensure that the decision-making is
scientific timely and efficient and safeguard the legitimate rights and interests of the company and
all shareholders.
69VI. The status of the special committees under the board of directors during the reporting
period
Number Important
Committee of comments Other
Details
of the
name Membership meetings Date Meeting content and performance
held suggestions of duties
objection
made (if any)
2024 Annual Periodic
Report on Financial
Information Internal
April 18 2025 Control Evaluation - No No
Report and Review
Opinions on Impairment
Audit Liu Yunguo
Provisions
He Jianguo 3 Financial Report and Committee Gao Zexia April 18 2025 Internal Audit Report for - No No the First Quarter of 2025
Review the
qualifications for
June 13 2025 appointing the chief financial officer and the - No No
person in charge of
internal audit
2025 semi-annual
July 23 2025 financial report and internal audit report; hire - No No
2025 audit agency
Tan Jinsong October 16 2025 third quarter report
Audit Li 2025 and internal audit report
- No No
Committee Chunhou 4 December 30
Shen Dong 2025 2025 Annual Audit Plan - No No
The company's 2025
December 30 internal audit work
2025 report and 2026 internal - No No
audit work plan
Nominate non-
independent directors
May 23 2025 and independent directors of the seventh - No No
Nomination He Jianguo board of directors of the
Committee Liu Yunguo 2 company Cheng Qi Review the
qualifications for
June 13 2025 appointing senior - No No
management personnel
of the company
2021 stock options do
not meet the exercise
conditions and are
cancelled; 2024 stock
options do not meet the
exercise conditions and
Remuneration Liu Yunguo are cancelled; the
and Appraisal He Jianguo 2 April 18 2025 company's 2021 stock
Committee Qian option incentive plan and
- No No
Xueqiao some stock options of the
2024 stock option
incentive plan are
cancelled; the
performance evaluation
indicators for the first
vesting period of the
70Number Important Details
Committee Membership of
comments Other
name meetings Date Meeting content and performance
of the
held suggestions of duties
objection
made (if any)
2024 employee stock
ownership plan are not
reached
Proposal on Amending
the "Remuneration
Management System for
Directors Supervisors
May 29 2025 and Senior Executives" and changing its name to No No
"Remuneration
Management System for
Directors and Senior
Executives"
Xue Hua
Strategy Xu Securities and Futures
Committee Yingzhuo 1 April 18 2025 and Derivatives Trading - No No
Gao Zexia Solutions
Xue Hua July 25 2025 Hedging scheme - No No
Strategy Xu The plan to spin off
Committee Yingzhuo 2 October 16 overseas subsidiaries and Qian 2025 list them on the Hong - No No
Xueqiao Kong Stock Exchange
VII. Work of the Audit Committee
Whether the audit committee found out whether the company was at risk during its oversight
activities during the reporting period
□Yes □No
The Audit Committee has no objection to the supervision matters during the reporting period.VIII. Company employees
1. Number of employees professional composition and education level
Number of employees of the parent company at the end of the
reporting period (persons) 2818
Number of employees in major subsidiaries at the end of the
reporting period (persons) 41358
Total number of employees at the end of the reporting period
(person) 44176
The total number of salaried employees in the current period
(person) 44176
Number of retired employees (persons) to be borne by the
parent company and its main subsidiaries 0
Professional composition
Professional composition category Professional composition (person)
71Production staff 21008
Salesperson 12151
Technician 4208
Financial officer 1959
Administrative staff 3799
Purchasing staff 1051
Total 44176
Education level
Education category Quantity (persons)
PhD 152
Master 2423
Undergraduate 10458
College 9314
High school technical secondary school and below 21829
Total 44176
2. Salary policy
On the basis of strictly abiding by the "Labor Law of the People's Republic of China" "Labor
Contract Law of the People's Republic of China" and other relevant national and local laws and
regulations departmental rules and normative documents combined with the characteristics of the
industry and the company's operation and taking the overall development strategy and human
resource management planning goals as the starting point the company has formulated the "Salary
Management System" "Performance Management System" and other systems forming a scientific
and reasonable salary incentive and performance appraisal management system Ensure that
employees receive proper labor compensation fully mobilize their enthusiasm initiative and
creativity and encourage employees to make positive contributions to the development of the
company.The general principles of the company's compensation policy are: based on job value and
employee contribution emphasizing efficiency first and taking into account fairness; the
compensation system implements dynamic balance and employee compensation is adjusted with
changes in position rank and job performance reflecting employee's job contribution and
performance; at the same time the compensation level comprehensively considers regional and
industry conditions maintains moderate competitiveness and relies on a scientific job system to
72objectively evaluate the relative value of each position to maintain internal fairness; In addition the
increase in total compensation is reasonably matched with the company's economic benefits
comprehensively considering the gradual increase in per capita efficiency and adhering to the
principle of economy so as to achieve the common sustainable development of the company and its
employees.At the same time in order to link work performance with salary and personal interests with team
interests improve employees' sense of team and responsibility and make employees' efforts
consistent with the company's goals the company continuously reforms and improves the salary
benefits and insurance systems to create better social and economic benefits.
3. Training plan
The company's talent training has always been centered on improving the capabilities of the
organization and employees to ensure the effective realization of strategic goals. The company has
always placed talent training in an important position and knows that the growth and development
of employees is the key driving force and core resource to promote the company's sustainable
prosperity. Haida College as the company's talent training functional department always follows the
group's strategic orientation closely meets business needs upholds the core value of "all efforts are
only for you to grow" and is committed to solving the core problems in the development of the
organization with the principle of combining elite training and inclusive education. Through the
online and offline teaching mode the talent training project is deeply integrated with the corporate
strategy and business and the path of "training is work continuous learning at work" is realized.During the reporting period Haida College continued to build a learning organization centered
on creating value for customers and promoted key projects such as the training of IDP core cadres
the training of regional reserve financial leaders and MDP outstanding managers and cultivated a
group of management cadres with cultural strategic vision business operation ability and leadership.At the same time the cultural education of new employees in campus recruitment and social
recruitment continued to be strengthened and standardized; The training of lecturers and mentors goes
hand in hand and has cultivated a group of lecturers and mentors with strong professional ability and
rich experience for the group. In terms of overseas talent training through carefully crafted talent
73training programs it has successfully cultivated a group of localized professional backbones and
cadre teams which effectively promoted cross-cultural communication and integration. The
resources of the group's online learning platform "Haiwei" continue to iterate and become more
abundant which provides strong support for accelerating the formation of the group's learning
ecology. A strong talent training atmosphere has been formed within the group the talent training
resource system has been improved day by day the learning path map of each professional center has
been continuously optimized and upgraded and the training system of each business line has
gradually matured and it has become the work highlight of HR and business managers It has laid a
solid foundation for the continuous enrichment of the learning resource library and the in-depth
construction of the learning ecology of Haida University.
4. Labor outsourcing
□ Applicable □Not Applicable
IX. Profit distribution of the company and capitalization of capital reserve into share capital
During the reporting period the profit distribution policy especially the formulation
implementation or adjustment of the cash dividend policy
□Applicable □ Not applicable
The 2024 Annual General Meeting of Shareholders held on May 13 2025 reviewed and
approved the "Proposal on the 2024 Profit Distribution Plan". The distribution plan is based on the
"total share capital of the repurchased shares deducted from the share registration date when the
distribution plan is implemented in the future (that is the number of shares that can participate in the
distribution on the share registration date when the distribution plan is implemented in the future)"
The cash dividend is 11.00 yuan (including tax) for every 10 shares and the total proposed cash
dividend shall not exceed the profit available for distribution to shareholders of the parent company
on December 31 2024. On June 27 2025 the implementation of the equity distribution was
completed.
74The 2025 Third Extraordinary Shareholders' Meeting held on August 14 2025 reviewed and
approved the "Proposal on the 2025 Interim Profit Distribution Plan". The distribution plan is: "The
total share capital of the repurchased shares will be deducted from the share registration date when
the distribution plan is implemented in the future (that is the number of shares that can participate in
the distribution on the share registration date when the distribution plan is implemented in the future)"
as the base and a cash dividend of RMB 2.00 (including tax) will be distributed for every 10 shares
The total amount of cash to be distributed shall not exceed the profit available for distribution to
shareholders of the parent company as of June 30 2025. On September 25 2025 the implementation
of this equity distribution was completed.During the reporting period the company strictly implemented the profit distribution policies
such as the Articles of Association the Dividend Return Plan for the Next Three Years (2022-2024)
and the Dividend Return Plan for the Next Three Years (2025-2027).Special description of cash dividend policy
Whether it complies with the provisions of the company's
articles of association or the requirements of the resolutions of Yes
the shareholders meeting:
Whether the dividend standard and ratio are clear and clear: Yes
Whether the relevant decision-making procedures and
mechanisms are complete: Yes
Whether independent directors perform their duties and play
their due role: Yes
If the company does not distribute cash dividends it shall
disclose the specific reasons and the measures it plans to take in Not applicable
the next step to enhance the level of investor returns:
Whether small and medium shareholders have the opportunity
to fully express their opinions and demands and whether their Yes
legitimate rights and interests are fully protected:
If the cash dividend policy is adjusted or changed whether the
conditions and procedures are compliant and transparent: Yes
The company made a profit during the reporting period and the parent company's profit available
for distribution to shareholders was positive but no cash dividend distribution plan was proposed
□ Applicable □Not Applicable
Profit distribution and capitalization of capital reserve during the reporting period
□Applicable □ Not applicable
Bonus shares for every 10 shares (shares) 0
Dividend per 10 shares (yuan) (including tax) 11
75The total share capital on the record date of the future
The share capital base of the distribution plan (shares) implementation of the distribution plan minus the repurchased
shares
Cash dividend amount (yuan) (tax included) 2142574278.70
Amount of cash dividends in other ways (such as repurchasing
shares) (yuan) 718617412.25
Total cash dividends (including other methods) (yuan) 2861191690.95
Distributable profit (yuan) 3963841466.35
The proportion of total cash dividends (including other
methods) to total profit distribution 100%
The cash dividend distribution
If the company's development stage is in the growth period and has major capital expenditure arrangements when the profit
distribution is carried out the proportion of cash dividends in this profit distribution should be at least 20%
Detailed description of the profit distribution or capital reserve transfer plan
According to the audit report issued by Grant Thornton Zhitong Certified Public Accountants LLP the net profit attributable to
shareholders of the listed company in the company's 2025 consolidated statement was RMB 4280330734.08 and the net profit of
the parent company was RMB 781782694.93.According to the relevant provisions of the Company Law and the Articles of Association the accumulated amount of the company's
statutory surplus reserve has reached more than 50% of the company's registered capital. The company will no longer withdraw the
statutory surplus reserve or withdraw the discretionary reserve in 2025. As of December 31 2025 The profit available for
distribution to shareholders in the consolidated statement is RMB 18316085114.07 and the profit available for distribution to
shareholders of the parent company is RMB 3963841466.35.According to the "Stock Listing Rules of the Shenzhen Stock Exchange" (hereinafter referred to as the "Stock Listing Rules ") the
profit distribution of a listed company shall be based on the profit available for distribution in the statement of the parent company.At the same time in order to avoid over-distribution the company should determine the specific profit distribution ratio based on
the principle of the lower of the profit available for distribution in the consolidated statement and the parent company's statement.Therefore the company's 2025 profit distribution plan is based on the parent company's profit available for distribution to
shareholders on December 31 2025.Based on the company's operations in 2025 combined with the company's business scale and future development needs as well as
the reasonable demands of investors and continuous return to shareholders the company has formulated a profit distribution plan
for 2025 (hereinafter referred to as the "distribution plan "): the company plans to deduct the total share capital of the repurchased
shares from the equity registration date when the distribution plan is implemented in the future (that is the number of shares that
can participate in the distribution on the equity registration date when the distribution plan is implemented in the future) as the base
The cash dividend of RMB 11.00 (including tax) will be distributed for every 10 shares. The total cash dividend to be distributed
shall not exceed the profit available for distribution to shareholders of the parent company on December 31 2025 and the remaining
undistributed profit will be carried forward to subsequent years. Based on the calculation of the total share capital of the company
deducting the repurchased shares as of the disclosure date of this distribution plan it is estimated that a total of 1809837124.70
yuan (tax included) will be distributed in cash dividends.The company's mid-term equity distribution for 2025 was completed on September 25 2025 with a cash dividend of RMB
332737154.00. Combined with the above-mentioned 2025 profit distribution plan it is estimated that cash dividends will be
distributed and the company's accumulated cash dividends in 2025 will total 2142574278.70 yuan. As of December 31 2025 the
company will use cash as the consideration to repurchase shares in the amount of 718617412.25 yuan by means of centralized
bidding. The shares corresponding to the repurchase amount have been cancelled on April 22 2026. In 2025 the company expects
to accumulate cash dividends and repurchase shares totaling 2861191690.95 yuan.X .Implementation of the company's equity incentive plan employee stock ownership plan or
other employee incentive measures
□Applicable □ Not applicable
761. Equity incentives
(1) 2021 Stock Option Incentive Plan
On April 18 2025 the company held the twenty-fourth meeting of the sixth board of directors
and the nineteenth meeting of the sixth board of supervisors. Deliberated and approved the "Proposal
on the Company's 2021 Stock Option Incentive Plan for the first grant of the fourth exercise period
and the reserved grant of the third exercise period that does not meet the exercise conditions and
cancels the corresponding stock options" and "The Proposal on the Cancellation of the Company's
2021 Stock Option Incentive Plan and Part of the 2024 Stock Option Incentive Plan". It was
determined that the first grant of the fourth exercise period and the reserved grant of the third exercise
period of the company's 2021 stock option incentive plan did not meet the exercise conditions and
9719550 corresponding stock options were agreed to be cancelled; 467490 stock options
corresponding to 241 incentive objects who resigned or terminated their labor relations in the 2021
stock option incentive plan were agreed to be cancelled. The proposal has been reviewed and
approved by the first meeting of the Remuneration and Appraisal Committee of the company's sixth
board of directors in 2025 and the company's board of supervisors issued a verification opinion. After
review and confirmation by China Securities Depository and Clearing Co. Ltd. Shenzhen Branch on
May 21 2025 the company completed the cancellation of 9719550 stock options granted for the
first time in the fourth exercise period of the 2021 stock option incentive plan and reserved for the
third exercise period as well as 467490 stock options granted by some incentive objects that have
been granted but have not met the exercise conditions.
(2) 2024 Stock Option Incentive Plan
On April 18 2025 the company held the twenty-fourth meeting of the sixth board of directors
and the nineteenth meeting of the sixth board of supervisors and reviewed and approved the
"Proposal on the first exercise period of the company's 2024 stock option incentive plan that does not
meet the exercise conditions and cancels the corresponding stock options" "The Proposal on
Canceling the Company's 2021 stock option incentive plan and some stock options in the 2024 stock
option incentive plan" It was determined that the first exercise period of the company's 2024 stock
option incentive plan did not meet the exercise conditions and 16191090 corresponding stock
options were agreed to be cancelled; 771205 stock options corresponding to 198 incentive objects of
77the 2024 stock option incentive plan who resigned or terminated their labor relations were agreed to
be cancelled. The proposal has been reviewed and approved by the first meeting of the Remuneration
and Appraisal Committee of the sixth board of directors of the company in 2025 and the board of
supervisors of the company issued a verification opinion. After review and confirmation by China
Securities Depository and Clearing Co. Ltd. Shenzhen Branch the company completed the
cancellation of 16191090 stock options in the first exercise period of the 2024 stock option incentive
plan and 771205 stock options that have been granted by some incentive objects and have not met
the exercise conditions on May 21 2025.
(3) Accounting treatment of equity incentives and its impact on company performance
According to the relevant provisions of "Accounting Standards for Business Enterprises No. 11
— Share Payment" the company will revise the number of stock options expected to be exercised on
each balance sheet date of the waiting period based on the latest obtained follow-up information such
as the change in the number of exercisers and the completion of performance indicators and the
services obtained in the current period will be included in the relevant costs or expenses and capital
reserve according to the fair value of the stock option grant date.The implementation of the above-mentioned equity incentive plan will not have a significant
impact on the company's financial position and operating results during the reporting period and in
the future.Equity incentives received by directors and senior managers of the company
□Applicable □ Not applicable
Unit: share
Num The Num
ber Num number
Num ber
of of ber Num The of
Num
Num ber of num newl ber
ber of newl Numby er of of
shares
exercis stoc Market
ber of ber y of
stock grant exerci share ed k price at
restri
cted of grant Grant
restri
optio s opti the end unloc ed price of cted
ns ed sable during share share
Name Position held stock shares
exerc the ons of the s held ked restri restrict s
at the optio during
ised
durin reporti
held reporti
at ng at the
share cted ed
ns the s in share stock
held
begin g the ng the period begin the s (yuan/s at the
ning durin reportig the ng repor
period
and the end (yuan/s
ning end
of the of the
curre durin hare) of
year repor period
ting exercis of hare) perio nt g the the
ting period e price
the d perio reporperi d ting perioperio (yuan/s
d hare) od perio
d
d
Qian Employe 5800 0 0 0 0 290 55.38 0 0 0 0 0
78Num The Num
ber Num ber
of Num
number
of ber Num The of
Num
Num newl Numb ber shares of ber of num newl
ber
ber of of of
stock y er of share exercis
stoc Market restri ber y restri
optio grant exerci ed
k price at cted of grant Grant cted
ns ed sable
s during opti the end share unloc ed price of
stock shares exerc the ons of the ked restri restrict
share
Name Position held optio during ised reporti held reporti
s held
at the share cted ed
s
at the held
begin ns the
durin
g the ng
at ng s in share stock
durin reporti period the period
begin
ning the s (yuan/s
at the
ning g the ng repor and the end (yuan/s
end
of the ting of hare) of the
curre durin hare)
repor period exercis perio nt g the
of
year ting perio
the
d e price
the d perio repor perio
perio (yuan/s peri d ting
d hare) od perio
d
d
Xueqi e 0 00
ao Represe
ntative
Director
Vice
Presiden
t Chief
Engineer
Chen Vice-
g Qi Presiden
6200
00000
310
00 55.38 0 0 0 0 0 t
Liu Vice-
Guoxi Presiden 54000 0 0 0 0
270
00 55.38 0 0 0 0 0 ang t
Vice
Yang Presiden
Shaol t Chief 5800 0 0 0 0 2900 00 55.38 0 0 0 0 0 in Financia
l Officer
Jiang Vice-
Xiew Presiden 5400 270
u t 0
00000055.3800000
Mi Vice-
Guoc Presiden 5400 2700 0 0 0 0 00 55.38 0 0 0 0 0 heng t
Chen Vice-
Zhon Presiden 62000 0 0 0 0
310
gzhu t 00
55.3800000
Huo Vice-
Quan Presiden 4600 0 0 0 0 230 55.38 0 0 0 0 0
wen t 0 00
Lu Vice-
Xuez Presiden 50000 0 0 0 0
250
00 55.38 0 0 0 0 0 hi t
Hou Vice-
Huapi Presiden 4800 0 0 0 0 2400 00 55.38 0 0 0 0 0 ng t
Wang Vice-Presiden 5000 0 0 0 0 250Jing 0 00 55.38 0 0 0 0 0 t
Vice
Huan Presiden
g t 5800 290
Zhijia Secretar 0 0 0 0 0 00 55.38 0 0 0 0 0
n y of the
Board
Total -- 6540 32700 0 0 0 -- 000 -- 0 0 0 -- 0
Remarks (if any) 1. During the reporting period the Company held the twenty-fourth meeting of the sixth board of directors
79Num The Num
ber number Num ber
of Num of ber The of
Num
Num ber of Num num newl ber
ber of newl Numb of shares y er of exercis stoc Market
ber of of
stock share k price at restri
ber y restri
optio grant exerci
of grant Grant
ed sable s
ed opti the end cted cted
ns exerc during ons of the share
unloc ed price of
stock shares the s held ked restri restrict
share
Name Position held ised s
at the optio during durin reporti
held reporti
at ng at the
share cted ed
ns the ng s in share stock
held
begin durin reporti g the period the period
begin
ning the s (yuan/s
at the
ning g the ng repor and the end (yuan/s of the curre durin hare)
end
of the repor period ting exercis of hare) nt g the
of
year ting perio e price the
perio
d perio repor
the
perio d (yuan/s peri d ting
perio
d
d hare) od period
and the nineteenth meeting of the sixth board of supervisors and reviewed and approved the "Proposal on
the Company's 2021 Stock Option Incentive Plan for the First Grant of the Fourth Exercise Period and the
Reserved Grant of the Third Exercise Period Does Not Meet the Exercise Conditions and Cancellation of the
Corresponding Stock Options" and agreed that the Company will cancel the first grant of stock options and
the reserved grant of stock options that the incentive objects have been granted but did not meet the exercise
conditions Among them the cancellation of a total of 363000 stock options for directors and senior
executives will be completed on May 21 2025.
2. Mr. Hou Huaping was appointed by the board of directors as the vice president of the company on June
16 2025. The number of stock options he held before taking office has been included in the report at the
beginning of the reporting period.
3. Mr. Zhang Guijun and Mr. Yang Jiantao have resigned from their positions as vice presidents of the
company on November 26 2025. The table does not include the number of stock options held by the two of
them.Evaluation mechanism and incentives for senior managers
The company has established a mechanism for the selection evaluation incentive and restraint
of senior management personnel. All senior management personnel of the company are appointed by
the board of directors. They are responsible to the board of directors and undertake the business
indicators issued by the board of directors. The board of directors has a special meeting of
independent directors to formulate and supervise the executive compensation and assessment system
to ensure its rationality and fairness. In order to ensure that the behavior of executives is consistent
with the company's long-term interests and improve the company's performance. The following
evaluation mechanism has been established: According to the company's strategic goals key
performance indicators such as financial (such as sales volume profit ROA) and non-financial
indicators (such as market share customer satisfaction and employee growth) are set and the
performance of executives is comprehensively evaluated from the four dimensions of finance
customers internal processes learning and growth. And through the group talent management
committee to collectively evaluate the performance of executives to ensure the combination of long-
term and short-term goals not only focusing on short-term performance but also evaluating the
80realization of long-term strategic goals. The design of executive incentive mechanism is diversified.
The compensation structure includes fixed compensation annual performance bonus growth sharing
long-term incentives etc. The compensation incentives are closely linked with performance appraisal
and the annual bonus growth sharing and long-term incentives are all linked to performance goals
and achievement. The company also pays attention to non-cash incentives such as honors and career
development opportunities to enhance the sense of belonging and achievement of executives. In
summary during the reporting period senior management's assessment and incentives took into
account the company's short-term performance and long-term development and through a reasonable
and diversified salary structure and equity incentives it ensured that the interests of senior
management were consistent with those of the company and shareholders.
2. Implementation of the Employee Stock Ownership Plan
□Applicable □ Not applicable
All effective employee stock ownership plans during the reporting period
As a percentage
Number of Total number of of the total Sources of funds for the Scope of employees employees shares held Changes share capital of implementation of the (shares) listed plan
companies
Participants of the 2024
Employee Stock Ownership Plan Employees' legitimate
are directors supervisors senior No more than 750 3357761 No 0.20%
income self-financing or
management and other core other means permitted by
personnel applicable law
Shareholding of directors and senior executives in the employee stock ownership plan during the
reporting period
Number of shares held Number of shares held
Name Position at the beginning of the at the end of the
As a percentage of the
reporting period reporting period total share capital of
(shares) (shares) listed companies
Employee
Representative
Qian Xueqiao Director Vice
President Chief
Engineer
Shen Dong Director
8640004320000.03%
Cheng Qi Vice-President
Liu Guoxiang Vice-President
Yang Shaolin Vice President Chief Financial Officer
Jiang Xiewu Vice-President
81Mi Guocheng Vice-President
Chen Zhongzhu Vice-President
Huo Quanwen Vice-President
Lu Xuezhi Vice-President
Hou Huaping Vice-President
Wang Jing Vice-President
Huang Zhijian Vice President Secretary of the Board
Changes in asset management institutions during the reporting period
□ Applicable □Not Applicable
Changes in equity during the reporting period due to the disposal of shares by holders etc
□Applicable □ Not applicable
As of the end of the reporting period some of the company's shares held by the ESOP in 2024
have been sold through centralized bidding. The number of shares traded was 3357700 shares and
the remaining number of shares held was 3357761 shares accounting for 0.20% of the company's
total share capital at the end of the reporting period.Exercise of shareholder rights during the reporting period
During the reporting period the company's 2024 employee stock ownership plan attended the
company's fourth extraordinary shareholders meeting in 2025 through online voting and exercised
shareholder rights and voted in favor of the proposals considered by the shareholders meeting.Other relevant circumstances and explanations of the employee stock ownership plan during the
reporting period
□ Applicable □Not Applicable
Changes in the membership of the Employee Stock Ownership Plan Management Committee
□Applicable □ Not applicable
On November 25 2025 the 2024 Employee Stock Ownership Plan held the first holders'
meeting in 2025 and the Proposal on Changing the Members of the 2024 Employee Stock Ownership
Plan Management Committee was reviewed and approved. Mr. Hou Huaping and Mr. Ye Moutian
resigned from the 2024 Employee Stock Ownership Plan Management Committee due to personal
reasons and Mr. Liu Changcheng and Mr. Wang Hua were elected as members of the 2024 Employee
82Stock Ownership Plan Management Committee. Together with the original member Ms. Yang
Huafang the management committee was formed and the term of office was the same as the duration
of this shareholding plan.The financial impact of the employee stock ownership plan on listed companies during the
reporting period and related accounting treatments
□Applicable □ Not applicable
The accounting treatment of the company's employee stock ownership plan is in accordance with
the "Accounting Standards for Business Enterprises No. 11 — Share-based Payment": For equity-
settled share-based payment in exchange for employee services after completing the service within
the waiting period or meeting the specified performance conditions the fair value of the equity
instrument on the grant date shall be based on the best estimate of the number of exercisable equity
instruments on each balance sheet date during the waiting period The services obtained in the current
period are included in the relevant costs or expenses and capital reserves.The implementation of the aforementioned employee stock ownership plan will not have a
significant impact on the company's financial position and operating results during the reporting
period and in the future.Termination of employee stock ownership plans during the reporting period
□ Applicable □Not Applicable
Other instructions:
No
3. Other employee incentives
□ Applicable □Not Applicable
83XI. Construction and implementation of the internal control system during the reporting
period
1. Construction and implementation of internal control
In accordance with the "Company Law" "Securities Law" "Basic Norms of Enterprise Internal
Control" "Shenzhen Stock Exchange Stock Listing Rules" and other laws and regulations the
company has established improved and effectively implemented internal control reasonably ensured
the legal compliance of operation and management asset safety authenticity and integrity of financial
reports and related information and improved operating efficiency and effectiveness. The company
revised supplemented and improved the daily operation and management regulations in a timely
manner and the internal control operation mechanism was effective which achieved the expected
goals of internal control protected the interests of the company and all shareholders and laid a good
institutional foundation for the healthy and rapid development of the company. The Company's
Internal Control Self-evaluation Report 2025 comprehensively truthfully and accurately reflected the
actual situation of the Company's internal control. During the reporting period the Company had no
major deficiencies and major deficiencies in internal control.
2. Details of major deficiencies in internal control discovered during the reporting period
□Yes □No
XII. The management and control of the company's subsidiaries during the reporting period
Problems Follow-
Company Integration plan Integration encountered Solutions Resolution up name progress in taken progress resolution
integration plan
In accordance with the relevant regulations
of the China Securities Regulatory
Commission the Shenzhen Stock
Zhuhai Dehai Exchange and the company's articles of
Biotechnology association of the listed company guide and Not Not Not Not
Co. Ltd. and standardize the target company's Integrated applicable applicable applicable applicable
its subsidiaries institutional setup personnel adjustment
internal control system financial system
etc. and incorporate it into the listed
company system for unified management
Zhejiang In accordance with the relevant regulations
Lanke Seed of the China Securities Regulatory Integrated Not Not Not Not
Technology Commission the Shenzhen Stock applicable applicable applicable applicable
84Problems Follow-
Company Integration plan Integration encountered Solutions Resolution up name progress in taken progress resolution
integration plan
Co. Ltd Exchange and the company's articles of
association of the listed company guide and
standardize the target company's
institutional setup personnel adjustment
internal control system financial system
etc. and incorporate it into the listed
company system for unified management
In accordance with the relevant regulations
of the China Securities Regulatory
PT BIBIT Commission the Shenzhen Stock
UNGGUL Exchange and Indonesia and the articles of
(Indonesia association of the listed company guide and
Quality Seed standardize the institutional setting Integrated
Not Not Not Not
personnel adjustment internal control applicable applicable applicable applicable Industry Co.Ltd.) system financial system and other aspects of the target company and incorporate it
into the listed company system for unified
management
There is an abnormality in the management and control of the subsidiary
□Yes □No
XIII. Internal control evaluation report or internal control audit report
1. Internal control evaluation report
Disclosure date of the full text of the
internal control evaluation report April 28 2026
Internal Control Evaluation Report Full
Text Disclosure Index Juchao Information Network (www.cninfo.com.cn)
The proportion of the total assets of the
units included in the evaluation scope to
the total assets of the company's 100.00%
consolidated financial statements
The proportion of the operating income
of the unit included in the evaluation
scope to the operating income of the 100.00%
company's consolidated financial
statements
Defect identification standard
Category Financial report Non-financial reporting
For details please refer to the "2025 For details please refer to the "2025
Qualitative criteria Internal Control Self-evaluation Report" Internal Control Self-evaluation Report"
disclosed on the same day disclosed on the same day
For details please refer to the "2025 For details please refer to the "2025
Quantitative standard Internal Control Self-evaluation Report" Internal Control Self-evaluation Report"
disclosed on the same day disclosed on the same day
Number of material defects in financial
reporting (a) 0
Number of material deficiencies in non-
financial reporting (pieces) 0
85Number of significant deficiencies in
financial reporting (a) 0
Number of significant deficiencies in
non-financial reporting (a) 0
2. Internal control audit report
□Applicable □ Not applicable
Deliberation opinion paragraph in the internal control audit report
On December 31 2025 the Company maintained effective internal control over financial reporting in all material aspects in
accordance with the Basic Norms for Enterprise Internal Control and relevant regulations.Disclosure of internal control audit reports Disclose
Disclosure date of the full text of the internal control audit
report April 28 2026
Internal Control Audit Report Full Text Disclosure Index Juchao Information Network (www.cninfo.com.cn)
Internal control audit report opinion type Standard unqualified opinion
Whether there are material deficiencies in non-financial
reporting No
Whether the accounting firm has issued a non-standard opinion on the internal control audit report
□Yes □No
Whether the internal control audit report issued by the accounting firm is consistent with the self-
evaluation report of the board of directors
□Yes □ No
Whether a non-standard audit opinion on internal control was issued during the reporting period or
the previous year
□Yes □No
XIV. The rectification of self-examination problems in the special action of listed company
governance
Not applicable.XV. Disclosure of environmental information
Whether listed companies and their main subsidiaries are included in the list of companies that
disclose environmental information according to law
86□Yes □ No
The number of enterprises included in the list of enterprises
that disclose environmental information according to law 17
(units)
Serial Business name Query Index of Environmental Information Legal Disclosure number Report
Notice of Guangzhou Municipal Bureau of Ecology and
1 Guangzhou Dachuan Feed Co. Ltd Environment on Announcement of the List of Enterprises Disclosure of Environmental Information According to Law in
2025
2 Zhanjiang Haida Feed Co. Ltd Zhanjiang City 2025 Environmental Information Disclosure List of Enterprises According to Law
Notice of Changzhou Municipal Bureau of Ecology and
3 Changzhou Haida Biological Feed Co. Ltd Environment on Announcement of the List of Enterprises Disclosure of Environmental Information According to Law in
2025
Announcement of the list of enterprises that disclose
4 Jingzhou Haida Feed Co. Ltd environmental information in accordance with the law in Jingzhou
in 2025
5 Tianmen Haida Feed Co. Ltd List of companies that disclose environmental information in Tianmen City in 2025 according to law (draft for comments)
6 Sichuan Hellinger Biopharmaceutical Co. Ltd Announcement on "Chengdu 2025 Enterprise Environmental Information Disclosure List According to Law"
Notice of Qingyuan Ecological Environment Bureau on Printing
7 Qingyuan Haibei Biotechnology Co. Ltd and Distributing the "List of Enterprises Disclosure of
Environmental Information in Qingyuan City in 2025"
8 Guizhou Aikexin Pig Breeding Co. Ltd Qiannan Prefecture 2025 Environmental Information Disclosure List of Enterprises According to Law
Hengshan County Yitun Ecological Agriculture Announcement of the list of companies that disclose 9 Co. Ltd environmental information in accordance with the law in Hengyang in 2025
Public announcement of the list of companies that disclose
10 Zixing Yitun Ecological Agriculture Co. Ltd environmental information in accordance with the law in
Chenzhou in 2025
Hengyang Jisheng Agriculture and Animal Announcement of the list of companies that disclose 11 Husbandry Development Co. Ltd environmental information in accordance with the law in Hengyang in 2025
Hengnan County Yitun Ecological Agriculture Announcement of the list of companies that disclose 12 Co. Ltd environmental information in accordance with the law in Hengyang in 2025
13 Shaoguan Zhenjiang District Yitun Ecological
Notice on Printing and Distributing the List of Enterprises
Agriculture Co. Ltd Disclosure of Environmental Information According to Law in Shaoguan City in 2025
14 Jiaxiang Haiying Food Co. Ltd Announcement on the list of enterprises that disclose environmental information according to law in Jining City in 2025
15 Linxi County Haiying Food Co. Ltd Announcement on the "List of Enterprises Disclosure of Environmental Information in Xingtai City in 2025"
16 Yiyuan Haiying Food Co. Ltd List of companies that disclose environmental information according to law in Zibo City in 2025
Enterprise Environmental Information Legal Disclosure System
17 Liyang Jiuhe Feed Co. Ltd of Jiangsu Provincial Department of Ecology and Environment
(Jiangsu)
XVI. Social Responsibility
For details please refer to the "2025 Sustainability Report" disclosed by the company in the
designated information disclosure media.
87XVII. Consolidate and expand the achievements of poverty alleviation and rural revitalization
As a responsible private enterprise rooted in agriculture rural areas and farmers and serving
agriculture and animal husbandry the company has always been adhering to the tenet of "promoting
agriculture through science and technology and assisting agriculture through industry" and has
actively participated in the main battlefield of rural revitalization. The company gives full play to the
resource advantages of the whole industry chain aims at the three goals of agricultural modernization
farmer professionalization and popularization of agricultural technology and contributes scientific
and technological strength and leadership to rural revitalization.For more than 20 years Haida people have been running on the road of popularization and
publicity of agricultural technology shuttled by the Tangtou bar in the fields and countryside. With
the advantages of the whole industry chain of seedlings feed biopharmaceuticals and breeding of
Haid Group and its strong R&D and innovation capabilities with advanced breeding concepts
technologies and products Haida people have effectively helped millions of farmers to scientifically
breed increase income and become rich open up the "last mile" of agricultural science and
technology services and promote the industrialization of agriculture the professionalization of
farmers and the popularization of agricultural technology. Contribute great strength to rural
revitalization.For details please refer to the "2025 Sustainability Report" disclosed by the company in the
designated information disclosure media.
88Section 5 Important Matters
I. Fulfillment of commitments
1. The company's actual controllers shareholders related parties acquirers and the
company and other related parties have fulfilled their commitments during the reporting
period and have not fulfilled their commitments as of the end of the reporting period
□Applicable □ Not applicable
Promise Promise Commitment party type Commitment content
Promise Commitment
time period Performance
1. Mr. Xue Hua promises not
to use the position of the actual
controller to damage the
interests of Haid Group and
other shareholders of Haid
Group. 2. During the period as
the actual controller of Haid
Group Mr. Xue Hua
guarantees that he and his
wholly-owned subsidiaries
Commitments holding subsidiaries and
Commitments on horizontal companies actually controlled
made in an competition (except Haid Group) will not
initial public Xue Hua related party directly or indirectly engage in November Long Strictly
offering or transactions any form of business activities 27 2009 performing
refinancing and capital within or outside China that
occupation compete with the main
business or main products of
Haid Group or pose a threat of
competition Including
companies enterprises or
other economic organizations
that do not invest acquire or
merge with the same or similar
main business or main
products of Haid Group within
or outside China.
1. Guarantee not to use the
position of the controlling
shareholder to damage the
interests of Haid Group and
other shareholders of Haid
Commitments Group. 2. During the period
Commitments on horizontal when Guangzhou Haihao is
made in an Guangzhou competition the controlling shareholder of
initial public Haihao Haid Group Guangzhou November Strictly
offering or Investment
related party Long
Co. Ltd transactions
Haihao guarantees that 27 2009 performing
refinancing and capital Guangzhou Haihao and its
occupation wholly-owned subsidiaries holding subsidiaries (except
Haid Group) and companies
actually controlled will not
directly or indirectly engage in
business activities that
compete with or threaten
89Promise Promise Commitment party type Commitment content
Promise Commitment
time period Performance
competition with the main
business or main products of
Haid Group in any form within
or outside China Including
companies enterprises or
other economic organizations
that do not invest acquire or
merge within or outside China
with the same or similar main
business or main products of
Haid Group.The Company promises not to
provide loans loan guarantees
Equity Guangdong
or any other forms of financial
Haid Other assistance for incentive objects May 20 May 20 2021 Incentive Strictly
Commitment Group Co. commitments
to obtain relevant rights and to June 27
Ltd. interests in accordance with
2021 2027 performing
the 2021 Stock Option
Incentive Plan of Guangdong
Haid Group Co. Ltd.The Company undertakes not
to provide loans loan
guarantees or any other forms
Equity Guangdong of financial assistance to the March 20
Incentive Haid Other incentive objects for the March 20 Group Co. commitments exercise of the stock options 2024 2024 to May
Strictly
Commitment performing Ltd. granted in the 2024 Stock 8 2028
Option Incentive Plan of
Guangdong Haid Group Co.Ltd.When the company
implements cash dividends
the following conditions must
be met at the same time:
(1) The company has made
profits in the year or half of the
year and the accumulated
distributable profits (that is
the remaining after-tax profits
after the company makes up
for losses and withdraws the
provident fund) are positive
and the cash flow is sufficient.The implementation of cash
Other dividends will not affect the
commitments Guangdong company's subsequent
made to the Haid Dividend continuous operations; May 09 May 9 2022
company's Group Co. Commitment (2) The audit institution shall 2022 to June 27 Fulfilled
minority Ltd. issue a standard unqualified 2025
shareholders audit report on the company's
annual financial report (if the
company implements interim
dividends the audit institution
shall have issued a standard
unqualified audit report on the
company's previous annual
financial report);
(3) The company has no major
foreign investment plans or
major cash expenditures in the
next twelve months (except for
fund-raising projects). A major
investment plan or major cash
expenditure means that the
90Promise Promise Commitment party type Commitment content
Promise Commitment
time period Performance
company's planned external
investment asset acquisition
or equipment purchase in the
next twelve months has
reached or exceeded 30% of
the company's most recent
audited net assets.
(4) There are no other
circumstances that the board of
directors considers
inappropriate for cash
dividend distribution.When the company
implements cash dividends
the following conditions must
be met at the same time:
(1) The company has achieved
profit in the year or half of the
year the accumulated
distributable profit is positive
and the cash flow is sufficient
the implementation of cash
dividends will not affect the
company's subsequent
continuous operation;
(2) The audit institution shall
Other issue a standard unqualified
commitments Guangdong audit report on the company's
made to the Haid Dividend annual financial report; June 16 2025
company's Group Co. Commitment (3) The company has no major
June 16 to June 15 Strictly
minority Ltd. foreign investment plans or
2025 2028 performing
shareholders major cash expenditures in the next twelve months. A major
investment plan or major cash
expenditure means that the
company's planned external
investment asset acquisition
or equipment purchase in the
next twelve months has
reached or exceeded 30% of
the company's most recent
audited net assets.
(4) There are no other
circumstances that the board of
directors considers
inappropriate for cash
dividend distribution.Whether the promise is fulfilled on time Yes
If the commitment is overdue and not
fulfilled the specific reasons for the non-
fulfillment and the next work plan shall be Not applicable.explained in detail
2. If there is a profit forecast for the company's assets or projects and the reporting period is
still in the profit forecast period the company will explain that the assets or projects have
reached the original profit forecast and the reasons for it
□ Applicable □Not Applicable
913. The company involves performance commitments
□ Applicable □Not Applicable
II. Non-operating capital occupation of listed companies by controlling shareholders and
other related parties
□ Applicable □Not Applicable
During the reporting period there was no non-operating capital occupation of the listed company by
the controlling shareholder and other related parties.III. Violation of external guarantees
□ Applicable □Not Applicable
During the reporting period the company had no illegal external guarantees.IV. Explanation of the Board of Directors on the latest "non-standard audit report"
□□ Applicable Not Applicable
V. Explanations of the board of directors and independent directors (if any) on the "non-
standard audit report" of the accounting firm during the reporting period
□ Applicable □Not Applicable
VI. Explanation of changes in accounting policies accounting estimates or corrections of
material accounting errors compared with the financial report of the previous year
□ Applicable □Not Applicable
During the reporting period the company had no accounting policies changes in accounting
estimates or corrections of major accounting errors.
92VII. Explanation of the changes in the scope of the consolidated statement compared with the
financial report of the previous year
□Applicable □ Not applicable
The company included 611 subsidiaries in the consolidated financial statements this year an
increase of 64 and a decrease of 27 over the previous year. For details please refer to Note VII in
Section VIII "Financial Reports". Interests in other entities.VIII. Appointment and Dismissal of Accounting Firms
Current accounting firm
Name of domestic accounting firm Grant Thornton Zhitong Certified Public Accountants LLP
Remuneration of domestic accounting firms (ten thousand
yuan) 480
Consecutive years of audit services of domestic accounting
firms 7 years
The name of the certified public accountant of the domestic
accounting firm Li Xujia Qiu Shuntong
The continuous number of years of CPA audit services of
domestic accounting firms Li Xujia 2 years Qiu Shuntong 3 years
Name of overseas accounting firm (if any) Not applicable
Remuneration of overseas accounting firm (ten thousand yuan)
(if any) 0
Continuous years of audit services of overseas accounting firms
(if any) Not applicable
The name of the certified public accountant of the overseas
accounting firm (if any) Not applicable
Continuous years of CPA audit services of overseas accounting
firms (if any) Not applicable
Whether to reappoint an accounting firm in the current period
□Yes □No
Engaging internal control audit accounting firm financial consultant or sponsor
□Applicable □ Not applicable
During the reporting period the company hired Grant Thornton Zhitong Certified Public
Accountants LLP as the internal control auditing accounting firm and paid a total of 1.2 million yuan
in internal control audit fees.
93IX. Delisting after the disclosure of the annual report
□ Applicable □Not Applicable
X .matters related to bankruptcy and reorganization
□ Applicable □Not Applicable
During the reporting period the company did not have any bankruptcy and reorganization related
matters.XI. Major litigation and arbitration matters
□ Applicable □Not Applicable
During the reporting period the company had no major lawsuits or arbitrations.XII. Punishment and rectification
□ Applicable □Not Applicable
During the reporting period there were no penalties and rectifications.XIII. The integrity of the company and its controlling shareholders and actual controllers
□ Applicable □Not Applicable
94XIV. Significant related party transactions
1. Related party transactions related to daily operations
□Applicable □ Not applicable
Pricing Amount ApprovePercenta d Whethe Related Available
Related Related Principles Related of related ge of transactio r it party market Related Relationsh transaction transaction for Related transactio transactio similar n amount exceeds transactio price of Disclosur Disclosure party ip type content Party n price ns (ten transactio (ten the n similar e date Index Transactio thousand approve settlement transactio
ns yuan) n amount thousand yuan) d quota method ns
"Announceme
nt on the
Based on Estimated
Foshan the On Daily Related
HNA market normal Party
Xingfa price the commerci Transactions
Agriculture Sales of Sales of two al terms in 2025"
and Animal Joint goods to feed and Market parties or in Not April 22 (Announceme
Husbandry venture related other pricing negotiate 9926.68 0.08% 9150 Yes accordanc applicable 2025 nt No. 2025-
Developme parties products to e with 012) disclosed
nt Co. Ltd. determin relevant in the
and its e the agreement company's
subsidiaries transactio s designated
n price information
disclosure
media
Based on "Announceme
the On nt on the
market normal Estimated
Procureme price the commerci Daily Related Wujiaqu
Taikun nt of raw two al terms
Party
Plant Joint materials
Procureme Transactions
venture from nt of raw
Market parties 10133.81 0.09% 9000 Yes or in Not April 22
Protein Co. materials pricing negotiate accordanc applicable 2025
in 2025"
(Announceme
Ltd related to e with parties determin relevant nt No. 2025-
e the agreement 012) disclosed
transactio s in the
n price company's designated
95information
disclosure
media
"Announceme
nt on the
Based on Estimated
the On Daily Related
market normal Party
Hutubi Procureme price the commerci Transactions
Tiankang nt of raw two al terms in 2025"
Plant Joint materials
Procureme
nt of raw Market parties 22356.32 0.19% 20000 Yes or in Not April 22 (Announceme
Protein Co. venture from materials pricing negotiate accordanc applicable 2025 nt No. 2025-
Ltd related to e with 012) disclosed parties determin relevant in the
e the agreement company's
transactio s designated
n price information
disclosure
media
"Announceme
nt on the
Based on Estimated
the On Daily Related
market normal Party
Alar Procureme price the commerci Transactions
Ruiliheng nt of raw Procureme two al terms in 2025"
Biological Joint materials nt of raw Market parties or in Not April 22 (Announceme
Protein Co. venture from materials pricing negotiate
10863.63 0.09% 8000 Yes accordanc applicable 2025 nt No. 2025-
Ltd related to e with 012) disclosed parties determin relevant in the
e the agreement company's
transactio s designated
n price information
disclosure
media
Total -- -- 53280.44 -- 46150 -- -- -- -- --
Details of large-value sales returns Not applicable.If the total amount of daily connected transactions that will occur in
the current period is estimated by category the actual performance Not applicable.during the reporting period (if any)
Reasons for the large difference between the transaction price and the
market reference price (if applicable) Not applicable.
962. Related-party transactions arising from the acquisition and sale of assets or equity
□ Applicable □Not Applicable
During the reporting period there were no related transactions involving the acquisition or sale of
assets or equity.
3. Related party transactions of joint foreign investment
□ Applicable □Not Applicable
During the reporting period the company did not have any related transactions of joint foreign
investment.
4. Related creditor's rights and debts
□ Applicable □Not Applicable
During the reporting period there was no related creditor's rights and debts.
5. Transactions with financial companies that have an associated relationship
□ Applicable □Not Applicable
There is no deposit loan credit or other financial business between the company and the financial
company that has an associated relationship and the associated party.
6. The transactions between the financial company controlled by the company and related
parties
□ Applicable □Not Applicable
There is no deposit loan credit or other financial business between the financial company
controlled by the company and related parties.
977. Other major related transactions
□ Applicable □Not Applicable
During the reporting period the company had no other major related transactions.XV. Major contracts and their performance
1. Custody contracting and leasing matters
(1) Custody
□ Applicable □Not Applicable
There was no custody of the company during the reporting period.
(2) Contracting situation
□ Applicable □Not Applicable
There was no contract in the company during the reporting period.
(3) Leasing
□ Applicable □Not Applicable
There was no lease in the company during the reporting period.
982. Major guarantee
□Applicable □ Not applicable
Unit: ten thousand yuan
External guarantees of the company and its subsidiaries (excluding guarantees to subsidiaries)
Disclosure Whether
date of the Actual to
Guaranteed object name announcement Guarantee Actual Guarantee Collateral Counter-guarantee (if any) Guarantee Is it
related to the amount date guarantee amount type (if any) period fulfilled
guarantee
guarantee a related
amount party
The spouse of the borrower
one of the adult children of the
borrower and one of the spouse
and a third party provide
Joint and counter-guarantee to the
December 25 January several company; the company has the
2024 20000 25 2024 23758.5 liability right to withhold the relevant 3 years No No
guarantee funds of the customer (including but not limited to the
remaining payment discounts
etc.) for repayment of the
principal and interest of the
Customers such as subsidiary overdue loan of the borrower.farmers or distributors The spouse of the borrower
one of the adult children of the
borrower and one of the spouse
and a third party provide
Joint and counter-guarantee to the
December 25 30000 February 37656.56 several company; the company has the 2024 02 2024 liability right to withhold the relevant 2 years No No
guarantee funds of the customer
(including but not limited to the
remaining payment discounts
etc.) for repayment of the
principal and interest of the
99overdue loan of the borrower.
The spouse of the borrower
one of the adult children of the
borrower and one of the spouse
and a third party provide
Joint and counter-guarantee to the
December 25 120000 January 274884.83 several
company; the company has the
2024 15 2024 liability right to withhold the relevant 3 years No No
guarantee funds of the customer (including but not limited to the
remaining payment discounts
etc.) for repayment of the
principal and interest of the
overdue loan of the borrower.The spouse of the borrower
one of the adult children of the
borrower and one of the spouse
and a third party provide
Joint and counter-guarantee to the
December 25 January several company; the company has the
2024 30000 02 2024 23923.09 liability right to withhold the relevant 3 years No No
guarantee funds of the customer (including but not limited to the
remaining payment discounts
etc.) for repayment of the
principal and interest of the
overdue loan of the borrower.The spouse of the borrower
one of the adult children of the
borrower and one of the spouse
and a third party provide
Joint and counter-guarantee to the
December 25 60000 March 21 2024 2024 109096.98
several company; the company has the liability right to withhold the relevant 3 years No No
guarantee funds of the customer
(including but not limited to the
remaining payment discounts
etc.) for repayment of the
principal and interest of the
100overdue loan of the borrower.
The spouse of the borrower
one of the adult children of the
borrower and one of the spouse
and a third party provide
Joint and counter-guarantee to the
December 25 company; the company has the
202430000
October several
24 2024 30193.43 liability right to withhold the relevant 3 years No No
guarantee funds of the customer (including but not limited to the
remaining payment discounts
etc.) for repayment of the
principal and interest of the
overdue loan of the borrower.The spouse of the borrower
one of the adult children of the
borrower and one of the spouse
and a third party provide
Joint and counter-guarantee to the
December 25 August several company; the company has the
2024 30000 30 2024 32826.25 liability right to withhold the relevant 3 years No No
guarantee funds of the customer (including but not limited to the
remaining payment discounts
etc.) for repayment of the
principal and interest of the
overdue loan of the borrower.The spouse of the borrower
one of the adult children of the
borrower and one of the spouse
and a third party provide
Joint and counter-guarantee to the
December 25
202455000
January
152024152124.51
several company; the company has the liability right to withhold the relevant 2 years No No
guarantee funds of the customer
(including but not limited to the
remaining payment discounts
etc.) for repayment of the
principal and interest of the
101overdue loan of the borrower.
The spouse of the borrower
one of the adult children of the
borrower and one of the spouse
and a third party provide
Joint and counter-guarantee to the
December 25 company; the company has the
20242000
February several
06 2024 1638.26 liability right to withhold the relevant 1 year No No
guarantee funds of the customer (including but not limited to the
remaining payment discounts
etc.) for repayment of the
principal and interest of the
overdue loan of the borrower.The spouse of the borrower
one of the adult children of the
borrower and one of the spouse
and a third party provide
Joint and counter-guarantee to the
December 25 June 18 several company; the company has the
2024 1500 2021 542.1 liability right to withhold the relevant 3 years No No
guarantee funds of the customer (including but not limited to the
remaining payment discounts
etc.) for repayment of the
principal and interest of the
overdue loan of the borrower.The spouse of the borrower
one of the adult children of the
borrower and one of the spouse
and a third party provide
Joint and counter-guarantee to the
December 25 1000 May 06 232 several company; the company has the Within 1 2024 2022 liability right to withhold the relevant year No No
guarantee funds of the customer
(including but not limited to the
remaining payment discounts
etc.) for repayment of the
principal and interest of the
102overdue loan of the borrower.
The spouse of the borrower
one of the adult children of the
borrower and one of the spouse
and a third party provide
Joint and counter-guarantee to the
December 25 20000 January 1175.74 several
company; the company has the
2024 01 2024 liability right to withhold the relevant
Within 1 No No
guarantee funds of the customer
year
(including but not limited to the
remaining payment discounts
etc.) for repayment of the
principal and interest of the
overdue loan of the borrower.The spouse of the borrower
one of the adult children of the
borrower and one of the spouse
and a third party provide
Joint and counter-guarantee to the
December 25 January several company; the company has the
2024 500 03 2025 114.03 liability right to withhold the relevant 3 years No No
guarantee funds of the customer (including but not limited to the
remaining payment discounts
etc.) for repayment of the
principal and interest of the
overdue loan of the borrower.The spouse of the borrower
one of the adult children of the
borrower and one of the spouse
and a third party provide
Joint and counter-guarantee to the
December 25
20241000
July 07
2023290.7
several company; the company has the liability right to withhold the relevant 5 years No No
guarantee funds of the customer
(including but not limited to the
remaining payment discounts
etc.) for repayment of the
principal and interest of the
103overdue loan of the borrower.
The spouse of the borrower
one of the adult children of the
borrower and one of the spouse
and a third party provide
Joint and counter-guarantee to the
December 25 September several company; the company has the
2024 500 05 2024 252.69 liability right to withhold the relevant 3 years No No
guarantee funds of the customer (including but not limited to the
remaining payment discounts
etc.) for repayment of the
principal and interest of the
overdue loan of the borrower.The spouse of the borrower
one of the adult children of the
borrower and one of the spouse
and a third party provide
Joint and counter-guarantee to the
December 25 January several company; the company has the
2024 1500 04 2025 374.32 liability right to withhold the relevant 3 years No No
guarantee funds of the customer (including but not limited to the
remaining payment discounts
etc.) for repayment of the
principal and interest of the
overdue loan of the borrower.The spouse of the borrower
one of the adult children of the
borrower and one of the spouse
and a third party provide
Joint and counter-guarantee to the
December 25
20245000
July 02
2025657.28
several company; the company has the liability right to withhold the relevant 3 years No No
guarantee funds of the customer
(including but not limited to the
remaining payment discounts
etc.) for repayment of the
principal and interest of the
104overdue loan of the borrower.
The spouse of the borrower
one of the adult children of the
borrower and one of the spouse
and a third party provide
Joint and counter-guarantee to the
December 25 1500 October 100.01 several
company; the company has the
2024 14 2025 liability right to withhold the relevant 2 years No No
guarantee funds of the customer (including but not limited to the
remaining payment discounts
etc.) for repayment of the
principal and interest of the
overdue loan of the borrower.The spouse of the borrower
one of the adult children of the
borrower and one of the spouse
and a third party provide
Joint and counter-guarantee to the
December 25 January company; the company has the
202460001120246420.07
several
liability right to withhold the relevant 3 years No No
guarantee funds of the customer (including but not limited to the
remaining payment discounts
etc.) for repayment of the
principal and interest of the
overdue loan of the borrower.Unused quota December 25 2024 29500
The total actual amount
The total amount of external guarantees approved of external guarantees
during the reporting period (A1) 445000 during the reporting 696261.35
period (A2)
The total balance of
The total amount of external guarantees approved actual external
at the end of the reporting period (A3) 445000 guarantees at the end of 259936.88 the reporting period
(A4)
105The company's guarantee to its subsidiaries
Disclosure
date of the Whether
announcement Guarantee Actual Actual Guaranteed object name Guarantee Collateral Guarantee Is it
to
related to the amount date guarantee amount type (if any)
Counter-guarantee (if any) period fulfilled guarantee
guarantee a related
amount party
China Joint and
Haida Feed Group (HK) December 25 2024 15463.36
April 15
202531376.69
several
Limited liability
Not applicable 1 year No No
guarantee
Joint and
China Haida Feed Group (HK) December 25
Limited 2024 30000
December
20202413743
several
liability Not applicable 1 year Yes No
guarantee
Joint and
Haid International Group October 31 June 13 several
Limited 2017 35144 2018 35144 liability Not applicable 7 years Yes No
guarantee
PT HAIDA Joint and
BIOTECHNOLOGY December 25 2024 3098.25
November several
INDONESIA 15 2023
3098.25 liability Not applicable 2 years Yes No
guarantee
Joint and Minority shareholders provide
Foshan HNA Feed Co. Ltd December 25 50 November several counter-guarantee to the 2024 13 2024 50 liability company according to their 1 year Yes No
guarantee shareholding ratio
Joint and Minority shareholders provide
Foshan HNA Feed Co. Ltd December 25 2024 67.5
November several counter-guarantee to the
13 2024 67.5 liability company according to their 3 years No No
guarantee shareholding ratio
Guangzhou Nansha Joint and Minority shareholders provide
Haishengyuan Aquaculture December 25 200 April 03 200 several counter-guarantee to the
Technology Co. Ltd 2024 2023 liability
company according to their 2 years Yes No
guarantee shareholding ratio
Joint and
Guangzhou Haida Feed Co. Ltd December 25 March 19 13 2024 29000 2025 29000 several Not applicable No No liability months
106guarantee
Joint and
Guangzhou Yitun Pig Industry December 25 January several 18
Investment Co. Ltd 2024 5000 03 2025 0.02 liability Not applicable months Yes No
guarantee
Joint and
Guangzhou Yitun Pig Industry
Investment Co. Ltd June 29 2019 55700
November
28201952252.75
several
liability Not applicable 12 years Yes No
guarantee
Joint and
Guangzhou Yitun Pig Industry June 29 2019 2750 September Investment Co. Ltd 10 2020 73810.35
several
liability Not applicable 12 years No No
guarantee
Joint and
Guangzhou Yitun Pig Industry July 27 2021 23000 October 13858.9 several Investment Co. Ltd 26 2022 liability Not applicable 13 years No No
guarantee
Joint and
Hainan Haihaida Aquatic Seed December 25 December several
Industry Development Co. Ltd 2024 83.06 12 2025 83.06 liability Not applicable 6 months No No
guarantee
Leizhou Yuexiu Haishengyuan Joint and Minority shareholders provide
Shrimp Breeding Technology December 25 289.58 December 336.63 several counter-guarantee to the
Co. Ltd 2024 02 2024 liability company according to their
3 years No No
guarantee shareholding ratio
Joint and
Qingyuan Haibei Biotechnology December 25 150 February several Co. Ltd 2024 26 2025 150 liability Not applicable 1 year No No
guarantee
Joint and
Qingyuan Haida Biotechnology December 25 December several
Co. Ltd 2024 70 28 2022 70 liability Not applicable 3 years Yes No
guarantee
Joint and
Qingyuan Hailong Biological December 25 373 August 373 several Technology Co. Ltd 2024 05 2024 liability Not applicable 2 years No No
guarantee
Shaoguan Haida Biotechnology December 25 30 June 17 30 Joint and Co. Ltd 2024 2024 several Not applicable 3 years No No
107liability
guarantee
Shaoguan Zhenjiang District Joint and
Yitun Ecological Agriculture July 27 2021 17400 January several 08 2022 17400 liability Not applicable 8 years No No Co. Ltd guarantee
Shaoguan Zhenjiang District Joint and
Yitun Ecological Agriculture July 27 2021 19200 March 16 several
Co. Ltd 2022
19200 liability Not applicable 8 years No No
guarantee
Joint and
Sihui Haifeng Ecological December 25 66 July 12 132 several Agriculture Co. Ltd 2024 2024 liability Not applicable 3 years No No
guarantee
Joint and
Yongzhou Haida Biotechnology December 25 180.93 July 17 Co. Ltd 2024 2025 180.93
several
liability Not applicable 9 months No No
guarantee
Joint and
Wholly-owned subsidiaries and December 25 400000 January 46262.06 several holding subsidiaries 2024 01 2025 liability Not applicable 1-3 years No No
guarantee
Unused quota December 25 2024 135878.32
The total actual amount
The total amount of guarantees approved for of guarantees to
subsidiaries during the reporting period (B1) 620000 subsidiaries during the 336819.14
reporting period (B2)
The total balance of
The total amount of guarantees approved for actual guarantees to
subsidiaries at the end of the reporting period 773194 subsidiaries at the end 61756.29
(B3) of the reporting period
(B4)
Subsidiary's guarantee to subsidiary
Disclosure Actual Whether
Guaranteed object name date of the Guarantee Actual guarantee Guarantee Collateral Counter-guarantee (if any) Guarantee Is it to
announcement amount date amount type (if any) period fulfilled guarantee
related to the a related
108guarantee party
amount
Joint and
BINH December 25 April 24
DINH HAI LONG CO. LTD 2024 5798.76 2025 1566.59
several
liability Not applicable 1 year Yes No
guarantee
Joint and
BINH DINH HAI LONG CO. December 25
LTD 2024 5623.04
July 10 several
2025 2529.02 liability Not applicable 1 year Yes No
guarantee
Joint and
BINH PHUOC HAI LONG December 25 July 03 several
COMPANY LIMITED 2024 2676.11 2025 559.06 liability Not applicable 4 years No No
guarantee
Joint and
BINH PHUOC HAI LONG December 25
COMPANY LIMITED 2024 4214.98
February several 1 year 4
27 2024 6322.47 liability Not applicable months No No
guarantee
Joint and
BINH PHUOC HAI LONG December 25 3514.4 April 10 821.79 several COMPANY LIMITED 2024 2025 liability Not applicable 1 year Yes No
guarantee
Joint and
HAI DUONG HAID December 25 August several
COMPANY LIMITED 2024 3345.14 29 2025 965.5 liability Not applicable 1 year No No
guarantee
Joint and
HAI DUONG HAID December 25
COMPANY LIMITED 2024 1757.2
May 23
2025685.55
several
liability Not applicable 1 year No No
guarantee
Joint and
HAI DUONG HAID December 25 3514.4 April 03 COMPANY LIMITED 2024 2025 1596.18
several
liability Not applicable 1 year Yes No
guarantee
Joint and
HAI DUONG HAID December 25 6690.28 May 27 several COMPANY LIMITED 2024 2025 1624.03 liability Not applicable 1 year Yes No
guarantee
HAID FEED BANGLADESH December 25 8434.56 December 8434.56 Joint and Not applicable 1 year No No
109LIMITED 2024 22 2025 several
liability
guarantee
Joint and
HAID FEED COMPANY December 25 July 15 several
LIMITED 2024 4014.17 2025 3886.17 liability Not applicable 4 years No No
guarantee
Joint and
HAID FEED COMPANY December 25 2811.52 May 27 4228.66 several LIMITED 2024 2025 liability Not applicable 1 year Yes No
guarantee
Joint and
MEKONG HAI LONG December 25 3211.33 July 15 several COMPANY LIMITED 2024 2025 5915.21 liability Not applicable 3 years No No
guarantee
Joint and
PT.HAIDA AGRICULTURE December 25 February several
INDONESIA 2024 20383.52 04 2025 26412.93 liability Not applicable 1 year Yes No
guarantee
Joint and
PT.HAIDA AGRICULTURE December 25 5623.04 February INDONESIA 2024 26 2025 9950.8
several
liability Not applicable 1 year No No
guarantee
SHENG LONG BIOTECH Joint and Minority shareholders provide
(HAI DUONG) December 25 3345.14 February 3669.74 several counter-guarantee to the INTERNATIONAL CO. 2024 21 2025 liability company according to their 1 year No No
LTD guarantee shareholding ratio
SHENG LONG BIOTECH Joint and Minority shareholders provide
(HAI DUONG) December 25 3951.54 February several counter-guarantee to the 1 year 2 INTERNATIONAL CO. 2024 27 2024 5927.32 liability company according to their months No No
LTD guarantee shareholding ratio
Joint and Minority shareholders provide
SHENG LONG BIO-TECH December 25 16056.66 November several counter-guarantee to the INTERNATIONAL CO LTD 2024 19 2024 21625.79 liability company according to their 5 years No No
guarantee shareholding ratio
Joint and Minority shareholders provide
SHENG LONG BIO-TECH December 25 13380.55 November several counter-guarantee to the INTERNATIONAL CO LTD 2024 15 2024 4183.67 liability company according to their 1 year Yes No
guarantee shareholding ratio
110Joint and Minority shareholders provide
SHENG LONG BIO-TECH December 25 8434.56 July 09 2069.57 several counter-guarantee to the INTERNATIONAL CO LTD 2024 2024 liability company according to their 1 year No No
guarantee shareholding ratio
Joint and Minority shareholders provide
SHENG LONG BIO-TECH December 25 30223.84 November 26272.51 several counter-guarantee to the INTERNATIONAL CO LTD 2024 21 2024 liability company according to their 1 year Yes No
guarantee shareholding ratio
Joint and Minority shareholders provide
SHENG LONG BIO-TECH December 25 May 22 several counter-guarantee to the
INTERNATIONAL CO LTD 2024 10169.22 2025 6008.54 liability company according to their 1 year Yes No
guarantee shareholding ratio
Joint and Minority shareholders provide
SHENG LONG BIO-TECH December 25 10169.22 August 332.48 several counter-guarantee to the INTERNATIONAL CO LTD 2024 22 2025 liability company according to their 1 year No No
guarantee shareholding ratio
SHENGLONG BIO-TECH Joint and Minority shareholders provide
(INDIA) PRIVATE LIMITED December 25 1647.1 March 28 several counter-guarantee to the (Thang Long Biotechnology 2024 2024 33.71 liability company according to their 1 year Yes No
(India) Limited) guarantee shareholding ratio
Joint and Minority shareholders provide
SHENGLONG BIO-TECH December 25 November
(INDIA) PRIVATE LIMITED 2024 5623.04 19 2024 3445.2
several counter-guarantee to the liability company according to their 1 year Yes No
guarantee shareholding ratio
Joint and Minority shareholders provide
SHENGLONG BIO-TECH December 25 2664.52 August 3844.53 several counter-guarantee to the (INDIA) PRIVATE LIMITED 2024 20 2024 liability company according to their 1 year Yes No
guarantee shareholding ratio
Joint and Minority shareholders provide
SHENGLONG BIO-TECH December 25 4423.95 August 1566 several counter-guarantee to the (INDIA) PRIVATE LIMITED 2024 07 2025 liability company according to their 1 year No No
guarantee shareholding ratio
Joint and Minority shareholders provide
SHENGLONG BIO-TECH December 25 3514.4 July 22 3353.47 several counter-guarantee to the (INDIA) PRIVATE LIMITED 2024 2024 liability company according to their 1 year Yes No
guarantee shareholding ratio
THANG LONG (VINH LONG) December 25 November Joint and Minority shareholders provide
BIOTECH CO. LTD 2024 12042.5 22 2024 27172.15 several counter-guarantee to the 3 years No No liability company according to their
111guarantee shareholding ratio
Joint and Minority shareholders provide
THANG LONG (VINH LONG) December 25 14057.6 July 17 20248.87 several counter-guarantee to the BIOTECH CO. LTD 2024 2024 liability company according to their 1 year Yes No
guarantee shareholding ratio
Joint and Minority shareholders provide
THANG LONG (VINH LONG) December 25 10169.22 March 07 4285.5 several counter-guarantee to the BIOTECH CO. LTD 2024 2025 liability company according to their 1 year Yes No
guarantee shareholding ratio
Joint and
VINH LONG HAI DAI CO. December 25 9366.39 August several LTD 2024 07 2025 2149.12 liability Not applicable 3 years No No
guarantee
Joint and
VINH LONG HAI DAI CO. December 25
LTD 2024 5798.76
January 13564.55 several 17 2025 liability Not applicable 1 year Yes No
guarantee
Joint and
VINH LONG HAI DAI CO. December 25 7028.8 February 3157.2 several LTD 2024 18 2025 liability Not applicable 1 year Yes No
guarantee
Joint and
Yangjiang Dehai Biological December 25
Technology Co. Ltd 2024 3000
May 24 3000 several 2024 liability Not applicable 5 years No No
guarantee
Joint and
Yangjiang Dehai Biological December 25 February several
Technology Co. Ltd 2024 1500 11 2025 1500 liability Not applicable 5 years No No
guarantee
Joint and
Huayuan County Yitun several
Ecological Agriculture Co. December 25 November liability
Ltd. Guangzhou Yitun Pig 2024 1800 15 2024 1800 guarantee Not applicable 1 year No No
Industry Investment Co. Ltd
Unused quota December 25 2024 220020.54
During the reporting period the total amount of The total actual amount
guarantees approved for subsidiaries (C1) 480000 234708.44 of guarantees to
112subsidiaries during the
reporting period (C2)
The total balance of
The total amount of guarantees approved for actual guarantees to
subsidiaries at the end of the reporting period 480000 subsidiaries at the end 30811.78
(C3) of the reporting period
(C4)
The total amount of company guarantees (that is the total of the first three items)
The total amount of
The total amount of approved guarantees during guarantees actually
the reporting period (A1 + B1 + C1) 1545000 incurred during the 1267788.93 reporting period (A2 +
B2 + C2)
Total actual guarantee
The total amount of guarantees approved at the 1698194 balance at the end of the end of the reporting period (A3 + B3 + C3) reporting period (A4 + 352504.95
B4 + C4)
The proportion of the total guarantee balance (ie A4 + B4 + C4) to the
company's net assets 14.54%
Of which:
Balance of guarantees provided to shareholders actual controllers and their
related parties (D) 0
Debt guarantee balance provided directly or indirectly to the guaranteed
object with an asset-liability ratio exceeding 70% (E) 28757.53
Amount of total guarantees exceeding 50% of net assets (F) 0
The total amount of the above three guarantees (D + E + F) 28757.53
For unexpired guarantee contracts a description of the circumstances in
which the guarantee liability occurred during the reporting period or there is During the reporting period the company has paid a total of RMB 66227200 for overdue guarantees
evidence that it is possible to bear joint and several liability for repayment (if completed the recovery of RMB 15882900 and the rest are still in the process of recovery.any)
Instructions for providing external guarantees in violation of prescribed
procedures (if any) Not applicable.Note:
1131. If the "actual occurrence date" is earlier than the "disclosure date of the relevant announcement of the guarantee quota" it is the guarantee business whose quota
has been considered to be extended or renewed during the reporting period when it first occurs;
2. The "actual guarantee amount" refers to the accumulated guarantee amount during the reporting period including the relevant amount after the guarantee was
provided and then released during the reporting period.
3. The amount of the subsidiary's external guarantee is converted according to the company's shareholding ratio in the subsidiary.
4. Foreign currency guarantees are converted at the intermediate exchange rate at the end of the reporting period.
1143. Entrusting others to manage cash assets
(1) Entrusted financial management
□Applicable □ Not applicable
Overview of entrusted wealth management during the reporting period
Unit: ten thousand yuan
The balance of entrusted
Product category Risk characteristics wealth management during Overdue amount
the reporting period
Bank wealth management
products Medium and low risk 142500 0
Brokerage financial products Medium and low risk 58000 0
As a single principal the company entrusts a financial institution to carry out asset
management or the specific situation of high-risk entrusted wealth management with low
investment security and poor liquidity
□Applicable □ Not applicable
Unit: ten thousand yuan
The The
actual actual
amoun recover Summa
Type t of y of ry of Trustee of Risk Investm profit profits matters Name (or
Trustee trustee characteris
Product Amou Start Terminat ent and and and
(or tics type nt date ion date directio loss losses related Name) trustee) n during during query the the index
reporti reporti (if any)
ng ng
period period
CITIC The
Securities product
Asset has not
Manage Securitie been
ment s redeem
Xinxin Medium companie June ed and Xiangron Securit and low s issue 2000 26 June 26 Debt the
Not
g ies 16.23 risk wealth 2025 2026 assets profit
applica
Exclusive managem and ble
No. 2 ent loss are
Collectiv products reflecte
e Asset d in the
Manage net
ment Plan value
CITIC Securitie The
Securities s product
Asset Medium companie has not Not
Manage Securities and low s issue
2000 July 30 July 30 Debt
ment risk wealth 0 2025 2026 assets
146.56 been applica
redeem ble
Xinxin managem ed and
Xiangron ent the
115g products profit
Exclusive and
No. 2 loss are
Collectiv reflecte
e Asset d in the
Manage net
ment Plan value
CITIC The
Securities product
Asset has not
Manage Securitie been
ment s redeem
Xinxin companie ed and
Xiangron Securit Medium Novem Novemb Not
g ies and low
s issue 2000
wealth 0 ber 04 er 04
Debt
assets 34.98
the
profit applica
Exclusive risk managem 2025 2026 and ble
No. 2 ent loss are
Collectiv products reflecte
e Asset d in the
Manage net
ment Plan value
CITIC The
Securities product
Asset has not
Manage Securitie been
ment s redeem
Xinxin companie ed and
Xiangron Securit Medium Novem Novemb Not
g ies and low
s issue
wealth 6000 ber 04 er 04
Debt 10.49 the applica
Exclusive risk managem 2025 2026
assets profit
and ble
No. 2 ent loss are
Collectiv products reflecte
e Asset d in the
Manage net
ment Plan value
CITIC The
Securities product
Asset has not
Manage Securitie been
ment s redeem
Xinxin companie ed and
Xiangron Securit Medium s issue 1000 Decem Decemb Debt the Not
g ies and low risk wealth 0
ber 10 er 10 assets 26.26 profit applica
Exclusive managem 2025 2026 and ble
No. 2 ent loss are
Collectiv products reflecte
e Asset d in the
Manage net
ment Plan value
Total 58000 -- -- -- 234.52 -- --
(2) Entrusted loans
□ Applicable □Not Applicable
There was no entrusted loan in the company during the reporting period.
1164. Other major contracts
□ Applicable □Not Applicable
There were no other major contracts in the company during the reporting period.XVI. Use of raised funds
□ Applicable □Not Applicable
The company had no use of raised funds during the reporting period.XVII. Explanation of other important matters
□ Applicable □Not Applicable
There were no other major events that need to be explained during the reporting period of the
company.XVIII. Major events of the company's subsidiaries
□Applicable □ Not applicable
The Company held the third meeting of the seventh board of directors and the fourth
extraordinary shareholders meeting of 2025 on October 16 2025 and November 14 2025
respectively and reviewed and approved the "Proposal on the Spin-off of its subsidiary Haida
International Holdings Limited on the Main Board of the Hong Kong Stock Exchange" and
other proposals related to this spin-off and listing For details please refer to the "Plan on Spin-
off of Subsidiary Haida International Holdings Limited to Listing on the Main Board of the
Hong Kong Stock Exchange" and related announcements (Announcement Nos. 2025-049
2025-050 2025-059) disclosed by the company on the designated information disclosure media
Juchao Information Network (http://www.cninfo.com.cn) on October 18 2025 and November
152025.
On January 12 2026 Haid Holdings submitted to the Hong Kong Stock Exchange the
application documents for an initial public offering and listing on the main board of the Hong
117Kong Stock Exchange. As of the date of issuance of this annual report the spin-off and listing
is still in progress.
118Section 6 Changes in Shares and Shareholders
I. Changes in shares
1. Changes in shares
Unit: share
Before this change Increase or decrease in this change (+ -) After this change
Issue Provident
Quantity Proportio new Bonu fund othe Subtotan share s conversio r l Quantity
Proportio
n
s n
I. Shares
subject to
sales 1228667 0.07% 1228667 0.07%
restrictions
1. State
shareholding
2. State-
owned legal
person
holding
shares
3. Other
domestic 1228667 0.07% 1228667 0.07%
shares
Of
which:
domestic
legal person
holdings
Domesti
c natural
person 1228667 0.07% 1228667 0.07%
holdings
4. Foreign
shareholding
Of
which:
overseas
legal person
holdings
Shares
held by
foreign
natural
persons
II.Unrestricted 166252130 99.93% 1662521303 3 99.93% Shares
1. RMB
ordinary 166252130 99.93% 166252130 99.93%
shares 3 3
2.
Domestically
119listed foreign
shares
3. Foreign
shares listed
overseas
4. Other
III. Total
number of 166374997 100.00% 166374997 100.00%
shares 0 0
Reasons for changes in shares
□ Applicable □Not Applicable
Approval of changes in shares
□ Applicable □Not Applicable
Transfer of share changes
□ Applicable □Not Applicable
The impact of share changes on financial indicators such as basic and diluted earnings per
share net assets per share attributable to the company's common shareholders in the most
recent year and the most recent period
□ Applicable □Not Applicable
Other disclosures that the company deems necessary or required by securities regulators
□ Applicable □Not Applicable
2. Changes in restricted shares
□ Applicable □Not Applicable
II. Securities Issuance and Listing
1. Securities issuance (excluding preferred shares) during the reporting period
□ Applicable □Not Applicable
1202. Explanation of changes in the total number of shares of the company and the
structure of shareholders and changes in the structure of the company's assets and
liabilities
□ Applicable □Not Applicable
3. Existing internal employee shares
□ Applicable □Not Applicable
III. Shareholders and actual controllers
1. The number of shareholders and shareholding of the company
Unit: share
The total The total
number of number of
Total ordinary preferred
number of shareholder shareholde
The total number of
preferred shareholders
common s at the end rs whose of the voting (if any) whose voting shareholde
rs at the 22454 previous 24178 rights were 0
rights were restored at
month restored at the end of the previous
0
end of the before the the end of month before the reporting
period disclosure the
disclosure date of the
date of the reporting annual report
annual period (if
report any)
Shareholding of shareholders holding more than 5% of the shares or the top 10 shareholders (excluding shares lent
through refinancing)
Number of Number The Pledge mark or
Name of Nature of shares held Changes of shares number of freeze
shareholde Shareholde Shareholdi at the end during the subject to shares held
r rs ng ratio of the reporting sales without Share reporting period restrictio selling status Quantity
period ns restrictions
Guangzhou Domestic
Haihao non-state-
Investment owned 54.73%
9105893 0 0 91058935 Pledge 549600059 9 0
Co. Ltd legal person
Hong
Kong
Securities Foreign Not
Clearing legal 3.91%
6501292-
person 4 45926988
0 65012924 applicabl 0
Company e
Limited
Industrial
and
Commerci 2800000 - Not
al Bank Of other 1.68% 0 13300000 0 28000000 applicabl 0
China Ltd. e
- Invesco
121Great Wall
Emerging
Growth
Hybrid
Securities
Investment
Fund
National
Social Not
Security other 1.37% 22809652 11925420 0 22809652 applicabl 0 Fund 106 e
Portfolio
Industrial
and
Commerci
al Bank Of
China Ltd.- Huatai
Bai Rui Not
CSI 300 other 0.83%
1378839
8 -642621 0 13788398 applicabl 0
Trading e
Open-end
Index
Securities
Investment
Fund
Bank of
China Ltd.- Invesco
Great Wall
Dingyi Not
Hybrid other 0.80%
1339130
0 -2608599 0 13391300 applicabl 0
Securities e
Investment
Fund
(LOF)
Industrial
and
Commerci
al Bank Of
China Ltd.- CSI
Major 1207873 Not
Consumer other 0.73% 5 4734296 0 12078735 applicabl 0
Trading e
Open-end
Index
Securities
Investment
Fund
National
Social Not
Security other 0.66% 11011618 5019138 0 11011618 applicabl 0
Fund 109 e
Portfolio
China
Zheshang
Bank Co.Ltd. -
Cathay
Pacific CSI 1082143 Not
Animal other 0.65% 9 3581553 0 10821439 applicabl 0
Husbandry e
Trading
Open
Index
Securities
122Investment
Fund
China
Constructi
on Bank
Corporatio
n - E Fund
CSI 300 Not
Trading other 0.59% 9822362 -96600 0 9822362 applicabl 0
Open-end e
Index-
Initiated
Securities
Investment
Fund
Strategic investors or
general legal persons
become the top 10
shareholders due to the Not applicable
placement of new shares
(if any)
Among the above-mentioned top 10 shareholders the first shareholder is the controlling
Description of the above- shareholder of the company and the first shareholder does not have an associated relationship
mentioned shareholders' with other shareholders nor is it a party acting in concert; it is unknown whether other
connected relationship or shareholders are parties acting in concert as stipulated in the Measures for the Administration
concerted action of Acquisitions of Listed Companies and it is also unknown whether there is an associated
relationship among other shareholders.Explanation of the above
shareholders involved in
entrusted/entrusted voting Not applicable
rights and abstention
from voting rights
Special instructions for
repurchasing special At the end of the reporting period the balance of shares in the special securities account
accounts among the top repurchased by Guangdong Haid Group Co. Ltd. was 13.259 million shares which were not
10 shareholders (if any) included in the list of the top 10 shareholders.
Shareholding of the top 10 shareholders with unrestricted sales conditions (excluding shares lent through refinancing and
locked shares by executives)
Name of shareholder The number of unrestricted shares held at the end of
Type of shares
the reporting period Type of shares Quantity
Guangzhou Haihao
Investment Co. Ltd 910589359
RMB ordinary
shares 910589359
Hong Kong Securities
Clearing Company 65012924 RMB ordinary shares 65012924 Limited
Industrial and
Commercial Bank Of
China Ltd. - Invesco RMB ordinary
Great Wall Emerging 28000000 shares 28000000
Growth Hybrid Securities
Investment Fund
National Social Security 22809652 RMB ordinary Fund 106 Portfolio shares 22809652
Industrial and
Commercial Bank Of
China Ltd. - Huatai Bai
Rui CSI 300 Trading 13788398 RMB ordinary 13788398
Open-end Index shares
Securities Investment
Fund
Bank of China Ltd. -
Invesco Great Wall RMB ordinary
Dingyi Hybrid Securities 13391300 shares 13391300
Investment Fund (LOF)
123Industrial and
Commercial Bank Of
China Ltd. - CSI Major 12078735 RMB ordinary Consumer Trading Open- shares 12078735
end Index Securities
Investment Fund
National Social Security
Fund 109 Portfolio 11011618
RMB ordinary
shares 11011618
China Zheshang Bank
Co. Ltd. - Cathay Pacific
CSI Animal Husbandry RMB ordinary
Trading Open Index 10821439 shares 10821439
Securities Investment
Fund
China Construction Bank
Corporation - E Fund CSI
300 Trading Open-end 9822362 RMB ordinary
Index-Initiated Securities shares
9822362
Investment Fund
Description of the
relationship or concerted
action among the top 10 Among the top 10 shareholders mentioned above the first shareholder is the controlling
shareholders of tradable shareholder of the company and the first shareholder does not have an associated
shares without tradable relationship with other shareholders nor is it a party acting in concert; it is unknown whether
shares and between the other shareholders are parties acting in concert as stipulated in the Measures for the
top 10 shareholders of Administration of Acquisitions of Listed Companies and it is also unknown whether there is
tradable shares without an associated relationship among other shareholders
tradable shares and the
top 10 shareholders
Description of the top 10
common shareholders
participating in margin Not applicable
financing and securities
lending business (if any)
Shareholders holding more than 5% of the shares the top 10 shareholders and the top 10
shareholders of tradable shares without selling restrictions participated in the refinancing
business and lent shares
□ Applicable □Not Applicable
The top 10 shareholders and the top 10 shareholders of tradable shares without selling
restrictions have changed from the previous period due to refinancing lending/return
□ Applicable □Not Applicable
Whether the company's top 10 common shareholders and top 10 common shareholders with
unrestricted sales conditions conducted agreed repurchase transactions during the reporting
period
□Yes □No
The top 10 common shareholders of the company and the top 10 common shareholders with
unrestricted sales conditions did not conduct agreed repurchase transactions during the
124reporting period.
2. The controlling shareholder of the company
Nature of controlling shareholder: natural person holding
Controlling shareholder type: legal person
Name of controlling Legal
shareholder representative/person
Date of Organization code Main business
in charge of the unit establishment
Enterprise's own
capital investment;
commodity wholesale
trade (except for
licensed
commodities);
Guangzhou Haihao September commodity retail trade
Investment Co. Ltd Xue Hua 27 2006 91440113793877530G (except for licensed commodities); import
and export of goods
(except for franchised
and controlled
commodities);
technology import and
export
Equity situation of other
domestic and overseas listed
companies that the
controlling shareholder No
controls and participates in
during the reporting period
Change of controlling shareholder during the reporting period
□ Applicable □Not Applicable
The controlling shareholder of the company did not change during the reporting period.
3. The actual controller of the company and those acting in concert
Nature of actual controller: domestic natural person
Type of actual controller: natural person
Whether to obtain the right
Name of actual controller Relationship with the actual controller Nationality of abode in other countries or regions
Xue Hua Myself China No
Main occupation and position Chairman and President (General Manager)
Domestic and overseas listed
companies that have held Not applicable
holdings in the past 10 years
125Change of actual controller during the reporting period
□ Applicable □Not Applicable
The actual controller of the company did not change during the reporting period.Block diagram of the property rights and control relationship between the company and the
actual controller
The actual controller controls the company through trust or other asset management methods
□ Applicable □Not Applicable
4. The cumulative number of pledged shares of the company's controlling shareholder or
the largest shareholder and its concerted parties accounted for 80% of the company's
shares held by them
□ Applicable □Not Applicable
5. Other corporate shareholders holding more than 10% of the shares
□ Applicable □Not Applicable
6. Controlling shareholders actual controllers restructuring parties and other
commitment entities are restricted from reducing their shareholdings
□ Applicable □Not Applicable
126IV. The specific implementation of share repurchase during the reporting period
Progress in the implementation of share repurchase
□Applicable □ Not applicable
The
proportion of
the number
Amount to of
Program Number of Percentage be Proposed Number of repurchased
disclosure shares to be of total repurchased Repurchase shares shares to the
time repurchased share (ten
repurchase use repurchased underlying
(shares) capital thousand period (shares) shares
yuan) involved in
the equity
incentive
plan (if any)
It is used to
cancel the
registered
capital
according to
From law and continue to
October 16129033 0.97% 100000 2025-11-~ ~ ~ implement
29 2025 25806451 1.55% 160000 14 to the company's 13194845 2026-04-
13 equity incentive plan
and/or
employee
stock
ownership
plan
The progress of the implementation of the use of centralized bidding transactions to reduce
the shareholding of repurchased shares
□ Applicable □Not Applicable
V. Preferred Shares
□ Applicable □Not Applicable
During the reporting period the company did not have preferred shares.
127Section 7 Bond Related Information
□ Applicable □Not Applicable
128Section 8 Financial Report
Audit report
Type of audit opinion Standard unqualified opinion
Audit report signing date April 24 2026
Audit institution name Grant Thornton Zhitong Certified Public Accountants LLP
Audit report number GTCNSZ(2026)NO. 440A016327
CPA name Li Xujia Qiu Shuntong
Auditor’s Report
To the Shareholders of Guangdong Haid Group Co. Ltd.I. Opinion
We have audited the financial statements of Guangdong Haid Group Co. Ltd. (the “Company”) which
comprise the consolidated balance sheet as of December 31 2025 and the consolidated income statement
consolidated statement of changes in shareholders’ equity and consolidated statement of cash flows for the
year then ended and the notes to the consolidated financial statements.In our opinion the accompanying financial statements present fairly in all material respects the consolidated
and the Company’s financial position as of December 31 2025 and the consolidated and the Company’s
financial performance and cash flows for the year then ended in accordance with Accounting Standards for
Business Enterprises.II. Basis for Opinion
We conducted our audit in accordance with China Standards on Auditing. Our responsibilities under those
standards are further described in the Auditor’s Responsibilities for the Audit of the Financial Statement
section of our report. We are independent of the Company in accordance with the Code of Ethics for Chinese
Certified Public Accountant (the “Ethics Code”) together with the Independence Standards for Chinese
Certified Public Accountant to audits of financial statements of public interest entities and we fulfilled our
other ethical responsibilities in accordance with these requirements and the Ethics Code. We believe that the
audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.III. Key audit matters
The key audit matters are those matters that in our professional judgment are of most significance in our
audit of the financial statements of the current period. These matters are addressed in the context of our audit
of the financial statements as a whole and in forming our opinion thereon and we do not provide a separate
opinion on these matters.(I) Revenue Recognition
129Please refer to Note III. 29 and Note V. 52 in the Notes to the Financial Statements for the disclosure of
revenue recognition.
1. Description
The Company is mainly engaged in feed production and sales. We identified revenue recognition as a key
audit matter because operating income is one of the Company’s key performance indicators and there is an
inherent risk that management may manipulate the timing of revenue recognition to achieve specific goals
or expectations.
2. How Our Audit Addressed the Key Audit Matter
(1) We understood and evaluated the design effectiveness of internal controls related to revenue recognition.
We tested the operating effectiveness of key internal controls.
(2) We assessed whether the identification of performance obligations the allocation of transaction prices
and the determination of when control of the related goods or services is transferred were consistent with the
Company’s business model and in compliance with the applicable Accounting Standards for Business
Enterprises.
(3) We performed analytical procedures to evaluate the reasonableness of changes in revenue and gross
margin; We examined the monthly average sales price of the Company’s major products and compared them
with the corresponding data from the prior period.
(4) We reviewed the profile of the key customers and searched their relevant information through public
channels to assess whether there is any related-party relationship with the Company.
(5) To test the authenticity and completeness of revenue we inspected the supporting documents related to
revenue recognition and reviewed the relevant documents. Additionally we reconciled and analyzed the
sales data within the Company’s logistics system with the information in the financial system.
(6) To evaluate the accuracy and completeness of revenue we performed confirmation procedures on revenue.
(7) We performed revenue cut-off testing as of the balance sheet date to evaluate whether revenue was
recognized in the appropriate period.(II) Expected Credit Losses on Accounts Receivable
Please refer to Note III. 11 (6) and Note V. 4 in the Notes to the Financial Statements for the disclosure of
expected credit losses on accounts receivable.
1. Description
The Company’s management evaluated the expected credit losses on accounts receivable both individually
and collectively by considering past events current situations and forecasts of future economic trends.Except for accounts receivable with provision of bad and doubtful debts made individually the management
classified the accounts receivable into corresponding portfolios based on similar credit risk characteristics.For these portfolios the management prepared comparison table of the accounts receivable aging and
expected credit loss rate based on the historical credit losses in conjunction with the current situation and
predictions of future economic conditions to calculate the expected credit losses.We identified expected credit losses on accounts receivable as a key audit matter because the Company’s
130process involved significant accounting estimates and judgments to determine the expected credit losses and
their impact on the financial statements was material.
2. How Our Audit Addressed the Key Audit Matter
(1) We understood and evaluated the design effectiveness of internal controls related to expected credit losses
on accounts receivable. We tested the operating effectiveness of key internal controls.
(2) For accounts receivable that were measured expected credit losses based on portfolio of credit risk
characteristics we evaluated the appropriateness of the portfolio classification reviewed the appropriateness
of the historical losses rate and prospective adjustment calculated using the migration rate model and
assessed whether the expected credit losses were adequately determined.
(3) We selected samples based on the distribution of accounts receivable as of the balance sheet date and the
revenue for the current year and performed confirmation procedure on these accounts receivable. We then
compared the confirmation results with the Company’s book records.
(4) For accounts receivables with significant balances as of balance sheet date or with long aging we selected
samples to examine the customers’ operating situation historical payment records and subsequent payments
made after the balance sheet date.(III) Inventory Provision
Please refer to Note III. 13 and Note V.7 in the Notes to the Financial Statements for disclosure of inventory
provision.
1. Description
The Company measures its inventories at the lower of cost and net realizable value. Net realizable value is
defined as the estimated selling price less the estimated costs to completion estimated selling expenses and
relevant tax expenses. The Company determines net realizable value based on conclusive evidence
considering the purpose for holding the inventories and the impact of subsequent events after the balance
sheet date.We identified inventory provision as a key audit matter because the inventory balance was material as of
December 31 2025 and determining the net realizable value required significant judgment from the
management.
2. How Our Audit Addressed the Key Audit Matter
(1) We understood evaluated and tested the design and operating effectiveness of internal controls related to
inventory.
(2) We performed inventory observation procedures to verify the quantity and condition of the inventories.
(3) We obtained the inventory provision calculation schedule and performed inventory provision testing to
analyze whether the inventory provision was adequate.
(4) We obtained the inventory list as of December 31 2025. We performed analytical review of inventories
with long aging considering their condition and evaluated the appropriateness of inventory provision.
(5) For inventory provision accrued in prior year we inspected its movement in the current period.
131(6) For products with available open market price we selected samples to perform independent research and
compared the open market price to the Company’s estimated selling price. For products without available
open market price we compared the Company’s estimated selling price to their most recent actual sales price
the actual sales price in the subsequent period or the actual sales price of similar products to evaluate if the
inventory provision was adequate.IV. Other Information
The Company’s management is responsible for the other information. The other information comprises all
of the information included in the Company’s 2025 Annual Report other than the financial statements and
our auditor’s report thereon.Our opinion on the financial statements does not cover the other information and we do not express any form
of assurance conclusion thereon.In connection with our audit of the financial statements our responsibility is to read the other information
and in doing so consider whether the other information is materially inconsistent with the financial
statements or our knowledge obtained in the audit or otherwise appears to be materially misstated.If based on the work we have performed we conclude that there is a material misstatement of this other
information we are required to report that fact. We have nothing to report in this regard.V. Responsibilities of Management and Those Charged with Governance for Financial Statements
The Company’s management is responsible for the preparation of the financial statements that give a fair
view in accordance with the Accounting Standards for Business Enterprises and for designing implementing
and maintaining such internal control as the management determines is necessary to enable the preparation
of financial statements that are free from material misstatement whether due to fraud or error.In preparing the financial statements the management is responsible for assessing the Company’s ability to
continue as a going concern disclosing as applicable matters related to going concern and using the going
concern basis of accounting unless the management either intends to liquidate the Company or to cease
operations or have no realistic alternative but to do so.Those charged with governance are responsible for overseeing the Company’s financial reporting process.VI. Auditor’s Responsibilities for Audit of Financial Statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free
from material misstatement whether due to fraud or error and to issue an auditor’s report that includes our
opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in
accordance with China Standards on Auditing will always detect a material misstatement when it exists.Misstatements can arise from fraud or error and are considered material if individually or in the aggregate
they could reasonably be expected to influence the economic decisions of users taken on the basis of these
financial statements.As part of an audit in accordance with CAS we exercise professional judgment and maintain professional
skepticism throughout the audit. We also:
(1) Identify and assess the risks of material misstatement of the financial statements whether due to fraud or
error design and perform audit procedures responsive to those risks and obtain audit evidence that is
132sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement
resulting from fraud is higher than for one resulting from error as fraud may involve collusion forgery
intentional omissions misrepresentations or the override of internal control.
(2) Obtain an understanding of internal control relevant to the audit in order to design audit procedures that
are appropriate in the circumstances.
(3) Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates
and related disclosures made by the management.
(4) Concluded on the appropriateness of the management’s use of the going concern basis of accounting and
based on the audit evidence obtained whether a material uncertainty exists related to events or conditions
that may cast significant doubt on the Company’s ability to continue as a going concern. If we concluded that
a material uncertainty exists we are required to draw attention in our auditor’s report to the related disclosures
in the financial statements or if such disclosures are inadequate to modify our opinion. Our conclusions are
based on the audit evidence obtained up to the date of our auditor’s report. However further events or
conditions may cause the Company to cease to continue as a going concern.
(5) Evaluate the overall presentation structure and content of the financial statements and whether the
financial statements represent the underlying transactions and events in a manner that achieves fair
presentation.
(6) Obtain sufficient appropriate audit evidence regarding the financial information of the entities or business
activities within the Company to express an opinion on the financial statements. We are responsible for the
direction supervision and performance of the group audit. We remain solely responsible for our audit opinion.We communicated with those charged with governance regarding among other matters the planned scope
and timing of the audit and significant audit findings including any significant deficiencies in internal control
that we identified during our audit.We also provided those charged with governance with a statement that we have complied with relevant ethical
requirements regarding independence and communicated with them all relationships and other matters that
may reasonably be thought to bear on our independence and where applicable related safeguards.From the matters communicated with those charged with governance we determine those matters that are of
most significance in the audit of the financial statements of the current period and are therefore the key audit
matters. We describe these matters in our auditor’s report unless law or regulation precludes public disclosure
about the matter or when in extremely rare circumstances we determine that a matter should not be
communicated in our report because the adverse consequences of doing so would reasonably be expected to
outweigh the public interest benefits of such communication.
133Financial statements
All amounts in the Notes to the Financial Statements are expressed in RMB.
1. Consolidated Balance Sheet
Prepared by: Guangdong Haid Group Co. Ltd.Expressed in RMB
Item 2025.12.31 2024.12.31
Current assets:
Cash and cash equivalents 3202836313.58 3478256875.63
Deposit reservation for balance 0.00 0.00
Loans to other banks 0.00 0.00
Held-for-trading financial assets 2118734927.43 4662427829.82
Derivative financial assets 0.00 0.00
Notes receivable 34343827.27 26837359.79
Accounts receivable 2978763231.09 2125872345.43
Accounts receivable financing 0.00 0.00
Prepayments 898028973.32 628293443.54
Premiums receivable 0.00 0.00
Reinsurance accounts receivable 0.00 0.00
Reinsurance contract reserves receivable 0.00 0.00
Other receivables 678782287.52 877870681.54
Including: Interest receivable 0.00 0.00
Dividends receivable 0.00 0.00
Financial assets held under resale agreements 0.00 0.00
Inventories 11371777008.15 11290384103.30
Including: Data resources 0.00 0.00
Contract assets 0.00 0.00
Assets held-for-sale 0.00 641999.09
Non-current assets due within one year 16869873.84 3841618.60
Other current assets 438119835.94 394689868.63
Total current assets 21738256278.14 23489116125.37
Non-current assets:
Loans and advances to customers 0.00 0.00
Debt investments 0.00 0.00
Other debt investments 0.00 0.00
Long-term receivables 218462655.69 169130714.29
Long-term equity investments 305960124.82 280217892.86
Investments in other equity instruments 0.00 0.00
134Item 2025.12.31 2024.12.31
Other non-current financial assets 245857402.68 238380604.68
Investment properties 47197067.54 92624790.99
Fixed assets 17007956953.83 16930687726.99
Construction in progress 603959168.05 426719987.46
Productive biological assets 478298798.43 465887321.92
Oil and gas assets 0.00 0.00
Right-of-use assets 2848775741.09 2769825756.21
Intangible assets 1898205575.03 1796432121.25
Including: Data resources 0.00 0.00
Development costs 58343976.60 46582788.74
Including: Data resources 0.00 0.00
Goodwill 391322506.75 245178825.99
Long-term deferred expenses 417290154.13 295462632.97
Deferred tax assets 1022909749.23 726995506.26
Other non-current assets 307915733.10 167343863.72
Total non-current assets 25852455606.97 24651470534.33
Total assets 47590711885.11 48140586659.70
Current liabilities:
Short-term loans 1163647077.79 251739887.29
Borrowings from the central bank 0.00 0.00
Borrowings from other banks 0.00 0.00
Held-for-trading financial liabilities 64970335.96 77390252.93
Derivative financial liabilities 0.00 0.00
Notes payable 3812737586.75 4995201488.07
Accounts payable 5726047396.44 5483061495.95
Advances from customers 5111059.70 4248165.06
Contract liabilities 2581711607.32 2251063282.58
Financial assets sold under agreement to repurchase 0.00 0.00
Customer deposits and due to banks and other financial
institutions 0.00 0.00
Securities brokering 0.00 0.00
Securities underwriting 0.00 0.00
Employee benefits payable 2495052562.79 2166662287.79
Taxes payable 373791899.89 359399237.64
Other payables 1519032906.76 952217282.62
Including: Interest payables 0.00 0.00
Dividends payable 0.00 92085342.39
Fee and commissions income payable 0.00 0.00
Amount due to reinsurer 0.00 0.00
135Item 2025.12.31 2024.12.31
Liabilities held-for-sale 0.00 0.00
Non-current liabilities due within one year 512564985.67 1229927887.97
Other current liabilities 759109813.20 763875809.34
Total current liabilities 19013777232.27 18534787077.24
Non-current liabilities:
Reserve of insurance contract 0.00 0.00
Long-term loans 249637310.50 1769821334.89
Debentures payable 0.00 0.00
Including: Preference shares 0.00 0.00
Perpetual debts 0.00 0.00
Lease liabilities 2155819284.66 2015568878.94
Long-term payables 53622597.72 67132880.83
Long-term employee benefits payable 144505946.60 142173512.17
Provisions 0.00 0.00
Deferred income 330565472.30 349550038.04
Deferred tax liabilities 131452417.03 140158361.24
Other non-current liabilities 11532893.24 24960906.42
Total non-current liabilities 3077135922.05 4509365912.53
Total liabilities 22090913154.32 23044152989.77
Shareholders' equity:
Share capital 1663749970.00 1663749970.00
Other equity instruments 0.00 0.00
Including: Preference shares 0.00 0.00
Perpetual debts 0.00 0.00
Capital reserve 4614057180.72 5151357352.87
Less: Treasury stock 870133667.50 300081705.48
Other comprehensive income -310781746.53 356509145.52
Specific reserve 1477355.46 835404.85
Surplus reserve 831874985.00 831874985.00
General risk provision 2511685.80 2389821.53
Retained earnings 18316085114.07 16198667745.26
Total equity attributable to shareholders of the parent company 24248840877.02 23905302719.55
Non-controlling interests 1250957853.77 1191130950.38
Total shareholders' equity 25499798730.79 25096433669.93
Total liabilities and shareholders' equity 47590711885.11 48140586659.70
Legal representative: Xue Hua
Person in charge of accounting function: Yang Shaolin
Person in charge of accounting department: Yang Shaolin
1362. Company Balance Sheet
Expressed in RMB
Item 2025.12.31 2024.12.31
Current assets:
Cash and cash equivalents 800809667.22 1349771214.43
Held-for-trading financial assets 1636403544.09 3916158115.71
Derivative financial assets 0.00 0.00
Notes receivable 11009586.18 18335530.49
Accounts receivable 88350.77 3741.00
Accounts receivable financing 0.00 0.00
Prepayments 434087.49 10466995.29
Other receivables 6028955843.98 9964613349.06
Including: Interest receivable 0.00 0.00
Dividends receivable 0.00 359974200.00
Inventories 44150761.34 88344171.47
Including: Data resources 0.00 0.00
Contract assets 0.00 0.00
Assets held-for-sale 0.00 641999.09
Non-current assets due within one year 0.00 0.00
Other current assets 81260160.58 34060885.46
Total current assets 8603112001.65 15382396002.00
Non-current assets:
Debt investments 0.00 0.00
Other debt investments 0.00 0.00
Long-term receivables 20848355.92 18845785.23
Long-term equity investments 13633906853.26 11123066584.65
Investments in other equity instruments 0.00 0.00
Other non-current financial assets 230984493.57 223504503.57
Investment properties 3179485.35 20834616.72
Fixed assets 202563197.95 362053853.38
Construction in progress 71088467.32 55777553.85
Productive biological assets 0.00 0.00
Oil and gas assets 0.00 0.00
Right-of-use assets 504744222.34 524883644.72
Intangible assets 158897281.53 150125142.55
Including: Data resources 0.00 0.00
Development costs 57126889.22 43586516.01
Including: Data resources 0.00 0.00
Goodwill 0.00 0.00
137Item 2025.12.31 2024.12.31
Long-term deferred expenses 205405718.33 134444955.06
Deferred tax assets 198531224.54 27157162.74
Other non-current assets 14485355.03 4967313.80
Total non-current assets 15301761544.36 12689247632.28
Total assets 23904873546.01 28071643634.28
Current liabilities:
Short-term loans 0.00 0.00
Held-for-trading financial liabilities 0.00 172234.37
Derivative financial liabilities 0.00 0.00
Notes payable 3812737586.75 4995201488.07
Accounts payable 102071059.56 113451141.04
Advances from customers 0.00 498532.00
Contract liabilities 5000.00 103863.84
Employee benefits payable 407991167.51 327808933.79
Taxes payable 2203437.90 1613014.11
Other payables 7670511307.56 7822320686.64
Including: Interest payables 0.00 0.00
Dividends payable 0.00 0.00
Liabilities held-for-sale 0.00 0.00
Non-current liabilities due within one year 86759903.82 597692302.50
Other current liabilities 19165205.06 35667876.45
Total current liabilities 12101444668.16 13894530072.81
Non-current liabilities:
Long-term loans 78137500.00 572687500.00
Debentures payable 0.00 0.00
Including: Preference shares 0.00 0.00
Perpetual debts 0.00 0.00
Lease liabilities 458226363.55 462036089.00
Long-term payables 171182.00 0.00
Long-term employee benefits payable 16678910.39 16736269.33
Provisions 0.00 0.00
Deferred income 17150739.14 23494128.00
Deferred tax liabilities 0.00 0.00
Other non-current liabilities 0.00 13000000.00
Total non-current liabilities 570364695.08 1087953986.33
Total liabilities 12671809363.24 14982484059.14
Shareholders' equity:
Share capital 1663749970.00 1663749970.00
Other equity instruments 0.00 0.00
138Item 2025.12.31 2024.12.31
Including: Preference shares 0.00 0.00
Perpetual debts 0.00 0.00
Capital reserve 5643731428.92 5549414081.28
Less: Treasury stock 870133667.50 300081705.48
Other comprehensive income 0.00 -648028.08
Specific reserve 0.00 0.00
Surplus reserve 831874985.00 831874985.00
Retained earnings 3963841466.35 5344850272.42
Total shareholders' equity 11233064182.77 13089159575.14
Total liabilities and shareholders' equity 23904873546.01 28071643634.28
3. Consolidated Income Statement
Expressed in RMB
Item Year ended Year ended 31/12/2025 31/12/2024
I. Operating income 128468230914.96 114601056662.29
Including: Operating income 128468230914.96 114601056662.29
Interest income 0.00 0.00
Premium earned 0.00 0.00
Fee and commission income 0.00 0.00
II. Operating costs 123084750006.30 108813860835.95
Including: Operating costs 115193343614.54 101639577488.17
Interest expenses 0.00 0.00
Fee and commission expense 0.00 0.00
Cash surrender value 0.00 0.00
Net claim settlement expenses 0.00 0.00
Net insurance reserves 0.00 0.00
Policy dividend expense 0.00 0.00
Reinsurance expense 0.00 0.00
Taxes and surcharges 164344585.09 148670999.79
Selling and distribution expenses 2838918272.58 2608350800.44
General and administrative expenses 3699769055.55 3187514888.49
Research and development expenses 933395251.56 860035315.34
Financial expenses 254979226.98 369711343.72
Including: Interest expenses 157345198.83 294041457.45
Interest income 33272254.65 63367108.52
Add: Other income 131216405.47 133786822.95
Investment income ("-" for losses) -42408720.31 -8829799.95
139Item Year ended Year ended 31/12/2025 31/12/2024
Including: Income from investment in associates and
joint ventures 25427228.02 39786542.41
Income from derecognition of financial assets
measured at amortized cost ("-" for losses) -1562481.87 -746985.21
Exchange gains ("-" for losses) 0.00 0.00
Net exposure hedge income ("-" for losses) 0.00 0.00
Gains from changes in fair value ("-" for losses) -26991930.86 25285899.79
Credit losses ("-" for losses) -148718379.10 -264471205.52
Impairment losses ("-" for losses) -47086754.23 -219506218.82
Gains from assets disposal ("-" for losses) -6526439.92 53544318.29
III. Operating profit ("-" for losses) 5242965089.71 5507005643.08
Add: Non-operating income 69290537.75 68867810.54
Less: Non-operating expenses 128793889.30 182190876.85
IV. Profit before income tax ("-" for losses) 5183461738.16 5393682576.77
Less: Income tax expenses 638067946.83 717586978.50
V. Net profit for the year ("-" for losses) 4545393791.33 4676095598.27
(I) Classification according to operation continuity
1. Net profit from continuing operations ("-" for net
loss) 4545393791.33 4676095598.27
2. Net profit from discontinued operations ("-" for net
loss) 0.00 0.00
(II) Attributable to:
1. Shareholders of the parent company ("-" for net
loss) 4280330734.08 4503995518.39
2. Non-controlling interests ("-" for net loss) 265063057.25 172100079.88
VI. Other comprehensive income net of tax -678995553.24 46538882.52
Other comprehensive income (net of tax) attributable
to shareholders of the parent company -667290892.05 57468771.21
(I) Items that will not be reclassified to profit or loss -16285.27 0.00
1. Gains (losses) on remeasurement of defined
benefit plan liabilities or assets -16285.27 0.00
2. Other comprehensive income not to be
reclassified to profit or loss under the equity method 0.00 0.00
3. Changes in fair value of other equity instrument
investments 0.00 0.00
4. Changes in fair value of enterprise's own credit
risk 0.00 0.00
5. Others 0.00 0.00
(II) Items that may be reclassified to profit or loss -667274606.78 57468771.21
1. Other comprehensive income that can be converted
to profit or loss under the equity method -5033010.45 -2669044.27
2. Changes in fair value of other debt investments 0.00 0.00
3. Financial assets reclassified into other
comprehensive income 0.00 0.00
4. Credit impairment allowance for other debt
investments 0.00 0.00
140Item Year ended Year ended 31/12/2025 31/12/2024
5. Cash flow hedge reserves -456672803.95 241791178.43
6. Translation differences arising from translation of
foreign currency financial statements -205568792.38 -181653362.95
7. Others 0.00 0.00
Other comprehensive income (net of tax) attributable
to non-controlling interests -11704661.19 -10929888.69
VII. Total comprehensive income for the year 3866398238.09 4722634480.79
Attributable to shareholders of the parent company 3613039842.03 4561464289.60
Attributable to non-controlling interests 253358396.06 161170191.19
VIII. Earnings per share
1. Basic earnings per share 2.58 2.71
2. Diluted earnings per share 2.57 2.70
For business combination involving enterprises under common control occurred during the current period
the net profit of the acquiree before the combination was RMB0.00 and the net profit of the acquiree for the
prior period was RMB0.00.Legal representative: Xue Hua
Person in charge of accounting function: Yang Shaolin
Person in charge of accounting department: Yang Shaolin
4. Company Income Statement
Expressed in RMB
Item Year ended Year ended 31/12/2025 31/12/2024
I. Operating income 3359820880.26 3215196573.23
Less: Operating costs 1401466278.20 1330493047.25
Taxes and surcharges 5322546.60 7091301.56
Selling and distribution expenses 0.00 0.00
General and administrative expenses 883855076.05 655301986.87
Research and development expenses 281210373.38 242132198.68
Financial expenses 252190.69 -108395935.44
Including: Interest expenses 187826118.39 190417613.87
Interest income 219295752.07 316849159.06
Add: Other income 15231414.42 28029335.70
Investment income ("-" for losses) 747548277.12 486836062.12
Including: Income from investment in associates and
joint ventures -4298.24 -296743.27
Income from derecognition of financial assets
measured at amortized cost ("-" for losses) 0.00 0.00
141Item Year ended Year ended 31/12/2025 31/12/2024
Net exposure hedge income ("-" for losses) 0.00 0.00
Gains from changes in fair value ("-" for losses) 10364939.61 3213801.21
Credit losses ("-" for losses) -861675.34 92100.60
Impairment losses ("-" for losses) -818689694.21 -71195498.37
Gains from assets disposal ("-" for losses) 1810189.60 -200935.33
II. Operating profit ("-" for losses) 743117866.54 1535348840.24
Add: Non-operating income 2967469.25 1007872.75
Less: Non-operating expenses 20378096.65 15990312.51
III. Profit before income tax ("-" for losses) 725707239.14 1520366400.48
Less: Income tax expenses -56075455.79 102269327.87
IV. Net profit for the year ("-" for losses) 781782694.93 1418097072.61
1. Net profit from continuing operations ("-" for net loss) 781782694.93 1418097072.61
2. Net profit from discontinued operations ("-" for net
loss) 0.00 0.00
V. Other comprehensive income net of tax 648028.08 -648028.08
(I) Items that will not be reclassified to profit or loss 0.00 0.00
1. Gains (losses) on remeasurement of defined benefit
plan liabilities or assets 0.00 0.00
2. Other comprehensive income not to be reclassified
to profit or loss under the equity method 0.00 0.00
3. Changes in fair value of other equity instrument
investments 0.00 0.00
4. Changes in fair value of enterprise's own credit risk 0.00 0.00
5. Others 0.00 0.00
(II) Items that may be reclassified to profit or loss 648028.08 -648028.08
1. Other comprehensive income that can be converted
to profit or loss under the equity method 0.00 0.00
2. Changes in fair value of other debt investments 0.00 0.00
3. Financial assets reclassified into other
comprehensive income 0.00 0.00
4. Credit impairment allowance for other debt
investments 0.00 0.00
5. Cash flow hedge reserves 648028.08 -648028.08
6. Translation differences arising from translation of
foreign currency financial statements 0.00 0.00
7. Others 0.00 0.00
VI. Total comprehensive income for the year 782430723.01 1417449044.53
VII. Earnings per share
1. Basic earnings per share
2. Diluted earnings per share
1425. Consolidated Cash Flow Statement
Expressed in RMB
Item Year ended Year ended 31/12/2025 31/12/2024
I. Cash flows from operating activities
Cash received from sales of goods and rendering of
services 129308694882.04 116288967039.94
Customer deposits and due to banks and other
financial institutions net increase 26966535.77 80140331.90
Net increase in due to central bank 0.00 0.00
Net increase in borrowings from other financial
institutions 0.00 0.00
Cash from premiums on original insurance contracts 0.00 0.00
Net increase from reinsurance business 0.00 0.00
Net increase in insured’s deposits and investments 0.00 0.00
Cash received from interest handling fee and
commission 60823653.04 56208399.10
Placements from banks and other financial
institutions net increase 0.00 0.00
Net increase in repurchases 0.00 0.00
Net cash receipts from securities brokering 0.00 0.00
Refund of taxes 56131421.72 24169583.78
Cash received from other operating activities 984780208.74 1357948263.00
Subtotal of cash inflows from operating activities 130437396701.31 117807433617.72
Cash paid for goods and services 112593487329.63 99850308469.21
Net increase in loans and advances to customers 0.00 0.00
Due from central banks and other banks net increase 0.00 0.00
Cash paid for claim settlements on original insurance
contracts 0.00 0.00
Placements with banks and other financial
institutions 0.00 0.00
Cash paid for interest fees and commissions 0.00 0.00
Cash paid for policy dividends 0.00 0.00
Cash paid to and on behalf of employees 7426304692.89 6296452000.72
Taxes payments 1265053959.21 1038486646.44
Cash paid for other operating activities 2892173396.36 2625931126.30
Subtotal of cash outflows for operating activities 124177019378.09 109811178242.67
Net cash flows from operating activities 6260377323.22 7996255375.05
II. Cash flows from investing activities
Cash received from disposal of investments 18846583137.19 17096194296.74
Cash received from investment gains 59030385.90 66958758.23
Cash received from disposal of fixed assets
intangible assets and other long-term assets 97472689.61 155745226.93
143Item Year ended Year ended 31/12/2025 31/12/2024
Net proceeds from disposal of subsidiaries and other
business units 37688250.55 58274059.80
Cash received from other investing activities 72137638.88 22888411.53
Subtotal of cash inflows from investing activities 19112912102.13 17400060753.23
Payment for acquisition of fixed assets intangible
assets and other long-term assets 3336532557.69 3136747295.93
Payment for acquisition of investments 16510170488.75 20600132997.25
Net increase in pledged loans 0.00 0.00
Net payments for acquisition of subsidiaries and
other business units 507360140.08 6081935.84
Cash paid for other investing activities 100460328.30 62604501.99
Subtotal of cash outflows for investing activities 20454523514.82 23805566731.01
Net cash flows from investing activities -1341611412.69 -6405505977.78
III. Cash flows from financing activities
Cash received from investors 72750000.00 76800000.00
Including: Proceeds from non-controlling
shareholders of subsidiaries 72750000.00 76800000.00
Cash received from borrowings 5053801279.66 7248186028.12
Cash received from other financing activities 146766897.87 425519628.41
Subtotal of cash inflows from financing activities 5273318177.53 7750505656.53
Repayments of borrowings 6582127115.88 9496523043.54
Payment for dividends profit distributions or
interests 2624222051.83 1282219907.31
Including: Dividends and profits paid to non-
controlling shareholders of subsidiaries 303258462.14 145187839.06
Cash paid for other financing activities 1242868791.70 582230094.03
Subtotal of cash outflows for financing activities 10449217959.41 11360973044.88
Net cash flows from financing activities -5175899781.88 -3610467388.35
IV. Effect of foreign exchange rate changes on cash and
cash equivalents -71235140.56 -20585936.88
V. Net increase in cash and cash equivalents -328369011.91 -2040303927.96
Add: Cash and cash equivalents at the beginning of
the period 3326944745.48 5367248673.44
VI. Cash and cash equivalents at the end of the period 2998575733.57 3326944745.48
6. Company Cash Flow Statement
Expressed in RMB
Item Year ended Year ended 31/12/2025 31/12/2024
I. Cash flows from operating activities
Cash received from sales of goods and rendering
of services 3490468959.88 3168959435.61
Refund of taxes 0.00 0.00
144Item Year ended Year ended 31/12/2025 31/12/2024
Cash received from other operating activities 163877668201.89 145106586154.11
Subtotal of cash inflows from operating activities 167368137161.77 148275545589.72
Cash paid for goods and services 817956841.17 699336789.90
Cash paid to and on behalf of employees 640604687.41 485613285.17
Taxes payments 120706393.49 177726432.32
Cash paid for other operating activities 162218543495.60 142689310866.17
Subtotal of cash outflows for operating activities 163797811417.67 144051987373.56
Net cash flows from operating activities 3570325744.10 4223558216.16
II. Cash flows from investing activities
Cash received from disposal of investments 13236393644.87 9105228376.96
Cash received from investment gains 845538773.88 374814564.69
Cash received from disposal of fixed assets
intangible assets and other long-term assets 2670113.94 172858.95
Net proceeds from disposal of subsidiaries and
other business units 0.00 0.00
Cash received from other investing activities 0.00 0.00
Subtotal of cash inflows from investing activities 14084602532.69 9480215800.60
Payment for acquisition of fixed assets intangible
assets and other long-term assets 232420393.16 281010518.68
Payment for acquisition of investments 14002820431.25 12874434552.42
Net payments for acquisition of subsidiaries and
other business units 0.00 0.00
Cash paid for other investing activities 0.00 0.00
Subtotal of cash outflows for investing activities 14235240824.41 13155445071.10
Net cash flows from investing activities -150638291.72 -3675229270.50
III. Cash flows from financing activities
Cash received from investors 0.00 0.00
Cash received from borrowings 1869063341.35 4865080020.52
Cash received from other financing activities 131818543.43 371883277.75
Subtotal of cash inflows from financing activities 2000881884.78 5236963298.27
Repayments of borrowings 2878622337.80 6557666982.34
Payment for dividends profit distributions or
interests 2295943936.77 1020923975.71
Cash paid for other financing activities 795714011.62 93763304.93
Subtotal of cash outflows for financing activities 5970280286.19 7672354262.98
Net cash flows from financing activities -3969398401.41 -2435390964.71
IV. Effect of foreign exchange rate changes on cash
and cash equivalents -2032880.18 4414231.41
V. Net increase in cash and cash equivalents -551743829.21 -1882647787.64
Add: Cash and cash equivalents at the beginning of
the period 1349771214.43 3232419002.07
VI. Cash and cash equivalents at the end of the period 798027385.22 1349771214.43
1457. Consolidated Statement of Changes in Shareholders' Equity
Expressed in RMB
Year ended 31/12/2025
Attributable to shareholders' equity of the parent company
Item
Other equity instruments Non-controlling
Total
Other interests shareholders' Share Capital reserve Less: Treasury comprehensive Specific capital stock Surplus reserve
General risk Retained earnings Others Subtotal equity
Preference Perpetual Others income
reserve provision
share debts
I. Balance at the
end of prior year 1663749970.00 0.00 0.00 0.00 5151357352.87 300081705.48 356509145.52 835404.85 831874985.00 2389821.53 16198667745.26 0.00 23905302719.55 1191130950.38 25096433669.93
Add: Changes in
accounting 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
policies
Correction of prior
period errors 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Others 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
II. Balance at the
beginning of the 1663749970.00 0.00 0.00 0.00 5151357352.87 300081705.48 356509145.52 835404.85 831874985.00 2389821.53 16198667745.26 0.00 23905302719.55 1191130950.38 25096433669.93
year
III. Changes in
equity during theyear (“- " for 0.00 0.00 0.00 0.00 -537300172.15 570051962.02 -667290892.05 641950.61 0.00 121864.27 2117417368.81 0.00 343538157.47 59826903.39 403365060.86decrease)
(I) Total
comprehensive 0.00 0.00 0.00 0.00 0.00 0.00 -667290892.05 0.00 0.00 0.00 4280330734.08 0.00 3613039842.03 253358396.06 3866398238.09
income
(II) Shareholders'
contributions and 0.00 0.00 0.00 0.00 -556226234.93 570051962.02 0.00 0.00 0.00 0.00 0.00 0.00 -1126278196.95 18800669.44 -1107477527.51
decrease of capital
1. Contribution by
ordinary 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 73693367.89 73693367.89
shareholders
2. Contribution by
holders of other 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
equity instruments
3. Share based
payment included
in shareholders' 0.00 0.00 0.00 0.00 9132073.53 0.00 0.00 0.00 0.00 0.00 0.00 0.00 9132073.53 3048240.94 12180314.47
equity
4.Others 0.00 0.00 0.00 0.00 -565358308.46 570051962.02 0.00 0.00 0.00 0.00 0.00 0.00 -1135410270.48 -57940939.39 -1193351209.87
(III) Appropriation
of profits 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 121864.27 -2162913365.27 0.00 -2162791501.00 -212332162.11 -2375123663.11
1. Appropriation
for surplus reserve 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
146Year ended 31/12/2025
Attributable to shareholders' equity of the parent company
Item
Other equity instruments Non-controlling
Total
Other interests shareholders' Share Capital reserve Less: Treasury comprehensive Specific capital stock reserve Surplus reserve
General risk
provision Retained earnings Others Subtotal
equity
Preference Perpetual income
share debts Others
2.Appropriation
for general risk 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 121864.27 -121864.27 0.00 0.00 0.00 0.00
provision
3.Distributions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -2162791501.00 0.00 -2162791501.00 -212332162.11 -2375123663.11
to shareholders
4.Others 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
(IV) Transfer
Within equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
1. Transfer of
capital reserve to 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
share capital
2. Transfer of
surplus reserve to 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
share capital
3. Surplus reserve
for making up 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
losses
4. Transfer the
changes in defined
benefit plan into 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
retained earnings
5. Transfer of
other
comprehensive 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
income to retained
earning
6. Others 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
(V) Specific
reserve 0.00 0.00 0.00 0.00 0.00 0.00 0.00 641950.61 0.00 0.00 0.00 0.00 641950.61 0.00 641950.61
1. Appropriation
during the year 0.00 0.00 0.00 0.00 0.00 0.00 0.00 696942.62 0.00 0.00 0.00 0.00 696942.62 0.00 696942.62
2. Utilization
during the year 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -54992.01 0.00 0.00 0.00 0.00 -54992.01 0.00 -54992.01
(VI) Others 0.00 0.00 0.00 0.00 18926062.78 0.00 0.00 0.00 0.00 0.00 0.00 0.00 18926062.78 0.00 18926062.78
IV. Balance at the
end of the year 1663749970.00 0.00 0.00 0.00 4614057180.72 870133667.50 -310781746.53 1477355.46 831874985.00 2511685.80 18316085114.07 0.00 24248840877.02 1250957853.77 25499798730.79
147Expressed in RMB
Year ended 31/12/2024
Attributable to shareholders' equity of the parent company
Item
Other equity Non-controlling Total
instruments Other interests shareholders'
Share capital Capital reserve Less: Treasury comprehensive Specific Surplus reserve General risk stock reserve provision Retained earnings Others Subtotal
equity
Preference Perpetual income
share debt Others
I. Balance at the
end of prior year 1663749970.00 0.00 0.00 0.00 5415541083.59 1092402857.64 299040374.31 398575.53 831874985.00 2599780.20 12526305153.20 0.00 19647107064.19 1264209861.20 20911316925.39
Add: Changes in
accounting 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
policies
Correction of
prior period 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
errors
Others 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
II. Balance at the
beginning of the 1663749970.00 0.00 0.00 0.00 5415541083.59 1092402857.64 299040374.31 398575.53 831874985.00 2599780.20 12526305153.20 0.00 19647107064.19 1264209861.20 20911316925.39
year
III. Changes in
equity during the
year ("- " for 0.00 0.00 0.00 0.00 -264183730.72 -792321152.16 57468771.21 436829.32 0.00 -209958.67 3672362592.06 0.00 4258195655.36 -73078910.82 4185116744.54
decrease)
(I) Total
comprehensive 0.00 0.00 0.00 0.00 0.00 0.00 57468771.21 0.00 0.00 0.00 4503995518.39 0.00 4561464289.60 161170191.19 4722634480.79
income
(II) Shareholders'
contributions and
decrease of 0.00 0.00 0.00 0.00 -265308610.89 -792321152.16 0.00 0.00 0.00 0.00 0.00 0.00 527012541.27 39637723.08 566650264.35
capital
1. Contribution
by ordinary 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 107600000.00 107600000.00
shareholders
2. Contribution
by holders of
other equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
instruments
3. Share based
payment included
in shareholders' 0.00 0.00 0.00 0.00 -271624071.72 -792321152.16 0.00 0.00 0.00 0.00 0.00 0.00 520697080.44 3983930.38 524681010.82
equity
4.Others 0.00 0.00 0.00 0.00 6315460.83 0.00 0.00 0.00 0.00 0.00 0.00 0.00 6315460.83 -71946207.30 -65630746.47
(III)
Appropriation of 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -209958.67 -831632926.33 0.00 -831842885.00 -273886825.09 -1105729710.09
profits
1. Appropriation
for surplus 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
reserve
2.Appropriation
for general risk 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -209958.67 209958.67 0.00 0.00 0.00 0.00
provision
148Year ended 31/12/2024
Attributable to shareholders' equity of the parent company
Item
Other equity Non-controlling Total
instruments Other interests shareholders'
Share capital Capital reserve Less: Treasury stock comprehensive
Specific General risk equity
Preference Perpetual income reserve
Surplus reserve provision Retained earnings Others Subtotal
share debt Others
3.Distributions
to shareholders 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -831842885.00 0.00 -831842885.00 -273886825.09 -1105729710.09
4.Others 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
(IV) Transfer
within equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
1. Transfer of
capital reserve to 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
share capital
2. Transfer of
surplus reserve to 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
share capital
3. Surplus
reserve for 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
making up losses
4. Transfer the
changes in
defined benefit 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
plan into retained
earnings
5. Transfer of
other
comprehensive 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
income to
retained earning
6. Others 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
(V) Specific
reserve 0.00 0.00 0.00 0.00 0.00 0.00 0.00 436829.32 0.00 0.00 0.00 0.00 436829.32 0.00 436829.32
1. Appropriation
during the year 0.00 0.00 0.00 0.00 0.00 0.00 0.00 555173.73 0.00 0.00 0.00 0.00 555173.73 0.00 555173.73
2. Utilization
during the year 0.00 0.00 0.00 0.00 0.00 0.00 0.00
-
118344.410.000.000.000.00-118344.410.00-118344.41
(VI) Others 0.00 0.00 0.00 0.00 1124880.17 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1124880.17 0.00 1124880.17
IV. Balance at the
end of the year 1663749970.00 0.00 0.00 0.00 5151357352.87 300081705.48 356509145.52 835404.85 831874985.00 2389821.53 16198667745.26 0.00 23905302719.55 1191130950.38 25096433669.93
1498. Company Statement of Changes in Shareholders' Equity
Expressed in RMB
Year ended 31/12/2025
Item Other equity instruments Other
Share capital Capital reserve Less: Treasury stock comprehensive
Specific
reserve Surplus reserve Retained earnings Others
Total shareholders'
Preference Perpetual equity
share debts Others
income
I. Balance at the end of prior year 1663749970.00 0.00 0.00 0.00 5549414081.28 300081705.48 -648028.08 0.00 831874985.00 5344850272.42 0.00 13089159575.14
Add: Changes in accounting policies 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Correction of prior period errors 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Others 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
II. Balance at the beginning of the year 1663749970.00 0.00 0.00 0.00 5549414081.28 300081705.48 -648028.08 0.00 831874985.00 5344850272.42 0.00 13089159575.14
III. Changes in equity during the year ( "- " for
decrease) 0.00 0.00 0.00 0.00 94317347.64 570051962.02 648028.08 0.00 0.00 -1381008806.07 0.00 -1856095392.37
(I) Total comprehensive income 0.00 0.00 0.00 0.00 0.00 0.00 648028.08 0.00 0.00 781782694.93 0.00 782430723.01
(II) Shareholders' contributions and decrease of
capital 0.00 0.00 0.00 0.00 55027164.07 570051962.02 0.00 0.00 0.00 0.00 0.00 -515024797.95
1. Contribution by ordinary shareholders 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
2. Contribution by holders of other equity
instruments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
3. Share based payment included in shareholders'
equity 0.00 0.00 0.00 0.00 62422310.39 0.00 0.00 0.00 0.00 0.00 0.00 62422310.39
4.Others 0.00 0.00 0.00 0.00 -7395146.32 570051962.02 0.00 0.00 0.00 0.00 0.00 -577447108.34
(III) Appropriation of profits 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -2162791501.00 0.00 -2162791501.00
1. Appropriation for surplus reserve 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
2. Distributions to shareholders 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -2162791501.00 0.00 -2162791501.00
3. Others 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
(IV) Transfer within equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
1. Transfer of capital reserve to share capital 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
2. Transfer of surplus reserve to share capital 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
3. Surplus reserve for making up losses 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
150Year ended 31/12/2025
Item Other equity instruments
Share capital Capital reserve Less: Treasury
Other
stock comprehensive
Specific
reserve Surplus reserve Retained earnings Others
Total shareholders'
Preference Perpetual equity
share debts Others
income
4. Transfer the changes in defined benefit plan
into retained earnings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
5. Transfer of other comprehensive income to
retained earning 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
6. Others 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
(V) Specific reserve 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
1. Appropriation during the year 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
2. Utilization during the year 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
(VI) Others 0.00 0.00 0.00 0.00 39290183.57 0.00 0.00 0.00 0.00 0.00 0.00 39290183.57
IV. Balance at the end of the year 1663749970.00 0.00 0.00 0.00 5643731428.92 870133667.50 0.00 0.00 831874985.00 3963841466.35 0.00 11233064182.77
Expressed in RMB
Year ended 31/12/2024
Item Other equity instruments
Share capital Capital reserve Less: Treasury Other comprehensive Specific Surplus reserve Retained Others Total shareholders'
Preference Perpetual stock income reserve earnings equity
share debts Others
I. Balance at the end of prior year 1663749970.00 0.00 0.00 0.00 5799984845.21 1092402857.64 0.00 0.00 831874985.00 4758596084.81 0.00 11961803027.38
Add: Changes in accounting policies 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Correction of prior period errors 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Others 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
II. Balance at the beginning of the year 1663749970.00 0.00 0.00 0.00 5799984845.21 1092402857.64 0.00 0.00 831874985.00 4758596084.81 0.00 11961803027.38
III. Changes in equity during the year ( "- " for
decrease) 0.00 0.00 0.00 0.00 -250570763.93 -792321152.16 -648028.08 0.00 0.00 586254187.61 0.00 1127356547.76
(I) Total comprehensive income 0.00 0.00 0.00 0.00 0.00 0.00 -648028.08 0.00 0.00 1418097072.61 0.00 1417449044.53
(II) Shareholders' contributions and decrease of
capital 0.00 0.00 0.00 0.00 -267733611.58 -792321152.16 0.00 0.00 0.00 0.00 0.00 524587540.58
1. Contribution by ordinary shareholders 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
151Year ended 31/12/2024
Item Other equity instruments
Share capital Capital reserve Less: Treasury Other comprehensive Specific Surplus reserve Retained Others Total shareholders'
Preference Perpetual stock income reserve earnings equity
share debts Others
2. Contribution by holders of other equity
instruments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
3. Share based payment included in
shareholders' equity 0.00 0.00 0.00 0.00 -267733611.58 -792321152.16 0.00 0.00 0.00 0.00 0.00 524587540.58
4.Others 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
(III) Appropriation of profits 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -831842885.00 0.00 -831842885.00
1. Appropriation for surplus reserve 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
2. Distributions to shareholders 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -831842885.00 0.00 -831842885.00
3. Others 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
(IV) Transfer within equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
1. Transfer of capital reserve to share capital 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
2. Transfer of surplus reserve to share capital 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
3. Surplus reserve for making up losses 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
4. Transfer the changes in defined benefit plan
into retained earnings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
5. Transfer of other comprehensive income to
retained earning 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
6. Others 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
(V) Specific reserve 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
1. Appropriation during the year 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
2. Utilization during the year 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
(VI) Others 0.00 0.00 0.00 0.00 17162847.65 0.00 0.00 0.00 0.00 0.00 0.00 17162847.65
IV. Balance at the end of the year 1663749970.00 0.00 0.00 0.00 5549414081.28 300081705.48 -648028.08 0.00 831874985.00 5344850272.42 0.00 13089159575.14
152I. Company Profile
Guangdong Haid Group Co. Ltd. (formerly known as "Guangdong Haid Industrial Co. Ltd." or "Guangdong
Haid Group Limited" and hereinafter the "Company") is a share limited company registered in Guangdong
Province listed on the Shenzhen Stock Exchange in November 2009 with business license registration
No.914400007578948436.The Company's headquarters is located at Building 1 Haid Science Park No. 8
Longtai Street Hualong Town Panyu District Guangzhou Guangdong Province.The Company and its subsidiaries (hereinafter the "Group") operate in the feed industry and the main
products include aquatic and livestock feed high-quality aquatic animal seedlings animal health products
biological products pig breeding aquatic products and so on covering all business chain such as research
and development design production sales and service of various products.The financial statements and notes have been approved by the sixth meeting of the seventh Board of Directors
of the Company on April 24 2026.II. Basis of Preparation
The financial statements are prepared in accordance with the Accounting Standards for Business Enterprises
and corresponding application guidance interpretations and other related provisions issued by the Ministry
of Finance (collectively "Accounting Standards for Business Enterprises"). In addition the Group also
disclosed the relevant financial information in accordance with the Explanatory Announcement No. 15 on
Information Disclosure for Companies Offering Their Securities to the Public—General Requirements for
Financial Reporting (2023 version) issued by the China Securities Regulatory Commission.The financial statements have been prepared on a going concern basis.The Group's accounting is based on the accrual basis of accounting. The financial statements are prepared
under the historical cost except for certain financial instruments. Non-current assets held-for-sale are
measured at the lower of the amount of the fair value less estimated costs and the book value when it is
recognized as held-for-sale. If the assets were impaired a provision for impairment shall be provided in
accordance with the relevant regulations.III. Significant Accounting Policies and Accounting Estimates
The Group has established its policies for fixed assets appreciation and revenue recognition based on the
specific characteristics of its production and operations in accordance with the relevant requirements of the
Accounting Standards for Business Enterprises. For detailed information on these accounting policies please
refer to Note III. 17 and Note III. 29.
1. Statement of compliance with the Accounting Standards for Business Enterprises
The financial statements have been prepared in accordance with the requirements of Accounting Standards
for Business Enterprises. These financial statements have truly and completely presented the consolidated
financial position and financial position of the Group as of December 31 2025 and their operating results
and cash flows for the year ended December 31 2025.
2. Accounting Period
The Group's accounting period is based on the calendar year which begins on January 1 and ends on
December 31 of each year.
3. Operating Cycle
The operating cycle of the Group is 12 months.
4. Functional currency
The Group and its domestic subsidiaries use RMB as their functional currency. The overseas subsidiaries of
153the Group determine their functional currency according to the primary economic environment where they
operate. The financial statements of the Group have been prepared in RMB.The subsidiaries joint ventures and associates of the Group determine their functional currency according to
the primary economic environment where they operate and the financial statements have been prepared in
RMB.
5. Significant criteria and basis for selection
Items Significant criteria
Significant accounts receivable
assessed for Individual provision value over 5% of total bad debt provision for the
bad and doubtful debts corresponding category
allowance individually
Significant provision for bad Individual recoveries or reversals over 5% of the total original value of the
and doubtful debts recovered or corresponding accounts receivable
reversed in current period category
Significant accounts receivable Individual write-offs over 5% of total original value of the corresponding
write-off during current period accounts receivable category
Significant prepayments
accounts payable
advances from customers Individual transaction account aged over 1 year represent more than 5% of
contract liabilities the total original value of the corresponding category
dividends receivable other
payables aged over 1 year
Significant construction in Individual project value over 5% of the Company's total construction in
progress progress
Significant non-wholly-owned Non-wholly owned subsidiaries whose net assets account for more than 4%
subsidiaries of the Group's total net assets
The book value of long-term equity investment in a single investee represents
Significant joint ventures and more than 5% of the Group's total net assets or the investment gains or losses
associates under the equity method of long-term equity investments accounts for more
than 5% of the Group's consolidated net profit
Significant capitalized research The value to be capitalized for the individual R&D project accounts for more
and development projects than 5% of the Group's total intangible assets
Significant investment activities A single investment activity accounts for more than 10% of the total cash inflows or outflows related to investment activities
6. Accounting treatments for business combinations involving enterprises under common control and business
combinations involving enterprises not under common control
(1) Business combinations involving enterprises under common control
For a business combination involving enterprises under common control the assets acquired and liabilities
assumed are measured based on their carrying amounts in the consolidated financial statements of the
ultimate controlling party at the combination date. The difference between the carrying amount of the net
assets acquired and the consideration paid for the combination is adjusted against capital reserve (share
premium/capital premium) with any excess adjusted against retained earnings.For a business combination involving entities under common control achieved in stages that involves
multiple exchange transactions
In the consolidated financial statements the assets acquired and liabilities assumed are measured based on
their carrying amounts in the consolidated financial statements of the ultimate controlling party at the
combination date; the difference between the aggregate carrying amount of the investment before
combination and the new consideration paid on the combination date and the carrying amount of the net
asset acquired in the combination is adjusted against capital reserve with any excess adjusted against
retained earnings. The long-term equity investment of the combining party before acquiring the control the
profit or loss other comprehensive income and other changes in the owner's equity recognized from the later
154of the initial acquisition date of the equity and the date when the combining party and the combined party
under common ultimate control party to the combination date shall be offset against the opening retained
earnings and profit or loss for the current period in the comparative statement.
(2) Business combinations involving enterprises not under common control
For business combinations involving enterprises not under common control the consideration costs are the
fair values of the assets paid the liabilities incurred or assumed and the equity instruments issued by the
acquirer in exchange for control over the acquiree on the acquisition date. At the acquisition date the acquired
assets liabilities and contingent liabilities of the acquiree are measured at their fair value.Where the combination cost exceeds the acquirer's interest in the fair value of the acquiree's identifiable net
assets the difference is recognized as goodwill and subsequently measured based on its cost less
accumulated impairment provisions. Where the combination cost is less than the acquirer's interest in the fair
value of the acquiree's identifiable net assets the difference is recognized in profit or loss for the current
period after reassessment.The contingent consideration involved is included in the combination cost at fair value at the date of purchase
and if new or further evidence of circumstances existing at the purchase date emerges within 12 months the
contingent consideration and goodwill are adjusted accordingly.For a business combination involving enterprises not under common control and achieved in stages that
involves multiple exchange transactions
In the consolidated financial statements the cost of business combination is the total of the consideration
paid at the acquisition date and the fair value of equity investment of the acquiree held prior to the acquisition
date. The cost of equity investment of the acquiree held prior to the acquisition date shall be re-measured at
the fair value at the acquisition date the difference between the fair value and par value shall be recognized
as profit or loss for the current period. Other comprehensive income and changes of other owners' equity
from the equity interest held in the acquiree prior to the acquisition date shall be transferred to profit or loss
for the current period except for other comprehensive income arising from the remeasurement of the net
liabilities or assets of defined benefit plans by the investees as well as other comprehensive income related
to the investments in the non-trading equity instruments that were originally designated to be measured at
fair value through other comprehensive income.
(3) Transaction costs for business combination
The overhead for the business combination including the expenses for audit legal services valuation
advisory and other administrative expenses are recorded in profit or loss for the current period when incurred.The transaction costs of equity or debt securities issued as the considerations of business combination are
included in the initial recognition amount of the equity or debt securities.
7. The criteria of control and the method of preparation of the consolidated financial statements
(1) The criteria of control
The scope of consolidated financial statements is based on control. Control exists when the Group has power
over the investee; exposure or rights to variable returns from its involvement with the investee and has the
ability to use its power to affect those returns. The Group will reassess whether control exists if changes in
relevant facts and circumstances cause variations in the elements that determine control.In determining whether to include a structured entity in the scope of consolidation the Group assesses
whether to control the structured entity on the basis of a combination of all the facts and circumstances
including an assessment of the purpose and design for which the structured entity was established the
identification of the types of variable returns and whether it assumes some or all of the variability of the
returns through its participation in its related activities.
(2) Method of preparation of consolidated financial statements
155The consolidated financial statements are prepared by the Group based on the financial statements of the
Group and its subsidiaries and other relevant information. When preparing consolidated financial statements
the accounting policies and accounting periods of the subsidiaries should be consistent with the Group and
all significant intra-company balances and transactions should be eliminated.Where a subsidiary or business was acquired during the reporting period through a business combination
involving enterprises under common control the financial statements of the subsidiary or business are
included in the consolidated financial statements as if the combination had occurred at the date that the
ultimate controlling party first obtained control.Where a subsidiary or business was acquired during the reporting period through a business combination
involving enterprises not under common control the identifiable assets and liabilities of the acquired
subsidiaries or business are included in the scope of consolidation from the date that control commences.The portion of a subsidiary's equity that is not attributable to the parent is treated as non-controlling interests
and presented separately in the consolidated balance sheet within shareholders' equity. The portion of net
profit or loss of subsidiaries for the period attributable to non-controlling interests is presented separately in
the consolidated income statement below the net profit line item. When the amount of loss for the current
period attributable to the non-controlling shareholders of a subsidiary exceeds the non-controlling
shareholders' share of the opening owners' equity of the subsidiary any excess is still allocated against the
non-controlling interests.
(3) Purchase of subsidiaries' non-controlling interests
The difference between the cost of long-term equity investment newly acquired due to the purchase of non-
controlling interest and the share of net assets of the subsidiary continuously calculated from the purchase
date or merger date according to the newly increased shareholding ratio and the difference between the
disposal price obtained as a result of partial disposal of the equity investment in the subsidiary without loss
of control and the share of net assets continuously calculated since the purchase date or the merger date
corresponding to the disposal of the long-term equity investment of the subsidiary should be adjusted to the
capital reserve in the consolidated balance sheet with any excess adjusted to retained earnings.
(4) Disposal of subsidiaries
When the Group loses control over a subsidiary because of disposing part of equity investment or other
reasons the remaining part of the equity investment is re-measured at fair value at the date when the control
is lost. The difference between the aggregate of consideration received in disposal and the fair value of
remaining part of the equity investment and the aggregate share of net assets in proportion to previous
shareholding percentage in the former subsidiary since acquisition date and the goodwill is recognized as an
investment gain or loss in the current period.Other comprehensive income related to the equity investment of the former subsidiary shall be accounted for
on the same basis as the direct disposal of the relevant assets or liabilities of the former subsidiary at the time
of loss of control and other changes in owner's equity related to the former subsidiary under the equity
method of accounting shall be transferred to profit or loss in the current period at the time of loss of control.
(5) The treatment of disposing equity investment by stages until the control is lost
The Group considers the arrangements of multiple transactions by disposing equity investment by stages
until the control is lost as a single transaction when the terms conditions and economic impact of each
transaction meet one or more of the following situations:
* The transactions are entered into at the same time or in contemplation of each other;
* The transactions are considered as a single transaction to achieve an overall commercial effect;
* The occurrence of one transaction dependent on the occurrence of at least one other transaction;
156* A transaction is not economically justifiable when considered on its own but it becomes economically
justifiable when considered as part of a series of related transactions.In the consolidated financial statements please refer to the above disposal of subsidiaries for the
measurement of remaining equity and accounting treatment for profit or loss of disposing equity investment
by stages until the control is lost. The difference between each consideration received and the share of the
subsidiary's net assets since acquisition date relevant to disposing investment until the control is lost:
* is recognized in other comprehensive income if the arrangements are regarded as a single transaction.Other comprehensive income is transferred to profit or loss for the current period when the control is lost.* is recognized in capital reserve (share premium/capital premium) as an equity transaction if the
arrangements are not regarded as a single transaction. Capital reserve is not transferred to profit or loss for
the current period when the control is lost.
8. Joint arrangement classification and accounting treatment for joint operation
A joint arrangement is an arrangement of which two or more parties have joint control. The Group classifies
joint arrangements into joint operations and joint ventures.
(1) Joint operations
A joint operation is a joint arrangement whereby the joint operators have rights to the assets and obligations
for the liabilities relating to the arrangement.The Group recognizes the following items relating to its interest in a joint operation and account for them in
accordance with relevant accounting standards:
A. Its solely-held assets and its share of any assets held jointly;
B. Its solely-assumed liabilities and its share of any liabilities assumed jointly;
C. Its revenue from the sale of its share of the output arising from the joint operation;
D. Its share of the revenue from the sale of the output by the joint operation; and
E. Its solely-incurred expenses and its share of any expenses incurred jointly.
(2) Joint ventures
A joint venture is a joint arrangement whereby the joint venturers have rights to the net assets of the
arrangement.The Group adopts equity method under long-term equity investment in accounting for its investment in joint
venture.
9. Cash and cash equivalents
Cash comprises cash in hand and deposits that can be readily withdrawn on demand. Cash equivalents include
short-term highly liquid investments that are readily convertible to known amounts of cash and are subject
to an insignificant risk of change in value.
10. Foreign currency transactions and translation of foreign currency financial statements
(1) Foreign currency transactions
The Group's foreign currency operations are translated into the local currency amounts at the spot rate of
exchange in effect on the date of the transaction or at a rate determined in accordance with a systematic and
rationalized method that approximates the spot rate of exchange in effect on the date of the transaction.
157At the balance sheet date monetary items denominated in foreign currencies are translated using the spot
exchange rate at the balance sheet date. Exchange differences arising from the difference between the spot
exchange rate at the balance sheet date and the spot exchange rate at the time of initial recognition or at the
previous balance sheet date are recognized in profit or loss for the current period; for foreign-currency non-
monetary items measured at historical cost they are still translated using the spot exchange rate at the date
of the transaction; for foreign-currency non-monetary items measured at fair value they are translated using
the spot exchange rate at the date of determination of the fair value and the difference between the amount
of the bookkeeping currency after translation and the amount of the original bookkeeping currency is
recognized in profit or loss for the current period. The difference between the translated amount in the
functional currency and the original amount in the functional currency is recognized in profit or loss or other
comprehensive income depending on the nature of the non-monetary item.
(2) Translation of foreign currency financial statements
On the balance sheet date when translating the foreign currency financial statements of foreign subsidiaries
the assets and liabilities items in the balance sheet are translated using the spot exchange rate on the balance
sheet date and the shareholders' equity items except for retained earnings are translated using the spot
exchange rate on the date of occurrence.Income and expense items in the income statement are translated at rates of exchange determined by a
systematic and rationalized method that approximate spot rates at the date of the transaction.All items in the statement of cash flows are translated at rates of exchange determined on a systematic and
rationalized basis that approximate the spot rates at the date of the cash flows. The effect of exchange rate
changes on cash is reflected as a reconciling item in the statement of cash flows under the separate line item
as effect of exchange rate changes on cash and cash equivalents.The resulting translation differences are recognized as other comprehensive income in the shareholders'
equity of the balance sheet.When disposing of a foreign operation and losing control the foreign currency translation differences related
to that foreign operation which are presented under the shareholders’ equity (or owners’ equity) section of
the balance are entirely or proportionally transferred to the income statement for the period of disposal based
on the proportion of the foreign operation disposed of.
11. Financial instruments
A financial instrument is any contract that gives rise to a financial asset of one enterprise and a financial
liability or an equity instrument of another enterprise.
(1) Recognition and derecognition of financial instruments
A financial asset or a financial liability is recognized when the Group becomes a party to the contractual
provisions of a financial instrument.If one of the following criteria is met a financial asset is derecognized:
* The contractual rights to the cash flows from the financial asset expire; or
* The financial asset was transferred and the transfer qualifies for derecognition in accordance with criteria
set out below in the section of transfer of financial assets.A financial liability (or partially) is derecognized when its contractual obligation (or partially) is discharged
or cancelled or expires. If the Group (as a debtor) makes an agreement with the creditor to replace the current
financial liability with assuming a new financial liability and contractual provisions are different in substance
the current financial liability is derecognized and a new financial liability is recognized.If the financial assets are traded regularly the financial assets are recognized and derecognized at the
transaction date.
158(2) Classification and measurement of financial assets
The Group classifies financial assets as measured at amortized cost fair value through other comprehensive
income or fair value through profit or loss at initial recognition on the basis of both the entity's business
model for managing the financial assets and the contractual cash flow characteristics of the financial asset.Financial assets are measured at fair value at initial recognition. For financial assets measured at fair value
through profit or loss the related transaction costs are directly recorded in current profit or loss; for other
types of financial assets related transaction costs are included in the initial recognition amount. For
receivables arising from the sale of products or the provision of services that do not contain or take into
account significant financing components the amount of consideration that the Group is expected to be
entitled to collect shall be the initial recognition amount.Financial assets measured at amortized cost
The Group classifies the financial assets that meet the following conditions and are not designated as
measured at fair value through profit or loss as financial assets measured at amortized cost:
* The Group's business model of managing the financial assets aims at collecting contractual cash flows;
* The contractual terms of the financial asset give rise on specified dates to cash flows that are solely
payments of principal and interest on the principal amount outstanding.After the initial recognition the effective interest rate method is adopted to measure the amortized cost of
such financial assets. Gains or losses arising from financial assets that are measured at amortized cost and
are not part of any hedging relationship shall be recorded in the current profit or loss when the financial assets
are derecognized amortized according to the effective interest method or impaired.Financial assets measured at fair value through other comprehensive income
The Group classifies the financial assets that simultaneously meet the following conditions and are not
specified as measured at fair value through profit or loss as financial assets measured at fair value through
other comprehensive income:
* The Group's business model of managing the financial asset aims at both collecting contractual cash
flows and selling the financial assets.* The contractual terms of the financial asset give rise on specified dates to cash flows that are solely
payments of principal and interest on the principal amount outstanding.After the initial recognition this type of financial assets is subsequently measured at fair value. The interest
loss allowance or gain and exchange loss or gain calculated using the effective interest rate method are
included in the current profit or loss while other gains or losses are included in other comprehensive income.When derecognized the accumulated gains or losses previously recorded in other comprehensive income
shall be transferred out from other comprehensive income and recorded in the current profit or loss.Financial assets measured at fair value through profit or loss
In addition to the above financial assets measured at amortized cost and measured at fair value through other
comprehensive income the Group classifies all other financial assets as financial assets measured at fair
value through profit or loss. At the time of initial recognition in order to eliminate or significantly reduce
accounting mismatches the Group irrevocably designates some financial assets that should have been
measured at amortized cost or measured at fair value through other comprehensive income as financial assets
measured at fair value through profit or loss.After the initial recognition this kind of financial asset is subsequently measured at fair value and the gains
or losses (including interest and dividend income) generated are recorded into the current profit or loss unless
the financial asset is part of the hedging relationship.
159The business model of managing financial assets refers to how the Group manages financial assets to generate
cash flows. The business model determines whether the cash flow from the financial assets under
management of the Group is derived from the receipt of contractual cash flows the sale of financial assets
or a combination of both. The Group determines its business model for managing financial assets on the basis
of objective facts and the specific business objectives for the management of financial assets determined by
key management personnel.The Group assesses the contractual cash flow characteristics of financial assets to determine whether the
contractual cash flows generated by the relevant financial assets on specified dates are solely payments of
principal and interest on the principal amount outstanding. Principal refers to the fair value of financial assets
at initial recognition. Interest includes consideration for the time value of money the credit risk associated
with the amount of principal outstanding over a given period and other basic lending risks and costs as well
as a profit margin. In addition the Group assesses contractual terms that may cause a change in the time
distribution or amount of the contractual cash flows of financial assets to determine whether they meet the
requirements of the above contractual cash flow characteristics.Only when the Group changes the business model of managing financial assets all affected related financial
assets shall be reclassified on the first day of the first reporting period after the change of the business model
otherwise the financial assets shall not be reclassified after the initial recognition.
(3) Classification and measurement of financial liabilities
At the time of initial recognition the financial liabilities of the Group are classified as: financial liabilities
measured at fair value through profit or loss and financial liabilities measured at amortized cost. For financial
liabilities that are not classified as measured at fair value through profit or loss relevant transaction costs are
included in their initial recognized amounts.Financial liabilities measured at fair value through profit or loss
Financial liabilities measured at fair value through profit or loss include financial liabilities held for trading
and financial liabilities designated at the time of initial recognition as measured at fair value through profit
or loss. For such financial liabilities the subsequent measurement shall be made according to the fair value
and the gains or losses caused by changes in the fair value as well as the dividends and interest expenses
related to such financial liabilities shall be recorded into current profit or loss.Financial liabilities measured at amortized cost
For other financial liabilities the effective interest rate method shall be adopted the subsequent measurement
shall be made at the amortized cost and the gains or losses arising from derecognition or amortization shall
be recorded into current profit or loss.Financial guarantee contract
Financial guarantee contracts do not belong to financial liabilities measured at fair value through profit or
loss. They are measured at fair value at initial recognition and are subsequently measured at the higher of the
amount of the loss allowance determined in accordance with the expected credit loss model and the amount
initially recognized less the cumulative amortization.The distinction between financial liabilities and equity instruments
Financial liabilities refer to liabilities that meet one of the following conditions:
* A contractual obligation to deliver cash or other financial assets to other parties.* A contractual obligation to exchange financial assets or financial liabilities with another party under
potentially adverse conditions.* A non-derivative contract that has to be settled with or can be settled with the firm's own equity instruments
in the future under which the firm will deliver a variable number of its own equity instruments.
160* A derivative contract that has to be settled with or can be settled with the firm's own equity instruments in
the future except for a derivative contract in which a fixed number of its own equity instruments are to be
exchanged for a fixed amount of cash or other financial assets.An equity instrument is a contract that certifies ownership of the remaining interest in an enterprise's assets
after all liabilities have been deducted.If the Group cannot unconditionally avoid fulfilling a contractual obligation by delivering cash or other
financial assets such contractual obligation meets the definition of a financial liability.If a financial instrument has to be settled with or can be settled with the Group's own equity instruments in
the future consideration needs to be given to whether the Group's own equity instruments used to settle the
instrument is to be used as a substitute for cash or other financial assets or to give the holder of the instrument
the remaining interest in the issuer's assets after deduction of all liabilities. If it is the former the instrument
is a financial liability of the Group; if it is the latter the instrument is an equity instrument of the Group.
(4) Derivative financial instruments and embedded derivative instruments
The Group's derivative financial instruments include forward foreign exchange contracts currency exchange
rate swap contracts interest rate swap contracts and foreign exchange options contracts etc. The initial
measurement is based on the fair value of the date of signing the derivative transaction contract and the
subsequent measurement is based on its fair value. A derivative with a positive fair value is recognized as an
asset; a negative fair value is recognized as a liability. Any gains or losses resulting from changes in fair value
that do not conform to the provisions of hedge accounting shall be directly recorded into the current profit or
loss.For a hybrid instrument containing an embedded derivative instrument if the host is a financial asset the
hybrid instrument as a whole shall be subject to the relevant provisions on the classification of financial
assets. If the host is not a financial asset the embedded derivative instrument shall be separated from the
hybrid instrument and accounted for as a separate derivative instrument if all of the following conditions are
met: the hybrid instrument is not measured at fair value through profit or loss; the economic characteristics
and risks of the embedded derivative are not closely related to the economic characteristics and risks of the
host; a separate instrument with the same terms as the embedded derivative would meet the definition of a
derivative. If it is not possible to measure the embedded derivative separately at the time of acquisition or on
the subsequent balance sheet date the hybrid instrument as a whole is designated as a financial asset or
financial liability measured at fair value through profit or loss.
(5) Fair value of financial instruments
For the determination of fair value of financial assets and financial liabilities see Note III.12.
(6) Impairment of financial assets
On the basis of expected credit losses the Group conducts impairment accounting treatment for the following
items and recognizes the allowance:
* Financial assets measured at amortized cost;
* Receivables and debt investments measured at fair value and accounted for in other comprehensive
income;
* Contract assets as defined in the Accounting Standards for Business Enterprises No. 14 - Revenue;
* Lease receivables;
* Financial guarantee contracts (except for financial assets measured at fair value through profit or loss
transfer of financial assets that do not meet the conditions for derecognition or those caused by
continuing involvement in transferred financial assets).
161Measurement of expected credit losses
Expected credit loss refers to the weighted average of the credit loss of a financial instrument weighted by
the risk of default. Credit loss refers to the difference between all contractual cash flows that are due to the
Group in accordance with the contract and all the cash flows that the Group expects to receive discounted at
the original effective interest rate that is the present value of all cash shortfalls.The Group calculates the probabilistic weighted amount of the present value of the difference between the
cash flows receivable under the contract and the cash flows expected to be received and recognizes the
expected credit loss taking into account reasonable and supportable information concerning past events
current conditions and forecast of future economic conditions with the respective risks of a default occurring
as the weights.The Group separately measures the expected credit losses of financial instruments at different stages. If the
credit risk of the financial instrument has not increased significantly since the initial recognition the financial
instrument is in the first stage and the Group shall measure the loss allowance at an amount equal to 12?month
expected credit losses; if the credit risk of the financial instrument has increased significantly since the initial
recognition but no credit losses have occurred the financial instrument is in the second stage and the Group
shall measure the loss allowance at an amount equal to lifetime expected credit losses; if credit losses have
occurred to a financial instrument since its initial recognition it is in the third stage and the Group shall
measure the loss allowance at an amount equal to lifetime expected credit losses.For financial instruments with low credit risk at the balance sheet date the Group assumes that the credit risk
has not increased significantly since the initial recognition and measures the loss allowance at an amount
equal to 12?month expected credit losses.Lifetime expected credit losses refers to the expected credit losses resulting from all possible events of default
during the entire expected life of a financial instrument. The expected credit losses within the next 12 months
refer to the expected credit loss caused by the default event of the financial instrument that may occur within
12 months after the balance sheet date (or the expected duration of the financial instrument if the expected
duration of the financial instrument is less than 12 months) and is part of lifetime expected credit losses.When measuring expected credit losses the Group shall take into account the longest contract period
(including the option to renew the contract) for which it is exposed to credit risk.The Group calculates interest income on the basis of the book value before impairment provisions and the
effective interest rate for financial instruments in stage I and stage II and with lower credit risk. For financial
instruments in the third stage the interest income is calculated on the basis of the amortized cost of the book
value less the impairment provision and the effective interest rate.For notes receivable accounts receivable accounts receivable financing other receivables contract assets
etc. if the credit risk characteristics of a customer are significantly different from those of other customers
in the group or the credit risk characteristics of such customer are significantly changed the Group shall
assess for impairment individually for such receivables. In addition to the receivables assessed for
impairment individually the Group divides the receivables into groups according to the credit risk
characteristics and calculates the loss allowance on the basis of the group.Notes receivable accounts receivable and contract assets
For notes receivable accounts receivable and contract assets regardless of whether there is a material
financing component the Group always measures its loss allowance at an amount equal to lifetime expected
credit losses.When an individual financial asset or contract asset cannot assess the information of expected credit loss at
a reasonable cost the Group divides the notes receivable accounts receivable and contract assets into groups
according to the credit risk characteristics calculates the expected credit losses based on the groups which
are determined as follows:
162A. Notes receivable
* Group 1 of notes receivable: Bank acceptance notes
* Group 2 of notes receivable: Commercial acceptance notes
* Group 3 of notes receivable: Usance letters of credit
B. Accounts receivable
* Group 1 of accounts receivable: Accounts receivable due from feed related customers
* Group 2 of accounts receivable: Accounts receivable due from related parties within the scope of
consolidation
* Group 3 of accounts receivable: Accounts receivable due from raw materials customers
For the notes receivable and contract assets divided into groups the Group calculates the expected credit loss
through default risk exposure and the lifetime expected credit loss rate by referring to the historical credit
loss experience combining the current situation and the forecast of the future economic situation.For the accounts receivable divided into groups the Group refers to the historical credit loss experience and
combines the current situation with the forecast of the future economic situation to compile a comparison
table between the age of receivables/overdue days and the lifetime expected credit loss rate and to calculate
the expected credit loss. The age of accounts receivable is calculated from the date of recognition/days
overdue is calculated from the expiration date of credit period.Other receivables
The Group divides other receivables into several groups according to the credit risk characteristics and
calculates the expected credit losses on the basis of the groups which are determined as follows:
* Group 1 of other receivables: Security deposits
* Group 2 of other receivables: Futures margin
* Group 3 of other receivables: Receivables due from external parties
* Group 4 of other receivables: Advance social insurance and housing fund
* Group 5 of other receivables: Petty cash
* Group 6 of other receivables: Other receivables due from related parties within the scope of
consolidation
* Group 7 of other receivables: Others
For other receivables divided into groups the Group calculates the expected credit losses by default risk
exposure and the expected credit losses rate over the next 12 months or the entire duration. For other
receivables grouped according to age the age is calculated from the date of recognition.Loans and advances to customers
For loans and advances to customer the Group calculates the expected credit loss through the exposure at
default and the expected credit loss rate within the next 12 months or the entire duration.Long-term receivables
The Group's long-term receivables include financial lease receivables contracting fees receivable in
installments security deposits receivables etc.
163According to the credit risk characteristics the Group divides financial lease receivables contracting fees
receivable in installments and security deposits receivables into several groups. The expected credit loss is
calculated on the basis of the groups which are determined as follows:
A. Finance lease receivables
* Group 1 of finance leases: Receivable due from related parties within the scope of consolidation.* Group 2 of finance leases: Receivable due from other customers.B. Contracting fees receivable in installments
* Group 1 of contracting fees receivable in installments: Receivable due from related parties within the
scope of consolidation.* Group 2 of contracting fees receivable in installments: Receivable due from other customers.C. Other long-term receivables
* Group 1 of long-term receivables: Security deposit receivables
* Group 2 of long-term receivables: Other receivables
For security deposits receivables the Group refers to historic credit losses experience combined with the
current situation and forecast for the future economic situation to calculate the expected credit losses by
default risk exposure and the lifetime expected credit loss rate.For other receivables and long-term receivables in addition to security deposits receivables the expected
credit losses are calculated by default risk exposure and the expected credit loss rate within the next 12
months or the entire duration.Debt investment and other debt investment
For debt investment and other debt investment the Group calculates the expected credit loss based on the
default risk exposure and the expected credit loss rate within the next 12 months or the entire duration
according to the nature of the investment and the various types of counterparties and risk exposures.Assessment of a significant increase in credit risk
By comparing the risk of default of financial instruments on the balance sheet date with the risk of default
on the initial recognition date the Group determines the relative change of default risk within the expected
duration of financial instruments so as to evaluate whether the credit risk of financial instruments has
significantly increased since the initial recognition.In determining whether credit risk has increased significantly since the initial recognition the Group
considers reasonable and supportable information including forward-looking information that can be
obtained without unnecessary additional cost or effort. Information considered by the Group includes:
* The debtor fails to pay the principal and interest as due under the contract;
* A material deterioration if any of the external or internal credit rating of the financial instrument that
has occurred or is expected to occur;
* A serious deterioration of the debtor's business results occurred or is expected to occur;
* A change in the existing or anticipated technological market economic or legal environment which will
have a material adverse effect on the debtor's ability to repay the Group.According to the nature of financial instruments the Group evaluates whether credit risk increases
significantly on the basis of individual financial instruments or a group of financial instruments. When
assessing on the basis of a group of financial instruments the Group may classify financial instruments based
164on common credit risk characteristics such as overdue information and credit risk rating.
Credit-impaired financial assets
On the balance sheet date the Group evaluates whether credit impairment has occurred in financial assets
measured at amortized cost and debt investments measured at fair value through other comprehensive income.When one or more events which have an adverse effect on the expected future cash flows of a financial asset
occur the financial asset becomes a credit-impaired financial asset. Evidence of credit impairment of
financial assets includes the following observable information:
* Major financial difficulties occur to the issuer or the debtor;
* A breach of contract by the debtor such as a default or late payment of interest or principal;
* The Group has granted concessions to the debtor would not otherwise be made based on economic or
contractual considerations related to the debtor's financial difficulties.* The debtor is likely to go bankrupt or undergo other financial restructuring;
* The financial difficulties of the issuer or debtor result in the disappearance of an active market for the
financial asset.Presentation of expected credit losses
In order to reflect the change of the credit risk of financial instruments since the initial recognition the Group
re-measures the expected credit losses on each balance sheet date and the increase or recovered amount of
the loss allowance thus formed shall be recorded into the current profit or loss as a loss allowance or gain.For a financial asset measured at amortized cost the loss allowance shall offset the carrying amount of the
financial asset as stated in the balance sheet; for the debt investment measured at fair value through other
comprehensive income the Group recognizes its loss allowance in other comprehensive income and does
not offset the carrying amount of the financial asset.Write-off
If the Group no longer reasonably expects that the contractual cash flows of a financial asset can be recovered
in its entirety or a portion thereof the carrying amount of the financial asset shall be directly written-off.Such a write-off constitutes derecognition of the relevant financial asset. This usually occurs when the Group
determines that the debtor does not have assets or sources of income that generate sufficient cash flows to
repay the amount to be written-off. However in accordance with the Group's procedures for recovering
amounts due the financial assets that have been written-off may still be affected by the execution activities.If a financial asset that has been written-off is recovered later a reversal of loss allowance shall be recorded
in profit or loss of the current period.
(7) Transfer of financial assets
Transfer of financial assets is the transfer or delivery of financial assets to another party (the transferee) other
than the issuer of financial assets.A financial asset is derecognized if the Group transfers substantially all the risks and rewards of ownership
of the financial asset to the transferee. A financial asset is not derecognized if the Group retains substantially
all the risks and rewards of ownership of the financial asset to the transferee.The Group neither transfers nor retains substantially all the risks and rewards of ownership of the financial
asset the accounting treatments are as following: if control over the financial assets is surrendered the Group
derecognizes the financial assets and recognize any assets and liabilities arose; if the Group retains the control
of the financial assets financial assets to the extent of the continuing involvement in the transferred financial
assets by the Group and any relating liability are recognized.
165(8) Offset between financial assets and financial liabilities
When the Group has the legal right to offset the recognized financial assets and financial liabilities and the
legal rights is enforceable and the Group plans to settle by net amount or realize the financial assets and pay
off the financial liabilities the amount after being offset is presented in the balance sheet. Otherwise financial
assets and financial liabilities are presented separately in the balance Sheet and not allowed to offset against
each other.
12. Fair value measurement
Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly
transaction between market participants at the measurement date.The Group measures related assets or liabilities at fair value assuming the assets or liabilities are exchanged
in an orderly transaction in the principal market; in the absence of a principal market assuming the assets or
liabilities are exchanged in an orderly transaction in the most advantageous market. Principal market (or the
most advantageous market) is the market that the Group can normally enter into a transaction on measurement
date. The Group adopts the presumptions that would be used by market participants in achieving the
maximized economic value of the assets or liabilities.For financial assets or financial liabilities with active markets the Group uses the quoted prices in active
markets as their fair value. Otherwise the Group uses valuation technique to determine their fair value.Fair value measurement of a non-financial asset takes into account market participants' ability to generate
economic benefits using the asset in its best way or by selling it to another market participant that would best
use the asset.The Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data
are available to measure fair value maximizing the use of relevant observable inputs and using unobservable
inputs only if the observable inputs aren't available or impractical.Fair value level for assets and liabilities measured or disclosed at fair value in the financial statements are
determined according to the significant lowest level input to the entire measurement: Level 1 inputs are
quoted prices (unadjusted) in active markets for identical assets or liabilities that the Group can access at the
measurement date; Level 2 inputs are inputs other than quoted prices included within Level 1 that are
observable for the assets or liabilities either directly or indirectly; Level 3 inputs are unobservable inputs for
the assets or liabilities.At the balance sheet date the Group revalues assets and liabilities being measured at fair value continuously
in the financial statements to determine whether to change the levels of fair value measurement.
13. Inventories
(1) Classification
Inventories include raw materials finished goods work in progress consumptive biological assets and costs
to fulfil a contract etc.
(2) Measurement method of cost of inventories
Inventories are initially measured at cost. If the inventories are managed by batch at the time of receipt and
delivery these inventories shall be carried forward at batch cost. Otherwise inventories are calculated by
using weighted average method.
(3) Basis for determining the net realizable value and method for provision for obsolete inventories
Net realizable value is the estimated selling price in the ordinary course of business less the estimated costs
of completion and the estimated costs necessary to make the sale and relevant taxes. The net realizable value
is measured based on the verified evidences and considerations for the purpose of holding inventories and
166the effect of post balance sheet events.
The Group generally makes inventory provision on the basis of individual inventory items. For inventories
of large quantities with low unit prices inventory provision is made according to inventory categories.At the balance sheet date if the factors for previous inventory provision have disappeared inventory
provision is reversed to the extent of the original amount.
(4) Inventory count system
The Group maintains a perpetual inventory system.
14. Assets held for sale and discontinued operations
(1) Classification and measurement of non-current assets or disposal groups held for sale
The Group classifies a non-current asset or disposal group as held for sale when the carrying amount of the
non-current asset or disposal group will be recovered through a sale transaction (including an exchange
transaction of non-monetary assets with commercial substance) rather than through continuing use.Non-current assets mentioned above do not include investment properties subsequently measured with the
fair value model biological assets measured at fair value less costs to sell assets arising from employee
benefits financial assets deferred tax assets and contractual rights under insurance contracts.The disposal group is a group of assets to be disposed of by sale or otherwise together as a whole in a single
transaction and liabilities directly associated with those assets that will be transferred in the transaction. In
certain circumstances disposal groups include goodwill acquired in a business combination.A non-current asset or disposal group is classified as held for sale when all the following criteria are met:
according to the customary practices of selling such asset or disposal group in similar transactions the non-
current asset or disposal group is available for immediate sale in its present condition; the sale is highly
probable to occur that is the Group has made a resolution on a sale plan and entered into a legally binding
purchase agreement with other parties. The sale is expected to be completed within one year. The Group that
is committed to a sale plan involving loss of control of a subsidiary classifies all the investment in that
subsidiary as held for sale in its separate financial statements and classifies all the assets and liabilities of
that subsidiary as held for sale in its consolidated financial statements when the classification criteria for
held for sale are met regardless of whether the Group retains a non-controlling interest in its former
subsidiary after the sale.Non-current assets or disposal groups held for sale are initially and subsequently measured at the lower of
carrying amount and fair value less costs to sell. Any excess of the carrying amount over the fair value less
costs to sell is recognized as a loss allowance in profit or loss. The loss allowance recognized for a disposal
group firstly reduces the carrying amount of goodwill allocated to the disposal group and then reduces the
carrying amount of other non-current assets pro rata on the basis of the carrying amount of each non-current
asset in the disposal group.The Group recognizes a gain for any subsequent increase in fair value less costs to sell of an asset but not in
excess of the cumulative loss allowance that has been recognized after classified as held for sale. The reduced
carrying amount of goodwill is not recovered.The Group does not depreciate (or amortize) a non-current asset while it is classified as held for sale or while
it is part of a disposal group classified as held for sale. Interest and other expenses attributable to the liabilities
of a disposal group classified as held for sale continue to be recognized. If an investment or a part of
investment in an associate or a joint venture is classified as held for sale equity method is not used for the
part classified as held for sale while equity method is used for the rest part (the part not classified as held for
sale) continually. When the Group does not have material impact on an associate or a joint venture due to the
sale transaction it stops using equity method.The Group measures a non-current asset that ceases to be classified as held for sale at the lower of:
167* Its carrying amount of the asset or disposal group before it was classifying as held-for-sale and adjusted
for any depreciation amortization or impairment as if it has not being classified as held-for-sale;
* Its recoverable amount.
(2) Discontinued operations
The Group classifies a component as a discontinued operation either upon disposal of the operation or when
the operation meets the criteria to be classified as held for sale if it is separately identifiable and satisfies one
of the following conditions:
* It represents a separate major line of business or a separate geographical area of operations;
* It is part of a single coordinated plan to dispose of a separate major line of business or a separate
geographical area of operations;
* It is a subsidiary acquired exclusively with a view to resale.
(3) Presentation
The Group presents a non-current asset classified as held for sale and the assets of a disposal group classified
as held for sale as assets held for sale in the balance sheet. The liabilities of a disposal group classified as
held for sale is presented as liabilities held for sale in the balance sheet.The Group presents profit or loss from discontinued operations separately from profit or loss from continuing
operations in income statement. Loss allowance and reversal amount and any disposal gain or loss of a non-
current asset or disposal group classified as held for sale that does not meet the definition of a discontinued
operation is included in profit or loss from continuing operations. Any gain or loss from continuing operation
of discontinued operations including loss allowance and reversal amount and disposal gain or loss is
included in profit or loss from discontinued operations.A disposal group which is planned to cease operation rather than for sale and meets the criteria of a part of
discontinued operation the Group presents it as discontinued operation from the date of cessation.Where an operation is classified as discontinued in the current period profit or loss from continuing
operations and profit or loss from discontinued operations are separately presented in the income statement
for the current period. If the Group ceases to classify a discontinued operation as held for sale the information
previously presented in discontinued operations is reclassified and included in income from continuing
operations for all periods presented.
15. Long-term equity investments
Long-term equity investments include equity investments in subsidiaries and equity investments in joint
ventures and associates. An associate is an enterprise over which the Group has significant influence.
(1) Determination of initial investment cost
The initial cost of a long-term equity investment acquired through a business combination involving
enterprises under common control is the Group's share of the carrying amount of the subsidiary's equity in
the consolidated financial statements of the ultimate controlling party at the combination date. For a long-
term equity investment obtained through a business combination not involving enterprises under common
control the initial cost is the combination cost.A long-term equity investment acquired other than through a business combination: A long-term equity
investment acquired other than through a business combination is initially recognized at the amount of cash
paid if the Group acquires the investment by cash or at the fair value of the equity securities issued if an
investment is acquired by issuing equity securities.
(2) Subsequent measurement and recognition of profit or loss
168Long-term equity investments in subsidiaries are accounted for using the cost method. An investment in a
joint venture or an associate is accounted for using the equity method for subsequent measurement.For a long-term equity investment which is accounted for using the cost method except for cash dividends
or profit distributions declared but not yet distributed that have been included in the price or consideration
paid in obtaining the investments the Group recognizes its share of the cash dividends or profit distributions
declared by the investee as investment income for the current period.For a long-term equity investment which is accounted for using the equity method where the initial cost of
a long-term equity investment exceeds the Group's interest in the fair value of the investee's identifiable net
assets at the date of acquisition the investment is initially recognized at cost. Where the initial investment
cost is less than the Group's interest in the fair value of the investee's identifiable net assets at the date of
acquisition the investment is initially recognized at the investor's share of the fair value of the investee's
identifiable net assets and the difference is recognized in profit or loss.Under the equity method the Group recognizes its share of the investee's profit or loss and other
comprehensive income as investment income or losses and other comprehensive income respectively and
adjusts the carrying amount of the investment accordingly. Once the investee declares any cash dividends or
profit distributions the carrying amount of the investment is reduced by the amount attributable to the Group.Changes in the Group's share of the investee's owners' equity other than those arising from the investee's net
profit or loss other comprehensive income or profit distribution (referred to as other changes in owners'
equity) is recognized directly in the Group's equity and the carrying amount of the investment is adjusted
accordingly. In calculating its share of the investee's net profits or losses other comprehensive income and
other changes in owners' equity the Group recognizes investment income and other comprehensive income
after making appropriate adjustments to align the accounting policies or accounting periods with those of the
Group based on the fair value of the investee's identifiable net assets at the date of acquisition.When the Group becomes capable of exercising joint control or significant influence (but not control) over
an investee due to additional investment or other reasons the Group uses the fair value of the previously-
held equity investment together with additional investment cost as the initial investment cost under the
equity method. If the original equity is classified as non-trading equity instrument investment measured at
fair value and its changes are included in other comprehensive income the relevant accumulative changes in
fair value originally included in other comprehensive income will be transferred to retained earnings when
changed to equity method accounting.When the Group can no longer exercise joint control of or significant influence over an investee due to partial
disposal of the equity investment or other reasons the remaining equity investment shall be accounting for
using Accounting Standard for Business Enterprises No. 22 - Recognition and Measurement of Financial
Instruments and the difference between the fair value and the carrying amount of the remaining equity
investment shall be charged to profit or loss for the current period at the date of the loss of joint control or
significant influence. Any other comprehensive income previously recognized under the equity method shall
be accounted for on the same basis as would have been required if the Group had directly disposed of the
related assets or liabilities for the current period upon discontinuation of the equity method. Other movement
of owner's equity related to original equity investment is transferred to profit or loss for the current period.When the Group can no longer exercise control over an investee due to partial disposal of the equity
investment or other reasons and the remaining equity after disposal can exercise joint control of or significant
influence over an investee the remaining equity is adjusted as using equity method from acquisition. When
the remaining equity can no longer exercise joint control of or significant influence over an investee the
remaining equity investment shall be accounted for using Accounting Standard for Business Enterprises No.
22-Recognition and Measurement of Financial Instruments and the difference between the fair value and the
carrying amount of the remaining equity investment shall be charged to profit or loss for the current period
at the date of loss of control.When the Group can no longer exercise control over an investee due to new capital injection by other
investors and the Group can exercise joint control of or significant influence over an investee the Group
recognizes its share of the investee's new added net assets using new shareholding percentage. The difference
between its new share of the investee's new added net assets and its decreased shareholding percentage of
169the original investment is recognized in profit or loss. And the Group adjusts to the equity method using the
new shareholding percentage as if it uses the equity method since it obtains the investment.Unrealized profits and losses resulting from transactions between the Group and its associates or joint
ventures are eliminated to the extent of the Group's interest in the associates or joint ventures. Unrealized
losses resulting from transactions between the Group and its associates or joint ventures are eliminated in the
same method as unrealized gains but only to the extent that there is no impairment.
(3) Criteria for determining the existence of joint control or significant influence over an investee
Joint control is the contractually agreed sharing of control of an arrangement which exists only when
decisions about the relevant activities require the unanimous consent of the parties sharing control. When
assessing whether the Group can exercise joint control over an investee the Group first considers whether
no single participant party is in a position to control the investee's related activities unilaterally and then
considers whether strategic decisions relating to the investee's related activities require the unanimous
consent of all participant parties that sharing of control. All the parties or a group of the parties control the
arrangement collectively when they must act together to direct the relevant activities. When more than one
combination of the parties can control an arrangement collectively joint control does not exist. A party that
holds only protective rights does not have joint control of the arrangement.Significant influence is the power to participate in the financial and operating policy decisions of an investee
but does not have control or joint control over those policies. When determining whether the Group can
exercise significant influence over an investee the effect of potential voting rights (for example warrants
share options and convertible bonds) held by the Group or other parties that are currently exercisable or
convertible shall be considered.When the Group directly or indirectly through subsidiaries owns 20% of the investee (including 20%) or
more but less than 50% of the voting shares it has significant influence over the investee unless there is clear
evidence to show that in this case the Group cannot participate in the production and business decisions of
the investee and cannot form a significant influence. When the Group owns less than 20% of the voting
shares generally it does not have significant influence over the investee unless there is clear evidence to
show that in this case the Group can participate in the production and business decisions of the investee so
as to form a significant influence.
(4) Equity investments held-for-sale
Accounting for an entity investment or a portion of an equity investment in an associate or a joint venture
that is classified as held for sale refers to Note II.14.Any remaining equity investment that has not been classified as held for sale shall be accounted for using the
equity method.When an equity investment in an associate or a joint venture previously classified as held for sale no longer
meets the criteria to be so classified it is accounted for using the equity method retrospectively as from the
date of its classification as held for sale.
(5) Method of impairment testing and impairment provision
For investments in subsidiaries associates and joint ventures refer to Note III. 23 for the Group's method of
asset impairment.
16. Investment properties
Investment properties are properties held either to earn rental income or for capital appreciation or for both.The Group's investment properties include leased land use rights land use right held with intention of
appreciation and subsequent transfer and leased buildings.Investment properties are initially measured at acquisition cost and depreciated or amortized using the same
policy as that for fixed assets or intangible assets.
170For the impairment of the investment properties accounted for using the cost model refer to Note III. 23.
Gains or losses arising from the sale transfer retirement or disposal of an item of investment property are
determined as the difference among the net disposal proceeds the carrying amount of the item related taxes
and surcharges and are recognized in profit or loss for current period.
17. Fixed assets
(1) Recognition of fixed assets
Fixed assets represent the tangible assets held by the Group for use in production of goods use in supply of
services rental or for administrative purposes with useful lives over one accounting year.Fixed assets are only recognized when its related economic benefits are likely to flow to the Group and its
cost can be reliably measured.Fixed asset are initially measured at cost.Subsequent expenditures related to fixed assets are included in the cost of fixed assets when the economic
benefits related to them are likely to flow into the Group and their costs can be measured reliably; the daily
repair expenses of fixed assets that do not meet the criteria for subsequent expenditure of fixed assets
capitalization shall be included in the current profit or loss or the cost of relevant assets according to the
beneficiary at the time of occurrence. The carrying amount of the replaced part shall be derecognized.
(2) Depreciation of fixed assets
The Group applies straight line method for depreciation. Fixed asset begin to be depreciated when it reaches
the state of intended use and stop being depreciated when being derecognized or classified as non-current
assets held for sale. Without considering impairment provision the Group’s annual depreciation rates are
shown as follows according to the categories expected useful lives and estimated residual values rates.Category Estimated useful life Residual value rate Annual depreciation rate (years) % %
Plant and buildings 5-40 (Note) 5.00 19.00-2.38
Machinery and equipment 3-12 5.00 31.67-7.92
Motor vehicles 5 5.00 19.00
Electronic equipment 3-5 5.00 31.67-19.00
Other equipment 3-5 5.00 31.67-19.00
Note: * For the immovable buildings on the leased land they are depreciated over the shorter of the lease
term of land use right and the expected useful lives of the immovable buildings.* The Group purchased lands in India Ecuador Indonesia Egypt and Bangladesh. No depreciation
is recognized for these lands because their estimated useful lives is uncertain. The Group tests for
impairment on these lands every year.For impaired fixed assets depreciation rate is calculated based on the carrying amounts after deducting the
provision for impairment.
(3) For the impairment of the fixed assets please refer to Note III. 23.
(4) Useful lives estimated residual values and depreciation methods are reviewed each year-end.
The Group adjusts the useful lives of fixed assets if their expected useful lives are different with the original
estimates and adjusts the estimated net residual values if they are different from the original estimates.
(5) Disposal of fixed assets
171When the fixed assets are disposed or no economic benefit is expected to be generated through the use or
disposal the fixed assets shall be derecognized. The amount of the disposal income from the sale transfer
scrapping or destruction of fixed assets after deducting its carrying value and relevant taxes is recorded into
the current profit or loss.
18. Construction in progress
Construction in progress is recognized based on the actual construction cost including all expenditures
incurred for construction Items capitalized borrowing costs and any other costs directly attributable to
bringing the asset to working condition for its intended use.Construction in progress is transferred to fixed asset when it is ready for its intended use.For the impairment of construction in progress please refer to Note III. 23.
19. Borrowing costs
(1) Capitalization criteria
Borrowing costs that are directly attributable to the acquisition construction or production of a qualifying
asset shall be capitalized as part of the cost of that asset. Other borrowing costs are expensed in profit or loss
as incurred. The capitalization of borrowing costs shall commence only when the following criteria are met:
* Capital expenditures have been incurred including expenditures that have resulted in payment of cash
transfer of other assets or the assumption of interest-bearing liabilities;
* Borrowing costs have been incurred;
* The activities that are necessary to prepare the asset for its intended use or sale have commenced.
(2) Capitalization period
The capitalization of borrowing costs ceases when the asset under acquisition or construction becomes ready
for its intended use the borrowing costs incurred thereafter are recognized in profit or loss for the current
period.Capitalization of borrowing costs is suspended during periods in which the acquisition or construction of a
fixed asset is interrupted abnormally and the interruption lasts for more than 3 months until the acquisition
or construction is resumed.
(3) Capitalization rate of borrowing costs and calculation basis of capitalized amount
For interest expense actually incurred on specific borrowings the eligible capitalized amount is the net
amount of the borrowing costs after deducting any investment income earned before some or all of the funds
are used for expenditures on the qualifying asset. To the extent that the Group borrows funds generally and
uses them for the purpose of obtaining a qualifying asset the Group shall determine the amount of borrowing
costs eligible for capitalization by applying a capitalization rate to the expenditures on that asset the
capitalization rate shall be the weighted average of the borrowing costs applicable to the borrowings of the
Group that are outstanding during the period other than borrowings specifically for the purpose of obtaining
a qualifying asset.In the capitalization period exchange differences of specific borrowings in foreign currency shall be
capitalized; exchange differences of general borrowings in foreign currency is recognized in profit or loss for
the current period.
20. Biological assets
(1) Recognition criteria for biological assets
172Biological assets are assets that composed of living animals and plants. Biological assets shall be recognized
if they satisfy all of the following conditions:
* The entity owns or controls the biological asset due to past transactions or events;
* The economic benefits or potential service related to the biological asset are probable to flow into the
entity;
* The cost of the biological asset can be measured reliably.
(2) Classification of biological assets
The Group's biological assets include consumptive biological assets and productive biological assets.* Consumptive biological assets
Consumptive biological assets are the biological assets held-for-sale or harvested as agricultural products in
the future including livestock for sale etc. Consumptive biological assets are initially measured at cost. The
cost of self-propagating or breeding consumptive biological assets is the necessary expenditure incurred that
can directly attributable to the asset before the asset is sold or shipped including capitalized borrowing costs.Subsequent expenditures after harvest such as management protection and feeding expenses are recognized
in the profit or loss for the current period.When the consumptive biological assets are harvested or sold the cost of goods sold is recognized based on
the carrying amount using the weighted average method.* Productive biological assets
Productive biological assets are the biological assets held for the purpose of producing agricultural products
providing services or leasing including livestock production. Productive biological assets are initially
measured at cost. The cost of productive biological asset by self-growing or propagating is the necessary
expenditure directly attributable to the asset incurred before the asset reaches its intended production and
operation purpose including capitalized borrowing costs.The subsequent expenditures for managing protecting and feeding the productive biological assets incurred
after crown closure or reaching its intended objective of production and operation is recognized in profit or
loss for the current period.Productive biological assets are depreciated by straight-line method. Depreciation for each period is
calculated and recognized based on the estimated useful lives less residual value of each type of biological
assets.At the end of each year the Group reviews the useful lives estimated net residual values and depreciation
methods of productive biological assets. If there is any change it is treated as a change in accounting
estimates.The proceeds on disposal of productive biological asset for the sales inventory loss dead or damage less the
carrying amount and related taxes are recognized in profit or loss for the current period.
(3) Impairment of biological assets
When the net realizable value of a consumptive biological asset is lower than its carrying amount the
difference is recognized as the impairment provision and the corresponding impairment loss is recognized in
profit or loss for the current period. If the previous factors caused the decline in value of consumptive
biological asset have disappeared at the balance sheet date the previously recognized provision for decline
in value of consumptive biological assets is reversed to the extent of provision recognized in the past the
reversal amount is recognized in profit or loss for the current period.For the impairment of productive biological assets please refer to Note III. 23.
17321. Intangible assets
Intangible assets include land use rights patent rights non-patent rights software use rights trademarks
marketing network and maritime rights etc.Intangible asset is initially measured cost and its useful life is determined at the time of acquisition. An
intangible asset with a finite useful life is amortized by a method which can reflect the expected realization
of economic benefits related to the asset since the intangible asset is available for use. When the expected
realization of economic benefits cannot be reliably determined intangible asset is amortized under straight-
line method. An intangible asset with an indefinite useful life is not amortized.At the end of each year the Group reviews the useful life and amortization method of intangible assets with
finite useful life. If there is any change adjustment made to original estimates and it shall be treated as the
change of accounting estimate.Where it is expected that an intangible asset will no longer generate future economic benefits for the entity
as at the balance sheet date the carrying amount of the intangible asset shall be charged to profit or loss for
the current period.For the impairment of intangible assets please refer to Note III. 23.
22. Research and development expenditure
The Group’s research and development (R&D) expenses are directly related to R&D activities including
employee compensation for R&D personnel direct input costs depreciation and long-term deferred expenses
amortization of intangible assets expenses for commissioned external research and development and other
expenses. Among these the salaries of R&D personnel are allocated to R&D expenses based on project hours.Equipment production lines and premises shared between R&D activities and other production and business
operations are allocated to R&D expenses based on reasonable allocation factors.Expenditure on an internal research and development project is classified into expenditure incurred during
the research phase and expenditure incurred during the development phase.Expenditure during the research phase is expensed when incurred.Expenditure during the development phase is capitalized if the product or process is technically and
commercially feasible; the Group intends to complete the development; the intangible asset can generate
economic benefits including there is evidence that the products produced using the intangible asset has a
market or the intangible asset itself has a market; if the intangible asset is for internal use there is evidence
that there is usage for the intangible asset; there is sufficient support in terms of technology financial
resources and other resources in order to complete the development and use or sell the intangible asset; and
development costs can be measured reliably. Other development expenditure is recognized as an expense in
the period in which it is incurred.Research and development projects of the Group will enter into the development phase when they meet the
above conditions technical and economic feasibility research is finished and necessary approval of the
project is obtained.Capitalized expenditure on the development phase is presented as development costs in the balance sheet
and is transferred to intangible assets when the project is completed to its intended use.
23. Impairment of assets
The impairment of long-term equity investments in subsidiaries associates and joint ventures investment
properties measured by the cost model fixed assets construction in progress productive biological assets
measured by the cost model right-of-use assets intangible assets goodwill etc. (excluding inventories
investment properties measured by the fair value model deferred tax assets and financial assets) are
determined as follows:
174At the balance sheet date the Group assesses whether there is any indication of impairment. If any indication
exists the Group will estimate the recoverable amount and test for impairment. For goodwill arising from a
business combination intangible assets with indefinite useful life and intangible assets that are not ready for
use are tested for impairment annually regardless of whether there is any indication of impairment.The recoverable amount of an asset is the higher of its fair value less disposal costs and the present value of
expected future cash flows. The Group estimates the recoverable amount based on each individual asset. If
it is impossible to estimate the recoverable amount of each individual asset the Group determines the
recoverable amount for the asset group to which the asset belongs. An asset group is determined based on
whether the main cash inflow generated by the asset group is independent of the cash inflow of other assets
or asset groups.An impairment loss is recognized in profit or loss when the recoverable amount of an asset is less than its
carrying amount. A provision for impairment of the asset is recognized accordingly.For the impairment test of goodwill the carrying amount of goodwill arising from a business combination
shall be allocated to the relevant asset groups by using a reasonable method from the date of acquisition. If
the carrying amount of goodwill is unable to be allocated to the asset group it shall be allocated to the relevant
set of asset groups. Relevant asset group or set of asset groups is the asset group or group of asset groups
that is expected to benefit from the synergies of the combination and not greater than the reportable segment
of the Group.If any impairment indication exists in asset group or set of asset groups related to goodwill the Group shall
perform an impairment test for the asset group or set of asset groups which does not contain goodwill first
the recoverable amount is calculated and recognized the corresponding impairment losses. Then the Group
shall perform an impairment test for the asset group or set of asset groups that contain goodwill by comparing
its carrying amount and recoverable amount. If the recoverable amount is less than the carrying amount
impairment loss of goodwill is recognized.Once an impairment loss is recognized it cannot be reversed in a subsequent period.
24. Long-term deferred expenses
Long-term deferred expenses are recorded at the actual cost and amortized using a straight-line method
within the benefit period. For long-term deferred expense that cannot bring benefit in future period the Group
recognized its amortized cost in profit or loss for the current period.
25. Employee benefits
(1) Scope of employee benefits
Employee benefits refer to all forms of consideration or compensation given by the Group in exchange for
service rendered by employees or for the termination of employment relationship. Employee benefits include
short-term employee benefits post-employment benefits termination benefits and other long-term employee
benefits. Benefits provided to the Group's spouse children dependents family members of deceased
employees or other beneficiaries are also part of the employee benefits.According to liquidity employee benefits are presented as employee benefits payable and long-term
employee benefits payable on the balance sheet.
(2) Short-term employee benefits
In the current period the Group has accrued for the actual wages bonuses medical insurance for employees
based on standard rate work injury insurance and maternity insurance and other social insurance and housing
fund incurred and these are recognized as liabilities and corresponding costs in the profit or loss.
(3) Post-employment benefits
Post-employment benefit plan includes defined contribution plans and defined benefit plans. Defined
175contribution plans are post-employment benefit plans which an entity pays a fixed fee to an independent fund
and has no further payment obligation. Defined benefit plans are post-employment benefit plans other than
defined contribution plans.Defined contribution plans
Defined contribution plans include basic pension insurance unemployment insurance etc.The contribution amount calculated according to the define contribution plan is recognized as a liability as
the employee provides services with a corresponding charge to profit or loss or included in the cost of assets
where appropriate.Defined benefit plans
For defined benefit plans independent actuaries estimate the actuarial value at the balance sheet date to
determine the cost of welfare by using the projected unit credit method. The Group recognizes the following
components of employee benefits cost arising from defined benefit plan:
* Service cost comprising current service cost past service cost and any gain or loss on settlement. Current
service cost is the increase in the present value of the defined benefit plan obligation resulting from employee
service in the current period. Past service cost is the increase or decrease in the present value of the defined
benefit plan obligation for employee service in prior periods resulting from a plan amendment.* Net interest on the net defined benefit plan liabilities or assets including interest income on plan assets
interest cost on the defined benefit plan obligation and interest on the effect of the asset ceiling.* Changes as a result of re-measurement of the net defined benefit liabilities or assets.Item * and item * above should be recognized in profit or loss for the current period unless another
accounting standard requires or permits the inclusion of the employee benefit costs in the cost of assets. Item
* shall be recognized in other comprehensive income and shall not reclassified to profit or loss in a
subsequent period. On termination of defined benefit plans other comprehensive income previously
recognized is transferred to retained earnings.
(4) Termination benefits
The Group provides for termination benefits to the employees and shall recognize an employee benefits
liability for termination benefits with a corresponding charge to the profit or loss for the current period at
the earlier of the following dates: When the Group cannot unilaterally withdraw the offer of the termination
benefits because of an employment termination plan or a redundancy proposal; or when the Group recognizes
the costs or expenses relating to a restructuring that involves the payment of the termination benefits.When the Group implements an internal retirement plan the economic compensation before the formal
retirement date is attributable to the termination benefits. The salaries and social insurance payment to be
paid for the early-retired employee are recognized as one-off expense in profit or loss for the current period
between the date when the employee stops rendering service and formal retirement. Economic compensation
after the date of formal retirement (such as normal pension) shall be accounted for as post-employment
benefits.
(5) Other long-term employee benefits
Other long-term employee benefits provided by the Group to the employees satisfied the conditions for
classifying as a defined contribution plan; those benefits shall be accounted for in accordance with the above
requirements relating to defined contribution plan. When the benefits satisfied a defined benefit plan it shall
be accounted for in accordance with the above requirements relating to defined benefit plan but the
movement of net liabilities or assets in re-measurement of defined benefit plan shall be recorded in profit or
loss for the current period or cost of relevant assets.
17626. Provisions
A provision is recognized for an obligation related to a contingency if all the following conditions are satisfied:
(1) The Group has a present obligation;
(2) It is probable that an outflow of economic benefits will be required to settle the obligation;
(3) The amount of the obligation can be estimated reliably.
A provision is initially measured at the best estimate of the expenditure required to settle the related present
obligation. Factors pertaining to a contingency such as the risks uncertainties and time value of money are
taken into account as a whole in reaching the best estimate. Where the effect of the time value of money is
material provisions are determined by discounting the expected future cash flows. The Group reviews the
carrying amount of a provision at the balance sheet date and adjusts the carrying amount to the current best
estimate.If all or part of the expenditure necessary for settling the provision is expected to be compensated by a third
party the amount of compensation is separately recognized as an asset when it is basically certain to be
received. The recognized compensation amount shall not exceed the carrying amount of the provision.
27. General risk provision
General risk allowance is a provision from unrecognized earnings to partially cover probable losses that have
not been identified after deducting the provision for loan losses that has been made after calculating the
estimated value of the potential risks of risk assets using the standard method. Risk assets include loans and
advances issued and other current assets held by subsidiaries engaged in financial operations.
28. Share-based payment and equity instruments
(1) Types of share-based payment
The Group's share-based payment is classified into equity-settled share-based payment and cash-settled
share-based payment.
(2) Recognition method of the fair value of equity instruments
If an active market exists for the equity instruments such as stock option granted by the Group the fair value
of the equity instrument shall be determined according to the quoted price in the active market. If an active
market does not exist the fair value of the equity instrument shall be determined by using the option pricing
model. The Group considers the following factors when selecting the model: A) the exercise price of the
option; B) the validity period of the option; C) current price of underlying stock; D) expected volatility of
the stock price; E) expected dividend of the stock; F) risk-free interest rate within the validity period of the
option.
(3) Basis for the best estimate of exercisable equity instruments
At each balance sheet date of the waiting period the Group revises the number of equity instruments that
will ultimately vest based on the best estimate of the latest number of eligible employees and other subsequent
information. On vesting date the number of expected vested equity instruments should be agreed with the
actual number vested.
(4) Accounting treatments for the implementation modification and termination of share-based payment plans
Equity-settled share-based payment is measured by the fair value of the equities instruments granted to
employees. As to an equity-settled share-based payment that the right may be exercised immediately after
the grant the fair value of the equity instruments shall on the date of the grant be charged to the relevant
cost or expense and the capital reserves shall be adjusted accordingly. As to an equity-settled share-based
payment that the right cannot be exercised until the vesting period comes to an end or until the prescribed
177performance conditions are met then on each balance sheet date within the vesting period the services
obtained in the current period shall based on the best estimate of the number of vested equity instruments
be charged to the relevant costs or expenses at the fair value of the equities instruments on the date of the
grant and the capital reserves shall be adjusted accordingly. After the vesting date the confirmed related
costs or expenses and the total owner's equity will not be adjusted.Cash-settled share-based payments is measured by the fair value of liability undertaken by the Group at the
mean of share or other equity instruments. As to a cash-settled share-based payment instruments that the right
may be exercised immediately after the grant the fair value of the liability undertaken by the Group shall on
the date of the grant be charged to the relevant costs or expenses and the liabilities shall be increased
accordingly. As to a cash-settled share-based payment that the right may not be exercised until the vesting
period comes to an end or until the specified performance conditions are met on each balance sheet date with
in the vesting period the services obtained in the current period shall based on the best estimate of the
information about the vesting conditions be charged to the relevant costs or expenses and the corresponding
liabilities at the fair value of the liability undertaken by the Group. On each balance sheet date and settlement
date before the settlement of related liabilities the fair value of liabilities is re-measured and the changes are
included in the current profit and loss.When the Group modifies the share-based payment plan if the fair value of the distributed equity instrument
is increased due to the modification the increment of the obtained services shall be recognized accordingly;
if the quantity of the distributed equity instrument is increased due to the modification the increment of
obtained services shall be recognized accordingly. The increase in the fair value of equity instruments refers
to the difference between the fair value of equity instruments before and after modification on the
modification date. If the modification decreases the fair value of equity instruments granted or adopt other
terms and conditions unfavorable to the employees the accounting treatment for the services obtained will
continue and be deemed that the change has never occurred unless the Group cancelled some or all of the
granted equity instruments.If the granted equity instruments are canceled or settled within the vesting period (except that canceled due
to failure to meet the vesting conditions) the Group shall regard the canceling or settlement as acceleration
of the vest and immediately recognize the amount supposed to be recognized within the residual vesting
period in the current profit and loss and capital reserves. If employees or other parties can choose to meet the
conditions of unfeasible rights but fail to meet them within the waiting period the Group will take it as the
cancellation of the instrument for granting rights and interests.
29. Revenue
(1) General principles
The Group recognizes the revenue when it satisfied its performance obligation stated in the contract that is
when the control of the good or service is transferred to the customer.If the contract comprises two or more performance obligations the Group allocates the transaction price to
each performance obligation based on the proportion of sales price for the goods or service committed by
each performance obligation at the commencement date of the contract. Revenue is recognized based on the
allocated transaction price for each performance obligation.A performance obligation is satisfied over time if one of the following criteria is met. Otherwise it is satisfied
at a point in time.* The customer simultaneously receives and consumes the economic benefits provided by the Group's
performance as the Group's performs its obligation;
* The Group's performance produces good that the customer control as the good is created;
* The Group's performance produces goods without an alternative use to the Group and the Group has an
enforceable right to payment for performance completed to date.
178For performance obligations satisfied over time the Group recognizes revenue over time by measuring the
progress towards complete satisfaction of those performance obligations. If the Group cannot reasonably
measure such progress but expects to recover the costs incurred in satisfying the performance obligation
revenue is recognized only to the extent of the costs incurred until such time that the progress can be
reasonably measured.For performance obligation satisfied at a point in time the Group recognizes revenue at the time when the
control of good or service is transferred to the customer. The Group considers the following indications when
determining whether the control of good or service is transferred to the customer:
* The Group has a present right to payment for goods or services i.e. the customer has a present payment
obligation for the goods.* The Group has transferred the legal title of the goods to the customer i.e. the customer has the legal title.* The Group has transferred the physical goods to the customer i.e. the customer has physical possession.* The Group has transferred the significant risks and rewards of ownership of the goods to the customer
i.e. the customer has the significant risks and rewards of ownership.* The customer has accepted the goods.* Other indicators that the customer has obtained control of the goods.
(2) Specific methods
The Group's revenue is mainly derived from sale of goods.Sales of goods
The Group produces and sells feed seedling animal health products hog and aquatic products.The Group recognizes the revenue when the customers collect the goods by door or the goods have been
delivered to the designated location and the customers accept the goods and obtain the control of goods.The credit periods granted by the Group to its customers are consistent with the practice in each industry and
have no significant financing components.The Group's cooperation model with franchiser is buyout sales and sales revenue recognition is consistent
with the direct sales model.Some contracts with customers have sales rebate arrangements resulting in variable consideration. The
Group determines the best estimate of variable consideration on the basis of expectation or the most likely
value to occur. The transaction price that includes variable consideration does not exceed the value by which
it is highly unlikely that a material reversal of the cumulative recognized revenue will occur when the related
uncertainty is removed.For the sale of goods with sales return clauses revenue recognition is limited to extent of cumulative
recognized revenue that is unlikely to be materially reversed. The Group recognizes a liability according to
the expected refund. The carrying amount of the returned goods less than the estimated cost to recover the
goods (including the decline in value for the returned goods) is recognized as an asset at the same time.
30. Contract costs
Contract costs include the incremental costs of obtaining a contract and costs to fulfill a contract.Incremental costs of obtaining a contract are the cost only incurred if the contract is obtained (i.e.commission). The Group expects to recover these costs and recognized as an asset of incremental costs of
obtaining a contract. Other expenditures of obtaining a contract except for the incremental costs expected to
179be recovered are recognized in profit or loss for the current period when incurred.
The Group recognizes the costs to fulfill a contract as an asset if the costs are incurred for fulfilling the
performance obligation of the contract do not fall within the scope of other accounting standards such as
inventory and meet the following criteria:
* The costs directly related to a contract or an anticipated contract that can specifically identify including
direct labor direct materials manufacturing overheads (or similar expenses) costs explicitly chargeable to
the customer and other costs incurred solely for the contract;
* The costs generate or enhance resources of the Group that will be used in satisfying performance
obligations in the future.* The cost is expected to be recovered.Assets recognized from costs of obtaining a contract and costs to fulfill a contract (hereinafter referred to as
assets related to contract cost) shall be amortized in the profit or loss for the current period on the same basis
as revenue recognition of goods or services related to such assets. If the amortization period does not exceed
one year it is recognized in profit or loss for the current period when it occurs.When the carrying amount of the assets related to the contract cost is greater than the difference between the
following two items. The Group shall make provision for impairment of the excess amount and recognize as
impairment loss:
* The remaining consideration that the Group is expected to be received as a result of the transfer of the
goods or services related to the asset;
* Costs probably incurred for transferring of the relevant goods or services.
31. Government grants
A government grant is recognized when there is reasonable assurance that the grant will be received and that
the Group will comply with the conditions attaching to the grant.If a government grant is in the form of a transfer of a monetary asset it is measured at the amount received
or receivable. If a government grant is in the form of a transfer of a non-monetary asset it is measured at fair
value. If fair value cannot be reliably determined it is measured at a nominal amount of RMB 1.Government grants related to assets are grants whose primary condition is that the Group qualifying for them
should purchase construct or otherwise acquire long-term assets. Government grants related to income are
grants other than those related to assets.For government grants with unspecified purpose the amount of grants used to form a long-term asset is
regarded as government grants related to an asset the remaining amount of grants is regarded as government
grants related to income. If it is not possible to distinguish the amount of grants is treated as government
grants related to income.A government grant related to an asset is offset against the carrying amount of the related asset or recognized
as deferred income and amortized to profit or loss over the useful life of the related asset on a reasonable and
systematic manner. A grant that compensates the Group for expenses or losses already incurred is recognized
in profit or loss or offset against related expenses directly. A grant that compensates the Group for expenses
or losses to be incurred in the future is recognized as deferred income and included in profit or loss or offset
against related expenses in the periods in which the expenses or losses are recognized. Government grants
measured at nominal amounts are directly recognized in the profit or loss for the current period. The Group
applies the same method to the same or similar government grant.A grant related to ordinary activities is recognized as other income or offset against related expenses based
on the economic substance. A grant not related to ordinary activities is recognized as non-operating income.
180For repayment of a government grant if the government grant is offset against the carrying amount of the
related asset at the time of recognition the carrying amount of the related asset shall be adjusted. If there is
related deferred income the repayment is offset against the carrying amount of the deferred income and any
excess is recognized in profit or loss for the current period. Otherwise the repayment is recognized
immediately in profit or loss for the current period.If the government directly appropriates the interest subsidy to the lending bank the Group recognized the
loan as the amount received and interest expense is calculated using the loan principal and policy-related
preferential interest rate. If the government directly appropriates the interest subsidy to the Group the interest
subsidy is offset against interest expense.
32. Deferred tax assets and deferred tax liabilities
Income tax comprises of current tax and deferred tax. Current tax and deferred tax are recognized in profit
or loss except to the extent that they relate to transactions or items recognized directly in equity and goodwill
arising from a business combination.Deferred tax assets and deferred tax liabilities arise from deductible and taxable temporary differences
respectively being the differences between the carrying amounts of assets and liabilities for financial
reporting purposes and their tax bases.All the taxable temporary differences are recognized as deferred tax liabilities except for those incurred in
the following transactions:
(1) initial recognition of goodwill or assets or liabilities in a transaction that is not a business combination
and that affects neither accounting profit nor taxable profit (or deductible loss) (except for individual
transactions in which the initial recognition of assets and liabilities results in equal amounts of taxable
temporary differences and deductible temporary differences);
(2) taxable temporary differences associated with investments in the Group associates and joint ventures
and the Group is able to control the timing of the reversal of the temporary difference and it is probable that
the temporary difference will not reverse in the foreseeable future.The Group recognizes a deferred tax asset for the deductible temporary differences deductible losses and tax
credits carried forward to subsequent periods to the extent that it is probable that future taxable profits will
be available against which deductible temporary differences deductible losses and tax credits can be utilized
except for those incurred in the following transactions:
(1) a transaction that is not a business combination and that affects neither accounting profit nor taxable
profit (or deductible loss) (except for individual transactions in which the initial recognition of assets and
liabilities results in equal amounts of taxable temporary differences and deductible temporary differences);
(2) deductible temporary differences associated with investments in the Group associates and joint ventures
the corresponding deferred tax asset is recognized when both of the following conditions are satisfied: it is
probable that the temporary difference will reverse in the foreseeable future; and it is probable that taxable
profits will be available in the future against which the temporary difference can be utilized.At the balance sheet date the Group measures the deferred tax assets and deferred tax liabilities according
to the applicable tax rate during the period when the assets are expected to be recovered or the liabilities are
settled and reflect the income tax impact of the expected asset recovery or liability settlement method on the
balance sheet date.At the balance sheet date the Group reviews the carrying amount of any deferred tax asset. If it is probable
that sufficient taxable profits will not be available in future periods to allow the benefit of the deferred tax
asset to be utilized the carrying amount of the deferred tax asset is reduced. Any such reduction in amount
is reversed to the extent that it becomes probable that sufficient taxable profits will be available.At the balance sheet date deferred tax assets and deferred tax liabilities are presented as net amounts after
offsetting when both of the following criteria are met:
181(1) The taxpayer of the Group has the legal right to net settlement of current tax assets and current tax
liabilities;
(2) Deferred tax assets and deferred tax liabilities are related to income taxes levied by the same tax collection
authority on the same taxpayer within the Group.
33. Leases
(1) Identification of leases
At inception of a contract the Group as a lessee or a lessor shall assess whether the customer under the
contract has the right to obtain substantially all of the economic benefits from use of the identified asset
during the period of use and has to right to direct the use of the identified asset during the period of use. The
Group considers the contract to be a lease or to include a lease if one of the parties to the contract conveys
the right to control the use of one or more identified assets for a certain period of time in exchange for
consideration.
(2) The Group acts as the lessee
At the commencement date the Group recognizes the right-of-use assets and lease liabilities for all leases
except for short-term leases and leases of low value assets that are accounted for according to the simplified
method.For the accounting policy of the right-of-use assets see Note III. 34.Lease liabilities are initially measured at the present value of the outstanding lease payments at the
commencement date of the lease using the interest rate implicit in the lease. If the interest rate implicit in the
lease cannot be determined the incremental borrowing rate shall be used as the discount rate. The lease
payments include: fixed payments and in-substance fixed payments; if there are lease incentives the relevant
amount of lease incentives shall be deducted; variable lease payments depending on an index or a rate; the
exercise price of the option provided that the lessee is reasonably certain that the option will be exercised;
the amount to be paid to exercise the option to terminate the lease if the lease term reflects that the lessee
will exercise the option to terminate the lease; and the amount expected to be payable based on the residual
value of the security provided by the lessee. The interest expense of the lease liability in each period of the
lease term shall be calculated in accordance with the fixed periodic interest rate and recorded into the profit
or loss of the current period. The variable lease payment not included in the measurement of lease liabilities
shall be recorded into the current profit or loss when actually incurred.Short-term leases
A short-term lease is a lease that at the commencement date has a lease term of 12 months or less except
for a lease that contains a purchase option.The Group records the lease payment amount of short-term lease into the cost of relevant assets or current
profit or loss in each period of the lease term according to the straight-line method
Leases of Low-value assets
Leases of low value assets refer to lease of a single leased asset whose value is less than RMB40000 when
it is a brand-new asset.The Group includes the lease payment of the low-value asset lease into the cost of the relevant asset or current
profit or loss in each period of the lease term according to the straight-line method
For low-value asset leases the Group chooses to apply the above simplified treatment depending on the
specific circumstances of each lease.Lease modifications
182A lessee shall account for a lease modification as a separate lease if both: (i) the lease modifies the scope of
the lease by adding the right to use one or more underlying assets; and (ii) the increase in consideration must
be commensurate with the stand-alone price for the increase in scope and any appropriate adjustments to that
stand-alone price to reflect the circumstances of the particular contract.If a lease modification is not accounted for as a separate lease at the effective date of the lease modification
the Group reallocates the consideration in the modified lease redetermines the lease term and remeasures
the present value of lease liability according to the revised lease payments and revised discount rate.If a lease modification results in a reduction in the scope of the lease or a shortening of the lease term the
Group reduces the carrying amount of the right-of-use asset accordingly and recognizes the gain or loss
related to partial termination or full termination of the lease in profit or loss for the current period.If all other lease modifications result in the remeasurement of the lease liabilities the Group makes a
corresponding adjustment to the carrying amount of right-of-use asset.
(3) The Group acts as the lessor
When the Group acts as the lessor the leases that substantially transfer all the risks and rewards related to
the ownership of the assets are recognized as finance leases and other leases other than finance leases are
recognized as operating leases.Finance leases
In the case of finance leases the Group takes the net investments in the lease as the carrying amounts of
finance lease receivables at the commencement date and the net lease investments are the sum of the
unguaranteed residual value and the present value of the lease payments receivable at the commencement
date discounted at the implicit interest rate. The Group as the lessor calculates and recognizes interest
income for each period of the lease term at a fixed periodic rate. The variable lease payments obtained by the
Group as the lessor and not included in the measurement of the net lease investments shall be recorded into
the current profit or loss when actually incurred.The derecognition and impairment of finance lease receivable shall be accounted for in accordance with the
provisions of Accounting Standards for Business Enterprises No. 22 - Recognition and Measurement of
Financial Instruments and Accounting Standards for Business Enterprises No. 23 - Transfer of Financial
Assets.Operating lease
For the rent in the operating lease the Group shall recognize the profit or loss of the current period in
accordance with the straight-line method during each period of the lease term. The initial direct costs incurred
in connection with the operating lease shall be capitalized allocated on the same basis as the recognition of
rental income during the lease term and recorded into the current profit or loss in installments. The variable
lease payments obtained in connection with the operating lease and not included in the lease payments shall
be recorded into the current profit or loss when actually incurred.Lease modifications
The Group treats it as a new lease for accounting treatment from the effective date of the modification and
the amount of lease payments received in advance or receivable related to the lease before the modification
will be regarded as the amount of new lease payments.The Group treats the finance lease modification as a separate lease if the following conditions are met: (i) the
modification increases the scope of the lease by adding the right to use one or more underlying assets; and
(ii) the consideration for the lease increases by an amount commensurate with the stand-alone price for the
increase in scope and any appropriate adjustments to that stand-alone price to reflect the circumstances of
the contract.If the finance lease modification is not accounted for as a separate lease the Group will deal with the modified
183lease under the following circumstances: (i) If the modification takes effect on the commencement date of
the lease the lease will be classified as an operating lease and the Group will treat it as a new lease from the
effective date of the lease modification and take the net investment in lease before the effective date of the
lease modification as the carrying amount of the leased asset; (ii) If the modification takes effect on the
commencement date of the lease the lease will be classified as a finance lease and the Group will conduct
accounting treatment in accordance with the provisions of the Accounting Standards for Business Enterprises
No. 22 - Recognition and Measurement of Financial Instruments concerning the modification or
renegotiation of the contract.
(4) Subleases
When the Group acts as a sublease lessor it classifies the sublease based on the right-of-use assets generated
from the original lease. If the original lease is a short-term lease and the Group uses the simplified method
to account for the original lease the sublease shall be classified as an operating lease.
34. Right-of-use assets
(1) Criteria for recognition of right-of-use assets
A right-of-use asset represents the right of the Group as a lessee to utilize the leased assets over the duration
of an agreed-upon lease term.On the commencement date the right-of-use assets shall be initially measured at cost. The cost includes: the
initial measurement of the lease liability; for the amount of lease payments paid on or before the
commencement date of the lease term if there is a lease incentive the relevant amount of lease incentive
already enjoyed will be deducted; initial direct costs incurred by the Group as the lessee; the costs which the
Group as the lessee expects to incur in dismantling and removing the leased assets restoring the premises
on which the leased assets are located or restoring the leased assets to the state agreed in the lease terms. The
Group as the lessee shall recognize and measure the costs of demolition and restoration in accordance with
the Accounting Standards for Business Enterprises No.13- Contingencies. Subsequent adjustments are made
for any remeasurement of the lease liability.
(2) Depreciation method of the right-of-use assets
The Group uses the straight line method of depreciation. Where the Group as the lessee can reasonably
determine that it obtains the ownership of the leased assets upon expiration of the lease term depreciation
shall be accrued over the remaining useful life of the leased assets. If the lessee cannot reasonably determine
that it will obtain ownership of the leased asset by the end of the lease term depreciation shall be charged
over the shorter of the lease term and the remaining useful life of the leased asset.
(3) See Note III. 23 for the impairment test method of the right-of-use assets and the method for impairment
provision.
35. Safety production expenses
In accordance with the relevant regulations the Group accrues safety production expenses at the rate of 1.00%
of the operating income from general freight business in the previous year.When safety production expenses are accrued they are charged to the cost of relevant products or profit or
loss for the current period and are recorded in the special reserve.When the accrued safety production expenses are used within the prescribed scope if they are of an expense
nature they directly reduce special reserve. For those that form fixed assets the expenditures incurred are
first capitalized in construction in progress and transferred to fixed assets upon completion and reaching its
state of intended use. Simultaneously the cost of the fixed assets is deducted from special reserve and
accumulated depreciation of the same amount is recognized. Such fixed assets shall not be depreciated in
subsequent periods.
36. Repurchase shares
184When the Group repurchase its own shares those shares are treated as treasury stock before they are cancelled
or transferred. All the expenditures relating to the repurchased shares are recorded as the cost of treasury
stock. The consideration and transaction costs paid in share repurchase reduce the shareholders' equity. No
profit or loss is recognized when repurchasing transferring or canceling the Group's shares.When the treasury stock is transferred the difference between the actual amount received and the carrying
amount of treasury stock is recognized in capital reserve. Any excess is recognized in surplus reserve and
retained earnings. When the treasury stock is cancelled the share capital should be reduced to the extent of
the total par value and the number of shares cancelled. The difference between the carrying amount and par
value of the treasure stock cancelled is recognized in capital reserve. Any excess is recognized in surplus
reserve and retained earnings.
37. Hedge accounting
At the inception of a hedging relationship the Group formally designates the hedging instrument and the
hedged item and documents in writing the hedging relationship risk management strategy and risk
management objective The documentation includes identification of the hedging instrument the hedged item
the nature of the risk being hedged and how the Group will assess whether the hedging relationship meets
the hedge effectiveness requirements.The Group assesses on an ongoing basis whether the hedging relationship meets the hedge effectiveness
requirements for the accounting periods during which it is designated. If it fails to meet those requirements
the Group shall discontinue hedge accounting. The following hedge effectiveness requirements must be met
to apply hedge accounting:
* There is an economic relationship between the hedged item and the hedging instrument.* The effect of credit risk does not dominate the value changes that result from that economic relationship
between hedged items and hedging instruments.* The hedge ratio of the hedging relationship shall be the same as that resulting from the quantity of hedged
items that the Group actually hedges and the quantity of the hedging instrument that the Group actually uses
to hedge that quantity of hedged item. However that designation shall not reflect an imbalance between the
weightings of the hedged item and the hedging instrument that would create hedge ineffectiveness and may
result in an accounting outcome inconsistent with the purpose of hedge accounting.The Group shall discontinue hedge accounting if one of the following conditions is met:
* The hedging relationship no longer meets the risk management objectives due to a changes in risk
management objective.* The hedging instrument has expired or has been sold terminated or exercised.* The economic relationship between the hedged item and the hedging instrument no longer exists or the
effect of credit risk dominates the value changes resulting from that economic relationship.* The hedging relationship no longer satisfies the other conditions for applying hedge accounting.Fair value hedge
A fair value hedge is a hedge of the exposure to changes in fair value of a recognized asset or liability or an
unrecognized firm commitment or a component of any such item that is attributable to a particular risk and
could affect the entity’s profit or loss or other comprehensive income.Any gain or loss arising from fair value hedge shall be recognized in profit or loss for the current period.Gain or loss of hedged item arising from the hedged risk exposure shall be recognized in profit or loss for
the current period and shall adjust the carrying amount of the recognized hedged items that is not measure
at fair value.
185If the hedged item is a financial instrument (or a component thereof) measured at amortized cost the
adjustment to the carrying amount of the hedged item shall be amortized to profit or loss. The amortization
shall be based on a recalculated effective interest rate at the date that amortization begins.If a firm commitment (or a component thereof) that is not recognized is designated as a hedged item the
cumulative change in the fair value of the hedged item arising from the hedged risk subsequent to designation
is recognized as an asset or a liability with corresponding gains or losses recognized in profit or loss in the
relevant periods. When the firm commitment is fulfilled and an asset or liability is recognized the initial
measurement of that asset or liability is adjusted to include the cumulative change in the fair value of the
hedged item previously recognized.Cash flow hedge
A cash flow hedge refers to a hedge of the exposure to variability in cash flows that is attributable to a
particular risk associated with a recognized asset or liability a highly probable forecast transaction or a
component of any such item and could affect the entity’s profit or loss.The portion of the gain or loss on the hedging instrument that is determined to be an effective hedge is
recognized in other comprehensive income as cash flow hedge reserve. The ineffective portion (i.e. the
remaining gain or loss after deducting the amount recognized in other comprehensive income) is recognized
in profit or loss.For a cash flow hedge if the hedged item is a forecast transaction that subsequently results in the recognition
of a non-financial asset or a non-financial liability or a hedged forecast transaction for a non-financial asset
or a non-financial liability becomes a firm commitment to which fair value hedge accounting is applied the
Group shall remove the amount previously recognized in the cash flow hedge reserve from equity and include
it directly in the initial measurement of such asset or liability.For cash flow hedges that do not fall into the above categories the Group reclassifies the amount previously
recognized in the cash flow hedge reserve from equity to profit or loss in the same period or periods during
which the hedged expected cash flows affect profit or loss.If the amount accumulated in the cash flow hedge reserve for a particular cash flow hedge is a loss and the
Group expects that all or a portion of that loss will not be recovered in future periods then it immediately
reclassifies to profit or loss the amount that is not expected to be recovered
When the Group discontinues hedge accounting for a cash flow hedge if the hedged future cash flows are
still expected to occur the cumulative amount of the cash flow hedge reserve recognized in other
comprehensive income shall remain in the cash flow hedge reserve until the expected transaction actually
occurs and is then treated in accordance with the above-mentioned accounting policies for cash flow hedges.If the hedged future cash flows are no longer expected to occur the cumulative amount of the cash flow
hedge reserve recognized in other comprehensive income shall be reclassified to profit or loss. If the hedged
future cash flows are no longer highly probable but may still be expected to occur the cumulative amount of
the cash flow hedge reserve recognized in other comprehensive income shall be retained until the expected
transaction actually occurs and is then treated in accordance with the above-mentioned accounting policies
for cash flow hedges.
38. Significant accounting judgments and estimates
The Group assesses the significant accounting estimates and key assumptions on an ongoing basis based on
the historical experience and other factors including reasonable expectation of future events. It is probable
that the significant adjustment risk to the carrying amount of assets and liability in the next accounting period
will arise from the following significant accounting judgments and key assumptions:
Measurement of expected credit losses on accounts receivable
The Group calculates the expected credit loss of accounts receivable through the default risk exposure of
accounts receivable and the expected credit loss rate of accounts receivable. The Group determines the
186expected credit loss rate based on the probability and loss rate of default. When determining the expected
credit loss rate the Group uses internal historical credit loss experience and other data and adjusts the
historical data in conjunction with current conditions and forward-looking information. When considering
forward-looking information the indicators used by the Group include the risk of economic downturn
changes in the external market environment technological environment and customer situation. The Group
regularly monitors and reviews assumptions related to the calculation of expected credit losses.Impairment of goodwill
The Group assesses the impairment of goodwill at least once a year. The Group shall evaluate the value in
use for the cash-generating units to which goodwill has been allocated. When assessing the value in use the
Group requires to estimate the expected future cash flows from the cash-generating unit and select an
appropriate discount rate to calculate the present value.Deferred tax asset
To the extent that there is likely that there will be sufficient profits to offset losses deferred tax assets should
be recognized for all unutilized tax losses. The management requires using many judgments to estimate the
time and amount of future taxable profits in conjunction with tax planning strategies to determine the
amount of deferred tax assets that should be recognized.
39. Changes in significant accounting policies accounting estimates
(1) Changes in significant accounting policies
There were no significant changes in the Company's accounting policies during the year.
(2) Changes in significant accounting estimates
There were no significant changes in the Company’s accounting estimates during the year.IV. Taxation
1. Main types of taxes and corresponding tax rates
Tax Tax base Statutory tax rate
Taxable value-added amount (the taxable amount is
Value-added tax calculated based on the balance of taxable sales Tax exemption
(VAT) multiplied by the applicable tax rate after deducting the 3% 5% 6% 9%
allowable input tax for the current period) 10% 13%
Urban maintenance
and construction tax Turnover tax paid 1% 5% 7%
On an ad valorem basis 1.2% of the residual value after
Property tax deducting 30% from the original value of the property; 1.2% 12%
On a rental basis 12% of the rental income
Corporate income tax Taxable income Please refer to Note IV.1
Note: Except for the following tax entities that are subjected to different corporate income tax rates all other
taxpayers within the scope of consolidation are subject to a corporate income tax rate of 25%.Taxpayer Income tax rate (%)
Guangdong Haid Group Co. Ltd. 15.00
Yangjiang Yangdong Fengwo Agriculture and Animal Husbandry Co. Ltd. 20.00
Gaozhou Sanhe Animal Husbandry Co. Ltd. 20.00
Shandong Yitun Ecological Agriculture Co. Ltd. 20.00
187Taxpayer Income tax rate (%)
Guizhou Yixin Seed Industry Technology Co. Ltd. 20.00
Hunan Yixin Pig Breeding Co. Ltd. 20.00
Qinzhou Qinnan Yitun Ecological Agriculture Co. Ltd. 20.00
Yingde Yitun Pig Breeding Co. Ltd. 20.00
Youxian Yitun Ecological Agriculture Co. Ltd. 20.00
Wengyuan Yitun Pig Breeding Co. Ltd. 20.00
Guiyang Yitun Ecological Agriculture Co. Ltd. 20.00
Weifang Yitun Ecological Agriculture Co. Ltd. 20.00
Hengyang Jisheng Agriculture and Animal Husbandry Development Co. Ltd. 20.00
Ji'an Yitun Ecological Agriculture Co. Ltd. 20.00
Qingdao Daxin Yitun Ecological Agriculture Co. Ltd. 20.00
Shaoguan Zhenjiang Yixian Food Co. Ltd. 20.00
Guangdong Yitun Supply Chain Management Co. Ltd. 15.00
Guangzhou Xitun Agricultural Investment Co. Ltd. 20.00
Hunan Xitun Ecological Agriculture Co. Ltd. 20.00
Guangdong Xitun Ecological Agriculture Co. Ltd. 20.00
Guangxi Xitun Ecological Agriculture Co. Ltd. 20.00
Anhui Xitun Ecological Agriculture Co. Ltd. 20.00
Hubei Xitun Ecological Agriculture Co. Ltd. 20.00
Binchuan Yitun Ecological Agriculture Co. Ltd. 20.00
Shicheng Yitun Ecological Agriculture Co. Ltd. 20.00
Mianyang Yitun Ecological Agriculture Co. Ltd. 20.00
Suqian Yitun Ecological Agriculture Co. Ltd. 20.00
Guangzhou Peiqi Investment Co. Ltd. 20.00
Qinzhou Peiqi Breeding Services Co. Ltd. 20.00
Yantai Peiqi Breeding Services Co. Ltd. 20.00
Guangzhou Haiyue Agriculture and Animal Husbandry Co. Ltd. 20.00
Qujing Haiyue Ecological Agriculture Co. Ltd. 20.00
Hunan Haiyue Ecological Agriculture Co. Ltd. 20.00
Hebei Haiyue Agriculture and Animal Husbandry Co. Ltd. 20.00
Guangdong Hinter Biotechnology Group Co. Ltd. 15.00
Guangzhou Haishengyuan Biotechnology Co. Ltd. 20.00
Zhuhai Haiyiyuan Supply Chain Management Co. Ltd. 20.00
Yangling Haid Feed Co. Ltd. 20.00
Gansu Haid Feed Co. Ltd. 15.00
Weinan Haid Feed Co. Ltd. 20.00
Wuwei Haid Feed Co. Ltd. 20.00
Anyang Haiyue Feed Technology Co. Ltd. 20.00
Wuhan Zeyi Investment Co. Ltd. 20.00
188Taxpayer Income tax rate (%)
Qingyuan Haibei Biotechnology Co. Ltd. 15.00
Chengdu Haid Biotechnology Co. Ltd. 15.00
Guangxi Haid Feed Co. Ltd. 15.00
KINGHILL HOLDINGS PTE.LTD. 17.00
KINGHILL PTE.LTD. 17.00
Haid Egypt Co. Ltd. 22.50
Haid Egypt Aquatic Co. Ltd 22.50
HAIDA AGRICULTURAL AND TECHNOLOGY NIGERIA LIMITED 30.00
Haid 3 Egypt Technology Co Ltd 22.50
HAI HANG International Trade Nigeria Co. Ltd. 30.00
Tanzania Haid Company Limited 30.00
KINGHILL RESOURCES PTE.LTD. 17.00
VINH LONG HAILIANKE Biotechnology CO. LTD Tax-exempt
KINGHILL AGRI PTE.LTD. 17.00
PT.HAIDA AGRICULTURE INDONESIA 22.00
PT.HAIDA SURABAYA TRADING 22.00
PT HISENOR TECHNOLOGY INDONESIA 22.00
HAID FEED BANGLADESH LIMITED 27.50
PT HAIDA Biotechnology INDONESIA 22.00
Dachuan Biotechnology Co. Ltd. 27.50
PT HISENOR GENETICS INDONESIA 22.00
PT.HAILIANK TECHNOLOGY INDONESIA 22.00
HAID AGRICULTURAL TECHNOLOGY MYANMAR COMPANY LIMITED 22.00
Haid technology (Thailand) Co. LTD 20.00
LAOS HAID COMPANY LIMITED Tax-exempt
PT Ocean Dragon Indonesia 22.00
Hisenor Aquatic Seed Industry Technology Pte.Ltd. 17.00
HISENOR (ECUADOR) CIA. LTDA. 22.00
HISENOR BIO TECH (M) SDN. BHD. 24.00
PT BIBIT UNGGUL 22.00
KINGHILL INVESTMENT (SINGAPORE) PTE.LTD. 17.00
KINGHILL INTERNATIONAL (SINGAPORE) PTE.LTD. 17.00
PT. APEX POULTRY BREEDING 22.00
HAID DO BRASIL LTDA 15.00
Zhuhai Hisenor Aquatic Seed Industry Technology Co. Ltd. 15.00
Huizhou Haizenong Marine Biotechnology Co. Ltd. 20.00
Guangzhou Haizehui Fishery Development Co. Ltd. 20.00
Zhaoqing Haizehui Fishery Development Co. Ltd. 20.00
Guangzhou Nansha Haishengyuan Aquaculture Technology Co. Ltd. 20.00
189Taxpayer Income tax rate (%)
Shanwei Haizenong Marine Biotechnology Co. Ltd. 20.00
Yongji Haijingzhou Fishery Technology Co. Ltd. 20.00
Jingtai Haijingzhou Fishery Technology Co. Ltd. 20.00
Shanwei Haizexin Marine Biotechnology Co. Ltd. 20.00
Huizhou Haizexin Marine Biotechnology Co. Ltd. 20.00
Yingkou Haizehui Seed Industry Technology Co. Ltd. 20.00
Liuzhou Haizehui Fishery Technology Co. Ltd. 20.00
Qingyuan Haizehui Fishery Technology Co. Ltd. 20.00
Raoping Haizexin Marine Biotechnology Co. Ltd. 20.00
Zhejiang Hisenor Marine Biotechnology Co. Ltd. 20.00
Jiangmen Haizenong Marine Biotechnology Co. Ltd. 20.00
Zhejiang Lanke Seed Industry Technology Co. Ltd. 20.00
Shanwei Haizenong Gene Technology Co. Ltd. 20.00
Yingkou Haishengyuan Biotechnology Co. Ltd. 20.00
Shanwei Haizehui Marine Biotechnology Co. Ltd. 20.00
Beihai Haizenong Seed Industry Technology Co. Ltd. 20.00
Jiangsu Haizehui Seed Industry Technology Co. Ltd. 20.00
Dongying Hailing Fresh Aquatic Food Co. Ltd. 20.00
Yangxin Bairong Aquatic Seed Co. Ltd. 20.00
Jingzhou Bairong Aquatic Seed Co. Ltd. 20.00
Shandong Bairong Aquatic Seed Co. Ltd. 20.00
Hainan Bairong Aquatic Seed Co. Ltd. 20.00
Zhaoqing Baishengyuan Aquatic Seed Co. Ltd. 20.00
Guangdong Baishengyuan Aquatic Seed Co. Ltd. 20.00
Zhaoqing Bairong Seed Industry Technology Co. Ltd. 20.00
Hainan Haizexin Marine Biotechnology Co. Ltd. 20.00
Rongcheng Yandunjiao Feed Co. Ltd. 20.00
Zhenyuan Haisheng Protein Feed Co. Ltd. 20.00
Haid Supply Chain Management (Zhuhai) Co. Ltd. 15.00
HAID INTERNATIONAL (SINGAPORE) PTE. LTD. 17.00
Sanya Fengmu Agricultural Development Co. Ltd. 20.00
Guizhou Delian Zhiyun Network Technology Co. Ltd. 20.00
Dandong Haiyufeng Agricultural Development Co. Ltd. 20.00
Ezhou Haifeng Ecological Agriculture Co. Ltd. 20.00
Nantong Fengmu Trading Co. Ltd. 20.00
Sichuan Haimufeng Agriculture Co. Ltd. 20.00
Hailet (Zhengzhou) Biotechnology Co. Ltd. 20.00
Rongcheng Haihesheng Marine Biotechnology Co. Ltd. 20.00
Beijing Haichengyuan Feed Technology Co. Ltd. 20.00
190Taxpayer Income tax rate (%)
Guangzhou Haishun Supply Chain Management Co. Ltd. 20.00
Haid Supply Chain Management (Guangzhou) Co. Ltd. 20.00
Guizhou Haipin Chemical Co. Ltd. 20.00
Haid International Group Limited 8.25 16.50 Tax-exempt
China Haida Feed Group (HK) Limited 16.50 Tax-exempt
Rickworth Investments Limited Tax-exempt
Hong Kong Longreat Trading Co. Limited 16.50 Tax-exempt
HAID FEED COMPANY LIMITED 15.00
DONG NAI HAID FARM COMPANY LIMITED 15.00
Haid International Holdings Limited Tax-exempt
Haidea Holdings Pte.Ltd. 17.00
LANKING RICKWORTH PTE.LTD. 17.00
HAID Biotechnology INDUSTRY (SINGAPORE) PTE. LTD. 17.00
Guangzhou Haituoer Consulting Co. Ltd. 20.00
PANASIA TRADING RESOURCES LIMITED Tax-exempt
SHENG LONG INTERNATIONAL LTD. Tax-exempt
SHENG LONG BIO-TECH INTERNATIONAL CO. LTD 10 15 17 20 Tax-exempt
SHENG LONG BIOTECH (HAI DUONG) INTERNATIONAL CO. LTD 20 Tax-exempt
SHENG LONG BIO-TECH(TIEN GIANG) INTERNATIONAL CO. LTD 15.00
LONG SHENG INTERNATIONAL CO. LTD 15.00 20.00
Long Sheng International (Suoi Dau) Co. Ltd 10.00
Hisenor International Limited Tax-exempt
KEMBANG SUBUR INTERNATIONAL LTD. 24.00
NAMDUONG VIETNAM AQUATIC HATCHERY CO. LTD. Tax-exempt
SHENG LONG BIO TECH(M)SDN.BHD. 24.00
SHENG LONG AQUA TECHNOLOGY (M) SDN. BHD. 24.00
THANG LONG(VINH LONG)BIOTECH CO. LTD. 20.00 Tax-exempt
Haihua Bio-Tech(Hong Kong)Limited 16.50
Haid International Biofarms Pte.Ltd. 17.00
Guigang Haid Feed Co. Ltd. 15.00
Yunnan Haid Biotechnology Co. Ltd. 15.00
Guangdong Mutai Biotechnology Co. Ltd. 15.00
Zhaoqing Haid Feed Co. Ltd. 20.00
Wuhan Shuijiyuan Biotechnology Co. Ltd. 20.00
LANKING PTE.LTD. 17.00
Haid Lanking International Trading Inc. Note
LANKING NEMO(SG) PTE.LTD. 17.00
191Taxpayer Income tax rate (%)
Lanking Nano PTE.LTD. 17.00
HAI DUONG HAID COMPANY LIMITED 15.00 20.00
HAI DAI COMPANY LIMITED 15.00
VINH LONG HAI DAI CO. LTD. 5.00 20.00
BINH DINH HAI LONG CO. LTD. 20.00 Tax-exempt
HISTAR VIETNAM AQUATIC BREEDING COMPANY LIMITED 20.00
BINH PHUOC HAI LONG COMPANY LIMITED Tax-exempt
MEKONG HAI LONG COMPANY LIMITED 10.00
CAMBODIAN HAIDA AGRICULTURE AND ANIMAL HUSBANDRY 1.00 20.00 Tax-
TECHNOLOGY CO. LTD. exempt
Guangzhou Changsheng Logistics Co. Ltd. 20.00
Guangdong Haid Pet Co. Ltd. 20.00
Haid Pet Food (Weihai) Co. Ltd. 20.00
Liaocheng Haiding Feed Co. Ltd. 20.00
Liaocheng Haiding Veterinary Services Co. Ltd. 20.00
Yucheng Haiding Agriculture and Animal Husbandry Co. Ltd. 20.00
Danxian Haiding Veterinary Services Co. Ltd. 20.00
Xinxiang Haiding Feed Co. Ltd. 20.00
Xinxiang Hairuida Feed Co. Ltd. 20.00
Heze Haiding Feed Technology Co. Ltd. 15.00
Heze Dingxin Veterinary Services Co. Ltd. 20.00
Jining Sishui Dingxin Veterinary Services Co. Ltd. 20.00
Jinan Fengcheng Agriculture and Animal Husbandry Co. Ltd. 20.00
Tengzhou Fengcheng Feed Co. Ltd. 20.00
Heze Haiding Ecological Breeding Co. Ltd. 20.00
Liaocheng Haixin Enterprise Management Consulting Co. Ltd. 20.00
Junan Haiding Feed Co. Ltd. 20.00
Sihong Haiding Feed Co. Ltd. 20.00
Linyi Dingxin Breeding Co. Ltd. 20.00
Linyi Haiding Veterinary Services Co. Ltd. 20.00
Linyi Haiding Lusheng Feed Co. Ltd. 20.00
Qinggang Fengcheng Baizun Feed Co. Ltd. 20.00
Suihua Fengcheng Baizun Feed Co. Ltd. 20.00
Chengwu Fengcheng Feed Co. Ltd. 20.00
Weifang Binhai Haiding Feed Co. Ltd. 20.00
Dongying Dinghao Breeding Co. Ltd. 20.00
Xuzhou Hairuida Feed Co. Ltd. 20.00
Linyi Haiding Biological Feed Co. Ltd. 20.00
Jiangsu Fengcheng Technology Co. Ltd. 20.00
192Taxpayer Income tax rate (%)
Qingdao Dinghao Fengying International Trade Co. Ltd. 20.00
Liaocheng Fengcheng Feed Co. Ltd. 20.00
HAID GROUP HAIDING AGRICULTURE AND ANIMAL HUSBANDRY
KAZAKHSTAN CO. Ltd. 20.00
Zhuhai Fengcheng Supply Chain Management Co. Ltd. 15.00
Dalian Haiding Jinyifeng Feed Co. Ltd. 20.00
Yingkou Dachuan Feed Technology Co. Ltd. 20.00
Zoucheng Haiyue Enterprise Management Consulting Co. Ltd 20.00
Yinan Haiyue Biotechnology Co. Ltd. 20.00
Dezhou Haiying Food Co. Ltd. 20.00
Yancheng Haid Biological Feed Co. Ltd. 20.00
Guangzhou Heshengtang Biotechnology Co. Ltd. 20.00
Henan Haihe Agriculture and Animal Husbandry Technology Co. Ltd. 20.00
Hexin Technology (Henan) Co. Ltd. 20.00
Guangdong Hairuite Supply Chain Management Co. Ltd. 15.00
Hunan Innovation Biotechnology Co. Ltd. 15.00
Guangdong Shunde Haid Biotechnology Co. Ltd. 20.00
Shijiazhuang Vike Biotechnology Co. Ltd. 15.00
Shenyang Haid Feed Co. Ltd. 20.00
Jiangsu Haihe Agriculture and Animal Husbandry Co. Ltd. 20.00
Xuzhou Haihe Feed Co. Ltd. 20.00
Xuzhou Haid Hexin Feed Co. Ltd. 20.00
Anshan Dachuan Feed Technology Co. Ltd. 20.00
Ganzhou Haid Biotechnology Co. Ltd. 15.00
Guangzhou Punong Investment Management Co. Ltd. 20.00
Guangzhou Yuannong Investment Management Co. Ltd. 20.00
Zhongshan Yugezi Food Co. Ltd. 20.00
Foshan Rongda Aquatic Seed Co. Ltd. 20.00
Foshan Ronghai Seed Technology Co. Ltd. 20.00
Zhongshan Rongda Aquatic Seedling Co. Ltd. 20.00
Weifang Daxin Feed Co. Ltd. 20.00
Qingdao Huaxin Feed Co. Ltd. 20.00
Yantai Daxin Agriculture and Animal Husbandry Development Co. Ltd. 20.00
Hunan Jinhuilong Technology Co. Ltd. 15.00
Yueyang Jinhuilong Biotechnology Co. Ltd. 20.00
Shijiazhuang Huilong Feed Co. Ltd. 20.00
Handan Huilong Feed Co. Ltd. 20.00
Huai'an Huilong Feed Co. Ltd. 20.00
Zhuhai Dachuan Biotechnology Co. Ltd. 20.00
Guangzhou Mingersi Biotechnology Co. Ltd. 20.00
193Taxpayer Income tax rate (%)
Zhanjiang Rongda Feed Co. Ltd. 20.00
Guangzhou Ronghai Breeding Technology Co. Ltd. 20.00
Yichang Zhihai Agriculture and Animal Husbandry Co. Ltd. 20.00
Mianyang Zhonggui Feed Co. Ltd. 20.00
Dali Haiwang Feed Co. Ltd. 20.00
Yunnan Zhonggui Feed Co. Ltd. 20.00
Chongqing Zhihai Feed Co. Ltd. 20.00
Guiyang Haid Zhihai Feed Co. Ltd. 20.00
Qujing Zhihai Feed Co. Ltd. 20.00
Yibin Zhihai Feed Co. Ltd. 20.00
Meishan Haid Zhihai Feed Co. Ltd. 20.00
Guangzhou Haiyin Financing Guarantee Co. Ltd. 15.00
Qinzhou Hailong Feed Co. Ltd. 15.00
Liuzhou Haid Feed Co. Ltd. 20.00
Hainan Haid Aquatic Seed Industry Development Co. Ltd. 20.00
Mianyang Hailong Feed Co. Ltd. 20.00
Guangzhou Nongzhidao Feed Co. Ltd. 20.00
Yancheng Runchuan Agricultural Technology Co. Ltd. 20.00
Jiangxi Gunan Herbal Technology Collaborative Innovation Co. Ltd. 20.00
Jiangxi Renxintang Biotechnology Co. Ltd. 20.00
Guangxi Rongchuan Feed Co. Ltd. 20.00
Ganzhou Lianduoli Feed Technology Co. Ltd. 15.00
Maoming Haiwei Feed Co. Ltd. 20.00
Qinzhou Haiwei Feed Co. Ltd. 15.00
Nanning Dachuan Biotechnology Co. Ltd. 15.00
Yongzhou Haid Biotechnology Co. Ltd. 20.00
Guilin Haid Biotechnology Co. Ltd. 20.00
Guiyang Dachuan Biotechnology Co. Ltd. 20.00
Guangdong Haifulai Biotechnology Co. Ltd. 20.00
Qingyuan Hailier Biotechnology Co. Ltd. 20.00
Guangdong Haiqi Investment Co. Ltd. 20.00
Heze Haibo Youmei Technical Services Co. Ltd. 20.00
Hubei Haiqi Technical Services Co. Ltd. 20.00
Guangzhou Haiqi Technology Co. Ltd. 20.00
Meizhou Haiqi Technology Co. Ltd. 20.00
Zhangzhou Haiqi Veterinary Medicine Co. Ltd. 20.00
Maoming Haiqi Technology Co. Ltd. 20.00
Yangjiang Haiqi Technology Co. Ltd. 20.00
Qingyuan Haiqi Technology Co. Ltd. 20.00
194Taxpayer Income tax rate (%)
Gansu Muqi Agricultural Technology Co. Ltd. 20.00
Raoping Haide Biotechnology Co. Ltd. 20.00
Yulin Haiqi Biotechnology Co. Ltd. 20.00
Qinzhou Pubei Haiqi Biotechnology Co. Ltd. 20.00
Xingtai Haiqi Breeding Technology Services Co. Ltd. 20.00
Suixi Haihe Veterinary Medicine Co. Ltd. 20.00
Yangchun Haihe Veterinary Medicine Co. Ltd. 20.00
Luoding Haihe Veterinary Medicine Co. Ltd. 20.00
Yangling Haiqi Agricultural Technology Co. Ltd. 20.00
Yangling Huashite Testing Technology Co. Ltd. 20.00
Bobai Haihe Veterinary Medicine Co. Ltd. 20.00
Jiangmen Haiqi Technology Co. Ltd. 20.00
Xishui Haiqi Technical Services Co. Ltd. 20.00
Jingshan Haiqi Technical Services Co. Ltd. 20.00
Huaihua Haiqi Technical Services Co. Ltd. 20.00
Jieshou Haiqi Technical Services Co. Ltd. 20.00
Kunming Haiqi Technical Services Co. Ltd. 20.00
Mianyang Haiqi Breeding Technology Co. Ltd. 20.00
Nanchang Haiqi Veterinary Medicine Co. Ltd. 20.00
Sichuan Haiqi Biotechnology Co. Ltd. 20.00
Ya'an Haiqi Breeding Technology Co. Ltd. 20.00
Kaifeng Haiqi Technical Services Co. Ltd. 20.00
Changde Haide Veterinary Medicine Co. Ltd. 20.00
Haile (Luliang) Biotechnology Co. Ltd. 20.00
Jingzhou Haiqi Technical Services Co. Ltd. 20.00
Hengyang Haiqi Technical Services Co. Ltd. 20.00
Yantai Zhizhuxia Breeding Services Co. Ltd. 20.00
Guangzhou Haifeng Breeding Services Co. Ltd. 20.00
Nanning Haililai Biotechnology Co. Ltd. 15.00
Shaoyang Haid Feed Co. Ltd. 20.00
Guangzhou Denong Feed Co. Ltd. 20.00
Foshan Dazhi Biotechnology Co. Ltd. 20.00
Taishan Debao Feed Co. Ltd. 20.00
Shaoguan Dachuan Biotechnology Co. Ltd. 20.00
Guizhou Hailongwang Biotechnology Co. Ltd. 20.00
Guangdong Huashite Testing Technology Co. Ltd. 20.00
Tianjin Haid Biotechnology Co. Ltd. 20.00
Yunnan Hairui Biotechnology Co. Ltd. 20.00
Henan Haid Jiuzhou Biotechnology Co. Ltd. 20.00
195Taxpayer Income tax rate (%)
Chaozhou Haid Biotechnology Co. Ltd. 20.00
Haixin (Tianjin) Biotechnology Co. Ltd. 20.00
Haid Biological (Beijing) Technology Co. Ltd. 20.00
Dalian Haid Biotechnology Co. Ltd. 20.00
Shenzhen Xinlingke Biotechnology Co. Ltd. 20.00
Weifang Haixin Biotechnology Co. Ltd. 20.00
Hubei Haid Seed Industry Technology Co. Ltd. 20.00
Yueyang Haid Biotechnology Co. Ltd. 20.00
Guiyang Haiyue Feed Technology Co. Ltd. 20.00
Chifeng Haid Biotechnology Co. Ltd. 20.00
Huizhou Haid Biotechnology Co. Ltd. 20.00
Guangzhou Hualaike Testing Technology Co. Ltd. 20.00
Huaibei Haid Biological Feed Co. Ltd. 20.00
Guizhou Haid Feed Co. Ltd. 20.00
Pizhou Haid Ruminant Feed Co. Ltd. 20.00
Nanping Haid Biotechnology Co. Ltd. 20.00
Taikun Feed (Tuanfeng) Co. Ltd. 20.00
Quzhou Haid Huilong Biological Feed Co. Ltd 20.00
HAID (ECUADOR) FEED CIA.LTDA. Tax-exempt
Zhuhai Haiyue Agriculture and Animal Husbandry Co. Ltd. 15.00
Qingyuan Haifulai Biotechnology Co. Ltd. 20.00
Guangzhou Haiying Commercial Management Co. Ltd. 20.00
Lishui Haid Huatong Biotechnology Co. Ltd. 20.00
Ningdu Haid Biotechnology Co. Ltd. 20.00
Huai'an Dachuan Feed Co. Ltd. 20.00
Zhuhai Haibei Supply Chain Management Co. Ltd. 15.00
Shenyang Shengkang Biotechnology Services Co. Ltd. 20.00
Heilongjiang Haid Biotechnology Co. Ltd. 20.00
Zhangzhou Dachuan Biotechnology Co. Ltd. 20.00
Dangshan Shengfeng Haid Feed Co. Ltd. 20.00
Hezhou Haid Feed Co. Ltd. 20.00
Nanchong Haid Biotechnology Co. Ltd. 20.00
Zhuhai Dehai Biological Technology Co. Ltd. 15.00
Zhuhai Dewekang Biotechnology Co. Ltd. 20.00
Guangdong Haituo Biotechnology Co. Ltd. 20.00
Chifeng Shengfeng Dachuan Feed Co. Ltd. 20.00
Guangdong Haiyi Investment Co. Ltd. 20.00
Jinhua Haiyi Seed Technology Co. Ltd. 20.00
Sui Ning Haid Biotechnology Co. Ltd. 20.00
196Taxpayer Income tax rate (%)
Nanning Wuming Haid Biotechnology Co. Ltd. 20.00
Yingkou Haid Biotechnology Co. Ltd. 20.00
Dezhou Haiying Animal Husbandry and Technology Co. Ltd. 20.00
Suqian Dachuan Guiliu Feed Co. Ltd. 20.00
Qinzhou Haid Guiliu Biotechnology Co. Ltd. 20.00
Note: As of the end of the current period the subsidiary Haid Lanking International Trading Inc. is subject
to federal corporate income tax at a rate of 21%. In addition for California state tax purposes the applicable
tax rate is 8.84%; however the subsidiary is only required to pay the minimum franchise tax of $800 for the
current period.
2. Tax preferential treatments and approval documents
(1) Value-added tax (VAT)
Pursuant to the Notice on the Exemption of Value-Added Tax on Feed Products issued by the Ministry of
Finance and the State Administration of Taxation (Caihui [2001] No. 121) enterprises are exempt from value-
added tax (VAT) on feed products that fall within the scope of tax-exempt feed products.In accordance with Article 15 of the Interim Regulations of the People's Republic of China on Value-Added
Tax which stipulates that agricultural products produced and sold by agricultural producers are exempt from
value-added tax enterprises are exempt from VAT on the sales of their self-produced agricultural products.In accordance with the provisions of the Notice on the Application of Low VAT Rates and Simplified Methods
for Levying VAT on Certain Goods issued by the Ministry of Finance and the State Administration of
Taxation (CaiShui [2009] No. 9) and the Notice on the Simplification of VAT Collection Rate Policies
(CaiShui [2014] No. 57) sales revenue from self-produced biologics made from microorganisms microbial
metabolites animal toxins human or animal blood or tissues is subject to VAT at a simplified collection rate
of 3%.In accordance with the provisions of the Announcement on Policies for VAT Exemptions and Reductions for
Small-Scale VAT Taxpayers (Announcement No. 1 of 2023 by the Ministry of Finance and the State Taxation
Administration) and the Announcement on Policies for VAT Exemptions and Reductions for Small-Scale
VAT Taxpayers (Announcement No. 19 of 2023 by the Ministry of Finance and the State Taxation
Administration) from January 1 2023 to December 31 2027: VAT is exempted for small-scale VAT
taxpayers with monthly sales of RMB100000 (inclusive) or less for taxable sales revenue subject to a 3%
collection rate VAT is levied at a reduced rate of 1% for prepaid VAT items subject to a 3% pre collection
rate VAT is prepaid at a reduced rate of 1%.In accordance with the provisions of the Announcement on the Extension of VAT Policies for Financing
Guarantees for Farmers Small and Micro Enterprises and Individual Business Households (Announcement
No. 18 of 2023 by the Ministry of Finance and the State Taxation Administration) from August 1 2023 to
December 31 2027: VAT is exempted on guarantee fees earned by taxpayers for providing financing
guarantees for loans and bond issuances to farmers small enterprises micro enterprises and individual
business households VAT is also exempted on re-guarantee fees earned for providing re-guarantees for the
aforementioned financing guarantees (hereinafter referred to as the original guarantees).In accordance with the provisions of the Announcement on Further Supporting Tax Policies for
Entrepreneurship and Employment of Key Groups (Announcement No. 15 of 2023 by the Ministry of Finance
the State Taxation Administration the Ministry of Human Resources and Social Security and the Ministry
of Agriculture and Rural Affairs) from January 1 2023 to December 31 2027: enterprises that hire
individuals who have been lifted out of poverty as well as those who have been registered as unemployed
for more than six months with public employment service institutions of the human resources and social
security departments and hold an Employment and Entrepreneurship Certificate or an Employment and
Unemployment Registration Certificate (noting “Enterprise Tax Absorption Policy”) and who sign a labor
197contract with a term of more than one year and legally pay social insurance premiums shall starting from
the month when the labor contract is signed and social insurance premiums are paid be granted a fixed
deduction for value-added tax (VAT) urban maintenance and construction tax education surcharge local
education surcharge and enterprise income tax based on the actual number of hires for a period of three
years. The fixed deduction amount is RMB6000 per person per year with a maximum increase of 30%. The
people's governments of provinces autonomous regions and municipalities directly under the Central
Government may determine the specific deduction amount within this range according to the actual situation
in their respective regions. The taxable basis for urban maintenance and construction tax education surcharge
and local education surcharge is the VAT payable before enjoying this tax preferential policy.In accordance with the relevant value-added tax (VAT) provisions of the Socialist Republic of Vietnam the
feed and related industries livestock and aquaculture industries and food-grade animal health products
industry are exempt from VAT. Income from agricultural product storage services derived by companies
established in Vietnam is subject to VAT at a rate of 5%.
(2) Corporate income tax
In accordance with the Article 28 of the Enterprise Income Tax Law of People's Republic of China (PRC)
the enterprise income tax shall be levied at a reduced rate of 20% for eligible small and low-profit enterprises;
The enterprise income tax will be levied at the reduced rate of 15% for high-tech enterprises that the state
needs to give priority support. If the Company and its subsidiaries meet the above conditions the enterprise
income tax shall be levied at preferential tax rates.In accordance with the Announcement on Taxation on Further Implementing the Preferential Income Tax
Policy for Small and Micro Enterprises CaiShui [2023] No.12 issued by the Ministry of Finance State
Taxation Administration the taxable income of small and micro-profit enterprises is reduced by 25% and
levying corporate income tax at a rate of 20% will continue to be implemented until December 31 2027.In accordance with Article 27 of the Corporate Income Tax Law of the People’s Republic of China and Article
86 of the Regulation on the Implementation of the Corporate Income Tax Law of the People’s Republic of
China income derived from breeding of livestock and poultry is exempted from corporate income tax;
Income derived from marine aquaculture and inland aquaculture by enterprises is subject to a 50% reduction
in corporate income tax. The Company and its subsidiaries which are engaged in the aforementioned income-
generating activities are subject to corporate income tax on such income under preferential policies.In accordance with the Notice on the Scope of Preliminary Processing of Agricultural Products Eligible for
Corporate Income Tax Preferences (Trial) issued by the Ministry of Finance and the State Administration of
Taxation (CaiShui [2008] No. 149) and the Supplementary Notice on the Scope of Preliminary Processing of
Agricultural Products Eligible for Corporate Income Tax Preferences (CaiShui [2011] No. 26) enterprises
are exempt from corporate income tax on the preliminary processed products they produce that fall within
the scope of agricultural product preliminary processing eligible for corporate income tax preferences. The
Company and its subsidiaries which are engaged in the aforementioned income-generating activities those
income is subject to the corporate income tax under these preferential policies.In accordance with the Announcement on the Extension of Corporate Income Tax Policies for the Western
Development Program issued by the Ministry of Finance the State Taxation Administration and the National
Development and Reform Commission (Announcement No. 23 of 2020) from January 1 2021 to December
31 2030 enterprises in the western region engaged in encouraged industries are subject to corporate income
tax at a reduced rate of 15%. The Group’ subsidiaries that are established in the western region as defined in
the announcement and meet the relevant conditions are subject to corporate income tax at a rate of 15%.In accordance with the Notice by the Ministry of Finance and the State Taxation Administration on Corporate
Income Tax Preferential Policies for the Guangdong-Macao In-Depth Cooperation Zone in Hengqin (CaiShui
[2022] No. 19) eligible industrial subsidiaries of the Group established in the Guangdong-Macao In-Depth
Cooperation Zone in Hengqin are subject to corporate income tax at a reduced rate of 15%.In accordance with the Notice by the Ministry of Finance and the State Taxation Administration on Corporate
Income Tax Preferential Policies for Guangzhou Nansha (CaiShui [2022] No. 40) the Group’s eligible
198subsidiaries engaged in encouraged industries and established in the Nansha pilot zone enjoy a reduced
corporate income tax of 15%.In accordance with the Notice on Corporate Income Tax Preferential Policies for Hainan Free Trade Port
issued by the Ministry of Finance and the State Taxation Administration (CaiShui [2020] No. 31) and the
Notice on the Extension of Corporate Income Tax Preferential Policies for Hainan Free Trade Port (CaiShui
[2025] No. 3) from January 1 2020 to December 31 2027 enterprises engaged in encouraged industries
that are registered in the Hainan Free Trade Port and operate substantially are subject to corporate income
tax at a reduced rate of 15%. Subsidiaries of the Group that are established within the scope of the
aforementioned policy and meet the relevant conditions are subject to corporate income tax at a rate of 15%.In accordance with the Announcement on Further Improving the Pre-tax Super-deduction Policy for Research
and Development Expenses issued by the Ministry of Finance and the State Taxation Administration
(Announcement No. 7 of 2023) for R&D expenses actually incurred by enterprises in carrying out R&D
activities that have not been capitalized as intangible assets but are recognized in profit or loss for the current
period on the basis of the actual deduction as stipulated an additional super-deduction of 100% of the actual
amount incurred shall be made for pre-tax purposes from January 1 2023. Where they become intangible
assets the expenses shall be amortized before tax at 200% of the cost of the intangible assets from January
12023.
In accordance with the Announcement on the Extension of Tax Preferential Policies for Microfinance
Companies issued by the Ministry of Finance and the State Taxation Administration (Announcement No. 54
of 2023) the Group is permitted to deduct the loan loss provisions accrued at 1% of the year-end loan balance
for microfinance companies approved by the provincial local financial regulatory authorities for corporate
income tax purposes.Under the tax laws of the British Virgin Islands the Group's subsidiaries registered in that jurisdiction are
not subject to corporate income tax.In accordance with the Hong Kong Tax Ordinance the Group's subsidiaries registered in Hong Kong are
subject to profits tax at a rate of 16.50%. Among them offshore income from China Haida Feed Group (HK)
Limited a subsidiary can be exempted from profits tax after declaration. For non-locally registered
subsidiaries whose place of actual operation and management is in Hong Kong which are Hong Kong tax
residents and engaged in qualified treasury activities a preferential tax rate of half the profits tax rate for
treasury center business (8.25%) is applicable for this year. In addition subsidiaries that meet the economic
substance requirements specified in Section 15K of the Inland Revenue Ordinance and have specified
foreign-sourced income are eligible for Tax-exempt in the relevant year.Subsidiaries of the Group registered in Malaysia are subject to a corporate income tax rate of 24% in
accordance with the Malaysian tax law.Subsidiaries of the Group registered in Singapore are subject to a corporate income tax rate of 17% in
accordance with the Singaporean tax law.Under the local tax laws of Ecuador eligible enterprises enjoy a 12-year tax holiday from the issuance date
of the first invoice after which a 25% rate applies. HAID (ECUADOR) FEED CIA. LTDA. a subsidiary of
the Group registered in Ecuador remains in the Tax-exempt period and is exempt from corporate income tax
as of the end of the current year.Under the local tax laws of Indonesia the Group’s subsidiaries registered there are subject to a corporate
income tax at a rate of 22%.Under the local tax laws of Egypt the Group’s subsidiaries registered there are subject to a corporate income
tax at a rate of 22.5%.Under the local tax laws of Bangladesh which feature a multi-tiered tax rate structure the Group's
subsidiaries registered in Bangladesh are subject to corporate income tax at 27.5% which may qualify for a
reduced rate of 25% upon meeting satisfying specific payment requirements.
199Under the local tax laws of India which feature a multi-tiered tax rate structure the Group's subsidiaries
registered in India reported losses as of the end of the current year and are not subject to corporate income
tax.Under the local tax laws of Kazakhstan the Group’s subsidiaries registered there are subject to corporate
income tax at rate of 20%.Under the local tax laws of Nigeria the Group’s subsidiaries registered there are subject to a corporate income
tax at a rate of 30%.Under the local tax laws of Myanmar the Group’s subsidiaries registered there are subject to a corporate
income tax at a rate of 22%.Under the local tax laws of Thailand the Group’s subsidiaries registered there are subject to a corporate
income tax at rate of 20%.Under the polices of the local management committee in Laos the Group’s subsidiaries registered there enjoy
a 5-year tax holiday from the year they first become profitable.Under the local tax laws of Cambodia the Group's subsidiaries registered there enjoy a 6-year tax holiday
on their feed production business from the date of first revenue. Following the tax holiday income tax is
payable at 25% of the full tax liability for the first 2 years at 50% for the next 2 years and at 75% for the
subsequent 2 years. For trading activities income tax is payable at the higher of 1% of revenue or 20% of
profit.Under the local tax laws of Tanzania the Group’s subsidiaries registered there are subject to a corporate
income tax at a rate of 30%.Under the local tax laws of Brazil the Group’s subsidiaries registered there are subject to a corporate income
tax at a rate of 15%.Under the local tax laws of Cayman Islands the Group’s subsidiaries registered there are not subject to
corporate income tax.Under the local tax laws of Vietnam the Group’s subsidiaries registered there are subject to corporate income
tax as follows:
a) Certain regions enjoy a preferential policy of 2-year exemption from corporate income tax from the profit-
making year followed by a 50% reduction for the next 4 years. MEKONG HAI LONG COMPANY
LIMITED became profitable in 2021 VINH LONG HAILIANKE BIOTECHNOLOGY CO. LTD and
SHENG LONG BIOTECH (HAI DUONG) INTERNATIONAL CO. LTD in 2024 and BINH PHUOC HAI
LONG COMPANY LIMITED in 2025.b) Certain regions enjoy a preferential policy of 4-year exemption from corporate income tax from the profit-
making year followed by a 50% reduction for the next 9 years. VINH LONG HAI DAI CO. LTD. became
profitable in 2021 THANG LONG (VINH LONG) BIOTECH CO. LTD. in 2022 and BINH DINH HAI
LONG CO. LTD. in 2023.c) SHENG LONG BIO-TECH INTERNATIONAL CO. LTD. qualifies for Vietnamese government
preferential policies applicable to new investments in disadvantaged areas and industry-specific incentives.Its factories in different regions continue to enjoy their original preferential corporate income tax rates of 10%
and 15%. Income is taxed as follows: cold storage rental income at 10%; raw material sales at 20%; animal
health products at 17%; income from shrimp fry cultivation exempt from corporate income tax; and other
income at 20%.d) Under local income tax policies in Vietnam income from NAMDUONG VIETNAM AQUATIC
HATCHERY CO. LTD. 's shrimp fry cultivation is exempt from corporate income tax.e) Under the corporate income tax policies of Vietnam which vary by region and business type income from
200sales of self-produced feed by LONG SHENG INTERNATIONAL CO. LTD. HAID FEED COMPANY
LIMITED and SHENG LONG BIO-TECH (TIEN GIANG) INTERNATIONAL CO. LTD. is subject to
corporate income tax at 15%; income from aquaculture/farming activities by HAI DAI COMPANY
LIMITED and DONG NAI HAID FARM COMPANY LIMITED is subject to corporate income tax at 15%;
income from agricultural product processing by Long Sheng International (Suoi Dau) Co. Ltd. is subject to
corporate income tax at 10%; income from agricultural product processing by HAI DUONG HAID
COMPANY LIMITED is subject to corporate income tax at 15%; and income from trading activities is
subject to corporate income tax at 20%.
(3) Other taxes
In accordance with the Announcement on Further Supporting the Development of Small and Micro
Enterprises and Individual Business Operators issued by the Ministry of Finance and the State Taxation
Administration (Announcement No. 12 of 2023) from January 1 2023 to December 31 2027 the following
taxes and fees are reduced by 50% for small-scale VAT taxpayers small and low-profit enterprises and
individual business operators: resource tax (excluding water resources tax) urban maintenance and
construction tax property Tax urban land use tax stamp duty (excluding securities transaction stamp duty)
cultivated land occupation tax and education surcharge and local education surcharge).V. Notes to the Consolidated Financial Statements
1. Cash and cash equivalents
Item 2025.12.31 2024.12.31
Cash on hand 87093.15 187338.98
Cash at bank 2738309591.35 2900103350.93
Other monetary funds 463981024.91 575096160.60
Accrued interest on deposits 458604.17 2870025.12
Total 3202836313.58 3478256875.63
Including: Total overseas deposits 1932039437.80 1541218925.89
Note: For cash with restriction as of December 31 2025 please refer to Note V. 26. Assets with restricted
ownership or use rights.
2. Held-for-trading financial assets
Item 2025.12.31 2024.12.31
Financial assets measured at fair value through profit or loss 2118734927.43 4662427829.82
Including: Derivative financial assets 102418275.77 357697371.99
Financial products 2015710196.94 4304368163.61
Equity instrument investments 606454.72 362294.22
Total 2118734927.43 4662427829.82
3. Notes receivable
2025.12.312024.12.31
Type
Book value Loss Carrying Book value Loss Carrying allowance amount allowance amount
Bank acceptance notes 29443269.19 - 29443269.19 18700897.53 - 18700897.53
Commercial acceptance
notes - - - 1000000.00 24800.00 975200.00
Usance letter of credit 4900558.08 - 4900558.08 7161262.26 - 7161262.26
2012025.12.312024.12.31
Type
Book value Loss Carrying Book value Loss Carrying allowance amount allowance amount
Total 34343827.27 - 34343827.27 26862159.79 24800.00 26837359.79
(1) The Group had no pledged notes receivable at the end of the year.
(2) Outstanding endorsed or discounted notes that have not matured at the end of the year.
Type Amount derecognized Amount not derecognized at year end at year end
Bank acceptance notes 579500202.34 -
Total 579500202.34 -
(3) At the end of the year the Group had no notes that were converted into accounts receivable due to the drawer’s
failure to fulfill their obligations.
(4) Classification by loss allowance method
2025.12.31
Book value Loss allowance
Type Expected Carrying
Amount Percentage (%) Amount
credit amount
Loss rate
(%)
Loss allowance on an individual
basis - - - - -
Loss allowance by group 34343827.27 100.00 - - 34343827.27
Including:
Bank acceptance notes 29443269.19 85.73 - - 29443269.19
Usance letter of credit 4900558.08 14.27 - - 4900558.08
Total 34343827.27 100.00 - - 34343827.27
Continued:
2024.12.31
Book value Loss allowance
Type Expected Carrying
Amount Percentage Amount credit amount (%) Loss rate
(%)
Loss allowance on an
individual basis - - - - -
Loss allowance by group 26862159.79 100.00 24800.00 0.09 26837359.79
Including:
Bank acceptance notes 18700897.53 69.62 - - 18700897.53
Commercial acceptance notes 1 0 0 0 0 0 0 . 0 0 3.72 24800.00 2.48 975200.00
Usance letter of credit 7161262.26 26.66 - - 7161262.26
Total 26862159.79 100.00 24800.00 0.09 26837359.79
(5) Additions recoveries or reversals of provision during the current period
202Loss allowance
Balance as of 2024.12.31 24800.00
Additions -24800.00
Recoveries or reversals -
Write-offs -
Balance as of 2025.12.31 -
(6) The Group had no instances of write-offs of notes receivable during the current period.
4. Accounts receivable
(1) Disclosed by aging
Aging 2025.12.31 2024.12.31
Within 1 year 2976397242.69 2034895529.60
1 to 2 years 209681958.73 238795711.21
2 to 3 years 218038944.56 170875635.85
3 to 4 years 95771774.79 60366838.94
4 to 5 years 31874124.57 51885949.90
More than 5 years 47787590.25 20430272.62
Subtotal 3579551635.59 2577249938.12
Less: Loss allowance 600788404.50 451377592.69
Total 2978763231.09 2125872345.43
(2) Disclosed by loss allowance method
2025.12.31
Book value Loss allowance
Type Expected Carrying
Amount Percentage Amount credit amount (%) loss rate
(%)
Loss allowance on an
individual basis 477831346.79 13.35 401649516.19 84.06 76181830.60
Loss allowance by
group 3101720288.80 86.65 199138888.31 6.42 2902581400.49
Including:
Accounts receivable
due from feed related 3021228161.99 84.40 196738680.51 6.51 2824489481.48
customers
Accounts receivable
due from raw materials 80492126.81 2.25 2400207.80 2.98 78091919.01
customers
Total 3579551635.59 100.00 600788404.50 16.78 2978763231.09
Continued:
2032024.12.31
Book value Loss allowance
Type Expected Carrying
Amount Percentage credit amount (%) Amount loss rate
(%)
Loss allowance on an
individual basis 405348850.10 15.73 323018727.81 79.69 82330122.29
Loss allowance by
group 2171901088.02 84.27 128358864.88 5.91 2043542223.14
Including:
Accounts receivable
due from feed related 2138481469.74 82.97 127740602.00 5.97 2010740867.74
customers
Accounts receivable
due from raw materials 33419618.28 1.30 618262.88 1.85 32801355.40
customers
Total 2577249938.12 100.00 451377592.69 17.51 2125872345.43
Accounts receivable assessed for loss allowance individually
2025.12.31
Name
Book value Loss Expected credit allowance loss rate (%) Reasons for accrual
Customer 1 27857268.00 27857268.00 100.00 Estimated to be uncollectible
Customer 2 23054768.61 23054768.61 100.00 Estimated to be uncollectible
Remaining customers
whose accounts
receivable are assessed 426919310.18 350737479.58 82.16 Expected to be
for loss allowance on an partially uncollectible
individual basis (Note)
Total 477831346.79 401649516.19 84.06
Continued:
2024.12.31
Name
Book value Loss
Expected Reasons for
allowance credit loss rate (%) accrual
Expected to be
Customer 3 42627135.16 27309359.29 64.07 partially
uncollectible
Customer 2 23254768.61 23254768.61 100.00 Estimated to be uncollectible
Remaining customers whose
accounts receivable are Expected to be
assessed for loss allowance on 339466946.33 272454599.91 80.26 partially
an individual basis (Note) uncollectible
Total 405348850.10 323018727.81 79.69
Note: The expected credit loss rate of the remaining customers whose accounts receivable are assessed for
loss allowance on an individual basis is the average proportion of the total individual loss allowance for these
customers to their accounts receivable carry amount.
204Accounts receivable assessed for loss allowance by group
Group: Accounts receivable due from feed related customers
2025.12.312024.12.31
Expected Expected
Book value Loss allowance credit loss Book value
Loss
rate (%) allowance
credit loss
rate (%)
Within 1 year 2846856613.16 99164749.62 3.48 1976377631.01 54430120.58 2.75
1 to 2 years 104901011.52 43544874.20 41.51 106445053.98 30209303.90 28.38
2 to 3 years 51169388.90 36131328.02 70.61 34060641.30 22237266.57 65.29
3 to 4 years 8399546.30 7996126.56 95.20 6303814.91 5569582.41 88.35
4 to 5 years 2304202.35 2304202.35 100.00 4643152.17 4643152.17 100.00
More than 5
years 7597399.76 7597399.76 100.00 10651176.37 10651176.37 100.00
Total 3021228161.99 196738680.51 6.51 2138481469.74 127740602.00 5.97
Group: Accounts receivable due from raw materials customers
2025.12.312024.12.31
Book value Loss
Expected Expected
allowance credit loss Book value
Loss credit loss
rate (%) allowance rate (%)
Within 1
year 79490114.02 1465769.64 1.84 33419618.28 618262.88 1.85
More than
1 year 1002012.79 934438.16 93.26 - - -
Total 80492126.81 2400207.80 2.98 33419618.28 618262.88 1.85
(3) Additions recoveries or reversals of loss allowance during the current period
Loss allowance
Balance as of 2024.12.31 451377592.69
Additions 151532187.12
Transfer in resulting from changes in the scope of consolidation 188608899.78
Recoveries or reversals 46798387.69
Write-offs 135682799.25
Transfer out resulting from changes in the scope of consolidation 2426893.91
Other movements -5822194.24
Balance as of 2025.12.31 600788404.50
There were no material loss allowances recovered or reversed in current period.
(4) Accounts receivable written off during the current period
Item Amount written off
Accounts receivable written off 135682799.25
There were no significant accounts receivable write-offs during the current period.
(5) Top five closing balances of accounts receivable and contract assets by debtor
205The aggregate amount of the top five accounts receivable by debtor at the end of the period was
RMB252496843.77 representing 7.05% of the total closing balances of accounts receivable. The total
closing balance of provision for loss allowance related to these top five debts was RMB51736057.89.
5. Prepayments
(1) Disclosed by aging
2025.12.312024.12.31
Aging
Amount Percentage % Amount Percentage %
Within 1 year 895910016.40 99.77 626721115.36 99.75
1 to 2 years 1718160.17 0.19 956159.55 0.15
2 to 3 years 134313.14 0.01 349983.03 0.06
More than 3 years 266483.61 0.03 266185.60 0.04
Subtotal 898028973.32 100.00 628293443.54 100.00
Less: Loss allowance - -- - --
Total 898028973.32 100.00 628293443.54 100.00
(2) There was no significant prepayments aged more than 1 year.
(3) Top five closing balances of prepayments by debtor
The aggregate amount of the top five prepayments by debtor at the end of the period was
RMB431459035.15 representing 48.05% of the total closing balance of prepayments.
6. Other receivables
Item 2025.12.31 2024.12.31
Interest receivable - -
Dividends receivable - -
Other receivables 678782287.52 877870681.54
Total 678782287.52 877870681.54
(1) Disclosed by aging
Aging 2025.12.31 2024.12.31
Within 1 year 638955425.23 866674522.37
1 to 2 years 46948614.95 32440019.58
2 to 3 years 28072003.50 12671739.14
3 to 4 years 12262463.18 8095308.13
4 to 5 years 5686776.19 2575204.06
5 years above 14259260.13 13150205.46
Subtotal 746184543.18 935606998.74
Less: Loss allowance 67402255.66 57736317.20
Total 678782287.52 877870681.54
(2) Disclosed by nature
206Aging 2025.12.31 2024.12.31
Futures margin 439853378.45 597681330.15
Security deposits 144603799.87 165747051.27
Receivables due from external parties 101259959.86 97166632.53
Advance social insurance and housing fund 19545166.54 17884054.44
Petty cash 9049876.27 7533960.89
Others 31872362.19 49593969.46
Subtotal 746184543.18 935606998.74
Less: Loss allowance 67402255.66 57736317.20
Total 678782287.52 877870681.54
(3) Additions recoveries or reversals of provision during the current period
The first stage The second stage The third stage
Lifetime expected
Loss allowance Expected credit
Lifetime expected credit losses Total
losses over the credit losses (no (credit
next 12 months credit impairment occurred) impairment has occurred)
Balance as of
December 31 2024 10137976.90 - 47598340.30 57736317.20
Movement during the
current period:
- Transfer to the second
stage - - - -
- Transfer to the third
stage -1424987.13 - 1424987.13 -
- Reverse to the second
stage - - - -
- Reverse to the first
stage - - - -
Additions 1214701.90 - 12433014.33 13647716.23
Reversals - - 1778796.18 1778796.18
Write-offs 708964.83 - 954545.82 1663510.65
Transfer out resulting
from changes in the 917.05 - 397216.43 398133.48
scope of consolidation
Other movements -34045.76 - -107291.70 -141337.46
Balance as of
December 31 2025 9183764.03 - 58218491.63 67402255.66
There were no significant recoveries or reversals of loss allowance during the current period.
(4) Other receivables written off during the current period
Item Amount written off
Other receivables written off 1663510.65
There are no significant other receivables written off during the current period.
207(5) Top five closing balances of other receivables by debtor
Proportion of the Loss allowance
Debtor Nature Other receivables as of December 31 2025 Aging
total closing
balance of other as of December
receivables (%) 31 2025
Company A Future margin 151165238.64 Within 1 year 20.26 -
Company B Security deposits others 76450560.00 Within 1 year 10.25 764529.00
Company C Receivables due from external parties 35415842.96 1 to 3 years 4.75 21689285.32
Company D Future margin 34451453.42 Within 1 year 4.62 -
Customer E Future margin 31618981.83 Within 1 year 4.24 -
Total 329102076.85 44.12 22453814.32
7. Inventories
(1) Inventory by type
2025.12.312024.12.31
Loss Loss
Type allowance of allowance of
Book value inventories/ Carrying amount Book value inventories/ Carrying amount
costs to fulfil a costs to fulfil a
contract contract
Raw materials 7043170250.96 2838373.02 7040331877.94 6327477610.58 882196.02 6326595414.56
Work in progress 11873814.32 - 11873814.32 11205014.40 - 11205014.40
Finished goods 1487444677.16 14411428.87 1473033248.29 1517119858.82 13327386.94 1503792471.88
Consumptive
biological assets 2845663701.24 10195948.43 2835467752.81 3462860778.00 25080952.78 3437779825.22
Costs to fulfil a
contract 11070314.79 - 11070314.79 11011377.24 - 11011377.24
Total 11399222758.47 27445750.32 11371777008.15 11329674639.04 39290535.74 11290384103.30
(2) Loss allowance of inventories/costs to fulfil a contract
Additions for the Decreases for the current
Item 2024.12.31 current period period Reversed or 2025.12.31 Provision Others written-off Others
Raw
materials 882196.02 2511940.82 - 555763.82 - 2838373.02
Finished
goods 13327386.94 18658587.27 341036.84 17864401.97 51180.21 14411428.87
Consumptive
biological 25080952.78 12339787.58 - 27224791.93 - 10195948.43
assets
Total 39290535.74 33510315.67 341036.84 45644957.72 51180.21 27445750.32
208Loss allowance of inventories/costs to fulfil a contract (continued)
Basis for determining the net realizable Reasons for reversals or write-
Item value/remaining consideration and the off of inventory loss
costs that are expected to be incurred allowances/provisions for costs to fulfil a contract
The estimated selling price of the related
Raw materials finished goods less the estimated costs of Utilized in the production of completion and the estimated selling goods and subsequently sold
expenses and relevant taxes
The estimated selling price of related
Finished goods finished products less the estimated selling Goods have been sold
expenses and relevant taxes
The estimated selling price of related
Consumptive assets less the estimated cost to be incurred Raised to a saleable condition and
biological assets until they reaching the saleable condition the estimated selling expenses and subsequently sold
relevant taxes.
8. Assets held-for-sale
2025.12.312024.12.31
Item Book Loss Carrying Loss Carrying
value allowance amount Book value allowance amount
Non-current assets
held-for-sale - - - 641999.09 - 641999.09
Including: Fixed
assets - - - 641999.09 - 641999.09
Total - - - 641999.09 - 641999.09
9. Non-current assets due within one year
Item 2025.12.31 2024.12.31
Long-term receivables due within 1 year 16869873.84 3841618.60
Total 16869873.84 3841618.60
10. Other current assets
Item 2025.12.31 2024.12.31
Rental expenses 10292257.27 8323972.41
Insurance expenses 22503924.48 20874879.55
Miscellaneous prepaid expenses 76383535.07 38745324.35
Input VAT to be deducted and verified 139237211.21 147269704.85
Taxes and charges paid in advance 100236972.70 81067645.58
Factoring receivables 51151719.98 71323637.69
Others 38314215.23 27084704.20
Total 438119835.94 394689868.63
Factoring receivables by overdue status
Item 2025.12.31 2024.12.31
Current 50351362.56 69282726.61
209Item 2025.12.31 2024.12.31
Overdue 29866336.83 30491461.03
Add: Interest receivable 402459.21 467559.80
Subtotal 80620158.60 100241747.44
Less: Provision for impairment 29468438.62 28918109.75
Total 51151719.98 71323637.69
11. Loans and advances to customers
(1) Loans and advances to customers by method of guarantee
2025.12.312024.12.31
Item Book Provision for Carrying
Provision
value amount Book value for
Carrying
impairment impairment amount
Secured loans 159295.58 159295.58 - 1527732.60 1527732.60 -
Add: Interest
receivable 4439.40 4439.40 - 14386.86 14386.86 -
Subtotal 163734.98 163734.98 - 1542119.46 1542119.46 -
Less: Due
within one - - - - - -
year
Total 163734.98 163734.98 - 1542119.46 1542119.46 -
(2) Loans and advances to customers by overdue status:
2025.12.312024.12.31
Item Book Provision for Carrying
Provision
value amount Book value for
Carrying
impairment impairment amount
Current - - - - - -
Overdue 159295.58 159295.58 - 1527732.60 1527732.60 -
Add: Interest
receivable 4439.40 4439.40 - 14386.86 14386.86 -
Subtotal 163734.98 163734.98 - 1542119.46 1542119.46 -
Less: Due
within one - - - - - -
year
Total 163734.98 163734.98 - 1542119.46 1542119.46 -
(3) Provision for impairment of loans
The first stage The second stage The third stage
Expected Lifetime expected Lifetime expected Provision for impairment of
credit losses credit losses credit losses loans Total
over the next (no credit (credit
12 months impairment impairment has occurred) occurred)
Balance as of December 31
2024--1542119.461542119.46
Movement during the current
period:
210The first stage The second stage The third stage
Expected Lifetime expected Lifetime expected Provision for impairment of
credit losses credit losses credit losses loans Total
over the next (no credit (credit
12 months impairment impairment has occurred) occurred)
- Transfer to the second stage - - - -
- Transfer to the third stage - - - -
- Reverse to the second stage - - - -
- Reverse to the first stage - - - -
Additions - - - -
Reversals - - 231734.05 231734.05
Write-offs - - 1146650.43 1146650.43
Balance as of December 31
2025--163734.98163734.98
12. Long-term receivables
(1) Long-term receivables by nature
2025.12.312024.12.31
Item Discounted
Book value Loss Carrying Loss Carrying rate allowance amount Book value allowance amount
Security deposits 141382963.43 - 141382963.43 154633423.91 - 154633423.91
Contracting fees
receivables in 115960764.82 - 115960764.82 23853433.31 - 23853433.31 3.5%~148.89%
installments
Others 1621714.13 - 1621714.13 528000.00 - 528000.00
Less: Unrealized
financing income 23632912.85 - 23632912.85 6042524.33 - 6042524.33
Subtotal 235332529.53 - 235332529.53 172972332.89 - 172972332.89 -
Less: Long-term
receivables due within 16869873.84 - 16869873.84 3841618.60 - 3841618.60
one year
Total 218462655.69 - 218462655.69 169130714.29 - 169130714.29 -
Note: The security deposits were primarily lease deposits and electricity deposits.
(2) The Group had no overdue long-term receivables during the current period.
(3) No long-term receivables were derecognized during the current period.
(4) The Group had no continuing involvement in transferred long-term receivables that resulted in the
recognition of assets or liabilities during the current period.
21113. Long-term equity investments
Movements during the current period
2024.12.31 2024.12.31 Investment Declared 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in income Other Other distribution Provision Carrying Provision for
amount impairment investment investment recognized comprehensive equity of cash for Others amount impairment under equity income movements dividends impairment
method or profits
* Associates
Bangpu Seed
Industry
Technology 9864033.29 - - - -4298.24 - - - - - 9859735.05 -
Co. Ltd.Foshan
Haihang
Xingfa
Agriculture
and Animal 11676214.81 - - - 3670342.57 - - - - - 15346557.38 -
Husbandry
Development
Co. Ltd.Wujiaqu
Taikun Plant
Protein Co. 49636938.47 - - - 4343844.72 - - -985376.98 - - 52995406.21 -
Ltd.Alar
Ruiliheng
Biological 42091913.68 - - - 338513.35 - - -872888.83 - - 41557538.20 -
Protein Co.Ltd.Hutubi
Tiankang
Plant Protein 64435541.24 - - - 7754114.99 394446.44 - - - - 72584102.67 -
Co. Ltd.Beijing
Haizhibao Pet 4900000.00 - 4900000.00 - -3738770.90 - - - - - 6061229.10 -
Co. Ltd.
212Movements during the current period
2024.12.31 2024.12.31 Investment Declared 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in income Other Other distribution Provision Carrying Provision for
amount impairment investment investment recognized comprehensive equity of cash for Others amount impairment under equity income movements dividends impairment
method or profits
Qingdao
Nongken
Dahuang
Trading - 10910542.10 - - - - - - - - - -
Development
Co. Ltd.Sichuan Smart
Fishing
Machinery 1186627.86 - - - -430596.38 - - - - - 756031.48 -
Technology
Co. Ltd.Weishi
(Shandong)
Biotechnology - - 2000000.00 - -55753.23 - - - - - 1944246.77 -
Co. Ltd.Subtotal 183791269.35 10910542.10 6900000.00 - 11877396.88 394446.44 - -1858265.81 - - 201104846.86 -
* Joint
ventures
Haid Cherry
Valley
Vietnam Co. 96426623.51 - - - 13856111.34 -5427456.89 - - - - 104855277.96 -
Ltd.Subtotal 96426623.51 - - - 13856111.34 -5427456.89 - - - - 104855277.96 -
Total 280217892.86 10910542.10 6900000.00 - 25733508.22 -5033010.45 - -1858265.81 - - 305960124.82 -
Note:The business license of Qingdao Nongken Dahuang Trading Development Co. Ltd. has been revoked during the current period.
21314. Other non-current financial assets
Item 2025.12.31 2024.12.31
Equity instrument investments 245857402.68 238380604.68
Total 245857402.68 238380604.68
15. Investment properties
(1) Investment properties
Item Buildings Land use rights Total
I. Cost
1. As of 2024.12.31 62213700.85 45375288.62 107588989.47
2. Additions during the period 3751589.24 -509095.37 3242493.87
(1) Purchases 679301.67 - 679301.67
(2) Translation differences arising
from translation of foreign - -509095.37 -509095.37
currency financial statements
(3) Transfer from fixed assets 3072287.57 - 3072287.57
3. Decreases during the period 4948558.22 41861793.45 46810351.67
(1) Disposals 799680.59 41861793.45 42661474.04
(2) Transfer to fixed assets 4148877.63 - 4148877.63
4. As of 2025.12.31 61016731.87 3004399.80 64021131.67
II. Accumulated depreciation and
amortization
1. As of 2024.12.31 14964198.48 - 14964198.48
2. Charges for the period 2808779.45 - 2808779.45
(1) Depreciation or amortization 2113732.82 - 2113732.82
(2) Transfer from fixed assets 695046.63 - 695046.63
3. Decreases during the period 948913.80 - 948913.80
(1) Disposals 41102.05 - 41102.05
(2) Transfer to fixed assets 907811.75 - 907811.75
4. As of 2025.12.31 16824064.13 - 16824064.13
III. Provision for impairment
1. As of 2024.12.31 - - -
2. Additions during the period - 9616326.03 9616326.03
(1) Charges for the period - 9616326.03 9616326.03
3. Decrease during the period - 9616326.03 9616326.03
(1) Disposals - 9616326.03 9616326.03
4. As of 2025.12.31 - - -
IV. Carrying amount
1. As of 2025.12.31 44192667.74 3004399.80 47197067.54
2. As of 2024.12.31 47249502.37 45375288.62 92624790.99
214(2) Investment properties without ownership certificates
Item Carrying amount Reason for not having obtained ownership certificate
Buildings 12298910.96 In progress
16. Fixed assets
Item 2025.12.31 2024.12.31
Fixed assets 17007956953.83 16926972419.08
Fixed assets to be disposed of - 3715307.91
Total 17007956953.83 16930687726.99
(1) Fixed assets
* Fixed assets
Item Plant and Machinery and Electronic Other buildings equipment Motor vehicles equipment equipment Total
I. Cost
1. As of 2024.12.31 12571695911.93 10726205804.44 448823344.97 672894648.57 748324778.17 25167944488.08
2.Additions during the period 811501704.71 905345946.65 61826425.24 82393149.79 82334437.14 1943401663.53
(1) Purchases 70086023.11 196249364.91 59304689.14 65749001.81 40998500.92 432387579.89
(2) Transfers from construction in progress 648409477.82 585385763.92 1706198.00 14648941.01 41608850.49 1291759231.24
(3) Additions due to business combinations 158216220.93 184742207.53 4548365.08 3912948.76 2356854.52 353776596.82
(4) Translation differences arising from
translation of foreign currency financial -69358894.78 -61031389.71 -3732826.98 -1917741.79 -2629768.79 -138670622.05
statements
(5) Others 4148877.63 - - - - 4148877.63
3. Decreases during the period 147986588.42 214053328.87 23667390.60 21732389.94 51776610.65 459216308.48
(1) Disposals or write-offs 72869078.57 151392883.88 23190665.56 19132967.25 47703776.35 314289371.61
215Item Plant and Machinery and buildings equipment Motor vehicles
Electronic Other
equipment equipment Total
(2) Reduction in the scope of consolidation 72045222.28 62660444.99 476725.04 2599422.69 4072834.30 141854649.30
(3) Others 3072287.57 - - - - 3072287.57
4. As of 2025.12.31 13235211028.22 11417498422.22 486982379.61 733555408.42 778882604.66 26652129843.13
II. Accumulated depreciation
1. As of 2024.12.31 2384852166.99 4610395189.84 286033921.73 493883699.13 398680175.44 8173845153.13
2. Charges for the period 516794095.63 989863054.18 57332046.28 78289021.05 102995655.03 1745273872.17
(1) Provision 487696052.44 925533453.01 56079125.93 77124167.42 103808556.53 1650241355.33
(2) Additions due to business combinations 37618814.58 86596970.57 3473308.84 2283289.95 518807.73 130491191.67
(3) Translation differences arising from
translation of foreign currency financial -9428583.14 -22267369.40 -2220388.49 -1118436.32 -1331709.23 -36366486.58
statements
(4) Others 907811.75 - - - - 907811.75
3. Decreases during the period 55485879.56 150767475.74 21497276.69 19333113.42 39875346.26 286959091.67
(1) Disposals or write-offs 33626027.89 110682834.66 21154657.12 17165159.06 36914119.88 219542798.61
(2) Reduction in the scope of consolidation 21164805.04 40084641.08 342619.57 2167954.36 2961226.38 66721246.43
(3) Others 695046.63 - - - - 695046.63
4. As of 2025.12.31 2846160383.06 5449490768.28 321868691.32 552839606.76 461800484.21 9632159933.63
III. Provision for impairment:
1. As of 2024.12.31 48545055.54 17256284.42 67047.85 257816.82 1000711.24 67126915.87
2. Charges for the period 1018871.95 - - - - 1018871.95
(1) Provision 854621.25 - - - - 854621.25
(2) Additions due to business combinations 164250.70 - - - - 164250.70
3. Decreases during the period 40525669.66 14654685.75 26585.37 235963.58 689927.79 56132832.15
(1) Disposals or write-offs 2364.34 - - - - 2364.34
(2) Reduction in the scope of consolidation 40523305.32 14654685.75 26585.37 235963.58 689927.79 56130467.81
216Item Plant and Machinery and Electronic Other buildings equipment Motor vehicles equipment equipment Total
4. As of 2025.12.31 9038257.83 2601598.67 40462.48 21853.24 310783.45 12012955.67
IV. Carrying amount
1. As of 2025.12.31 10380012387.33 5965406055.27 165073225.81 180693948.42 316771337.00 17007956953.83
2. As of 2024.12.31 10138298689.40 6098554330.18 162722375.39 178753132.62 348643891.49 16926972419.08
* Impairment test of fixed assets
The recoverable amount is determined by the net amount of fair value less disposal expenses.Item Carrying Accumulated Recoverable Impairment
Determination of fair Key Basis for determining key
amount depreciation amount amount value and disposal expenses parameters parameters
Fixed assets with Refer to the recent Based on the asset status refer to the
impairment 1074000.00 219378.75 - 854621.25 disposal recovery ratio Fair value and recoverable ratio of similar assets
indicators of similar assets disposal rate disposed by the Company during the year
* Fixed assets temporarily idle
Item Cost Accumulated depreciation Provision for impairment Carrying amount Notes
Plant and buildings 20454751.05 3946904.93 8273699.31 8234146.81
Machinery and equipment 23651238.16 15546273.82 2592902.67 5512061.67
Motor vehicles 112227.24 64367.26 40462.48 7397.50
Electronic equipment 285000.93 170797.65 7493.06 106710.22
Other equipment 1203234.98 903624.58 285219.94 14390.46
Total 45706452.36 20631968.24 11199777.46 13874706.66
* There were no fixed assets leased out under operating leases during the current period.
217* Fixed assets without ownership certificates
Item Carrying amount Reasons for not having obtained ownership certificate
Plant and buildings 401521636.41 In progress
* The Group did not offset any government grants against the carrying amount of fixed assets during the current period.
(2) Fixed assets to be disposed of
Item 2025.12.31 2024.12.31 Reason for disposal
Machinery and equipment - 3703935.78 No longer satisfies the requirements for production and business activities
Motor vehicles - 7170.00 No longer satisfies the requirements for production and business activities
Electronic equipment - 1868.00 No longer satisfies the requirements for production and business activities
Other equipment - 2334.13 No longer satisfies the requirements for production and business activities
Total - 3715307.91
17. Construction in progress
Item 2025.12.31 2024.12.31
Construction in progress 603959168.05 426719987.46
Construction materials - -
Total 603959168.05 426719987.46
218Construction in progress
(1) Details of construction in progress
2025.12.312024.12.31
Project
Book value Provision for impairment Carrying amount Book value
Provision for
impairment Carrying amount
Supporting construction for animal health projects 5711811.18 - 5711811.18 2852280.20 - 2852280.20
Supporting construction for feed projects 414952547.42 104720.00 414847827.42 268120987.03 104720.00 268016267.03
Supporting construction for breeding projects 97955466.92 - 97955466.92 80782567.10 - 80782567.10
Supporting construction for butcher projects 3172804.26 - 3172804.26 7686836.48 - 7686836.48
Supporting construction for other projects 82271258.27 - 82271258.27 67382036.65 - 67382036.65
Total 604063888.05 104720.00 603959168.05 426824707.46 104720.00 426719987.46
(2) Movements of major construction in progress
Transfers to Transfers to Accumulated Including: Interest rate
Project 2024.12.31 Additions Transfers to intangible other long- Other capitalized interest for
Sources
fixed assets reductions capitalized capitalization 2025.12.31 of assets term assets interest in 2025 in 2025 (%) funding
Supporting
construction Self-
for feed 173303397.08 401532465.77 330912454.75 - - 1805237.61 - - - 242118170.49 raised
projects fund
Supporting
construction Self-
for breeding 12777467.61 67476748.01 78917065.62 - - - - - - 1337150.00 raised
projects fund
Supporting
construction Self-
for other 55777553.85 161627734.37 4226002.12 31652287.27 110438531.51 - - - - 71088467.32 raised
projects fund
Total 241858418.54 630636948.15 414055522.49 31652287.27 110438531.51 1805237.61 - - - 314543787.81
219(3) Impairment provisions for construction in progress
Items 2024.12.31 Addition Reduction 2025.12.31
Supporting construction for feed projects 104720.00 - - 104720.00
Total 104720.00 - - 104720.00
18. Productive biological assets
(1) Measured by cost
* Details of productive biological assets
Animal
husbandry Aquaculture Item Others Total
Breeding Pig Breeding shrimp Breeding fish
I. Cost
1. As of 2024.12.31 563518716.52 27221244.50 9215914.40 17809584.83 617765460.25
2. Additions during the period 594073413.76 93277415.44 20103692.61 19753798.43 727208320.24
(1) Purchases 134852692.96 21109181.84 2072403.57 1852674.48 159886952.85
(2) Self-cultivated 459220720.80 72482820.47 18053483.29 17904193.58 567661218.14
(3) Translation differences arising from translation of
foreign currency financial statements - -314586.87 -22194.25 -3069.63 -339850.75
3. Decreases during the period 597693631.00 94627742.27 18896870.30 17038809.54 728257053.11
(1) Disposals 597693631.00 94627742.27 18660916.46 16135963.24 727118252.97
(2) Others - - 235953.84 902846.30 1138800.14
4. As of 2025.12.31 559898499.28 25870917.67 10422736.71 20524573.72 616716727.38
II. Accumulated depreciation
1. As of 2024.12.31 139315035.68 8715059.79 2083409.38 1764633.48 151878138.33
2. Charges for the period 134582732.23 88540384.58 8081422.08 16518113.50 247722652.39
(1) Provision 134582732.23 88682198.45 8090071.17 16519891.18 247874893.03
220Animal
Item husbandry
Aquaculture
Others Total
Breeding Pig Breeding shrimp Breeding fish
(2) Translation differences arising from translation of
foreign currency financial statements - -141813.87 -8649.09 -1777.68 -152240.64
3. Decreases during the period 161353269.61 86933463.07 7648400.30 10578762.41 266513895.39
(1) Disposals 161353269.61 86933463.07 7648400.30 10248569.67 266183702.65
(2) Others - - - 330192.74 330192.74
4. As of 2025.12.31 112544498.30 10321981.30 2516431.16 7703984.57 133086895.33
III. Provision for impairment
1. As of 2024.12.31 - - - - -
2. Charges for the period 5331033.62 - - - 5331033.62
(1) Provision 5331033.62 - - - 5331033.62
3. Decreases during the period - - - - -
4. As of 2025.12.31 5331033.62 - - - 5331033.62
IV. Carrying amount
As of 2025.12.31 442022967.36 15548936.37 7906305.55 12820589.15 478298798.43
As of 2024.12.31 424203680.84 18506184.71 7132505.02 16044951.35 465887321.92
* Impairment test of productive biological assets
The recoverable amount is determined by the net amount of fair value less disposal expenses.Item Carrying Accumulated Recoverable Impairment Determination of fair value Key Basis for determining key amount depreciation amount amount and disposal expenses parameters parameters
Breeding With reference to recent With reference to the recent
Pig 21926977.80 879877.10 15716067.08 5331033.62 transaction prices of similar
Estimated
assets disposed of selling price
selling price of similar assets
disposed of by the Company
(2) There were no productive biological assets measured at fair value during the current period.
22119. Right-of-use assets
Item Land use rights Plant and Machinery Motor Electronic Other buildings equipment vehicles equipment equipment Total
I. Cost
1. As of 2024.12.31 1806105691.77 1543941646.67 392071250.60 23902582.86 5344934.16 17722163.43 3789088269.49
2. Additions during the period 421989884.22 214896597.37 58040284.90 2649339.31 83011.84 5647721.77 703306839.41
(1) Rent in 380663688.72 223672058.42 60068557.93 2684546.55 83088.58 5648936.65 672820876.85
(2) Lease liability adjustment 29258609.71 -7494055.49 -2028273.03 -2642.09 -76.74 -1214.88 19732347.48
(3) Translation differences arising from
translation of foreign currency financial -2431227.07 -1562967.10 - -32565.15 - - -4026759.32
statements
(4) Additions due to business
combinations 14498812.86 281561.54 - - - - 14780374.40
3. Decreases during the period 278643064.16 109392969.45 43474799.83 4072505.87 7540.90 649580.52 436240460.73
(1) Lease termination 210462710.22 107498994.80 43474799.83 4072505.87 7540.90 649580.52 366166132.14
(2) Reduction in the scope of
consolidation 28951442.09 1893974.65 - - - - 30845416.74
(3) Others 39228911.85 - - - - - 39228911.85
4. As of 2025.12.31 1949452511.83 1649445274.59 406636735.67 22479416.30 5420405.10 22720304.68 4056154648.17
II. Accumulated depreciation
1. As of 2024.12.31 434300292.68 390278913.05 146468862.10 11124997.59 3250820.80 7326714.31 992750600.53
2. Charges for the period 148553883.56 210935487.61 50482702.64 5651492.70 1243637.08 2552419.41 419419623.00
(1) Provision 148061173.75 211263026.50 50482702.64 5661271.79 1243637.08 2552419.41 419264231.17
(2) Translation differences arising from
translation of foreign currency financial -260771.08 -468319.66 - -9779.09 - - -738869.83
statements
(3) Additions due to business
combinations 753480.89 140780.77 - - - - 894261.66
3. Decreases during the period 110453093.05 75963651.25 29366110.27 4007907.23 7540.90 507290.09 220305592.79
(1) Lease termination 91511747.30 75284762.79 29366110.27 4007907.23 7540.90 507290.09 200685358.58
222Item Land use rights Plant and Machinery Motor Electronic Other buildings equipment vehicles equipment equipment Total
(2) Reduction in the scope of
consolidation 4752792.34 678888.46 - - - - 5431680.80
(3) Others 14188553.41 - - - - - 14188553.41
4. As of 2025.12.31 472401083.19 525250749.41 167585454.47 12768583.06 4486916.98 9371843.63 1191864630.74
III. Provision for impairment
1. As of 2024.12.31 25473752.43 1038160.32 - - - - 26511912.75
2. Charges during the period - - - - - - -
3. Decreases during the period 9959476.09 1038160.32 - - - - 10997636.41
(1) Lease termination - - - - - - -
(2) Reduction in the scope of
consolidation 9959476.09 1038160.32 - - - - 10997636.41
4. As of 2025.12.31 15514276.34 - - - - - 15514276.34
IV. Carrying amount
1. As of 2025.12.31 1461537152.30 1124194525.18 239051281.20 9710833.24 933488.12 13348461.05 2848775741.09
2. As of 2024.12.31 1346331646.66 1152624573.30 245602388.50 12777585.27 2094113.36 10395449.12 2769825756.21
The Company recognized lease expenses related to short-term leases and leases of low-value assets. Please refer to Note V. 70 for details.
20. Intangible assets
(1) Details of intangible assets
Patent and Software use rights Marketing network Item Land use rights non-patent rights and trademarks maritime rights and Total others
I. Cost
1. As of 2024.12.31 1758445379.71 285521336.03 401685489.79 62403744.86 2508055950.39
2. Additions during the period 201163767.32 11851655.76 37572372.87 - 250587795.95
(1) Purchases 179414105.62 366000.00 4275128.32 - 184055233.94
223Item Land use rights Patent and Software use rights
Marketing network
non-patent rights and trademarks maritime rights and Total others
(2) Transfers from internal R&D - 11485655.76 - - 11485655.76
(3) Transfers from constructions in progress - - 33358620.53 - 33358620.53
(4) Additions due to business combinations 31721164.59 - - - 31721164.59
(5) Translation differences arising from translation of
foreign currency financial statements -9971502.89 - -61375.98 - -10032878.87
3. Decreases during the period 40474456.68 8743687.64 8392881.42 4067038.38 61678064.12
(1) Disposals 40474456.68 8743687.64 8392881.42 4067038.38 61678064.12
4. As of 2025.12.31 1919134690.35 288629304.15 430864981.24 58336706.48 2696965682.22
II. Accumulated amortization
1. As of 2024.12.31 260502656.60 190874765.68 219014882.36 30923679.79 701315984.43
2. Charges during the period 43789905.27 18015227.85 42716484.39 2301869.42 106823486.93
(1) Provision 43658380.19 18015227.85 42761799.44 2301869.42 106737276.90
(2) Additions due to business combinations 2541907.33 - - - 2541907.33
(3) Translation differences arising from translation of
foreign currency financial statements -2410382.25 - -45315.05 - -2455697.30
3. Decreases during the period 2879442.23 6732712.98 6703034.86 3372018.81 19687208.88
(1) Disposals 2879442.23 6732712.98 6703034.86 3372018.81 19687208.88
4. As of 2025.12.31 301413119.64 202157280.55 255028331.89 29853530.40 788452262.48
III. Provision for impairment
1. As of 2024.12.31 - 10307844.71 - - 10307844.71
2. Charges during the period - - - - -
3. Decreases during the period - - - - -
4. As of 2025.12.31 - 10307844.71 - - 10307844.71
IV. Carrying amount
1. As of 2025.12.31 1617721570.71 76164178.89 175836649.35 28483176.08 1898205575.03
224Patent and Software use rights Marketing network Item Land use rights non-patent rights and trademarks maritime rights and Total others
2. As of 2024.12.31 1497942723.11 84338725.64 182670607.43 31480065.07 1796432121.25
At the end of the period internally developed intangible assets represented 8.19% of the total carrying amount of intangible assets.
(2) Land use rights without ownership certificates
Item Carrying amount Reason for not having obtained ownership certificate
Land use rights 49877508.17 In progress
21. Development costs
Project 2024.12.31 Additions during the Decreases during the period period 2025.12.31
Development costs 46582788.74 37921778.21 26160590.35 58343976.60
For details refers to Note VI. Research and development expenditure.
22522. Goodwill
(1) Book value of goodwill
Additions
during the Decreases during
Name of the period
the period
investee or matters Effect of
giving rise to 2024.12.31 translation 2025.12.31
goodwill Business Combination Disposals
of foreign
currency
financial
statement
Guangzhou
Runchuan 50000.00 - - - 50000.00
Investment Co. Ltd.Feicheng Heruifeng
Agricultural 57092523.20 - 57092523.20 - -
Technology Co. Ltd.Weifang Xuheng
Agricultural 30507361.78 - 30507361.78 - -
Technology Co. Ltd.Gaotang Huayu Pig
Farming Co. Ltd. 1455358.51 - - - 1455358.51
Gaozhou Haiyuan
Agricultural Co. 2799980.27 - - - 2799980.27
Ltd.Sichuan Hailinge
Biopharmaceutical 76410471.64 - - - 76410471.64
Co. Ltd.Taizhou Haid
Biological Feed Co. 578247.88 - - - 578247.88
Ltd.Guangzhou Haihe
Feed Co. Ltd. 76663.70 - - - 76663.70
Dongguan Haid
Feed Co. Ltd. 2831241.61 - - - 2831241.61
Zhanjiang Hisenor
Marine
Biotechnology Co. 4100845.79 - - - 4100845.79
Ltd.Foshan Sanshui
Fanling Feed Co. 4841934.68 - - - 4841934.68
Ltd.Dalian Haid
Rongchuan Trading 32178.11 - - - 32178.11
Co. Ltd.PANASIA
TRADING
RESOURCES
LIMITED & 45164642.73 - - 1002765.15 44161877.58
SHENG LONG
INTERNATIONAL
LTD.KEMBANG
SUBUR 359282.56 - - 7976.95 351305.61
INTERNATIONAL
226Additions
during the Decreases during the period
Name of the period
investee or matters Effect of
giving rise to 2024.12.31 translation 2025.12.31
goodwill Business Combination Disposals
of foreign
currency
financial
statement
LTD.SHENG LONG
BIO-TECH
INTERNATIONAL 5822936.39 - - 298368.10 5524568.29
CO. LTD
Kaifeng Haid Feed
Co. Ltd. 8838854.56 - - - 8838854.56
Guangzhou
Heshengtang
Biotechnology Co. 127116.22 - - - 127116.22
Ltd.Guangdong Hairui
Biotechnology Co. 5809578.76 - - - 5809578.76
Ltd.Hunan Innovation
Biotechnology Co. 19210769.76 - - - 19210769.76
Ltd.Jiaxing Haid
Yongwang
Biological Feed Co. 8312415.28 - - - 8312415.28
Ltd.Shandong Daxin
Group Co. Ltd. 115902036.20 - - - 115902036.20
Qingdao Haihe
Agriculture and
Animal Husbandry 220674.27 - - - 220674.27
Technology Co. Ltd.Hunan Jinhuilong
Technology Co. Ltd. 2400475.64 - - - 2400475.64
Zhongshan Yugezi
Food Co. Ltd. 9620427.34 - - - 9620427.34
Yunnan Zhonggui
Feed Co. Ltd. 3088765.62 - - - 3088765.62
Qingyuan Ronghai
Food Technology 1218130.86 - - - 1218130.86
Co. Ltd.Hainan Zhuangmei
Agriculture and
Animal Husbandry 1999796.32 - - - 1999796.32
Co. Ltd.Jiangxi Jiabo
Biological
Engineering Co. 17826753.49 - - - 17826753.49
Ltd.Ganzhou Lianduoli
Feed Technology 4228394.10 - - - 4228394.10
Co. Ltd.
227Additions
during the Decreases during the period
Name of the period
investee or matters Effect of
giving rise to 2024.12.31 translation 2025.12.31
goodwill Business Combination Disposals
of foreign
currency
financial
statement
Foshan Debao
Biological Group 24182145.13 - 1166760.77 - 23015384.36
Co. Ltd.Xishui Chenke Feed
Technology Co. Ltd. 55850881.86 - - - 55850881.86
Zhejiang Lanke Seed
Industry Technology - 1742452.87 - - 1742452.87
Co. Ltd.Zhuhai Dehai
Biological - 130908331.91 - - 130908331.91
Technology Co. Ltd.PT BIBIT UNGGUL
CGU - 25419574.21 - - 25419574.21
Total 510960884.26 158070358.99 88766645.75 1309110.20 578955487.30
(2) Provision for impairment of goodwill
Additions
during the Decreases during the
period period Name of the
investee or Effect of
matters giving rise 2024.12.31 translation 2025.12.31
to goodwill Provisions Disposals of foreign currency
financial
statement
Guangzhou
Runchuan
Investment Co. 50000.00 - - - 50000.00
Ltd.Guangzhou Haihe
Feed Co. Ltd. 76663.70 - - - 76663.70
Dalian Haid
Rongchuan Trading - 32178.11 - - 32178.11
Co. Ltd.SHENG LONG
BIO-TECH
INTERNATIONAL 5822936.39 - - 298368.10 5524568.29
CO. LTD
Guangzhou
Heshengtang
Biotechnology Co. - 127116.22 - - 127116.22
Ltd.Guangdong Hairui
Biotechnology Co. 5809578.76 - - - 5809578.76
Ltd.
228Additions
during the Decreases during the
Name of the period
period
investee or Effect of
matters giving rise 2024.12.31 translation 2025.12.31
to goodwill Provisions Disposals of foreign currency
financial
statement
Hunan Innovation
Biotechnology Co. 4038440.41 4075623.47 - - 8114063.88
Ltd.Sichuan Hailinge
Biopharmaceutical 76410471.64 - - - 76410471.64
Co. Ltd.Shandong Daxin
Group Co. Ltd. 42788077.07 - - - 42788077.07
Hunan Jinhuilong
Technology Co. - 959755.34 - - 959755.34
Ltd.Feicheng
Heruifeng
Agricultural 57092523.20 - 57092523.20 - -
Technology Co.Ltd.Weifang Xuheng
Agricultural
Technology Co. 30507361.78 - 30507361.78 - -
Ltd.KEMBANG
SUBUR
INTERNATIONAL 359282.56 - - 7976.95 351305.61
LTD.Gaotang Huayu Pig
Farming Co. Ltd. 1455358.51 - - - 1455358.51
Yunnan Zhonggui
Feed Co. Ltd. - 3088765.62 - - 3088765.62
Zhongshan Yugezi
Food Co. Ltd. 9620427.34 - - - 9620427.34
Qingdao Haihe
Agriculture and
Animal Husbandry 220674.27 - - - 220674.27
Technology Co.Ltd.Jiangxi Jiabo
Biological
Engineering Co. 17826753.49 - - - 17826753.49
Ltd.Hainan Zhuangmei
Agriculture and
Animal Husbandry - 1999796.32 - - 1999796.32
Co. Ltd.Gaozhou Haiyuan
Agricultural Co. 2799980.27 - - - 2799980.27
Ltd.
229Additions
during the Decreases during the
Name of the period
period
investee or Effect of
matters giving rise 2024.12.31 translation 2025.12.31
to goodwill Provisions Disposals of foreign currency
financial
statement
Foshan Debao
Biological Group 10903528.88 - 526082.77 - 10377446.11
Co. Ltd.Total 265782058.27 10283235.08 88125967.75 306345.05 187632980.55
Note: The Group uses the present value of expected future cash flows to calculate the recoverable amount of
the asset groups. The Group forecasts cash flows for the next five years based on the financial budget
approved by management with a cash flow growth rate of 0.00% for subsequent years (prior period: 0.00%).Management has prepared the above financial budget based on past performance and its expectations for
market development. The pre-tax discount rates used to calculate the present value of future cash flows for
asset groups range from 9.24% to 17.54% (prior period: 8.04%~20.54%) which reflect the risks associated
with the respective segments. According to the results of the impairment test the balance of goodwill
impairment provision as of December 31 2025 was RMB187632980.55 (December 31 2024:
RMB265782058.27).
23. Long-term deferred expenses
Item 2024.12.31 Additions during
Decreases during the period
the period Amortization 2025.12.31
for the period Others
Rental
expenses 1288951.76 1221326.48 468542.60 - 2041735.64
Transfer fee
for contracted
management 2134077.83 - 1215321.39 - 918756.44
rights
Improvement
and
renovations 277791533.88 217386165.69 96626016.51 169728.70 398381954.36
expenses
Others 14248069.50 7840686.65 6122741.02 18307.44 15947707.69
Total 295462632.97 226448178.82 104432621.52 188036.14 417290154.13
24. Deferred tax assets and deferred tax liabilities
(1) Unoffset deferred tax assets and deferred tax liabilities
2025.12.312024.12.31
Deductible or Deferred tax Deductible or Item taxable assets/ deferred taxable
Deferred tax
temporary tax liabilities temporary
assets/ deferred
differences differences tax liabilities
Deferred tax assets:
Provision of credit
losses 743699951.45 178236432.68 508740572.13 119922787.44
Provisions for assets
impairment 838190918.46 127790080.42 41475708.33 8982965.65
2302025.12.312024.12.31
Deductible or Deferred tax Deductible or Item taxable taxable Deferred tax
temporary assets/ deferred assets/ deferred
differences tax liabilities
temporary
differences tax liabilities
Start-up expenses 25580012.63 5910984.45 25048403.65 5193695.05
Depreciation on fixed
assets 6644638.82 1629222.22 6031106.19 817928.46
Amortization of
intangible assets 4922970.35 741199.61 - -
Deductible losses 2334152459.92 540784409.26 2163425915.22 497995931.88
Accrued sales discount/
expenses 185155175.57 25717304.59 188352253.92 25030356.15
Unrealized profits of
intra-group transactions 282649373.62 52797477.90 344444589.49 69884574.54
Movements of fair value 9619204.04 2399648.98 67566076.19 16882245.05
Deferred income 201005581.66 46652257.27 206173283.74 43737336.66
Employee compensation 120762516.05 25530094.11 128616353.63 23578681.24
Equity incentive 442169555.72 66325433.36 143007901.13 21451185.17
Advertising expenses 48277.82 9876.04 49549.08 8251.90
Accrued tax deduction 210266265.53 31539939.83 209973636.00 31496045.40
Lease liabilities 1987201018.96 418905760.52 1718446870.60 296953755.29
Subtotal 7392067920.60 1524970121.24 5751352219.30 1161935739.88
Deferred tax liabilities:
Value-added assessment
from business
combination not under 259861761.51 62173621.64 225048169.87 53256220.18
common control
Valuation of held-for-
trading financial
instruments and 112226479.56 26313369.50 308152540.63 75805950.05
derivative financial
instruments
Depreciation on fixed
assets 515096879.40 111798522.81 532382083.30 112803681.67
Amortization on
intangible assets 4647173.18 996900.23 6631904.09 1236928.70
Expected profits to be
distributed by overseas 210266265.53 31539939.83 209973636.00 31496045.40
subsidiaries
Right-of-use assets 1879009962.56 394694969.69 1618737339.94 277762992.09
Others 24715656.92 5995465.34 93392321.55 22736776.77
Subtotal 3005824178.66 633512789.04 2994317995.38 575098594.86
231(2) Deferred tax assets or liabilities presented at the net amount after offsetting
Offset amount Offset mount of
of deferred tax Deferred tax assets deferred tax Deferred tax assets
Item assets and or liabilities after assets and or liabilities after liabilities at the offsetting at the end liabilities at the offsetting at the
end of current of current period end of prior end of prior year
period year
Deferred tax assets 502060372.01 1022909749.23 434940233.62 726995506.26
Deferred tax
liabilities 502060372.01 131452417.03 434940233.62 140158361.24
(3) Details of unrecognized deferred tax assets from deductible temporary differences and deductible losses
Item 2025.12.31 2024.12.31
Deductible temporary differences 43799439.28 87165003.59
Deductible losses 2146026294.22 1074522760.26
Total 2189825733.50 1161687763.85
(4) Expiration of deductible tax losses for unrecognized deferred tax assets
Year 2025.12.31 2024.12.31
2025——55283802.09
202695338404.28108418008.54
202772570000.40118726327.10
2028405633076.79390137806.15
2029311345029.22342238941.38
2030 and onwards 1261139783.53 59717875.00
Total 2146026294.22 1074522760.26
25. Other non-current assets
2025.12.312024.12.31
Item
Book value Impairment Carrying Book value Impairment Carrying provision amount provision amount
Prepayments for
equipment and 270472199.89 - 270472199.89 100712662.23 - 100712662.23
constructions
Prepayments for
other long-term 28865094.63 - 28865094.63 36342448.54 - 36342448.54
assets
Time deposits
with maturities 8578438.58 - 8578438.58 - - -
over one year
Factoring
accounts - - - 30750003.00 461250.05 30288752.95
receivable
Total 307915733.10 - 307915733.10 167805113.77 461250.05 167343863.72
23226. Assets with restricted ownership or use rights
2025.12.31
Item Carrying
amount Reason for restriction
Cash and cash equivalents 204086896.82 Land reclamation deposit guarantee deposits funds in futures accounts etc.Notes receivable - /
Held-for-trading financial assets - /
Fixed assets 151335692.15 Pledged as collateral for loans
Intangible assets 20009343.43 Pledged as collateral for loans
Total 375431932.40
Continued:
2024.12.31
Item
Carrying amount Reason for restriction
Cash and cash equivalents 149124842.12 Land reclamation deposit guarantee deposit bank guarantee etc.Notes receivable 1000000.00 Unexpired endorsed notes receivable that have not been derecognized
Held-for-trading financial assets 653572.61 Frozen due to litigation
Fixed assets - /
Intangible assets - /
Total 150778414.73
27. Short-term loans
(1) Classification of short-term loans
Item 2025.12.31 2024.12.31
Unsecured loans 1082548619.91 250844832.05
Pledged loans 1187500.00 -
Mortgage loans 76500000.00 -
Accrued interests 3410957.88 895055.24
Total 1163647077.79 251739887.29
Note: Unsecured loans included loans guaranteed by members within the Group.
(2) As of December 31 2025 there were no overdue short-term loans.
28. Held-for-trading financial liabilities
Item 2025.12.31 2024.12.31
Held-for-trading financial liabilities 64970335.96 77390252.93
Including: Derivative financial liabilities 64970335.96 77390252.93
Total 64970335.96 77390252.93
23329. Notes payable
Item 2025.12.31 2024.12.31
Bank acceptance notes 3593570904.93 4447545146.08
Domestic letter of credit 219166681.82 547656341.99
Total 3812737586.75 4995201488.07
Note: As of December 31 2025 there were no unsettled overdue notes payable.
30. Accounts payable
Item 2025.12.31 2024.12.31
Within one year 5562155881.79 5302228937.75
More than one year 163891514.65 180832558.20
Total 5726047396.44 5483061495.95
Note: There were no significant accounts payable with aging over one year.
31. Advances from customers
Item 2025.12.31 2024.12.31
Rental income 5111059.70 3749633.06
Others - 498532.00
Total 5111059.70 4248165.06
Note: There were no significant advances from customers with aging over one year.
32. Contract liabilities
Item 2025.12.31 2024.12.31
Advances from customers 2581711607.32 2251063282.58
Less: Contract liabilities recognized in other
non-current liabilities - -
Total 2581711607.32 2251063282.58
Note: There were no significant contract liabilities with aging over one year.
33. Employee benefits payable
Accrued Decreased
Item 2024.12.31 during the during the 2025.12.31
period period
Short-term employee
benefits 2157149248.60 7392690662.37 7065715868.51 2484124042.46
Post-employment
benefits - defined 1309366.94 350845741.25 350129258.97 2025849.22
contribution plans
Termination benefits 8203672.25 19723385.91 19024387.05 8902671.11
Total 2166662287.79 7763259789.53 7434869514.53 2495052562.79
234(1) Short-term employee benefits
Accrued Decreased
Item 2024.12.31 during the during the 2025.12.31
period period
Salaries bonus
allowances 1589508433.84 6223175496.43 6019321128.27 1793362802.00
Staff welfare 28388799.57 245287657.43 245411515.99 28264941.01
Social insurances 1061386.46 165970491.41 164180443.94 2851433.93
Including:
1. Medical and 1045735.56 149472117.92 147670374.29 2847479.19
maternity insurance
2. Work-related injury
insurance 2968.44 14434387.53 14433401.23 3954.74
3. Serious disease
subsidies 12682.46 2063985.96 2076668.42 -
Housing Fund 93871.70 63384406.45 63365302.64 112975.51
Labor union fees 1477825.54 14239818.64 14214322.94 1503321.24
Employee education
fee 1419422.86 14669651.89 15062393.41 1026681.34
Short-term profit -
sharing plan 535199508.63 665963140.12 544160761.32 657001887.43
Total 2157149248.60 7392690662.37 7065715868.51 2484124042.46
(2) Defined contribution plans
Accrued Decreased
Item 2024.12.31 during the during the 2025.12.31
period period
Post-employment benefits 1309366.94 350845741.25 350129258.97 2025849.22
Including:
1. Basic pension 1303188.74 336934594.42 336216295.76 2021487.40
insurance
2. Unemployment
insurance 6178.20 13911146.83 13912963.21 4361.82
Total 1309366.94 350845741.25 350129258.97 2025849.22
34. Taxes payable
Item 2025.12.31 2024.12.31
VAT 12146615.66 11175766.01
Urban maintenance and construction tax 669806.47 393532.32
Education surcharge and local education surcharge 535222.13 308914.98
Corporate income tax 300356769.13 303149627.11
Individual income tax 22112751.08 13547929.44
Stamp tax 17038712.81 15527964.97
Property tax 10371232.64 6231230.19
Land use tax 3888258.75 3316266.47
Environmental protection tax 487066.94 438020.26
Withholding tax 5181172.76 4324752.32
235Item 2025.12.31 2024.12.31
Others 1004291.52 985233.57
Total 373791899.89 359399237.64
35. Other payables
Item 2025.12.31 2024.12.31
Interest payables - -
Dividends payable - 92085342.39
Other payables 1519032906.76 860131940.23
Total 1519032906.76 952217282.62
(1) Dividends payable
Item 2025.12.31 2024.12.31
Payables due to minority shareholder - 92085342.39
Total - 92085342.39
Note: As of December 31 2025 there were no significant dividends payable with aging over one year.
(2) Other payables (disclosed by nature)
Item 2025.12.31 2024.12.31
Security deposits 688388944.31 600139853.73
Expense reimbursement 8100754.28 14145503.26
Rental expenses 41597490.25 40976916.34
Payment for employee
shareholding plan 67087455.39 134174910.78
Payables to external parties 81014031.28 61680755.20
Payables for equity transfer 616279411.24 -
Others 16564820.01 9014000.92
Total 1519032906.76 860131940.23
Including: significant other payables with aging over one year.Item 2025.12.31 Explanation for outstanding balances
Payment for employee The second vesting period of the 2024
shareholding plan 67087455.39 Employee Stock Ownership Plan remains in the lock-up period
36. Non-current liabilities due within one year
Item 2025.12.31 2024.12.31
Long-term loans due within one year 106605291.97 863994845.76
Long-term payables due within one year 14942117.82 8035914.21
Lease liabilities due within one year 378836622.21 346516119.42
Other non-current liabilities due within one year 12180953.67 11381008.58
Total 512564985.67 1229927887.97
236(1) Long-term loans due within one year
Item 2025.12.31 2024.12.31
Guaranteed loans 33981500.00 9500000.00
Unsecured loans 72290761.47 851711161.09
Accrued interests 333030.50 2783684.67
Total 106605291.97 863994845.76
(2) Long-term payables due within one year
Item 2025.12.31 2024.12.31
Security deposits 247728.09 600000.00
Sea area usage fee 2603850.45 2603850.45
Others 12090539.28 4832063.76
Total 14942117.82 8035914.21
37. Other current liabilities
Item 2025.12.31 2024.12.31
Water and electricity 92914084.07 88804811.18
Steam fuel and power expenses 44290233.50 42102572.16
Transportation and warehousing charges 20931039.98 21739112.43
Office and meeting service charges 37233442.73 27705911.35
Travel expenses 24771513.48 23364282.86
Rental expenses 4274749.65 2555541.73
Vehicle costs 20857515.57 21148175.04
Research and development expenses 1467449.85 1919522.24
Business promotion expenses 21234401.26 22688566.16
Repair costs 3609708.85 5102229.22
Entrusted cultivation charges 367293611.27 386620151.15
Output VAT to be transferred 11449559.48 30823119.39
Guarantee compensation reserve 34105439.31 21662672.98
Others 74677064.20 67639141.45
Total 759109813.20 763875809.34
38. Long-term loans
Item 2025.12.31 Interest rate 2024.12.31 Interest rate
2.65%~4.8125%
Unsecured loans 267089571.97 2.50%~4.975% 5YLPR-5BP~19.5BP 2606532495.98 6M SOFR+1.7% 5YLPR-5BP~20BP
Guaranteed loans 15000000.00 1YLPR+50BP 24500000.00 1YLPR+35BP~50BP
Pledged loans 22500000.00 3.40% -
Mortgage loans 51320000.00 3.60% 1YLPR+30BP~95BP -
Accrued interests 333030.50 2783684.67
237Item 2025.12.31 Interest rate 2024.12.31 Interest rate
Subtotal 356242602.47 2633816180.65
Less: Long-term
loans due within 106605291.97 863994845.76
one year
Total 249637310.50 1769821334.89
39. Lease liabilities
Item 2025.12.31 2024.12.31
Lease liabilities 3124435733.27 2905037096.33
Less: Unrecognized financing costs 589779826.40 542952097.97
Subtotal 2534655906.87 2362084998.36
Less: Lease liabilities due within one year 378836622.21 346516119.42
Total 2155819284.66 2015568878.94
Note: Interest expenses for lease liabilities accrued in 2025 was RMB98.7034 million which was recognized
as financial expenses - unrecognized financing costs.
40. Long-term payables
Item 2025.12.31 2024.12.31
Long-term payables 53622597.72 67132880.83
Special payables - -
Total 53622597.72 67132880.83
Long-term payables (disclosed by nature)
Item 2025.12.31 2024.12.31
Guarantee deposits 25922319.33 30341657.95
Payables for equity transfer 1000000.00 5000000.00
Sea area usage fee 26954248.50 29590248.50
Other payables 19632810.17 16584184.04
Less: Unrecognized financing costs 4944662.46 6347295.45
Subtotal 68564715.54 75168795.04
Less: Long-term payables due within one year 14942117.82 8035914.21
Total 53622597.72 67132880.83
41. Long-term employee benefits payable
Item 2025.12.31 2024.12.31
Net liabilities of defined benefit plans 322346.92 -
Termination benefits - -
Long-term profit sharing plans 360716634.48 677373020.80
Subtotal 361038981.40 677373020.80
Less: Long-term employee benefits payable due within one year 216533034.80 535199508.63
Total 144505946.60 142173512.17
23842. Deferred income
Additions Decreases
Item 2024.12.31 during the during the 2025.12.31 Reason for
period period deferral
Government 349550038.04 52292493.22 71277058.96 330565472.30 Receipt of grant government grant
For the government grants recognized as deferred income refer to Note VIII. Government Grants.
43. Other non-current liabilities
Item 2025.12.31 2024.12.31
Contingent consideration - 13000000.00
Advance rent 11532893.24 11960906.42
Total 11532893.24 24960906.42
44. Share capital (Unit: share)
Movements during the period (+ -)
Shares
Item 2024.12.31 New Stock converted 2025.12.31
issuance dividends from Others Subtotal capital
reserve
Total
shares 1663749970.00 - - - - - 1663749970.00
45. Capital reserve
Item 2024.12.31 Additions Decreases during the period during the period 2025.12.31
Share premium 4529640896.56 60939910.09 626298218.55 3964282588.10
Other capital
reserves 621716456.31 28058136.31 - 649774592.62
Total 5151357352.87 88998046.40 626298218.55 4614057180.72
Note 1: The increase in share premium during the current period was mainly attributable to the excess of
proceeds received from the sale of corresponding treasury shares over their cost as the performance targets
were not met upon the expiry of the first lock-up period of the 2024 Employee Stock Ownership Plan. The
decrease during the current period was mainly attributable to the difference between the consideration
received or paid for transactions with minority shareholders and the Group’s share of net assets of the
subsidiary at the transfer date.Note 2: The increase in other capital reserves during the current period was attributable to the equity-settled
share-based payment recognized under the equity incentive plan implemented during the current period
attributable to the parent company (refer to Note XII for details) as well as the tax effect arising from the
estimated tax-deductible amount of unexercised/unvested equity incentives exceeding the recognized equity
incentive expenses.
46. Treasury stock
Item 2024.12.31 Additions Decreases during the period during the period 2025.12.31
Share repurchase 300081705.48 718670652.91 148618690.89 870133667.50
Total 300081705.48 718670652.91 148618690.89 870133667.50
239Note: The increase during the current period was mainly attributable to the repurchase of shares for
cancellation to reduce registered capital and/or for the implementation of the equity incentive plan and/or
employee stock ownership plan. The decrease during the current period was mainly attributable to the sale
of corresponding treasury shares as the performance targets were not met upon the expiry of the first lock-up
period of the 2024 Employee Stock Ownership Plan.
47. Other comprehensive income
Other comprehensive income attributable to the parent company in the balance sheet:
Movements during the period
Less: Amounts
previously
recognized in
Item 2024.12.31 2025.12.31
Amount after tax OCI and transferred to
profit or loss
during current
period
I. Items that will not be
reclassified to profit or - -16285.27 - -16285.27
loss
1.Remeasurement of net
defined benefit plan - -16285.27 - -16285.27
II. Items that may be
reclassified to profit or 356509145.52 -667274606.78 - -310765461.26
loss
1. Other comprehensive
income that can be
converted into profit or -2669044.27 -5033010.45 - -7702054.72
loss under the equity
method
2. Cash flow hedge
reserves 599221063.08 -456672803.95 - 142548259.13
3. Translation differences
arising from translation of
foreign currency financial -240042873.29 -205568792.38 - -445611665.67
statements
Total other
comprehensive income 356509145.52 -667290892.05 - -310781746.53
Other comprehensive income attributable to the parent company in the income statement:
2025
Less: Amounts
previously
recognized in Less: Amount Amount
Item Amount before OCI and Less: Income attributable to attributable to
tax transferred to tax expenses minority the parent
profit or loss shareholders company after
during the after tax tax
current period
I. Items that will not be
reclassified to profit or -20878.55 - -4593.28 - -16285.27
loss
1.Remeasurement of net
defined benefit plan -20878.55 - -4593.28 - -16285.27
2402025
Less: Amounts
previously
recognized in Less: Amount Amount
Item Amount before OCI and Less: Income attributable to attributable to
tax transferred to tax expenses minority the parent
profit or loss shareholders company after
during the after tax tax
current period
II. Items that may be
reclassified to profit or -77129780.03 599221063.08 2628424.86 -11704661.19 -667274606.78
loss
1. Other comprehensive
income that can be
converted into profit or -5033010.45 - - - -5033010.45
loss under the equity
method
2. Cash flow hedge
reserves 145437360.05 599221063.08 2628424.86 260676.06 -456672803.95
3. Translation differences
arising from translation of
foreign currency financial -217534129.63 - - -11965337.25 -205568792.38
statements
Total other
comprehensive income -77150658.58 599221063.08 2623831.58 -11704661.19 -667290892.05
Note: The net amount of other comprehensive income after tax for the current period is RMB-678995553.24.Of which the net amount attributable to shareholders of the parent company is RMB-667290892.05; the
net amount attributable to minority shareholders is RMB-11704661.19.
48. Special reserve
Item 2024.12.31 Additions Decreases during the period during the period 2025.12.31
Safety production expenses 835404.85 696942.62 54992.01 1477355.46
Total 835404.85 696942.62 54992.01 1477355.46
Note: The increase in the special reserve during the period represents the safety production expenses accrued
by the Company at 1.00% of the actual operating income from general freight services in the prior period in
accordance with relevant regulations.
49. Surplus reserve
Item 2024.12.31 Additions Decreases during the period during the period 2025.12.31
Statutory surplus reserve 831874985.00 - - 831874985.00
Total 831874985.00 - - 831874985.00
Note: According to the Company's articles of association if the accumulated amount of the statutory reserve
fund reaches 50% or more of the Company’s registered capital the Company may cease to appropriate the
statutory reserve.
50. General risk provision
Item 2024.12.31 Additions Decreases during the period during the period 2025.12.31
General risk allowance 2389821.53 142548.23 20683.96 2511685.80
Total 2389821.53 142548.23 20683.96 2511685.80
51. Retained earnings
241Appropriation
Item 2025 2024 or distribution
percentage
Opening balance of retained earnings before
adjustment 16198667745.26 12526305153.20 --
Total adjustments for opening balance of
retained earnings (“+” for increase; “-” for - - --
decrease)
Opening balance of retained earnings after
adjustment 16198667745.26 12526305153.20
Add: Net profits for the year attributable to
shareholders of the parent company 4280330734.08 4503995518.39 --
Less: Appropriation for statutory surplus
reserve - -
Appropriation for general risk provision 121864.27 -209958.67
Dividends payable on common stock 2162791501.00 831842885.00
Closing balance of retained earnings 18316085114.07 16198667745.26
52. Operating income and operating cost
(1) Operating income and operating cost
20252024
Item Income Cost Income Cost
Principal
activities 128291884126.68 115086039929.55 114320116180.76 101482420447.49
Other operating
activities 176346788.28 107303684.99 280940481.53 157157040.68
Total 128468230914.96 115193343614.54 114601056662.29 101639577488.17
242(2) Operating income and operating cost by products
20252024
Main product category
Income Cost Income Cost
Feed 105257615986.92 95075398107.81 91202471546.02 82315983104.74
Animal health products 891050510.76 485883904.63 845785008.00 368047297.51
Agricultural products 17958922847.61 15506477221.90 18826479018.92 15384621981.11
Trading business 4124515406.60 4016901743.07 3435411501.16 3413103070.42
Others 236126163.07 108682637.13 290909588.19 157822034.39
Total 128468230914.96 115193343614.54 114601056662.29 101639577488.17
(3) Operating income and operating cost by regions
20252024
Main business region
Income Cost Income Cost
South China 68610857366.39 62411244649.22 67393687661.28 60465150039.27
East China 18139504851.76 17030498113.15 16343599813.21 15343642240.56
North China 29197174546.67 27759517038.81 27435014704.38 26087969176.03
Central China 34662098357.55 33106730999.13 30865136138.53 28851852669.77
Overseas 16636118527.14 14051934824.02 14339378668.54 12420785985.76
Elimination on consolidation -38777522734.55 -39166582009.79 -41775760323.65 -41529822623.22
Total 128468230914.96 115193343614.54 114601056662.29 101639577488.17
(4) Operating income and operating cost by the timing of goods transfer
2025
Item Sales of goods Others Total
Income Cost Income Cost Income Cost
Principal activities 128232104751.89 115084660977.41 59779374.79 1378952.14 128291884126.68 115086039929.55
Including: Revenue recognized at a
point in time 128232104751.89 115084660977.41 - - 128232104751.89 115084660977.41
2432025
Item Sales of goods Others Total
Income Cost Income Cost Income Cost
Revenue recognized over time - - 59779374.79 1378952.14 59779374.79 1378952.14
Operating income from other
operating activities - - 176346788.28 107303684.99 176346788.28 107303684.99
Including: Revenue recognized at a
point in time - - 144354955.52 78438527.61 144354955.52 78438527.61
Revenue recognized over time - - - - - -
Rental income - - 31991832.76 28865157.38 31991832.76 28865157.38
Total 128232104751.89 115084660977.41 236126163.07 108682637.13 128468230914.96 115193343614.54
53. Taxes and surcharges
Item 2025 2024
Urban maintenance and construction tax 6284033.12 6657361.68
Education surcharge and local education surcharge 4811833.19 5042241.47
Stamp duty 71275034.61 60655604.07
Property tax 56237224.68 53050571.63
Land usage tax 19471041.45 18054457.94
Environmental protection tax 2067521.33 1812152.08
Others 4197896.71 3398610.92
Total 164344585.09 148670999.79
For the criteria of major taxes and surcharges please refer to Note IV. Taxation.
24454. Selling and distribution expenses
Item 2025 2024
Employee compensation 2175728554.96 1957043350.02
Travel expenses 338362998.56 308525882.34
Business promotion expenses 250840166.78 253291784.65
Share incentive expenses -1892257.22 7590597.01
Others 75878809.50 81899186.42
Total 2838918272.58 2608350800.44
55. General and administrative expenses
Item 2025 2024
Employee compensation 2346051995.70 2061873472.37
Travel expenses 147081258.54 132128634.09
Office expenses 746370668.96 671525320.51
Training and consulting service
charges 170895649.58 108908223.18
Share incentive expenses 9283432.02 30797210.04
Others 280086050.75 182282028.30
Total 3699769055.55 3187514888.49
56. Research and development expenses
Item 2025 2024
Employee compensation 571971737.82 516985822.23
Materials 136521354.95 132958662.05
Travel expenses 52337408.17 49694045.24
Office expenses 124028325.31 118220504.75
Training and consulting service
charges 39628967.75 25832956.18
Expense on R&D entrusted to
external parties 2349575.89 6889081.01
Share incentive expenses 5984587.66 5524933.68
Others 573294.01 3929310.20
Total 933395251.56 860035315.34
57. Financial expenses
Item 2025 2024
Interest expenses 157345198.83 294041457.45
Less: Interest income 33272254.65 63367108.52
Add: Net exchange losses/gains -5137891.42 -2555066.87
Add: Unrecognized financing costs 99020056.85 91686721.41
Add: Bank charges and others 37024117.37 49905340.25
Total 254979226.98 369711343.72
24558. Other income
Item 2025 2024
Government grants 120486732.10 114153992.08
Other items related to daily operating activities that
should be directly recognized in other income 10729673.37 19632830.87
Total 131216405.47 133786822.95
Note: For the details of government grants refer to Note VIII. Government Grants.
59. Investment income
Item 2025 2024
Income from long-term equity investments under equity
method 25427228.02 39786542.41
Investment income from disposal of long-term equity
investments 32532911.18 -1454295.98
Investment income earned from held-for-trading financial
assets during the holding period 56734643.59 38135740.72
Interest income from debt investments - 100943.40
Investment income earned from other non-current
financial assets during the holding period 437476.50 533574.61
Investment income from disposal of other non-current
financial assets - -1296986.53
Investment income from disposal of held-for-trading
financial assets -155978497.73 -83888333.37
Gains from derecognition of financial assets measured at
amortized cost -1562481.87 -746985.21
Total -42408720.31 -8829799.95
60. Gains from changes in fair value
Source of the gains from changes in fair value 2025 2024
Held-for-trading financial assets -128776461.42 90027797.12
Held-for-trading financial liabilities 95204540.56 -57151486.50
Other non-current financial assets 6579990.00 -7590410.83
Total -26991930.86 25285899.79
61. Credit losses ("-" for losses)
Item 2025 2024
Loss allowance on accounts receivable -115694433.37 -205845928.34
Loss allowance on loans factoring and financial
guarantees -33023945.73 -58625277.18
Total -148718379.10 -264471205.52
62. Impairment losses ("-" for losses)
Item 2025 2024
Impairment losses on inventories -21001538.25 -24324136.92
Impairment losses on goodwill -10283235.08 -100275700.83
Impairment losses on right-of-use assets - -26511912.75
246Item 2025 2024
Impairment losses on fixed assets -854621.25 -68289748.32
Impairment losses on construction in progress - -104720.00
Impairment losses on investment properties -9616326.03 -
Impairment losses on productive biological assets -5331033.62 -
Total -47086754.23 -219506218.82
63. Gains from assets disposal (“-" for losses)Item 2025 2024Gains from disposals of fixed assets (“-" for losses) -3714365.38 38270580.34Gains from disposals of intangible assets (“-" for losses) -237905.30 17111589.79Gains from disposals of right-of-use assets (“-" for losses) 449229.57 -1837851.84Gains from disposal of non-current assets (disposalgroups) held for sale (“-“ for losses) 899598.85 -Gains from disposals of construction in progress (“-" forlosses) -3922997.66 -
Total -6526439.92 53544318.29
64. Non-operating income
Amount included in
Item 2025 2024 non-recurring gains or losses for the
current period
Gains on disposal of non-current
assets resulted from damage or - 137260.73 -
obsolescence
Insurance compensation 20300362.80 21327018.65 20300362.80
Debt repayment income 18874398.41 12773614.72 18874398.41
Default penalty 21336251.90 24195653.73 21336251.90
Others 8779524.64 10434262.71 8779524.64
Total 69290537.75 68867810.54 69290537.75
65. Non-operating expenses
Amount included
Item 2025 2024 in non-recurring gains or losses for
the current year
Loss on disposal of non-current assets
resulted from damage or obsolescence 62165070.70 110394973.29 62165070.70
Donations 28440715.46 23942640.85 28440715.46
Loss in damage and scrap of
inventory 2163964.51 5179667.14 2163964.51
Default penalty 16962623.22 6652220.59 16962623.22
Fines and penalty 2698399.21 4115547.17 2698399.21
Others 16363116.20 31905827.81 16363116.20
Total 128793889.30 182190876.85 128793889.30
24766. Income tax expenses
(1) Details of income tax expenses
Item 2025 2024
Current income tax expenses calculated based on tax law
and related regulations 827726887.33 760862227.71
Deferred income tax expenses -241968837.83 -70853564.46
Pillar Two top-up tax 52309897.33 27578315.25
Total 638067946.83 717586978.50
(2) Reconciliation between income tax expenses and accounting profit is as follow:
Item 2025 2024
Profit before income tax 5183461738.16 5393682576.77
Income tax expenses calculated based on applicable tax
rate 777519260.72 809052386.52
Impact of different tax rates applied by subsidiaries -72956827.61 387318903.38
Adjustment of income tax for prior period 8769773.88 11155051.18
Impact of non-taxable income (shown as "-") -469807944.60 -697686731.27
Impact of non-deductible costs expenses and losses 131508919.67 86677764.84
Impact of the opening balance of deferred taxes due to
changes in tax rate -8049053.07 390969.78
Impact of utilizing the deductible temporary differences or
deductible losses for which no deferred tax assets was -25407909.06 -6692431.85
previously recognized (shown as "-")
Tax impact of unrecognized deductible temporary
differences and deductible losses 304789776.25 159739601.09
Tax impact of the super deduction for research and
development expenses (shown as "-") -60607946.68 -59946850.42
Pillar Two top-up tax 52309897.33 27578315.25
Income tax expenses 638067946.83 717586978.50
Note: Under the Pillar Two Model Rules published by the Organization for Economic Co-operation and
Development (OECD) jurisdictions with an effective tax rate below 15% may be subject to top-up tax.Certain jurisdictions in which the Group's overseas operations are located have enacted Pillar Two legislation.Based on information currently available the Group has assessed the potential risk exposure relating to its
financial performance for the current year; however such assessment may not fully reflect actual future
circumstances. Based on the assessment results the Group has provided for Pillar Two tax provisions. As
more jurisdictions are expected to enact Pillar Two legislation the Group will continue to monitor legislative
developments in the jurisdictions in which it operates to evaluate their potential future impact on the financial
statements.
67. Notes to cash flow statement
(1) Cash received from other operating activities
Item 2025 2024
Operating receivables 789110815.26 1103774455.61
Fiscal subsidies 104494822.94 133669192.91
Interest income from deposits 35683675.60 60753434.04
Others 55490894.94 59751180.44
248Item 2025 2024
Total 984780208.74 1357948263.00
(2) Cash paid for other operating activities
Item 2025 2024
Operating payables 915929854.94 1000257249.33
Other expenses 1976243541.42 1625673876.97
Total 2892173396.36 2625931126.30
(3) Cash received from other investing activities
Item 2025 2024
Investment-related deposits 67262597.67 22888411.53
Others 4875041.21 -
Total 72137638.88 22888411.53
(4) Cash paid for other investing activities
Item 2025 2024
Investment-related deposits 100460328.30 62604501.99
Total 100460328.30 62604501.99
(5) Cash received from other financing activities
Item 2025 2024
Deposits related to notes loans and letters of credit 14993666.45 53636350.66
Gains from liquidation of employee shareholding plan 131773231.42 237708366.97
Subscription from shareholding plan - 134174910.78
Total 146766897.87 425519628.41
(6) Cash paid for other financing activities
Item 2025 2024
Deposit for bills loans and letters of credit 40951761.28 60768692.62
Stock repurchase 718668954.27 -
Lease payment 404975935.20 426986597.74
Bank swap settlement - 30308608.00
Payments for acquisition of non-controlling interests 74070254.41 64166195.67
Others 4201886.54 -
Total 1242868791.70 582230094.03
(7) Movements in liabilities arising from financing activities
Movement during 2025
Item Balance as of 2024.12.31
Cash inflow Cash outflow
Short-term loans 251739887.29 4696859764.50 3906821056.39
249Movement during 2025
Item Balance as of 2024.12.31
Cash inflow Cash outflow
Long-term loans 2633816180.65 56941515.16 2461142879.60
Lease liabilities 2362084998.36 - 404975935.20
Bonds payable - 300000000.00 300000000.00
Total 5247641066.30 5053801279.66 7072939871.19
Continued:
Non-cash movement
Item Balance as of
Accrued interest Change in 2025.12.31 fair value Others
Short-term loans 33818482.39 - 88050000.00 1163647077.79
Long-term loans 52083586.26 - 74544200.00 356242602.47
Lease liabilities 98703356.89 - 478843486.82 2534655906.87
Bonds payable - - - -
Total 184605425.54 - 641437686.82 4054545587.13
68. Supplementary information on cash flow statement
(1) Supplement to cash flow statement
Item 2025 2024
1. Reconciliation of net profit to cash flows from
operating activities:
Net profit 4545393791.33 4676095598.27
Add: Provisions for impairment losses 47086754.23 219506218.82
Provisions for credit losses 148718379.10 264471205.52
Depreciation of fixed assets investment properties and
productive biological assets 1900229981.18 1829927864.69
Depreciation of right-of-use assets 419419623.00 380961537.57
Amortization of intangible assets 106737276.90 114057533.24
Amortization of long-term deferred expenses 104432621.52 71719039.97
Losses from disposal of fixed assets intangible assets
and other long-term assets ("-" for gains) 6526439.92 -53544318.29
Losses on scrapping of fixed assets ("-" for gains) 62165070.70 102588018.88
Losses from changes in fair value ("-" for gains) 26991930.86 -25285899.79
Financial expenses ("-" for income) 253809980.20 389102974.87
Losses arising from investments ("-" for gains) 42408720.31 8829799.95
Decrease in deferred tax assets ("-" for increase) -227943789.02 -61317755.75
Increase in deferred tax liabilities ("-" for decrease) -24442036.31 -36289314.74
Decrease in inventories ("-" for increase) 413024881.62 -1088404522.14
Decrease in operating receivables ("-" for increase) -366839770.48 116078238.81
Increase in operating payables ("-" for decrease) -1210294112.43 1026067571.60
Share incentive expenses 12180314.47 46516865.10
Others 771266.12 15174718.47
250Item 2025 2024
Net cash flows from operating activities 6260377323.22 7996255375.05
2. Significant investing and financing activities not
requiring the use of cash:
Conversion of debt into capital - -
Convertible bonds due within one year - -
New right-of-use assets in the current period - -
3. Change in cash and cash equivalents:
Cash at the end of the period 2998575733.57 3326944745.48
Less: Cash at the beginning of the period 3326944745.48 5367248673.44
Add: Cash equivalents at the end of the period - -
Less: Cash equivalents at the beginning of the period - -
Net increase/decrease in cash and cash equivalents -328369011.91 -2040303927.96
(2) Net cash flows from acquisition of subsidiaries during the year
Item 2025
Cash or cash equivalents paid during the current period for business
combinations occurred during the current period 522852834.91
Including: Zhuhai Dehai Biological Technology Co. Ltd. 500000000.00
Zhejiang Lanke Seed Industry Technology Co. Ltd. 5500000.00
PT BIBIT UNGGUL 17352834.91
Less: Cash and cash equivalents held by subsidiaries at the acquisition date 26873703.41
Including: Zhuhai Dehai Biological Technology Co. Ltd. 26319521.35
Zhejiang Lanke Seed Industry Technology Co. Ltd. 344545.58
PT BIBIT UNGGUL 209636.48
Add: Cash or cash equivalents paid during the current period for business
combinations occurred in the prior periods 11381008.58
Including: Xishui Chenke Feed Technology Co. Ltd. 11381008.58
Net cash outflows for acquisition of subsidiaries 507360140.08
(3) Net cash flows from disposal of subsidiaries during the period
Item 2025
Cash or cash equivalents received by the disposed subsidiary during the current period 37688250.55
Including: Maoming Debao Agriculture and Animal Husbandry Co. Ltd. 6619145.55
Feicheng Heruifeng Agricultural Technology Co. Ltd. 31069105.00
Less: Cash and cash equivalents held by the subsidiary on the date of loss of control -
Including: Maoming Debao Agriculture and Animal Husbandry Co. Ltd. -
Feicheng Heruifeng Agricultural Technology Co. Ltd. -
Add: Cash or cash equivalents received during the current period from
disposal of subsidiaries in prior periods -
Net cash inflows from disposal of subsidiaries 37688250.55
(4) Details of cash and cash equivalents
251Item 2025.12.31 2024.12.31
1.Cash 2998575733.57 3326944745.48
Including: Cash on hand 87093.15 187338.98
Digital currency - -
Bank deposits available on demand 2731128422.64 2895639994.35
Other monetary funds available on demand 267360217.78 431117412.15
Cash at central bank available on demand - -
Amounts due from banks - -
Loans to banks - -
2. Cash equivalents - -
Including: Bond investments with a maturity of 3 months or less - -
3. Cash and cash equivalents at the end of the period 2998575733.57 3326944745.48
Including: Restricted cash and cash equivalents held by the
Company or subsidiaries of the Group - -
69. Monetary items in foreign currencies
(1) Monetary items in foreign currencies
Item Balance in foreign Exchange rate Balance translated to currency 2025.12.31 RMB 2025.12.31
Cash and cash equivalents —— —— 1978319695.29
Including: USD 155429671.64 7.0288 1092484075.99
KZT 125146.90 0.0140 1746.80
EGP 555283355.31 0.1473 81789095.69
NGN 5339639550.17 0.0048 25797693.52
TZS 56837408.53 0.0028 161740.40
VND 2569050183711.00 0.0003 687505803.61
IDR 110833111329.00 0.0004 46262192.91
MMK 195482.00 0.0033 654.29
THB 1000.39 0.2225 222.61
LAK 11385503.00 0.0003 3701.84
MYR 4871483.05 1.7319 8437075.54
INR 252780330.99 0.0783 19792162.08
SGD 376585.58 5.4586 2055630.07
HKD 1259306.00 0.9032 1137430.38
EUR 0.27 8.2355 2.22
BDT 226329746.92 0.0570 12890467.34
Notes receivable —— —— 4893667.20
Including: USD 116400.00 7.0288 818152.32
INR 52051412.93 0.0783 4075514.88
Accounts receivable —— —— 1681312431.30
USD 90338516.01 7.0288 634971361.34
EGP 892648486.35 0.1473 131480462.71
252Item Balance in foreign Balance translated to currency 2025.12.31 Exchange rate RMB 2025.12.31
VND 2663536424368.21 0.0003 712791350.44
IDR 403533163996.21 0.0004 168436389.29
MYR 9355937.25 1.7319 16203843.59
INR 222598946.97 0.0783 17429023.93
Other receivables —— —— 162243201.95
USD 21759508.99 7.0288 152943236.77
EGP 12421930.88 0.1473 1829657.75
TZS 9900005.85 0.0028 28172.13
VND 22119918444.92 0.0003 5919531.04
IDR 1387247746.24 0.0004 579042.87
BUK 17028012.89 0.0033 56993.57
LAK 28881719.35 0.0003 9390.50
MYR 55721.00 1.7319 96504.96
INR 8162108.51 0.0783 639075.73
BDT 2486141.78 0.0570 141596.63
Non-current assets due
within one year —— —— 4893537.02
IDR 11723740251.04 0.0004 4893537.02
Long-term receivables —— —— 33584084.76
USD 3881681.10 7.0288 27283560.11
EGP 8585785.38 0.1473 1264622.13
TZS 7904005.51 0.0028 22492.18
VND 2903466462.14 0.0003 776999.25
IDR 4144587200.26 0.0004 1729967.61
LAK 324149541.04 0.0003 105392.83
INR 22199232.22 0.0783 1738152.65
BDT 11639107.62 0.0570 662898.00
Other current assets —— —— 8578438.58
VND 3099035741.00 0.0003 829336.05
IDR 17415100000.00 0.0004 7269132.40
INR 6129886.65 0.0783 479970.13
Short-term loans —— —— 1085877635.42
USD 28000000.00 7.0288 196806400.00
VND 3039644637547.55 0.0003 813442003.75
IDR 143438465238.26 0.0004 59871800.70
INR 201249797.73 0.0783 15757430.97
Accounts payable —— —— 897629768.54
USD 28823311.76 7.0288 202593293.70
EGP 327263021.85 0.1473 48203401.67
NGN 77280643.27 0.0048 373370.21
253Item Balance in foreign Balance translated to currency 2025.12.31 Exchange rate RMB 2025.12.31
VND 1826856694022.62 0.0003 488886743.98
IDR 211141007102.22 0.0004 88131117.93
BUK 9000006.40 0.0033 30123.45
THB 194438.86 0.2225 43266.32
LAK 1851614.38 0.0003 602.03
MYR 607417.15 1.7319 1052004.97
INR 289192010.57 0.0783 22643119.13
BDT 801917886.82 0.0570 45672725.15
Employee benefits payable —— —— 278879735.76
USD 16435648.63 7.0288 115522887.10
EGP 36387863.26 0.1473 5359660.80
NGN 16874369.36 0.0048 81526.07
TZS 6112658.11 0.0028 17394.60
VND 485823275879.63 0.0003 130011598.76
IDR 27988886579.00 0.0004 11682675.48
BUK 12010247.54 0.0033 40198.87
THB 52532.53 0.2225 11689.48
LAK 844498.80 0.0003 274.58
MYR 527507.36 1.7319 913606.68
INR 113130271.24 0.0783 8857859.54
BDT 112025893.79 0.0570 6380363.80
Taxes payable —— —— 137366581.93
USD 943948.82 7.0288 6634827.46
EGP 207992974.16 0.1473 30635813.42
NGN 49327443.49 0.0048 238318.39
TZS 99600.07 0.0028 283.43
VND 324408106196.18 0.0003 86815141.71
IDR 25253927615.61 0.0004 10541092.43
BUK 3181637.26 0.0033 10649.09
MYR 471230.19 1.7319 816138.47
INR 1607963.15 0.0783 125900.09
BDT 27186983.99 0.0570 1548417.44
Other payables —— —— 641734531.99
USD 88780510.61 7.0288 624020452.97
EGP 3371099.58 0.1473 496537.82
NGN 2677160.00 0.0048 12934.31
TZS 3956136.11 0.0028 11257.85
VND 37578332544.64 0.0003 10056370.98
IDR 4250532404.22 0.0004 1774189.57
254Item Balance in foreign currency 2025.12.31 Exchange rate
Balance translated to
RMB 2025.12.31
BUK 640537666.03 0.0033 2143910.07
THB 655213.70 0.2225 145797.44
LAK 276460258.87 0.0003 89887.31
MYR 11258.81 1.7319 19499.49
INR 34997306.54 0.0783 2740214.64
BDT 3923835.06 0.0570 223479.54
Non-current liabilities due
within one year —— —— 54508127.57
VND 203442666664.00 0.0003 54508127.57
Long-term loans —— —— 27221774.50
VND 101721333338.00 0.0003 27221774.50
(2) Overseas operating entities
Name Functional Principal place Basis for selecting the currency of business functional currency
KINGHILL HOLDINGS PTE.LTD. USD Singapore Primary local currency
KINGHILL PTE.LTD. USD Singapore Primary local currency
Haid Egypt Co. Ltd. EGP Egypt Primary local currency
Haid Egypt Aquatic Co. Ltd EGP Egypt Primary local currency
HAIDA AGRICULTURAL AND
TECHNOLOGY NIGERIA LIMITED NGN Nigeria Primary local currency
Haid 3 Egypt Technology Co Ltd EGP Egypt Primary local currency
HAI HANG International Trade Nigeria
Co. Ltd. NGN Nigeria Primary local currency
Tanzania Haid Company Limited TZS Tanzania Primary local currency
KINGHILL RESOURCES PTE.LTD. USD Singapore Primary local currency
VINH LONG HAILIANKE
BIOTECHNOLOGY CO. LTD VND Vietnam Primary local currency
KINGHILL AGRI PTE.LTD. USD Singapore Primary local currency
PT.HAIDA AGRICULTURE
INDONESIA IDR Indonesia Primary local currency
PT.HAIDA SURABAYA TRADING IDR Indonesia Primary local currency
PT HISENOR TECHNOLOGY
INDONESIA IDR Indonesia Primary local currency
HAID FEED BANGLADESH
LIMITED BDT Bangladesh Primary local currency
PT HAIDA BIOTECHNOLOGY
INDONESIA IDR Indonesia Primary local currency
Dachuan Biotechnology Co. Ltd. BDT Bangladesh Primary local currency
PT HISENOR GENETICS
INDONESIA IDR Indonesia Primary local currency
PT.HAILIANK TECHNOLOGY
INDONESIA IDR Indonesia Primary local currency
255Name Functional Principal place Basis for selecting the currency of business functional currency
HAID AGRICULTURAL
TECHNOLOGY MYANMAR MMK Myanmar Primary local currency
COMPANY LIMITED
Haid technology (Thailand) Co. LTD THB Thailand Primary local currency
LAOS HAID COMPANY LIMITED LAK Laos Primary local currency
PT Ocean Dragon Indonesia IDR Indonesia Primary local currency
Hisenor Aquatic Seed Industry
Technology Pte.Ltd. USD Singapore Primary local currency
HISENOR (ECUADOR) CIA. LTDA. USD Ecuador Primary local currency
HISENOR BIO TECH (M) SDN. BHD. MYR Malaysia Primary local currency
PT BIBIT UNGGUL IDR Indonesia Primary local currency
KINGHILL INVESTMENT
(SINGAPORE) PTE.LTD. USD Singapore Primary local currency
KINGHILL INTERNATIONAL
(SINGAPORE) PTE.LTD. USD Singapore Primary local currency
PT. APEX POULTRY BREEDING IDR Indonesia Primary local currency
HAID DO BRASIL LTDA BRL Brazil Primary local currency
HAID INTERNATIONAL
(SINGAPORE) PTE. LTD. USD Singapore Primary local currency
Haid International Group Limited USD Hong Kong China Primary local currency
China Haida Feed Group(HK)Limited USD Hong Kong China Primary local currency
Rickworth Investments Limited USD Hong Kong China Primary local currency
Hong Kong Longreat Trading Co.Limited USD
Hong Kong
China Primary local currency
HAID FEED COMPANY LIMITED VND Vietnam Primary local currency
DONG NAI HAID FARM COMPANY
LIMITED VND Vietnam Primary local currency
Haid International Holdings Limited USD Singapore Primary local currency
Haidea Holdings Pte.Ltd. USD Singapore Primary local currency
LANKING RICKWORTH PTE.LTD. USD Singapore Primary local currency
HAIDMARINO CIA.LTDA. USD Ecuador Primary local currency
HAID BIOTECHNOLOGY
INDUSTRY (SINGAPORE) PTE. LTD. USD Singapore Primary local currency
PANASIA TRADING RESOURCES
LIMITED USD
Hong Kong
China Primary local currency
SHENG LONG INTERNATIONAL Hong Kong
LTD. USD China Primary local currency
SHENG LONG BIO-TECH
INTERNATIONAL CO. LTD VND Vietnam Primary local currency
SHENG LONG BIOTECH (HAI
DUONG) INTERNATIONAL CO. VND Vietnam Primary local currency
LTD
SHENG LONG BIO-TECH(TIEN
GIANG) INTERNATIONAL CO. LTD VND Vietnam Primary local currency
256Name Functional Principal place Basis for selecting the currency of business functional currency
LONG SHENG INTERNATIONAL
CO. LTD. VND Vietnam Primary local currency
Long Sheng International (Suoi Dau)
Co. Ltd VND Vietnam Primary local currency
Hisenor International Limited USD Hong Kong China Primary local currency
KEMBANG SUBUR
INTERNATIONAL LTD. MYR Malaysia Primary local currency
NAMDUONG VIETNAM AQUATIC
HATCHERY CO. LTD. VND Vietnam Primary local currency
SHENG LONG BIO
TECH(M)SDN.BHD. MYR Malaysia Primary local currency
SHENG LONG AQUA
TECHNOLOGY (M) SDN. BHD. MYR Malaysia Primary local currency
THANG LONG(VINH
LONG)BIOTECH CO. LTD. VND Vietnam Primary local currency
Haihua Bio-Tech(Hong Kong) USD Hong Kong Limited China Primary local currency
HISTARRY INTERNATIONAL PTE.LTD. USD Singapore Primary local currency
Haid International Biofarms Pte.Ltd. USD Singapore Primary local currency
LANKING PTE.LTD. USD Singapore Primary local currency
Haid Lanking International Trading Inc. USD United States of America Primary local currency
LANKING NEMO(SG) PTE.LTD. USD Singapore Primary local currency
SHENGLONG BIO-
TECH(INDIA)PRIVATE LIMITED INR India Primary local currency
Lanking Nano PTE.LTD. USD Singapore Primary local currency
HAI DUONG HAID COMPANY
LIMITED VND Vietnam Primary local currency
HAI DAI COMPANY LIMITED VND Vietnam Primary local currency
VINH LONG HAI DAI CO. LTD. VND Vietnam Primary local currency
BINH DINH HAI LONG CO. LTD. VND Vietnam Primary local currency
HISTAR VIETNAM AQUATIC
BREEDING COMPANY LIMITED VND Vietnam Primary local currency
BINH PHUOC HAI LONG
COMPANY LIMITED VND Vietnam Primary local currency
MEKONG HAI LONG COMPANY
LIMITED VND Vietnam Primary local currency
CAMBODIAN HAIDA
AGRICULTURE AND ANIMAL
HUSBANDRY TECHNOLOGY CO. USD Cambodia Primary local currency
LTD.HAID GROUP HAIDING
AGRICULTURE AND ANIMAL
HUSBANDRY KAZAKHSTAN CO. KZT Kazakhstan Primary local currency
Ltd.HAID (ECUADOR) FEED CIA.LTDA. USD Ecuador Primary local currency
70. Leases
257(1) As lessee
Item 2025
Short-term lease expenses 115940874.96
Low-value lease expenses 623302.46
Total 116564177.42
(2) As leaser
Operating lease
Rental income
Item 2025
Rental income 31991832.76
Including: Income from variable lease payments not included in lease receivables -
VI. Research and Development Expenditure
(1) Research and development expenditure
20252024
Item
Expensed Capitalized Expensed Capitalized
Employee compensation 571971737.82 22294045.94 516985822.23 36411137.69
Materials expenses 136521354.95 7515152.57 132958662.05 6476435.87
Travel expenses 52337408.17 2008915.78 49694045.24 2430342.63
Office expenses 124028325.31 4528727.23 118220504.75 5058703.57
Training and consulting service fee 39628967.75 1432693.81 25832956.18 1198259.69
Expense on R&D entrusted to
external parties 2349575.89 126415.09 6889081.01 -
Equity incentive expenses 5984587.66 - 5524933.68 128442.07
Other expenses 573294.01 15827.79 3929310.20 72840.06
Total 933395251.56 37921778.21 860035315.34 51776161.58
258(2) Development costs
Additions during the period Decreases during the period
Item 2024.12.31 Internal Recognized as 2025.12.31
development costs Others intangible
Recorded in
assets profit or loss
Development of animal health products and healthy breeding model 35384251.72 17786124.06 - 6583566.44 13646045.32 32940764.02
Development of family selection and breeding technology 6710.97 12090559.53 - - 6710.97 12090559.53
Application and development of feed formulation technology 10448244.16 7889554.04 - 4897846.32 532733.75 12907218.13
Application and development of feed additives 743581.89 155540.58 - 4243.00 489444.55 405434.92
Total 46582788.74 37921778.21 - 11485655.76 14674934.59 58343976.60
Note: The Group has no significant capitalized research and development projects during the current period.VII. Interests in Other Entities
1. Interests in subsidiaries
(1) Structure of the Group
In addition to the subsidiaries listed below the Company also has 405 indirectly controlled subsidiaries mainly distributed in 26 provinces and cities in China as well as
Southeast Asia Egypt and other countries etc. They are primarily engaged in feed production breeding etc.Subsidiary Registered capital Principal place Place of
Shareholding %
(in RMB10000) of business registration Business nature Acquisition method Direct Indirect
Guangzhou Runchuan Guangzhou Guangzhou Business combination
Investment Co. Ltd. 147000.00 Guangdong Guangdong Investment 100.00 involving entities under common control
Guangzhou Haiwei Feed Co. Guangzhou Guangzhou Production and Business combination
Ltd. 1170.00 Guangdong Guangdong sales 100.00 involving entities under common control
Guangzhou Rongchuan Feed Guangzhou Guangzhou Business combination
Co. Ltd. 1310.00 Guangdong Guangdong Sales 100.00 involving entities under common control
259Subsidiary Registered capital Principal place Place of
Shareholding %
(in RMB10000) of business registration Business nature Acquisition method Direct Indirect
Foshan Foshan Production and Business combination Foshan Haihang Feed Co. Ltd. 1000.00 Guangdong Guangdong sales 87.50 involving entities not under common control
Guangzhou Dachuan Feed Co. 1000.00 Guangzhou Guangzhou Production and
Business combination
Ltd. Guangdong Guangdong sales 100.00 involving entities under common control
Business combination
Hubei Haid Feed Co. Ltd. 2000.00 Wuhan Hubei Wuhan Hubei Production and sales 100.00 involving entities under common control
Guangdong Hinter Guangzhou Guangzhou Production and
Biotechnology Group Co. Ltd. 8000.00 Guangdong Guangdong sales 97.00 3.00 Establishment
Shaanxi Haid Agriculture and
Animal Husbandry Co. Ltd. 2000.00
Yangling Yangling Production and
Shaanxi Shaanxi sales 67.00 Establishment
Hunan Haid Biological Feed Co.Ltd. 1500.00 Changde Hunan Changde Hunan
Production and
sales 100.00 Establishment
Guangzhou Haihe Feed Co. Ltd. 10764.24 Guangzhou Guangzhou Guangdong Guangdong Sales 100.00 Establishment
Foshan Haipu Feed Co. Ltd. 300.00 Foshan Foshan Guangdong Guangdong Sales 87.50 Establishment
Qingyuan Haibei Biotechnology 10000.00 Qingyuan Qingyuan Production and Co. Ltd. Guangdong Guangdong sales 100.00 Establishment
Zhanjiang Haid Feed Co. Ltd. 1300.00 Zhanjiang Zhanjiang Production and Guangdong Guangdong sales 100.00 Establishment
Jiangmen Haid Feed Co. Ltd. 8000.00 Jiangmen Jiangmen Production and Guangdong Guangdong sales 100.00 Establishment
Chengdu Haid Biotechnology
Co. Ltd. 1300.00 Xinjin Sichuan Xinjin Sichuan
Production and
sales 100.00 Establishment
Taizhou Haid Biological Feed
Co. Ltd. 1660.00 Xinghua Jiangsu
Xinghua Production and
Jiangsu sales 100.00 Establishment
Jingzhou Haid Feed Co. Ltd. 1000.00 Jingzhou Hubei Jingzhou Hubei Production and sales 100.00 Establishment
Business combination
Dongguan Haid Feed Co. Ltd. 1000.00 Dongguan Dongguan Production and Guangdong Guangdong sales 100.00 involving entities not under common control
260Registered capital Principal place Place of Shareholding % Subsidiary (in RMB10000) of business registration Business nature Acquisition method Direct Indirect
Fujian Haid Feed Co. Ltd. 1000.00 Changtai Fujian Changtai Fujian Production and sales 100.00 Establishment
Zhejiang Haid Feed Co. Ltd. 1000.00 Shaoxing Shaoxing Production and Zhejiang Zhejiang sales 100.00 Establishment
Guangxi Haid Feed Co. Ltd. 2000.00 Qinzhou Qinzhou Production and Guangxi Guangxi sales 100.00 Establishment
KINGHILL HOLDINGS USD
PTE.LTD. 5234.01 Singapore Singapore Investment 100.00 Establishment
Jiangxi Haid Feed Co. Ltd. 7370.00 Nanchang Nanchang Production and Jiangxi Jiangxi sales 100.00 Establishment
Business combination
Guangzhou Haid Feed Co. Ltd. 1000.00 Guangzhou Guangzhou Guangdong Guangdong Trading 100.00 involving entities not under common control
Maoming Hailong Feed Co. Ltd. 1000.00 Maoming Maoming Production and Guangdong Guangdong sales 100.00 Establishment
Nanchang Haid Biotechnology 300.00 Nanchang Nanchang Production and Co. Ltd. Jiangxi Jiangxi sales 100.00 Establishment
Zhuhai Rongchuan Feed Co. 3000.00 Zhuhai Zhuhai Production and Ltd. Guangdong Guangdong sales 100.00 Establishment
Foshan Sanshui Fanling Feed 200.00 Foshan Foshan Production and
Business combination
Co. Ltd. Guangdong Guangdong sales 100.00 involving entities not under common control
Dalian Haid Rongchuan Trading Business combination
Co. Ltd. 5000.00 Dalian Liaoning Dalian Liaoning Trading 100.00 involving entities not under common control
Haid International Group USD Hong Kong British Virgin
Limited 3837.00 China Islands Trading 100.00 Establishment
Changzhou Haid Biological Feed
Co. Ltd. 2000.00 Liyang Jiangsu Liyang Jiangsu
Production and
sales 100.00 Establishment
Tianjin Haid Feed Co. Ltd. 15000.00 Tianjin Tianjin Production and sales 97.00 3.00 Establishment
Jiangmen Xinhui Aote Animal Business combination
Feed Co. Ltd. 250.00
Jiangmen Jiangmen Production and
Guangdong Guangdong sales 80.00 involving entities not under common control
261Subsidiary Registered capital Principal place Place of
Shareholding %
(in RMB10000) of business registration Business nature Acquisition method Direct Indirect
Tianmen Haid Feed Co. Ltd. 500.00 Tianmen Hubei Tianmen Hubei Production and sales 100.00 Establishment
Zhuhai Hailong Biotechnology 1000.00 Zhuhai Zhuhai Production and Co. Ltd. Guangdong Guangdong sales 100.00 Establishment
Yangjiang Haid Feed Co. Ltd. 500.00 Yangjiang Yangjiang Production and Guangdong Guangdong sales 100.00 Establishment
Guigang Haid Feed Co. Ltd. 500.00 Guigang Guigang Production and Guangxi Guangxi sales 100.00 Establishment
Yiyang Haid Feed Co. Ltd. 1000.00 Yiyang Hunan Yiyang Hunan Production and sales 99.00 1.00 Establishment
Nantong Haid Biotechnology
Co. Ltd. 10000.00 Nantong Jiangsu
Nantong Production and
Jiangsu sales 100.00 Establishment
Yunnan Haid Biotechnology Co. 500.00 Kunming Kunming Production and Ltd. Yunnan Yunnan sales 100.00 Establishment
Guangdong Mutai Biotechnology
Co. Ltd. 500.00
Zhuhai Zhuhai Production and
Guangdong Guangdong sales 100.00 Establishment
Zhaoqing Haid Feed Co. Ltd. 500.00 Gaoyao Gaoyao Production and Guangdong Guangdong sales 100.00 Establishment
Wuhan Shuijiyuan Production and
Biotechnology Co. Ltd. 500.00 Ezhou Hubei Ezhou Hubei sales 100.00 Establishment
Shenzhen Longreat Trading Co. 200.00 Shenzhen Shenzhen Ltd. Guangdong Guangdong Trading 70.00 Establishment
LANKING PTE.LTD. USD 9232.16 Singapore Singapore Trading 100.00 Establishment
Hunan Dongting Haid Feed Co. 2000.00 Dongting Hunan Dongting Production and Ltd. Hunan sales 100.00 Establishment
Zhangzhou Haid Feed Co. Ltd. 2000.00 Zhangzhou Zhangzhou Production and Fujian Fujian sales 85.00 Establishment
Anhui Haid Feed Co. Ltd. 1000.00 Chizhou Anhui Chizhou Anhui Production and sales 100.00 Establishment
Xiangtan Haid Feed Co. Ltd. 2000.00 Xiangtan Hunan Xiangtan Hunan Production and sales 100.00 Establishment
Guangzhou Changsheng Guangzhou Guangzhou
Logistics Co. Ltd. 1000.00 Guangdong Guangdong Logistics service 100.00 Establishment
262Subsidiary Registered capital Principal place Place of
Shareholding %
(in RMB10000) of business registration Business nature Acquisition method Direct Indirect
Guangdong Haid Pet Co. Ltd. 1000.00 Guangzhou Guangzhou Guangdong Guangdong Investment 100.00 Establishment
Shandong Haiding Agriculture Investment and
and Animal Husbandry Co. Ltd. 10000.00 Heze Shandong Heze Shandong trading 55.00 Establishment
Xishui Haid Feed Co. Ltd. 300.00 Huanggang Huanggang Production and Hubei Hubei sales 100.00 Establishment
Yancheng Haid Biological Feed 3000.00 Yancheng Yancheng Production and Co. Ltd. Jiangsu Jiangsu sales 100.00 Establishment
Honghu Haid Feed Co. Ltd. 700.00 Honghu Hubei Honghu Hubei Production and sales 100.00 Establishment
Business combination
Kaifeng Haid Feed Co. Ltd. 2000.00 Kaifeng Henan Kaifeng Henan Production and sales 100.00 involving entities not under common control
Guangzhou Heshengtang Guangzhou Guangzhou Production and Business combination
Biotechnology Co. Ltd. 1000.00 Guangdong Guangdong sales 100.00 involving entities not under common control
Guangzhou Heshengtang Business combination
Animals Pharmaceutical Co. 6000.00 Guangzhou Guangzhou Production and Guangdong Guangdong sales 100.00 involving entities not under Ltd. common control
Guangdong Hairui Guangzhou Guangzhou Research and Business combination
Biotechnology Co. Ltd. (Note1) 10000.00 Guangdong Guangdong trading 100.00 involving entities not under common control
Henan Haihe Agriculture and
Animal Husbandry Technology 1000.00 Luoyang Henan Luoyang Henan Production and
Co. Ltd. sales
67.00 Establishment
Suqian Haid Feed Co. Ltd. 2000.00 Siyang Jiangsu Siyang Jiangsu Production and sales 100.00 Establishment
Huaihua Haid Feed Co. Ltd. 1300.00 Huaihua Hunan Huaihua Hunan Production and sales 100.00 Establishment
Guangdong Hairuite Supply Zhuhai Zhuhai
Chain Management Co. Ltd. 1000.00 Guangdong Guangdong sales 100.00 Establishment
Hunan Innovation Biotechnology Business combination
Co. Ltd. 8088.00
Hengyang Hengyang Production and
Hunan Hunan sales 100.00 involving entities not under common control
263Registered capital Principal place Place of Shareholding % Subsidiary (in RMB10000) of business registration Business nature Acquisition method Direct Indirect
Qingyuan Haid Biotechnology 1000.00 Qingyuan Qingyuan Production and Co. Ltd. Guangdong Guangdong sales 100.00 Establishment
Xuancheng Haid Biotechnology 500.00 Xuancheng Xuancheng Production and Co. Ltd. Anhui Anhui sales 100.00 Establishment
Guangdong Shunde Haid Shunde Shunde
Biotechnology Co. Ltd. 500.00 Guangdong Guangdong sales 100.00 Establishment
Jiaxing Haid Yongwang Jiaxing Production and Business combination
Biological Feed Co. Ltd. 1800.00 Jiaxing Zhejiang Zhejiang sales 80.00 involving entities not under common control
Shijiazhuang Vike Biotechnology 1000.00 Jinzhou Hebei Jinzhou Hebei Production and
Business combination
Co. Ltd. sales 70.00 involving entities not under common control
Chongqing Haid Feed Co. Ltd. 2500.00 Chongqing Chongqing Production and sales 100.00 Establishment
Shenyang Haid Feed Co. Ltd. 300.00 Shenyang Shenyang Production and Liaoning Liaoning sales 85.00 Establishment
Jiangsu Haihe Agriculture and
Animal Husbandry Co. Ltd. 1000.00 Xuzhou Jiangsu Xuzhou Jiangsu sales 67.00 Establishment
Anshan Dachuan Feed Anshan Anshan
Technology Co. Ltd. 500.00 Liaoning Liaoning sales 100.00 Establishment
Guangzhou Haiyuan Commercial
Factoring Co. Ltd. 15000.00
Guangzhou Guangzhou Commercial
Guangdong Guangdong factoring 100.00 Establishment
Haid Pet Food Co. Ltd. 18000.00 Weihai Weihai Shandong Shandong sales 100.00 Establishment
Ganzhou Haid Biotechnology 5000.00 Ganzhou Jiangxi Ganzhou Production and Co. Ltd. Jiangxi sales 100.00 Establishment
Guangzhou Punong Investment
Management Co. Ltd. 460.00
Guangzhou Guangzhou
Guangdong Guangdong Investment 100.00 Establishment
Guangzhou Yuannong
Investment Management Co. 1975.81 Guangzhou Guangzhou
Ltd. Guangdong Guangdong
Investment 100.00 Establishment
Business combination
Liyang Jiuhe Feed Co. Ltd. 880.00 Liyang Jiangsu Liyang Jiangsu Production and sales 80.00 involving entities not under common control
264Registered capital Principal place Place of Shareholding % Subsidiary (in RMB10000) of business registration Business nature Acquisition method Direct Indirect
Shaoguan Haid Biotechnology Shaoguan Shaoguan Production and
Co. Ltd. 1500.00 Guangdong Guangdong sales 100.00 Establishment
Qingdao Qingdao Investment and Business combination Shandong Daxin Group Co. Ltd. 5204.00 Shandong Shandong trading 90.00 involving entities not under common control
Huai’an Hailong Feed Co. Ltd. 5000.00 Huai’an Jiangsu Huai’an Jiangsu Production and sales 100.00 Establishment
Hunan Jinhuilong Technology Investment Business combination
Co. Ltd. 10000.00 Yueyang Hunan Yueyang Hunan production and 51.00 involving entities not under sales common control
Fuzhou Haid Feed Co. Ltd. 15500.00 Fuzhou Fujian Fuzhou Fujian Production and sales 100.00 Establishment
Zhaoqing Gaoyao Haid 8000.00 Zhaoqing Zhaoqing Production and Biotechnology Co. Ltd. Guangdong Guangdong sales 100.00 Establishment
Nanning Haid Biotechnology 12000.00 Nanning Nanning Production and Co. Ltd. Guangxi Guangxi sales 100.00 Establishment
Guangzhou Haiyuan
Microfinance Co. Ltd. 20000.00
Guangzhou Guangzhou Micro finance
Guangdong Guangdong service 100.00 Establishment
Jiangmen Rongchuan Feed Co. 37500.00 Jiangmen Jiangmen Production and Ltd. Guangdong Guangdong sales 100.00 Establishment
Chongqing Kaizhou Haid
Biotechnology Co. Ltd. 3500.00 Chongqing Chongqing sales 100.00 Establishment
Meizhou Haid Biotechnology 9000.00 Meizhou Meizhou Production and Co. Ltd. Guangdong Guangdong sales 70.00 Establishment
Yicheng Haid Biotechnology 4500.00 Xiangyang Xiangyang Production and Co. Ltd. Hubei Hubei sales 100.00 Establishment
Zhuhai Dachuan Biotechnology Zhuhai Zhuhai Production and
Co. Ltd. 4800.00 Guangdong Guangdong sales 100.00 Establishment
Hexian Haid Biotechnology Co. 26000.00 Ma’anshan Ma’anshan Research and Ltd. Anhui Anhui trading 100.00 Establishment
Guangzhou Nansha Haid 10000.00 Guangzhou Guangzhou Production and Technology Co. Ltd. Guangdong Guangdong sales 100.00 Establishment
Tianjin Rongchuan Feed Co.Ltd. 23170.00 Tianjin Tianjin
Production and
sales 70.00 Establishment
265Subsidiary Registered capital Principal place Place of
Shareholding %
(in RMB10000) of business registration Business nature Acquisition method Direct Indirect
Zhanjiang Rongda Feed Co. Ltd. 4000.00 Zhanjiang Zhanjiang Guangdong Guangdong sales 100.00 Establishment
Huainan Haid Biological Feed
Co. Ltd. 12900.00 Huainan Anhui Huainan Anhui
Production and
sales 100.00 Establishment
Maoming Haid Biotechnology
Co. Ltd. 6000.00
Maoming Maoming
Guangdong Guangdong sales 100.00 Establishment
Guangzhou Ronghai Breeding 80000.00 Guangzhou Guangzhou Technology Co. Ltd. Guangdong Guangdong Investment 100.00 Establishment
Sichuan Rongchuan Feed Co. 12000.00 Meishan Meishan Production and Ltd. Sichuan Sichuan sales 100.00 Establishment
Yulin Haid Feed Co. Ltd. 9500.00 Yulin Guangxi Yulin Guangxi Production and sales 100.00 Establishment
Sichuan Haile Agriculture and Chengdu Chengdu Investment and
Animal Husbandry Co. Ltd. 3000.00 Sichuan Sichuan sales 55.00 Establishment
Qingyuan Ronghai Food Business combination
Technology Co. Ltd. 7100.00
Qingyuan Qingyuan Production and
Guangdong Guangdong sales 100.00 involving entities not under common control
Guangzhou Haiyin Financing
Guarantee Co. Ltd. 25000.00
Guangzhou Guangzhou Financing
Guangdong Guangdong guarantee 100.00 Establishment
Qinzhou Hailong Feed Co. Ltd. 4000.00 Qinzhou Qinzhou Production and Guangxi Guangxi sales 100.00 Establishment
Hainan Haid Biotechnology Co. 15000.00 Wenchang Wenchang Production and Ltd. Hainan Hainan sales 100.00 Establishment
Liuzhou Haid Feed Co. Ltd. 500.00 Liuzhou Liuzhou Production and Guangxi Guangxi sales 100.00 Establishment
Jiangsu Haixin Biotechnology Business combination
Co. Ltd. 3000.00 Huai’an Jiangsu Huai’an Jiangsu
Production and
sales 100.00 involving entities not under common control
Gaoan Haid Biotechnology Co.Ltd. 4000.00 Yichun Jiangxi Yichun Jiangxi
Production and
sales 100.00 Establishment
Shanggao Haid Biotechnology
Co. Ltd. 2500.00
Shanggao Shanggao Production and
Jiangxi Jiangxi sales 100.00 Establishment
Qingyuan Hailong Qingyuan Qingyuan Production and
Biotechnology Co. Ltd. 13000.00 Guangdong Guangdong sales 100.00 Establishment
266Registered capital Principal place Place of Shareholding % Subsidiary (in RMB10000) of business registration Business nature Acquisition method Direct Indirect
Guangdong Haid International Guangzhou Guangzhou
Trade Co. Ltd. 10000.00 Guangdong Guangdong Trading 100.00 Establishment
Guangzhou Nansha Haid 700.00 Guangzhou Guangzhou Production and Biotechnology Co. Ltd. Guangdong Guangdong sales 100.00 Establishment
Yancheng Haiwei Biotechnology 6000.00 Yancheng Yancheng Production and Co. Ltd. Jiangsu Jiangsu sales 100.00 Establishment
Hainan Haid Aquatic Seed 4500.00 Wenchang Wenchang Production and Industry Development Co. Ltd. Hainan Hainan sales 100.00 Establishment
Wuzhou Haid Biotechnology
Co. Ltd. 2500.00
Wuzhou Wuzhou Production and
Guangxi Guangxi sales 100.00 Establishment
Zhangzhou Haiheng Feed Co.Ltd. 500.00
Zhangzhou Zhangzhou Production and
Fujian Fujian sales 100.00 Establishment
Deyang Dachuan Agriculture and
Animal Husbandry Technology 11000.00 Deyang Sichuan Deyang Sichuan Production and
Co. Ltd. sales
100.00 Establishment
Mianyang Hailong Feed Co.Ltd. 500.00
Mianyang Mianyang Production and
Sichuan Sichuan sales 70.00 16.50 Establishment
Guangzhou Nongzhidao Feed
Co. Ltd. 1000.00
Guangzhou Guangzhou Production and
Guangdong Guangdong sales 60.00 Establishment
Jiesou Haid Feed Co. Ltd. 1500.00 Fuyang Anhui Fuyang Anhui Production and sales 100.00 Establishment
Anlu Haid Feed Co. Ltd. 2000.00 Xiaogan Hubei Xiaogan Hubei Production and sales 100.00 Establishment
Jingzhou Haihe Biotechnology
Co. Ltd. 4000.00 Jingzhou Hubei Jingzhou Hubei
Production and
sales 100.00 Establishment
Hainan Zhuangmei Agriculture Danzhou Production and Business combination
and Animal Husbandry Co. Ltd. 4000.00 Danzhou Hainan Hainan sales 100.00 involving entities not under common control
Yancheng Runchuan Agricultural
Technology Co. Ltd. 100.00
Yancheng Yancheng Production and
Jiangsu Jiangsu sales 100.00 Establishment
Zigong Hailong Biotechnology
Co. Ltd. 9000.00 Zigong Sichuan Zigong Sichuan
Production and
sales 100.00 Establishment
267Registered capital Principal place Place of Shareholding % Subsidiary (in RMB10000) of business registration Business nature Acquisition method Direct Indirect
Jiangxi Jiabo Biological Business combination
Engineering Co. Ltd. 8000.00 Jiujiang Jiangxi Jiujiang Jiangxi
Production and
sales 60.00 involving entities not under common control
Guangxi Rongchuan Feed Co. 500.00 Nanning Nanning Production and Ltd. Guangxi Guangxi sales 100.00 Establishment
Dali Haid Biotechnology Co.Ltd. 9000.00 Dali Yunnan Dali Yunnan
Production and
sales 100.00 Establishment
Guangzhou Haid Technology 1310.00 Guangzhou Guangzhou Production and Development Co. Ltd. Guangdong Guangdong sales 100.00 Establishment
Ganzhou Lianduoli Feed Ganzhou Production and Business combination
Technology Co. Ltd. 2000.00 Ganzhou Jiangxi Jiangxi sales 70.00 involving entities not under common control
Maoming Haiwei Feed Co. Ltd. 1000.00 Maoming Maoming Production and Guangdong Guangdong sales 70.00 Establishment
Qinzhou Haiwei Feed Co. Ltd. 3500.00 Qinzhou Qinzhou Production and Guangxi Guangxi sales 100.00 Establishment
Yancheng Rongchuan
Biotechnology Co. Ltd. 19500.00
Yancheng Yancheng Production and
Jiangsu Jiangsu sales 100.00 Establishment
Nanning Dachuan Biotechnology Nanning Nanning Production and
Co. Ltd. 900.00 Guangxi Guangxi sales 100.00 Establishment
Yongzhou Haid Biotechnology
Co. Ltd. 500.00
Yongzhou Yongzhou Production and
Hunan Hunan sales 100.00 Establishment
Guiyang Haid Biotechnology 5000.00 Guiyang Guiyang Production and Co. Ltd. Guizhou Guizhou sales 100.00 Establishment
Wuwei Haimu Biotechnology
Co. Ltd. 8500.00 Wuwei Gansu Wuwei Gansu
Production and
sales 100.00 Establishment
Guilin Haid Biotechnology Co.Ltd. 500.00 Guilin Guangxi Guilin Guangxi
Production and
sales 100.00 Establishment
Inner Mongolia Haid Feed Co. 7000.00 Bayannur Inner Bayannur Inner Production and Ltd. Mongolia Mongolia sales 100.00 Establishment
Guiyang Dachuan Biotechnology 500.00 Guiyang Guiyang Production and Co. Ltd. Guizhou Guizhou sales 100.00 Establishment
Xingtai Haid Biotechnology Co.Ltd. 10000.00 Xingtai Hebei Xingtai Hebei
Production and
sales 100.00 Establishment
268Subsidiary Registered capital Principal place Place of
Shareholding %
(in RMB10000) of business registration Business nature Acquisition method Direct Indirect
Guangdong Haifulai 5000.00 Guangzhou Guangzhou Research and Biotechnology Co. Ltd. Guangdong Guangdong sales 100.00 Establishment
Liupanshui Haid Biotechnology 4000.00 Liupanshui Liupanshui Production and Co. Ltd. Guizhou Guizhou sales 100.00 Establishment
Guangdong Haiqi Investment
Co. Ltd. 7000.00
Guangzhou Guangzhou
Guangdong Guangdong Investment 100.00 Establishment
Nanning Haililai Biotechnology 1000.00 Nanning Nanning Production and Co. Ltd. Guangxi Guangxi sales 70.00 Establishment
Shaoyang Haid Feed Co. Ltd. 1000.00 Shaoyang Shaoyang Production and Hunan Hunan sales 100.00 Establishment
Foshan Debao Biological Group 9073.75 Foshan Foshan Production and
Business combination
Co. Ltd. Guangdong Guangdong sales 100.00 involving entities not under common control
Shaoguan Dachuan
Biotechnology Co. Ltd. 500.00
Shaoguan Shaoguan Production and
Guangdong Guangdong sales 100.00 Establishment
Liaoning Haid Biotechnology 6500.00 Shenyang Shenyang Production and Co. Ltd. Liaoning Liaoning sales 100.00 Establishment
Guizhou Hailongwang 50.00 Qiannan Qiannan Biotechnology Co. Ltd. Guizhou Guizhou sales 100.00 Establishment
Guangdong Huashite Testing 200.00 Guangzhou Guangzhou Research and Technology Co. Ltd. Guangdong Guangdong sales 100.00 Establishment
Tianjin Haid Biotechnology Co.Ltd. 1000.00 Tianjin Tianjin
Production and
sales 100.00 Establishment
Dali Dachuan Biotechnology
Co. Ltd. 8000.00 Dali Yunnan Dali Yunnan
Production and
sales 100.00 Establishment
Yunnan Hairui Biotechnology
Co. Ltd. 3500.00 Qujing Yunnan Qujing Yunnan
Production and
sales 100.00 Establishment
Henan Haid Jiuzhou 1000.00 Zhumadian Zhumadian Production and Biotechnology Co. Ltd. Henan Henan sales 75.00 Establishment
Enshi Haid Biotechnology Co. 5000.00 Enshi Hubei Enshi Hubei Production and Ltd. sales 100.00 Establishment
Ningguo Haid Biotechnology
Co. Ltd. 3000.00
Xuancheng Xuancheng Production and
Anhui Anhui sales 65.00 Establishment
269Subsidiary Registered capital Principal place Place of
Shareholding %
(in RMB10000) of business registration Business nature Acquisition method Direct Indirect
Chaozhou Haid Biotechnology Chaozhou Chaozhou
Co. Ltd. 1000.00 Guangdong Guangdong sales 100.00 Establishment
Haixin (Tianjin) Biotechnology
Co. Ltd. 3000.00 Tianjin Tianjin
Production and
sales 100.00 Establishment
Haid Nanshan Biotechnology
(Jinhu) Co. Ltd. 5000.00 Huai’an Jiangsu Huai’an Jiangsu
Production and
sales 70.00 Establishment
Guangdong Haizhihui
Aquaculture Technology Co. 10000.00 Guangzhou Guangzhou Research and Guangdong Guangdong sales 53.00 12.75 Establishment Ltd.Jiangsu Haiwei Feed Co. Ltd. 6500.00 Huai’an Jiangsu Huai’an Jiangsu Production and sales 100.00 Establishment
Hubei Haid Seed Industry
Technology Co. Ltd. 3000.00 Ezhou Hubei Ezhou Hubei
Research and
sales 100.00 Establishment
Qianjiang Hailong Qianjiang Production and
Biotechnology Co. Ltd. 7000.00 Qianjiang Hubei Hubei sales 100.00 Establishment
Yueyang Haid Biotechnology
Co. Ltd. (Note 2) 1500.00 Yueyang Hunan Yueyang Hunan
Production and
sales 100.00 Establishment
Guiyang Haiyue Feed 1000.00 Guiyang Guiyang Production and Technology Co. Ltd. Guizhou Guizhou sales 100.00 Establishment
Chifeng Haid Biotechnology Co.Ltd. (Note 3) 300.00
Hohhot Inner Hohhot Inner Production and
Mongolia Mongolia sales 100.00 Establishment
Huizhou Haid Biotechnology 880.00 Huizhou Huizhou Production and Co. Ltd. Guangdong Guangdong sales 100.00 Other method
Guangzhou Hualaike Testing Guangzhou Guangzhou Production and
Technology Co. Ltd. 200.00 Guangdong Guangdong sales 100.00 Establishment
Huaibei Haid Biological Feed
Co. Ltd. 1000.00 Huaibei Anhui Huaibei Anhui
Production and
sales 100.00 Establishment
Guigang Hailong Biotechnology 500.00 Guigang Guigang Production and Co. Ltd. Guangxi Guangxi sales 100.00 Establishment
Guizhou Haid Feed Co. Ltd. 500.00 Zunyi Guizhou Zunyi Guizhou Production and sales 100.00 Establishment
Pizhou Haid Ruminant Feed Co.Ltd. 500.00 Xuzhou Jiangsu Xuzhou Jiangsu
Production and
sales 100.00 Establishment
270Registered capital Principal place Place of Shareholding % Subsidiary (in RMB10000) of business registration Business nature Acquisition method Direct Indirect
Nanping Haid Biotechnology 1800.00 Nanping Fujian Nanping Fujian Production and Co. Ltd. sales 100.00 Establishment
Xishui Chenke Feed Technology Production and Business combination
Co. Ltd. 5200.00 Xishui Hubei Xishui Hubei sales 65.00 involving entities not under common control
Quzhou Haid Huilong Biological 1000.00 Quzhou Quzhou Production and Feed Co. Ltd Zhejiang Zhejiang sales 100.00 Establishment
HAID (ECUADOR) FEED
CIA.LTDA. USD5920.00 Ecuador Ecuador
Production and
sales 95.00 5.00 Establishment
Xinyu Haihe Biotechnology Co.Ltd 2000.00 Xinyu Jiangxi Xinyu Jiangxi
Production and
sales 100.00 Establishment
Zhuhai Haiyue Agriculture and 2000.00 Zhuhai Zhuhai Production and Animal Husbandry Co. Ltd. Guangdong Guangdong sales 100.00 Establishment
Qingyuan Haifulai 3000.00 Qingyuan Qingyuan Production and Biotechnology Co. Ltd. Guangdong Guangdong sales 100.00 Establishment
Guangdong Konong Culture Co. 500.00 Guangzhou Guangzhou Ltd Guangdong Guangdong Others 100.00 Establishment
Fuzhou Hailong Biotechnology Production and
Co. Ltd. 8750.00 Fuzhou Fujian Fuzhou Fujian sales 70.00 Establishment
Guangzhou Haiying Commercial 500.00 Guangzhou Guangzhou Management Co. Ltd. Guangdong Guangdong Others 100.00 Establishment
Lishui Haid Huatong
Biotechnology Co. Ltd. 3000.00 Lishui Zhejiang Lishui Zhejiang
Production and
sales 60.00 Establishment
Ningdu Haid Biotechnology Co. 1200.00 Ganzhou Jiangxi Ganzhou Production and Ltd. Jiangxi sales 60.00 Establishment
Huai'an Dachuan Feed Co. Ltd. 2000.00 Huai’an Jiangsu Huai’an Jiangsu Production and sales 100.00 Establishment
Zhuhai Haibei Supply Chain Zhuhai Zhuhai Production and
Management Co. Ltd. 500.00 Guangdong Guangdong sales 100.00 Establishment
Shenyang Shengkang
Biotechnology Services Co. Ltd. 50.00
Shenyang Shenyang Production and
Liaoning Liaoning sales 51.00 Establishment
Heilongjiang Haid Harbin Harbin Production and
Biotechnology Co. Ltd. 1000.00 Heilongjiang Heilongjiang sales 100.00 Establishment
271Subsidiary Registered capital Principal place Place of
Shareholding %
(in RMB10000) of business registration Business nature Acquisition method Direct Indirect
Zhangzhou Dachuan 500.00 Zhangzhou Zhangzhou Production and Biotechnology Co. Ltd. Fujian Fujian sales 80.00 Establishment
Dangshan Shengfeng Haid Feed
Co. Ltd. 1000.00 Suzhou Anhui Suzhou Anhui
Production and
sales 55.00 Establishment
Shanxi Haid Agriculture and
Animal Husbandry Technology 1000.00 Yuncheng Yuncheng Production and
Co. Ltd. Shanxi Shanxi sales
67.00 Establishment
Hezhou Haid Feed Co. Ltd. 500.00 Hezhou Guangxi Hezhou Production and Guangxi sales 100.00 Establishment
Nanchong Haid Biotechnology
Co. Ltd. 500.00
Nanchong Nanchong Production and
Sichuan Sichuan sales 100.00 Establishment
Zhuhai Dehai Biological Zhuhai Zhuhai Production and Business combination
Technology Co. Ltd. 4000.00 Guangdong Guangdong sales 100.00 involving entities not under common control
Guangdong Haituo Guangzhou Guangzhou
Biotechnology Co. Ltd. 3500.00 Guangdong Guangdong Others 40.00 45.00 Establishment
Chifeng Shengfeng Dachuan Chifeng Inner Chifeng Inner Production and
Feed Co. Ltd. 4500.00 Mongolia Mongolia sales 55.00 Establishment
Guangdong Haiyi Investment 500.00 Guangzhou Guangzhou Co. Ltd. Guangdong Guangdong Others 100.00 Establishment
Sui Ning Haid Biotechnology Production and
Co. Ltd. 3000.00 Suining Sichuan Suining Sichuan sales 100.00 Establishment
Nanning Wuming Haid
Biotechnology Co. Ltd. 10000.00
Nanning Nanning Production and
Guangxi Guangxi sales 100.00 Establishment
Jiangmen Ronghai Breeding
Technology Co. Ltd. 14000.00
Jiangmen Jiangmen Production and
Guangdong Guangdong sales 100.00 Establishment
Yingkou Haid Biotechnology
Co. Ltd. 2000.00
Yingkou Yingkou Production and
Liaoning Liaoning sales 100.00 Establishment
Dezhou Haiying Animal
Husbandry and Technology Co. 3000.00 Dezhou Dezhou Production and Shandong Shandong sales 51.00 Establishment Ltd.Suqian Dachuan Guiliu Feed Co.Ltd. 1500.00 Suqian Jiangsu Suqian Jiangsu
Production and
sales 70.00 Establishment
272Subsidiary Registered capital Principal place Place of
Shareholding %
(in RMB10000) of business registration Business nature Acquisition method Direct Indirect
Qinzhou Haid Guiliu
Biotechnology Co. Ltd. 3000.00
Qinzhou Qinzhou Production and
Guangxi Guangxi sales 70.00 Establishment
Note 1: Guangdong Haid Livestock Veterinary Research Institute Co. Ltd. a subsidiary of the Company changed its name to Guangdong Hairui Biotechnology Co. Ltd. in
November 2025.Note 2: Pingjiang Bairuilai Biotechnology Co. Ltd. a subsidiary of the Company changed its name to Yueyang Haid Biotechnology Co. Ltd. in April 2025.Note 3: Inner Mongolia Haishan Feed Co. Ltd. a subsidiary of the Company changed its name to Chifeng Haid Biotechnology Co. Ltd. in June 2025.
(2) Significant non-wholly-owned subsidiaries
Subsidiary Non-controlling Profit or loss for the current period Dividends declared for non-controlling Closing balance of non-interests (%) attributable to non-controlling interests interests for the current period controlling interests
Guangdong Hisenor
Group Co. Ltd. 15.00 50696812.88 20750000.00 165018164.64
(3) Key financial information of significant non-wholly-owned subsidiaries
2025.12.31
Subsidiary
Current assets Non-current assets Total assets Current liabilities Non-current liabilities Total liabilities
Guangdong Hisenor Group Co. Ltd. 628624273.01 1462153814.05 2090778087.06 376878840.77 563742757.55 940621598.32
Continued (1):
2024.12.31
Subsidiary
Current assets Non-current assets Total assets Current liabilities Non-current liabilities Total liabilities
Guangdong Hisenor Group Co. Ltd. 1023194142.29 973342024.19 1996536166.48 748857303.46 350215745.34 1099073048.80
273Continued (2):
20252024
Subsidiary Operating Total Net cash flows Operating Total Net cash flows
income Net profit comprehensive from operating income Net profit comprehensive from operating income activities income activities
Guangdong
Hisenor Group 1509941929.77 435210456.64 435210456.64 777903206.58 1376273206.11 322437880.64 322437880.64 304257213.76
Co. Ltd.
(4) Transactions that result in changes to the Company’s interests in subsidiaries without causing a loss of control.
* Changes in the Company’s interests in subsidiaries
Shareholding percentage Shareholding percentage
Subsidiary Date of equity change before the change (%) after the change (%)
Direct Indirect Direct Indirect
Yuncheng Haiding Hongda Feed Co. Ltd. January 2025 27.50 49.50
Lanling Haiding Hekangyuan Agriculture and Animal Husbandry Co. Ltd. January 2025 35.75 55.00
Haile (Luliang) Biotechnology Co. Ltd. January 2025 55.00 100.00
LANKING NEMO(SG) PTE.LTD. January 2025 80.00 100.00
Yingkou Dachuan Feed Technology Co. Ltd. February 2025 100.00 55.00
Zoucheng Haiyue Enterprise Management Consulting Co. Ltd March 2025 100.00 55.00
Yinan Haiyue Biotechnology Co. Ltd. March 2025 100.00 55.00
Liaocheng Haixin Enterprise Management Consulting Co. Ltd. April 2025 100.00 55.00
Yantai Zhizhuxia Breeding Services Co. Ltd. April 2025 71.55 100.00
Fuzhou Hailong Biotechnology Co. Ltd. April 2025 100.00 70.00
Chifeng Haid Biotechnology Co. Ltd. May 2025 60.00 100.00
Mianyang Zhonggui Feed Co. Ltd. May 2025 54.87 55.00
Yueyang Yitun Agriculture and Animal Husbandry Co. Ltd. June 2025 92.00 100.00
Gaomi Haihe Agriculture and Animal Husbandry Technology Co. Ltd. June 2025 42.93 71.55
274Shareholding percentage Shareholding percentage
Subsidiary Date of equity change before the change (%) after the change (%)
Direct Indirect Direct Indirect
Shandong Fengying Food Co. Ltd. September 2025 57.00 40.80
Gaotang Huayu Pig Farming Co. Ltd. September 2025 80.00 100.00
Shandong Yitun Ecological Agriculture Co. Ltd. September 2025 60.00 80.00
Zhongshan Rongda Aquatic Seedling Co. Ltd. September 2025 51.00 100.00
Shandong Daxin Group Co. Ltd. September 2025 71.55 90.00
Guangdong Bairong Aquatic Breeding Group Co. Ltd. October 2025 100.00 85.00
Zhongshan Ronghai Aquaculture Co. Ltd. October 2025 80.00 100.00
Guangzhou Rongda Aquatic Technology Co. Ltd. October 2025 70.00 100.00
Nanping Haid Biotechnology Co. Ltd. November 2025 80.00 100.00
Yingkou Haizexin Fishery Technology Co. Ltd. December 2025 73.95 85.00
HAID BIOTECHNOLOGY INDUSTRY (SINGAPORE) PTE. LTD. December 2025 88.00 100.00
PANASIA TRADING RESOURCES LIMITED December 2025 80.00 100.00
* Impact of transactions on non-controlling interests and equity attributable to the parent company
Yuncheng Lanling Haiding Haile Yingkou Zoucheng Yinan Liaocheng Yantai
Haiding Hekangyuan (Luliang) Dachuan Haiyue Haiyue Haixin Zhizhuxia
Item Hongda Feed Agriculture and Biotechnology Feed Enterprise Biotechnol Enterprise Breeding Co. Ltd. Animal Co. Ltd. Technology Management ogy Co. Management Services Co.Husbandry Co. Co. Ltd. Consulting Ltd. Consulting Ltd.Ltd. Co. Ltd Co. Ltd.Acquisition cost / consideration of
disposal
--Cash 1198166.80 1750000.00 - - - - - -
--Fair value of non-cash assets - - - - - - - -
Total acquisition cost /
consideration of disposal 1198166.80 1750000.00 - - - - - -
Less: Share of subsidiary’s net 980603.33 -2087399.32 -177424.01 - 46758.13 147844.26 101293.96 -32386.60
275Yuncheng Lanling Haiding Haile Yingkou Zoucheng Yinan Liaocheng Yantai
Haiding Hekangyuan (Luliang) Dachuan Haiyue Haiyue Haixin Zhizhuxia
Item Hongda Feed Agriculture and Biotechnology Feed Enterprise Biotechnol Enterprise Breeding Co. Ltd. Animal Co. Ltd. Technology Management ogy Co. Management Services Co.Husbandry Co. Co. Ltd. Consulting Ltd. Consulting Ltd.Ltd. Co. Ltd Co. Ltd.assets at the percentage of 3156131.45
shareholding acquired or disposed
Difference: Adjustment to capitalreserve (“-“ for decrease) -217563.47 -3837399.32 -177424.01 3156131.45 -46758.13 -147844.26 -101293.96 -32386.60Continued:
Fuzhou Chifeng Haid Mianyang Yueyang Gaomi Haihe Shandong Gaotang Shandong
Hailong Biotechnology Zhonggui Yitun Agriculture Fengying Huayu Pig Yitun
Item Biotechnology Co. Ltd. Feed Co. Agriculture and Animal Food Co. Farming Co. Ecological Co. Ltd. Ltd. and Animal Husbandry Ltd. Ltd. Agriculture
Husbandry Technology Co. Ltd.Co. Ltd. Co. Ltd.Acquisition cost / consideration
of disposal
--Cash - 1257243.00 26617.02 2800000.00 3000000.00 - - 30315590.00
--Fair value of non-cash assets - - - - - - - -
Total acquisition cost /
consideration of disposal - 1257243.00 26617.02 2800000.00 3000000.00 - - 30315590.00
Less: Share of subsidiary’s net
assets at the percentage of
shareholding acquired or -433294.92 1232924.90 16317.72 -2661258.41 2698643.98
-
1978174.71-3588781.4629639300.27
disposed
Difference: Adjustment tocapital reserve (“-“ for decrease) 433294.92 -24318.10 -10299.30 -5461258.41 -301356.02 1978174.71 -3588781.46 -676289.73
276Continued:
Zhongshan Shandong Daxin Guangdong Zhongshan Guangzhou Rongda
Item Rongda Aquatic Group Co. Ltd. Bairong Aquatic Ronghai Aquatic Technology Seedling Co. Breeding Group Aquaculture Co. Co. Ltd.Ltd. Co. Ltd. Ltd.Acquisition cost / consideration of disposal
--Cash - 29693750.81 - - -
--Fair value of non-cash assets - - - - -
Total acquisition cost / consideration of disposal - 29693750.81 - - -
Less: Share of subsidiary’s net assets at the percentage of
shareholding acquired or disposed -8234732.32 33459775.30 -10292838.16 10419676.84 9653293.26Difference: Adjustment to capital reserve (“-“ for decrease) -8234732.32 3766024.49 10292838.16 10419676.84 9653293.26Continued:
Nanping Haid Yingkou Haizexin HAID PANASIA LANKING
Biotechnology Fishery BIOTECHNOLO TRADING NEMO(SG)
Item Co. Ltd. Technology Co. GY INDUSTRY RESOURCES PTE.LTD.Ltd. (SINGAPORE) LIMITED
PTE. LTD.Acquisition cost / consideration of disposal
--Cash 4028871.77 150000.00 7.14 607059181.12 7.87
--Fair value of non-cash assets - - - - -
Total acquisition cost / consideration of disposal 4028871.77 150000.00 7.14 607059181.12 7.87
Less: Share of subsidiary’s net assets at the percentage of
shareholding acquired or disposed 3456568.35 -1569033.27 -2852536.94 160410333.42 -21690886.55
Difference: Adjustment to capital reserve (“-” for decrease) -572303.42 -1719033.27 -2852544.08 -446648847.70 -21690894.42
2772. Business combinations involving entities not under common control
(1) Business combinations not under common control during the current period
Date of Acquiree’s Acquiree’s net Acquiree’s cash
Name of the acquisition of Acquisition Equity acquired Acquisition Acquisition
Basis for
acquisition revenue from profit from flows from acquiree equity cost (%) method date date acquisition date to acquisition date acquisition date interest period end to period end to period
Zhuhai Dehai
Biological Obtaining
Technology 2025/10/31 500000000.00 100.00 Purchase 2025/10/31 actual 201871873.64 -3202637.98 -21587558.55
Co. Ltd. control
Zhejiang Lanke
Seed Industry Obtaining
Technology 2025/10/20 5500000.00 100.00 Purchase 2025/10/20 actual 111512.50 -4058834.83 -344545.58
Co. Ltd. control
PT BIBIT Obtaining
UNGGUL 2025/12/19 25590871.25 100.00 Purchase 2025/12/19 actual - -41787.65 -164198.90 control
278(2) Cost of business combination and goodwill
Zhuhai Dehai Zhejiang Lanke PT BIBIT
Item Biological Seed Industry UNGGUL Technology Co. Technology Co.Ltd. Ltd.Cost of business combination:
Cash 500000000.00 5500000.00 25590871.25
Fair value of non-cash assets - - -
Fair value of debt issued or assumed - - -
Fair value of equity securities issued - - -
Fair value of contingent consideration - - -
Fair value of previously held equity
interest at the acquisition date - - -
Total cost of business combination 500000000.00 5500000.00 25590871.25
Less: Share of the fair value of the
identifiable net assets acquired 369091668.09 3757547.14 171297.04
Goodwill/Excess of the fair value of
identifiable net assets acquired over cost 130908331.91 1742452.86 25419574.21
of business combination
(3) Acquiree's identifiable assets and liabilities at acquisition date
Zhuhai Dehai Biological Zhejiang Lanke Seed Industry
Technology Co. Ltd. Technology Co. Ltd. PT BIBIT UNGGUL
Item Fair value at Carrying Fair value at Carrying Fair value at Carrying
acquisition amount at acquisition amount at acquisition acquisition acquisition
amount at
date date date
acquisition
date date date
Assets
Current
assets 475426231.55 475426231.55 3687575.37 3687575.37 446087.57 446087.57
Non-current
assets 306109514.58 243717819.62 19401247.86 19401247.86 2254041.36 2254041.36
Liabilities
Current
liabilities 331137610.71 331137610.71 10908002.02 10908002.02 2528831.89 2528831.89
Non-current
liabilities 80766995.53 65327837.40 8423274.07 8423274.07 - -
Net assets 369631139.89 322678603.06 3757547.14 3757547.14 171297.04 171297.04
Less: Non-
controlling 539471.80 539471.80 - - - -
interests
Net assets
acquired
through 369091668.09 322139131.26 3757547.14 3757547.14 171297.04 171297.04
business
combination
2793. Disposal of subsidiaries
(1) Disposal of investments in subsidiaries through a single transaction resulting in loss of control
Difference
between disposal Goodwill
Percentage Basis for proceeds and relating to the
Disposal of equity Disposal Date of determining share of net subsidiary in Subsidiary proceeds interest method loss of the date of assets of the the disposed control loss of subsidiary in the consolidated
(%) control consolidated financial
financial statements
statements
Maoming
Debao
Agriculture
and Animal 6619145.55 51.00 Sales 2025/5/12
Transfer of
control -2440943.76 640678.00
Husbandry
Co. Ltd.Feicheng
Heruifeng
Agricultural 31069105.00 80.00 Sales 2025/9/16 Transfer of control 34973854.86 - Technology
Co. Ltd.Continued:
Amount of other
Percentage of Carrying amount of Fair value Method and
comprehensive
remaining of Gain or loss key income related to
equity remaining Subsidiary equity remaining from assumptions
equity investments
interest on interest on equity on remeasurement for
in the former
date of lose date of lose date of lose at fair value determining
subsidiary
control control control fair value
transferred to profit
or loss or retained
earnings
Maoming
Debao
Agriculture
and Animal - - - - - -
Husbandry
Co. Ltd.Feicheng
Heruifeng
Agricultural - - - - - -
Technology
Co. Ltd.
4. Changes in the scope of consolidation due to other reasons
Subsidiary Method of change
Long Sheng International (Suoi Dau) Co. Ltd Newly established
Guangzhou Haishun Supply Chain Management Co. Ltd. Newly established
Heilongjiang Haid Biotechnology Co. Ltd. Newly established
Binchuan Yitun Ecological Agriculture Co. Ltd. Newly established
Yingkou Haizehui Seed Industry Technology Co. Ltd. Newly established
Foshan Ronghai Seed Technology Co. Ltd. Newly established
Zhangzhou Dachuan Biotechnology Co. Ltd. Newly established
Haihua Bio-Tech(Hong Kong)Limited Newly established
Hunan Xitun Ecological Agriculture Co. Ltd. Newly established
280Subsidiary Method of change
Jiangsu Haizehui Seed Industry Technology Co. Ltd. Newly established
Rongcheng Haihesheng Marine Biotechnology Co. Ltd. Newly established
Guangdong Xitun Ecological Agriculture Co. Ltd. Newly established
Guangxi Xitun Ecological Agriculture Co. Ltd. Newly established
Anhui Xitun Ecological Agriculture Co. Ltd. Newly established
Hubei Xitun Ecological Agriculture Co. Ltd. Newly established
Dalian Haiding Jinyifeng Feed Co. Ltd. Newly established
Shicheng Yitun Ecological Agriculture Co. Ltd. Newly established
Haid 3 Egypt Technology Co Ltd Newly established
SHENG LONG BIO-TECH(TIEN GIANG) INTERNATIONAL CO. LTD. Newly established
CAMBODIAN HAIDA AGRICULTURE AND ANIMAL HUSBANDRY
TECHNOLOGY CO. LTD. Newly established
Dangshan Shengfeng Haid Feed Co. Ltd. Newly established
Yantai Peiqi Breeding Services Co. Ltd. Newly established
Dongying Hailing Fresh Aquatic Food Co. Ltd. Newly established
Yingkou Haizexin Fishery Technology Co. Ltd. Newly established
HAID AGRICULTURAL TECHNOLOGY MYANMAR COMPANY LIMITED Newly established
Hezhou Haid Feed Co. Ltd. Newly established
Shanxi Haid Agriculture and Animal Husbandry Technology Co. Ltd. Newly established
HAI HANG International Trade Nigeria Co. Ltd. Newly established
Hebei Haiyue Agriculture and Animal Husbandry Co. Ltd. Newly established
Haid technology (Thailand) Co. LTD Newly established
Nanchong Haid Biotechnology Co. Ltd. Newly established
Tanzania Haid Company Limited Newly established
HISENOR (ECUADOR) CIA. LTDA. Newly established
Guangdong Sea Spirit Machinery Manufacturing Co. Ltd. Newly established
Guangdong Haituo Biotechnology Co. Ltd. Newly established
Chifeng Shengfeng Dachuan Feed Co. Ltd. Newly established
Haid International Holdings Limited Newly established
Guangdong Haiyi Investment Co. Ltd. Newly established
HISENOR BIO TECH (M) SDN. BHD. Newly established
Haidea Holdings Pte.Ltd. Newly established
Sui Ning Haid Biotechnology Co. Ltd. Newly established
LAOS HAID COMPANY LIMITED Newly established
HISTARRY INTERNATIONAL PTE. LTD. Newly established
Haid International Biofarms Pte.Ltd. Newly established
Mianyang Yitun Ecological Agriculture Co. Ltd. Newly established
Haid Supply Chain Management (Guangzhou) Co. Ltd. Newly established
Nanning Wuming Haid Biotechnology Co. Ltd. Newly established
Yingkou Haid Biotechnology Co. Ltd. Newly established
281Subsidiary Method of change
HAID DO BRASIL LTDA Newly established
Dezhou Haiying Animal Husbandry and Technology Co. Ltd. Newly established
PT. APEX POULTRY BREEDING Newly established
Jinhua Haiyi Seed Technology Co. Ltd. Newly established
Suqian Yitun Ecological Agriculture Co. Ltd. Newly established
Hainan Haizexin Marine Biotechnology Co. Ltd. Newly established
Guangzhou Haituoer Consulting Co. Ltd. Newly established
PT Ocean Dragon Indonesia Newly established
Guizhou Haipin Chemical Co. Ltd. Newly established
Suqian Dachuan Guiliu Feed Co. Ltd. Newly established
Qinzhou Haid Guiliu Biotechnology Co. Ltd. Newly established
Yuncheng Haiding Veterinary Services Co. Ltd. Deregistered
Guangdong Qingyuan Guanghong Feed Co. Ltd. Deregistered
Laibin Yitun Ecological Agriculture Co. Ltd. Deregistered
Xinyi Fengmu Trading Co. Ltd. Deregistered
Linyi Zhizhuxia Breeding Technology Services Co. Ltd. Deregistered
Changning Yitun Ecological Agriculture Co. Ltd. Deregistered
Heshan Haiwei Feed Co. Ltd. Deregistered
Tongliao Haid Biotechnology Co. Ltd. Deregistered
Guangzhou Ronghai Seed Technology Co. Ltd Deregistered
Yangxi Haizexin Marine Biotechnology Co. Ltd. Deregistered
Guangzhou Mutai Feed Technology Co. Ltd. Deregistered
Foshan Hanheng Luggage Manufacturing Co. Ltd Deregistered
Yiyang Dachuan Feed Co. Ltd. Deregistered
Meishan Haid Biotechnology Co. Ltd. Deregistered
Chaoyang Haihong Agricultural Development Co. Ltd. Deregistered
Suixian Haiding Veterinary Services Co. Ltd. Deregistered
Chongqing Hainong Veterinary Services Co. Ltd Deregistered
Linyi Haihe Agriculture and Animal Husbandry Technology Co. Ltd. Deregistered
Guangzhou Meinong Investment Management Co. Ltd. Deregistered
Yinan Haiding Biotechnology Co. Ltd Deregistered
Sichuan Hailong Biotechnology Co. Ltd. Deregistered
Guangzhou Xingnong Ecological Agriculture and Animal Husbandry Development
Co. Ltd. Deregistered
Guangzhou Haijian Investment Co. Ltd. Deregistered
Binzhou Haiding Veterinary Services Co. Ltd. Deregistered
2825. Interests in joint ventures or associates
(1) The Group has no significant joint ventures or associates during the current period
(2) Summary of financial information of insignificant joint ventures and associates
Item 2025.12.31/ 2024.12.31/ 2025 2024
Associates:
Total carrying amount of investments 201104846.86 183791269.35
Totals calculated based on shareholding percentage
Net profit 10883175.99 8982736.02
Other comprehensive income 394446.44 220692.56
Total comprehensive income 11277622.43 9203428.58
Joint ventures: - -
Total carrying amount of investments 104855277.96 96426623.51
Totals calculated based on shareholding percentage
Net profit 13905915.45 32058788.44
Other comprehensive income -5427456.89 -2101524.67
Total comprehensive income 8478458.56 29957263.77
VIII. Government Grants
1. As of December 31 2025 there were no government grants recognized as other receivables.
2. Government grants recognized in deferred income
(1) Government grants recognized in deferred income and subsequently measured using the gross presentation
method
Additions Recognized Line item
Item 2024.12.31 during the in profit or Other 2025.12.31 recognized Related to
period loss movements in profit or asset/income loss
Development
support fund 50920073.14 2169150.00 5151811.18 -4500000.00 43437411.96
Other Related to
income asset
Development
support fund 2094384.09 - 2084352.52 - 10031.57
Other Related to
income income
Research
grants 19660500.51 - 5444095.43 - 14216405.08
Other Related to
income asset
Research
grants 9460776.94 7153270.00 11591021.97 - 5023024.97
Other Related to
income income
Grants for
production 240350322.36 41120595.22 35951812.07 -1215748.18 244303357.33 Other Related to
activities income asset
Grants for
production 4936.12 - 4936.12 - - Other Related to
activities income income
Government
incentive 5525772.82 50000.00 1485940.80 - 4089832.02 Other Related to
grants income asset
Others 21441891.00 1799478.00 3807143.03 - 19434225.97 Other Related to income asset
Total 349458656.98 52292493.22 65521113.12 -5715748.18 330514288.90
283(2) Government grants recognized in deferred income and subsequently measured using the net presentation
method
Additions Line item
Item 2024.12.31 during Recognized in Other recognized Related to the profit or loss movements 2025.12.31 in profit or asset/income
period loss
Government
interest 91381.06 - 40197.66 - 51183.40 Financial Related to
subsidy expenses asset
Total 91381.06 - 40197.66 - 51183.40
3. Government grants recognized in profit or loss and subsequently measured using the gross presentation method
Recognized in Recognized in Line item
Item profit or loss for profit or loss for recognized in profit Related to
the current year the prior year or loss asset/income
Development
Support Fund 5151811.18 2323781.84 Other income Related to asset
Development
Support Fund 3606984.86 17330344.64 Other income Related to income
Research grants 5444095.43 2997064.38 Other income Related to asset
Research grants 16932812.97 11429957.20 Other income Related to income
Grants for Gains from assets
production activities 37167560.25 20723042.81 disposal/other Related to asset income
Grants for
production activities 17591025.56 12412307.06 Other income Related to income
Government
incentive grants 1485940.80 690024.97 Other income Related to asset
Government
incentive grants 17651774.27 21503968.40 Other income Related to income
Others 3807143.03 3742037.40 Other income Related to asset
Others 13748101.93 22403979.05 Other income Related to income
Total 122587250.28 115556507.75
4. Government grants offset against related costs by net presentation method
Offset against Offset against Line item offset
Item related costs in the related costs in the against related Related to
current period prior period costs and expenses asset/income
Government interest
subsidy 40197.66 50243.01 Financial expenses Related to asset
Government interest
subsidy 851940.74 3324553.00 Financial expenses Related to income
Total 892138.40 3374796.01
5. Return of government grants during current year
Item Amount Reason
Funds were adjusted and recovered based on the
Development support fund 4500000.00 implementation plan for regional coordinated
fiscal special incentive projects
Total 4500000.00
284IX. Risk Management of Financial Instruments
The Group’s principal financial instruments include cash and cash equivalents notes receivable accounts
receivable other receivables non-current assets due within one year other current assets loans and advances
to customer held-for-trading financial assets debt investments other non-current financial assets long-term
receivables notes payable accounts payable other payables short-term loans held-for-trading liabilities
non-current liabilities due within one year long-term loans lease liabilities and long-term payables. Details
of these financial instruments are disclosed in the relevant notes. The risks associated with these financial
instruments and the risk management policies adopted by the Group to mitigate these risks are described
below. The Group’s management manages and monitors these risk exposures to ensure that the above risks
are controlled within defined limits.
1. Objectives and policies of risk management
The principal risks arising from the Group's financial instruments are credit risk liquidity risk and market
risk (comprising currency risk interest rate risk and commodity price risk).The Group's objects in undertaking risk management are to achieve an appropriate balance between risk and
return and to minimize the adverse impact of financial risk on the Group's financial performance. Based on
these risk management objectives the Group has established risk management policies to identify and
analyze the risks faced by the Group set appropriate acceptable risk level and design corresponding internal
control procedures to monitor the Group’s risk exposure. The Group reviews these risk management policies
and related internal control systems regularly to adapt to changes in market conditions or the Group’s
operating activities. The Group’s internal audit department also conducts regular or random inspections to
assess whether the internal control systems are operating in accordance with the risk management policies.The Board of Directors is responsible for planning and establishing the Group's risk management framework
formulating the Group's risk management policies and related guidelines and supervising the implementation
of risk management measures. The Group has formulated risk management policies to identify and analyze
the risks faced by the Group. These risk management policies provide clear provisions for specific risks
covering various aspects including market risk credit risk and liquidity risk. The Group regularly evaluates
changes in the market environment and the Group’s operating activities to determine whether to update the
risk management policies and systems. The Group’s is management is carried out by the relevant departments
in accordance with the policies approved by the Board of Directors. These departments work in close
collaboration with other business units of the Group to identify assess and mitigate relevant risks
The Group mitigates financial instrument risks through appropriate diversification of investments and
business portfolios and reduces concentration risks in a single industry specific region or particular
counterparty by establishing corresponding risk management policies.
(1) Credit Risk
Credit risk is the risk that a counterparty will fail to fulfill its contractual obligations resulting in financial
losses to the Group.The Group manages credit risk on a portfolio basis. Credit risk arises primarily from bank deposits notes
receivable accounts receivable other receivables other current assets long-term receivables loans and
advances to customer etc.The Group's bank deposits are mainly deposited with reputable financial institutions with high credit ratings.The Group expects that there is no significant risk associated with bank deposits.For notes receivable accounts receivable other receivables other current assets loans and advances to
customers the Group has established relevant policies to control credit risk exposure. The Group assesses
the credit quality of customers based on their financial position credit history and other factors such as
current market conditions and sets appropriate credit periods accordingly. The Group regularly monitors the
credit records of customers. For customers with poor credit records the Group adopts measures such as
written notices shortening of credit periods or cancellation of credit periods to ensure that the overall credit
risk of the Group is maintained within a controllable range.
285The debtors of the Group’s accounts receivable and loans and advances to customers are customers
distributed across various industries and regions. The Group continuously conducts credit assessments of the
financial positions of accounts receivables and purchase credit guarantee insurance when appropriate.The maximum credit risk exposure of the Group is the carrying amount of each financial asset in the balance
sheet. The Group is also exposed to credit risk through the provision of financial guarantee. Please refer to
Note XIII. 2.Of the Group’s accounts receivable the top five accounts receivable accounted for 7.05% of the Group’s
total accounts receivable (2024: 8.66%). Of the Group’s other receivables other receivables due from the
top five companies accounted for 44.12% of the Group’s total other receivables (2024: 35.36%).
(2) Liquidity Risk
Liquidity risk is the risk that the Group will experience a shortage of funds when fulfilling obligations to
settle financial liabilities by delivering cash or other financial assets.The Group’s subsidiaries are each responsible for their own cash flow forecasts. The Group’s finance
company monitors the long-term and short-term funding requirements at the group level based on the cash
flow forecasts of subsidiaries. The Group coordinates and deploys surplus funds within the group through
cash pooling arrangements established with major banking financial institutions and ensures that subsidiaries
maintain adequate cash reserves to meet payment obligations due for settlement. In addition the Group has
entered into credit facility agreements with its principal banks to support the Group in meeting obligations
related to commercial bills.The Group fiancés its working capital requirements through funds generated from operating activities and
borrowings from banks and other financial institutions. As of December 31 2025 the Group's unused credit
facilities granted by financial institutions amounted to RMB32.377 billion (December 31 2024: RMB30.317
billion).
(3) Market Risk
Market risk of financial instrument is the risk that the fair value or future cash flows of financial instruments
will fluctuate due to changes in market prices including interest rate risk currency risk and other price risk.Interest rate risk
Interest rate risk is the risk that the fair value or future cash flows of financial instruments will fluctuate due
to changes in market interest rates. Interest rate risk may arise from recognized interest-bearing financial
instruments and unrecognized financial instruments (such as certain loan commitments).The Group's interest rate risk arises primarily from long-term and short term interest–bearing bank loans.Financial liabilities at floating interest rates expose the Group to cash flow interest rate risk while financial
liabilities with fixed interest rates expose the Group to fair value interest rate risk. The Group determines the
relative proportion of fixed and floating interest rate contracts based on prevailing market conditions and
maintains an appropriate mix of fixed and floating rate instruments through regular review and monitoring.The Group closely monitors the impact of interest rate movements on its interest rate risk. The Group
currently does not employ interest rate hedging policy. However management is responsible for monitoring
interest rate risk and will consider hedging significant interest rate when necessary. Increases in interest rates
would increase the cost of new interest-bearing borrowings and the interest expense on the Group's
outstanding floating-rate interest-bearing borrowings which could have a material adverse effect on the
Group's financial performance. Management will make timely adjustments based on the latest market
conditions.Currency risk
Currency risk is the risk that the fair value or future cash flows of financial instruments will fluctuate due to
changes in foreign exchange rates. Currency risk may arise from financial instruments that are denominated
286in a currency other than the functional currency.
The Group’s principal operations are located in mainland China and its principal transactions are settled in
RMB. The Group imports raw materials of a certain scale and the transactions volume of overseas
subsidiaries whose functional currency is other than RMB has also increased. Therefore fluctuations in
exchange rates have a certain impact on the Group’s operating results.As of December 31 2025 the Group’s foreign currency monetary items were mainly denominated in US
dollar Vietnamese dong Indonesian rupiah for financial assets and financial liabilities (refer to Note V. 69
(1) Monetary items in foreign currencies for details). Other currencies are used infrequently and in immaterial
amounts and their exchange rate movements do not have a significant impact on the Group’s operating
activities.The Group closely monitors the impact of exchange rate movements on its currency risk. The Group
continuously monitors the scale of foreign currency transactions and foreign currency denominated assets
and liabilities to minimize currency risk exposure. To this end the Group may enter into forward exchange
contracts or currency swap contracts to mitigate currency risk.Other price risk
Other price risk is the risk of fluctuations arising from changes in market prices other than those arising from
currency risk or interest rate risk whether such changes are caused by factors specific to an individual
financial instrument or its issuer or by factors affecting all similar financial instruments traded in the market.Other price risk may arise from changes in commodity prices equity market indices equity instrument prices
and other risk variables.The Company adheres to the principle of serving the spot market namely basing procurement on spot
purchase plans with risk control as the core principle. Company employs one or more hedging instruments
to hedge against commodity price risk credit risk etc. such that changes in the fair value or cash flows of
the hedging instruments are expected to offset changes in the fair value or cash flows of the hedged item in
whole or in part thereby reducing the impact of raw material commodity price fluctuations on production
and operations.
2. Capital management
The objective of the Group's capital management policy is to ensure the Group's ability to continue as a going
concern so as to provide returns to shareholders and benefits to other stakeholders while maintaining an
optimal capital structure to reduce the cost of capital.To maintain or adjust the capital structure the Group may adjust financing methods adjust the amount of
dividends paid to shareholders return capital to shareholders issue new shares or other equity instruments
or sell assets to reduce debt.The Group monitors its capital structure on the basis of debt-to asset ratio (i.e. total liabilities divided by total
assets). As of December 31 2025 the Group's debt-to-asset ratio was 46.42% (December 31 2024: 47.87%).
2873. Hedging
(1) Company undertakes hedging activities for risk management
Risk Qualitative and Economic relationships Effectiveness of Impact of
Item management quantitative between hedged item risk hedging strategies and information on and hedging management activities on
objectives hedged risk instruments objectives risk exposure
An economic
Exchange rate relationship exists
To hedge the movements result in between the hedged item Purchasing
currency risk on corresponding and the hedging The risk
the Group’s exchange gains or instrument. This management
hedging
Currency instruments to
risk foreign currency losses on the
economic relationship objectives are mitigate the
denominated Group’s foreign causes the hedging expected to be
assets and currency instrument and the effectively
impact of
liabilities. denominated assets hedged item to move in achieved.exchange rate
risk exposure.and liabilities. opposite directions in value due to exposure to
the same hedged risk.An economic
relationship exists
Changes in raw between the hedged item Purchasing
material and and the hedging The risk hedging
To hedge the inventory instrument. This management instruments to
Commodity Group's commodity prices economic relationship objectives are mitigate the
price risk commodity price lead to fluctuations causes the hedging expected to be impact of
risk in the Group's instrument and the effectively commodity
revenue and cost of hedged item to move in achieved. price risk
sales. opposite directions in exposure.value due to exposure to
the same hedged risk.
(2) Company engages in qualifying hedging activities and applies hedge accounting
* Type of hedged risk
Cumulative fair
Carrying value hedge
amount of adjustments Hedge Impact of hedge
Item hedged items included in the effectiveness and accounting on the
and hedging carrying amount sources of hedge company's financial
instruments of recognized ineffectiveness statements
hedged item
Other than hedging costs
There was no fair value changes of
hedge hedging instruments and
Currency ineffectiveness exchange gains or losses on
risk - Note 1 arising from foreign currency assets and currency risk liabilities are offset with the
during the net difference recognized in
currency period. other comprehensive
income.Commodity Refer to the
price risk Note 2 Note 3 Note 2 Note 3 category of hedges
Refer to the category of
for details. hedges for details.
288* Category of hedge
Cumulative fair
Carrying value hedge
amount of adjustments Hedge Impact of hedge
Item hedged items included in the effectiveness and accounting on the
and hedging carrying amount sources of hedge company's financial
instruments of recognized ineffectiveness statements
hedged item
Changes in the fair value of
hedging instruments are
Commodity Hedge first recognized in the
price risk— ineffectiveness of carrying amount of the
fair value Note 2 Note 2 fair value hedge hedged item and
hedge during the current subsequently transferred to period cost of sales in the current
period as the hedged item is
sold.The effective portion of
changes in fair value of
Commodity Hedge hedging instruments is first
price risk— ineffectiveness of recognized in other
cash flow Note 3 Note 3 cash flow hedge comprehensive income and
hedge during the current subsequently transferred to period revenue or cost of sales in
the current period as the
hedged item is sold.Note 1: The Group uses forward exchange contracts foreign exchange option contracts foreign exchange
swap contracts and currency swap contracts to mitigate the exchange rate fluctuation risk of foreign currency
denominated monetary funds foreign currency bank borrowings foreign currency accounts payable and
other foreign currency denominated assets and liabilities. The forward exchange contracts and foreign
exchange option contracts entered into by the Group meet the conditions for applying hedge accounting.On December 31 2025 the Group held the forward exchange contracts with a nominal amount of
USD31400000.00. Under these contracts the Group is obligated or entitled to purchase RMB at a fixed
exchange rate at maturity. The purpose is to hedge foreign currency risk arising from intra-group transactions
that cannot be eliminated in the consolidated financial statements.The Group separates the intrinsic value and time value of options and designates only changes in the intrinsic
value of options as hedging instruments. The Group separates the forward element and spot element of
forward contracts and designates only changes in the value of the spot element as hedging instruments. The
Group separately identifies the foreign currency basis spread of financial instruments and designates only
the financial instrument excluding the foreign currency basis spread as the hedging instrument.Note 2: The Group engages in feed production and processing business. The corn soybean meal and other
products held by the Group are exposed to price fluctuation risks. Therefore the Group uses futures contracts
on corn soybean meal and other products to manage the commodity price risks associated its holdings of
such products.The Group uses standard corn futures contracts of the Dalian Commodity Exchange to hedge a portion of the
Group's corn inventory and unrecognized firm purchase commitments in order to mitigate the risk of changes
in fair value arising from fluctuations in corn market prices. The corn contained in the feed products produced
and processed by the Group is exposed to price fluctuations that include risk components associated with
standard corn futures contracts. The Group designates such risk components as hedged items and standard
corn futures contracts as hedging instruments. Through qualitative analysis the Group has determined that
the hedge ratio between hedging instruments and hedged items is 1:1.
289Hedge ineffectiveness primarily arises from timing differences in the matching of hedging instruments and
hedged items. The amount of hedge ineffectiveness recognized in the current year is not material. The Group
applies fair value hedge accounting for such hedging arrangements which are detailed as follows:
Hedged item Hedging instrument Hedging method
Risk components of corn Standard corn futures contracts Selling commodity futures
inventory and unrecognized firm on the Dalian Commodity contracts to lock in price
purchase commitments Exchange fluctuations of corn inventory
During 2025 the above fair value hedging instruments of the Group accumulated fair value changes of
RMB3731560.00 and the cumulative fair value adjustment of the hedged items was RMB-2468230.00.These amounts were recorded in the balance of other current assets at the end of the period.Note 3: The Group is engaged in feed production and processing and pig breeding businesses. To mitigate
the risk of cash flow fluctuations arising from future commodity price and exchange rate movements the
Group designates foreign exchange forward contracts commodity futures and option contracts as hedging
instruments for future purchases and sales.As of December 31 2025 the balance of cash flow reserves is as follows:
Carrying amount of hedging Fair value
instrument changes of
Notional Balance
hedging
instruments
Cash flow quantity of
sheet line
item that used as the
hedge hedging includes the basis for instrument Assets Liabilities hedging recognizing (tons) instrument hedge ineffectiveness
for the current
year
Held-for-
Commodity trading
price risk - 279408.00 89624788.33 1959920.00 financial -280719.08
expected sales assets/
liabilities
Commodity Held-for-
price risk - trading
expected 1499944.00 - 60260687.25 financial -27941778.48
purchases liabilities
Continued:
Amount not yet
Cash flow hedge transferred to profit or loss Impact on
Cash flow
from hedging instruments income tax hedge
closed out at period end reserves
Commodity price risk - expected sales 54764001.18 2628424.86 140081163.73
Commodity price risk - expected
purchases 35422796.38 - 3103887.61
(3) Company engages in hedging activities for risk management purposes that are expected to achieve the risk
management objectives but does not apply hedge accounting thereto
Item Reasons for not applying Impact on the financial statements
hedge accounting
290Commodity The Group did not formally Gains or losses on held-for-trading financial assets
price risk designate its hedging instruments or liabilities are directly recognized in the changes and hedged items in fair value and investment income.
4. Transfer of financial assets
(1) Classification by transfer methods
Nature of Amount of
Transfer transferred transferred Derecognition
method financial financial status Basis for determining derecognition
assets assets
The discounted bank acceptance notes
Bank were accepted by banks with high credit
acceptance ratings.Notes notes
discounted discounted 459019516.34 Derecognized
Credit risk and deferred payment risk
were minimal and substantially all risks
but not yet and rewards were transferred upon
matured discounting. Therefore the notes were
derecognized.The endorsed bank acceptance notes
Bank were accepted by banks with high credit
acceptance ratings.Notes notes Credit risk and deferred payment risk
endorsed endorsed 120480686.00 Derecognized were minimal and substantially all risks
but not yet and rewards were transferred upon
matured endorsement. Therefore the notes were
derecognized.Total 579500202.34
(2) Financial assets derecognized due to transfer
Item Transfer method Amount Gains or losses derecognized on derecognition
Bank acceptance notes discounted but
not yet matured Discounting 459019516.34 -589193.64
Bank acceptance notes endorsed but not
yet matured Endorsement 120480686.00 -
Total 579500202.34 -589193.64
X. Fair Value
The fair value hierarchy is determined based on the lowest level input that is significant to the fair value
measurement. The levels are defined as follows:
Level 1 inputs: unadjusted quoted prices in active markets for identical assets or liabilities.Level 2 inputs: inputs other than quoted prices included within Level 1 that are observable for the asset or
liability either directly (i.e. as prices) or indirectly (i.e. derived from prices)
Level 3 inputs: inputs that are unobservable for assets or liabilities. (Unobservable inputs)
(1) Items and amounts measured at fair value
As of December 31 2025 assets and liabilities measured at fair value are presented by the above three levels
as follows:
291Item Level 1 Level 2 Level 3 Total
I. Recurring fair value
measurements
1. Held-for-trading financial
assets 93946452.02 1195381705.70 829406769.71 2118734927.43
(1) Investments in equity
instruments 606454.72 - - 606454.72
(2) Derivative financial assets 93339997.30 9078278.47 - 102418275.77
(3) Financial products - 1186303427.23 829406769.71 2015710196.94
2. Other non-current financial
assets - - 245857402.68 245857402.68
Total assets measured at fair
value on a recurring basis 93946452.02 1195381705.70 1075264172.39 2364592330.11
3. Held-for-trading financial
liabilities 64831322.82 139013.14 - 64970335.96
Total liabilities measured at
fair value on a recurring 64831322.82 139013.14 - 64970335.96
basis
II. Non-recurring fair value
measurements -
Assets held-for-sale - - - -
Total assets at non-recurring
at fair value - - - -
The Company recognizes transfers between different levels as of the date of the event that caused the transfer.During the current year the Group had no transfers between Level 1 and Level 2 and no transfers into or out
of Level 3 for financial assets and financial liabilities measured at fair value.For financial instruments traded in active markets the Company determines their fair value based on the
quoted prices in those active markets. For financial instruments not traded in active markets the Company
determines their fair value using valuation techniques. The valuation models used are primarily discounted
cash flow models and market comparable company models. Inputs to these valuation techniques mainly
include risk-free interests rate benchmark interest rates foreign exchange rates credit spreads liquidity
premiums and lack of liquidity discounts etc.XI. Related Parties and Related-Party Transactions
1. Information on the Company's parent company
Registered Shareholding Percentage of
Name Place of Business capital (in percentage in voting rights in registration nature RMB the Company the Company
10000)(%)(%)
Investment
Guangzhou Haihao trading
Investment Co. Ltd.(hereinafter Guangzhou
import and
export of 3000.00 54.73 54.73“Guangzhou Guangdong commoditiesHaihao”) and
technologies
Guangzhou Haihao is the parent company of the Company and was established on September 27 2006. Mr.Xue Hua holds 39.75% of equity in Guangzhou Haihao and is the ultimate controller of the Company.The ultimate controlling party of the Company is Xue Hua.During the reporting period the changes in the registered capital of the parent company were as follows:
292(in RMB 10000)
2024.12.31 Additions Decreases 2025.12.31
3000.00--3000.00
2. Information on the subsidiaries of the Company
For information on the subsidiaries of the Company refer to Note VII.1.
3. Information on joint ventures and associates of the Company
For information on joint ventures and associates of the Company refer to Note VII.5.Other joint ventures and associates with which the Company had related party transactions during the current
period or which had balances arising from prior period related party transactions with the Company are as
follows:
Name of joint venture or associate Relationship with the Company
Bangpu Seed Industry Technology Co. Ltd. Associate the Group holds a 16% equity interest
Foshan Haihang Xingfa Agriculture and Animal Husbandry Associate the Group holds a 49%
Development Co. Ltd. equity interest
Wujiaqu Taikun Plant Protein Co. Ltd. Associate the Group holds a 35% equity interest
Alar Ruiliheng Biological Protein Co. Ltd. Associate the Group holds a 35% equity interest
Hutubi Tiankang Plant Protein Co. Ltd. Associate the Group holds a 35% equity interest
Beijing Haizhibao Pet Co. Ltd. Associate the Group holds a 49% equity interest
Qingdao Nongken Dahuang Trading Development Co. Ltd. Associate the Group holds a 30% equity interest
Sichuan Smart Fishing Machinery Technology Co. Ltd. Associate the Group holds a 40% equity interest
Weishi (Shandong) Biotechnology Co. Ltd. Associate the Group holds a 10% equity interest
Haid Cherry Valley Vietnam Co. Ltd. Joint venture the Group holds a 40% equity interest
4. Information on other related parties
Related party Relationship with the Company
Guangdong Haihaowan Development Co. Ltd. Controlled by the same ultimate controlling party
Guangzhou Haoan Biotechnology Development Co. Ltd. Controlled by the same ultimate controlling party
Guangzhou Haihao Investment Co. Ltd. Controlled by the same ultimate controlling party
Guangzhou Haikun Commercial Management Co. Ltd. Controlled by the same ultimate controlling party
Guangzhou Haihao Technology Industry Operation Co. Ltd. Controlled by the same ultimate controlling party
Guangzhou Haikun Smart Property Services Co. Ltd. Controlled by the same ultimate controlling party
Guangzhou Haoyue Biotechnology Development Co. Ltd. Controlled by the same ultimate controlling party
Mingzhong Chen Key management
2935. Transactions with related parties
(1) Purchases from and sales to related parties
* Purchase of goods and receipt of services
Related party Nature of transaction 2025 2024
Alar Ruiliheng Biological Protein Co. Ltd. Raw materials 108636272.93 119447505.13
Foshan Haihang Xingfa Agriculture and
Animal Husbandry Development Co. Ltd. Agricultural products 2165623.77 1194385.46
Haid Cherry Valley Vietnam Co. Ltd. and Agricultural products
its subsidiaries raw materials 3412382.07 2983877.87
Sichuan Smart Fishing Machinery Machinery and
Technology Co. Ltd. equipment 434189.67 9000.00
Wujiaqu Taikun Plant Protein Co. Ltd. Raw materials 101338139.54 124342200.95
Hutubi Tiankang Plant Protein Co. Ltd. Raw materials 223563219.16 23703063.38
Guangzhou Haikun Smart Property
Services Co. Ltd. Services 242563.00 -
Guangzhou Haoyue Biotechnology
Development Co. Ltd. Services 459650.31 -
* Sale of goods and rendering of services
Related party Nature of transaction 2025 2024
Alar Ruiliheng Biological Protein Co. Ltd. Services 180000.00 157500.00
Foshan Haihang Xingfa Agriculture and Feed animal health
Animal Husbandry Development Co. Ltd. products services and 99266756.63 81039019.20 others
Wujiaqu Taikun Plant Protein Co. Ltd. Services 180000.00 180000.00
Haid Cherry Valley Vietnam Co. Ltd. and Feed animal health
its subsidiaries products and fixed 88331486.39 75945665.16 assets
Hutubi Tiankang Plant Protein Co. Ltd. Services 240000.00 120000.00
Guangzhou Haoyue Biotechnology
Development Co. Ltd. Services 4586756.28 1279589.40
Sichuan Smart Fishing Machinery
Technology Co. Ltd. Services 38900.00 -
Bangpu Seed Industry Technology Co. Ltd. Raw materials 15685.00 -
Guangdong Haihaowan Development Co. Agricultural products
Ltd. services 9390.00 -
Guangzhou Haoan Biotechnology
Development Co. Ltd. Agricultural products 14219.20 -
Guangzhou Haoyue Biotechnology
Development Co. Ltd. Agricultural products 290628.70 -
Guangzhou Haihao Investment Co. Ltd. Services 25280.00 -
Weishi (Shandong) Biotechnology Co. Ltd. Intangible assets 2000000.00 -
Beijing Haizhibao Pet Co. Ltd. Pet food 7449399.31 -
Note: All transaction amounts above are inclusive of tax.
(2) Related party entrustment and contracting
During the reporting period the Group had no entrustment management contracting or contracting out
294arrangements with related parties.
(3) Leases
* As the lessor
Lessee Type of leased Lease income Lease income assets recognized in 2025 recognized in 2024
Guangzhou Haoyue Biotechnology
Development Co. Ltd. Buildings 1027092.00 -
Guangzhou Haihao Investment
Co. Ltd. Buildings 73872.00 73872.00
* As the lessee
Lessor Type of leased
Lease Lease
assets expenses expenses paid in 2025 paid in 2024
Mingzhong Chen Buildings 1565840.00 1502360.00
Guangzhou Haikun Commercial Management
Co. Ltd. Buildings 879266.61 -
Guangzhou Haihao Technology Industry
Operation Co. Ltd. Buildings 879266.62 -
Guangzhou Haoyue Biotechnology
Development Co. Ltd. Buildings 62906891.90 34596750.00
Right-of-use assets newly added by the Company as lessee during the year:
Lessor Type of leased assets 2025 2024
Mingzhong Chen Buildings - 2877418.68
Guangzhou Haikun Commercial Management
Co. Ltd. Buildings 16081063.85 -
Guangzhou Haoyue Biotechnology
Development Co. Ltd. Buildings 32572646.94 526740682.41
Interest expenses recognized on lease liabilities by the Company as lessee for the year:
Lessor Type of leased
Interest expenses Interest expenses
assets recognized in recognized in 2025 2024
Mingzhong Chen Buildings 37084.00 48183.44
Guangzhou Haikun Commercial
Management Co. Ltd. Buildings 83831.99 -
Guangzhou Haihao Technology Industry
Operation Co. Ltd. Buildings 130472.36 -
Guangzhou Haoyue Biotechnology
Development Co. Ltd. Buildings 18888365.58 14597194.16
(4) Related party guarantees
During the reporting period the Group had no guarantee arrangements with related parties either as
guarantor or beneficiary.
(5) Related party borrowing and lending
During the reporting period the Group had no fund borrowing or lending arrangements with related parties.
295(6) Related party asset transfers and debt restructuring
During the reporting period the Group had no asset transfers or debt restructuring with related parties.
(7) Remuneration of key management personnel
The Company had 19 key management personnel during the current period and 22 during the prior period.Details of their compensation are listed below:
(in RMB 10000)
Item 2025 2024
Remuneration of key management personnel 13054.87 12788.08
(8) Other related party transactions
During the reporting period the Group had no other significant related party transactions.
6. Receivables from and payables to related parties
(1) Receivables from related parties
2025.12.312024.12.31
Item Related party
Book value Loss allowance Book value
Loss
allowance
Foshan Haihang Xingfa
Accounts Agriculture and Animal
receivable Husbandry Development Co. 122652.84 3924.89 - -
Ltd.Accounts Guangdong Haihaowan
receivable Development Co. Ltd. 2040.00 65.28 - -
Accounts Guangzhou Haoan
receivable Biotechnology Development 7207.20 230.63 - - Co. Ltd.Accounts Guangzhou Haoyue
receivable Biotechnology Development 3043947.07 97406.30 94671.40 2356.20 Co. Ltd.Accounts Guangzhou Haihao
receivable Investment Co. Ltd. 5540.00 177.28 - -
Prepayment Alar Ruiliheng Biological Protein Co. Ltd. 11618634.63 - 12712663.25 -
Prepayment Hutubi Tiankang Plant Protein Co. Ltd. 4620684.69 - 3883436.62 -
Prepayment Wujiaqu Taikun Plant Protein Co. Ltd. 5992524.29 - 6332752.00 -
Long-term
receivables Mingzhong Chen 333270.00 - 333270.00 -
Foshan Haihang Xingfa
Long-term Agriculture and Animal
receivables Husbandry Development Co. 20000.00 - - -
Ltd.Long-term Guangzhou Haihao
receivables Technology Industry 1055149.05 - - - Operation Co. Ltd.Long-term Guangzhou Haikun Smart
receivables Property Services Co. Ltd. 157665.95 - - -
2962025.12.312024.12.31
Item Related party
Book value Loss Loss allowance Book value allowance
Long-term Guangzhou Haoyue
receivables Biotechnology Development 16275294.00 - 15210000.00 - Co. Ltd.
(2) Payables to related parties
Item Related party 2025.12.31 2024.12.31
Notes payables Alar Ruiliheng Biological Protein Co. Ltd. - 5945000.00
Notes payables Wujiaqu Taikun Plant Protein Co. Ltd. - 10935000.00
Contract Foshan Haihang Xingfa Agriculture and
liabilities Animal Husbandry Development Co. Ltd. 2478048.48 878426.57
Account Foshan Haihang Xingfa Agriculture and
payables Animal Husbandry Development Co. Ltd. 172737.77 77453.38
Account Sichuan Smart Fishing Machinery
payables Technology Co. Ltd. - 1672.05
Long-term Guangzhou Haoyue Biotechnology
payables Development Co. Ltd. 171182.00 -
Other payables Guangzhou Haoyue Biotechnology Development Co. Ltd. 1813516.78 -
Contract
liabilities Beijing Haizhibao Pet Co. Ltd. 2963607.69 -
297XII. Share-based Payments
1. Summary of share-based payments
Granted during the Exercised during Vested during the Lapsed during the
Type of grantee current period the current period current period current period Number Number Number Number of
of shares Amount of shares Amount of shares Amount shares Amount
2021 Stock Option Incentive Plan – Initial Grant (Note 1) - - - - - - 7014854.67 196415930.67
2021 Stock Option Incentive Plan – Reserved Grant (Note 2) - - - - - - 1956390.00 31360931.70
2024 Stock Option Grant Plan (Note 3) - - - - - - 1073330.00 20880239.82
2024 Employee Stock Ownership Plan (Note 4) 80600.00 2959632.00 - - - - 104950.00 2469473.50
Total 80600.00 2959632.00 - - - - 10149524.67 251126575.69
Note 1: The initial grant under the 2021 Stock Option Incentive Plan lapsed during the current period because the vesting conditions for the fifth exercise period were not met
and certain grantees under the initial grant left the company or had their employment terminated causing their granted but unvested stock options to be cancelled during the
current period.Note 2: The reserved grant under the 2021 Stock Option Incentive Plan lapsed during the current period because the vesting conditions for the fourth exercise period were not
met and certain grantees under the reserved grant left the company or had their employment terminated causing their granted but unvested stock options to be cancelled
during the current period.Note 3: The 2024 Stock Option Grant Plan lapsed during the current period because certain grantees under the second exercise period left the company or had their employment
terminated causing their granted but unvested stock options to lapse.Note 4: The 2024 Employee Stock Ownership Plan lapsed during the current period as certain participants in the second vesting period left the company or had their employment
terminated causing their granted but unvested shares to lapse. The current period grants consist of shares re-granted to participants from the shares that lapsed in the second
vesting period.
298Outstanding stock options or other equity instruments as of December 31 2025
Stock options Other equity
outstanding at period instruments
end outstanding at
Type of grantee period end
Range of Remaining Range Remaining
exercise contractual of
prices term exercise
contractual
prices term
2021 Stock Option Incentive Plan – Initial Grant 59.21 5.33 months - -
2021 Stock Option Incentive Plan – Reserved Grant 59.21 4.50 months - -
2024 Stock Option Grant Plan 28.16 4.30 months - -
2. Equity-settled share-based payments
The fair value of the company’s stock options is
determined using the Black-Scholes option pricing
Method for determining fair value of equity model. The fair value of awards under the Employee
instruments at grant dates Stock Ownership Plan is determined based on the
difference between the closing price on the grant date
and the exercise price.Key assumptions for determining the fair value of Risk-free rate historical stock price volatility dividend
equity instruments at the date of grant yield
Basis for determining the number of vested equity When the equity instruments granted in each period
instruments satisfy the corresponding performance conditions stipulated by the company.Reasons for significant differences between
estimates in the current period and the prior period None
Accumulated equity-settled share-based payment
in capital reserve 727309130.55
3. Cash-settled share-based payments
During the reporting period the Group had no cash-settled share-based payments.
4. Expenses for share-based payment during the current period
Expenses for Expenses for
Type of grantee equity-settled cash-settled share-based share-based
payment payment
2021 Stock Option Incentive Plan – Initial Grant -140226973.10 -
2021 Stock Option Incentive Plan – Reserved Grant -20580615.24 -
2024 Stock Option Grant Plan 136263088.26 -
2024 Employee Stock Ownership Plan 36724814.55 -
Total 12180314.47 -
5. Modification and termination of share-based payments
During the reporting period the Group had no modifications or terminations of share-based payments.
299XIII. Commitments and Contingencies
1. Significant commitments
As of December 31 2025 the Company had no significant commitments to disclose.
2. Contingencies
Contingent liabilities and their financial impact arising from guarantees provided to other entities
As of December 31 2025 the Company provided guarantees for the loans of the following entities:
Name of guaranteed
entity Guarantee matters
Amount
(in RMB 10000) Term Note
1.Subsidiaries
Wholly-owned and Bank loan financing
controlled subsidiaries payables for raw material
within the scope of procurements and other 92568.07 1-10 years
consolidation non-financial guarantees
2. Other entities
Farmers distributors and
other customers of the
wholly-owned and Guarantees for customer
controlled subsidiaries borrowings to purchase 260243.79 1-3 years
within the scope of the company's products
consolidation
Total 352811.86
As of December 31 2025 the Group had no other significant contingencies to disclose.XIV. Post Balance Sheet Events
1. Significant non-adjustment events after the balance sheet date
As of April 24 2026 the Company had no significant non-adjusting subsequent events to disclose.
2. Profit distribution after balance sheet date
According to the dividend proposal approved by the Board of
Directors on April 24 2026 the Company intends to declare cash
Proposed profit distributions or dividends of RMB 11 per 10 shares (tax inclusive) based on the total
dividends shares outstanding as of the record date for the distribution net of repurchased shares (i.e. the number of shares eligible for distribution
on the record date). The proposal is subject to approval by the
shareholders' meeting.
3. Significant sales returns
As of April 24 2026 the Company had no material sales returns to disclose.
4. Other subsequent events
As of April 24 2026 the Company had no other subsequent events to disclose.XV. Other Significant Events
1. Segment reporting
In accordance with the Company's internal organizational structure management requirements and internal
300reporting system the Company's operations are organized into 5 reporting segments. These segments are
identified based on the financial information used for the Company's routine internal management. The
Group's management periodically reviews the operating results of these segments to make decisions
regarding resource allocation and performance evaluation.
(1) The Group's reporting segments are as follows:
Feed: production and sale of feed and related products;
Animal health: production and sale of animal health products and related products;
Farming: farming and sales of agricultural products and related products;
Trading: sale of raw materials related to feed and animal health;
Other: corporate headquarters and support functions for the above segments.Segment information is reported based on the accounting policies and measurement standards adopted by
each segment when reporting to management which are consistent with those used in preparing the financial
statements.
301(2) Segment profit or loss assets and liabilities
Current period /
Period-end Feed Animal health Farming Trading Other Elimination Total
Operating income 112302347079.40 1257977085.72 18038726322.96 12998939298.94 593086597.44 -16722845469.50 128468230914.96
Including: Income
from third party 105257615986.92 891050510.76 17958922847.61 4124515406.60 236126163.07 - 128468230914.96
Income from inter-
segment 7044731092.48 366926574.96 79803475.35 8874423892.34 356960434.37 -16722845469.50 -
Operating costs and
expenses 107229256849.68 1069995425.32 16923852366.62 13018494497.78 1590646658.07 -16911840376.26 122920405421.21
Net profit (note) 4320552832.64 161087391.31 1051306117.53 68733017.34 803457756.41 -1859743323.90 4545393791.33
Total assets 35808946883.36 2254601876.52 13756302554.10 3573560345.24 29030984078.67 -36833683852.78 47590711885.11
Total liabilities 17900885727.95 978590270.12 7316260658.50 1975753409.20 14883005841.52 -20963582752.97 22090913154.32
Note: During the current year the Group spun off its subsidiary Haid International Holdings Limited (hereinafter "Haid Holdings") for listing on the Main Board of the Stock
Exchange of Hong Kong Limited (hereinafter "HKEX"). As part of the equity restructuring under common control various segments were impacted leading to fluctuations
in the amount of inter-segment profit elimination at the Group level.Prior period /
Period-end Feed Animal health Farming Trading Other Elimination Total
Operating income 98684957926.61 1110204229.82 19079812184.45 14294905960.40 567220886.88 -19136044525.87 114601056662.29
Including:
Income from third 91202471546.02 845785008.00 18826479018.92 3435411501.16 290909588.19 - 114601056662.29
party
Income from inter-
segment 7482486380.59 264419221.82 253333165.53 10859494459.24 276311298.69 -19136044525.87 -
Operating costs and
expenses 94443388975.62 947128963.08 16996189842.16 14339913534.31 983498429.96 -19044929908.97 108665189836.16
Net profit 3644022612.00 137586963.00 1788351825.52 8606620.40 -74993680.31 -827478742.34 4676095598.27
Total assets 31890970128.26 1827989414.41 13147858556.00 4782622433.13 29582202340.00 -33091056212.10 48140586659.70
Total liabilities 16993832963.82 939861345.99 8252628078.71 3075114654.75 15687926997.03 -21905211050.53 23044152989.77
3022. Others
On October 16 2025 and November 14 2025 the Company held the Third Meeting of the Seventh Board
of Directors and the Fourth Extraordinary General Meeting of Shareholders in 2025 respectively. Proposal
on the Spin-off of the Company's Subsidiary Haid International Holdings Limited for Listing on the Main
Board of the Hong Kong Stock Exchange in Compliance with Applicable Laws and Regulations Proposal
on the Listing Plan for the Spin-off of Subsidiary Haid International Holdings Limited to the Main Board of
the Hong Kong Stock Exchange and Proposal on Guangdong Haid Group Co. Ltd.'s Preliminary Plan for
the Spin-off of Subsidiary Haid International Holdings Limited to the Main Board of the Hong Kong Stock
Exchange were approved. On January 12 2026 Haid Holdings submitted its application for an initial public
offering and listing on the Main Board of the Hong Kong Stock Exchange. As of the date of this report the
spin-off listing is still ongoing.XVI. Notes to the Company’s financial statements
1. Other receivables
Item 2025.12.31 2024.12.31
Interest receivable - -
Dividends receivable - 359974200.00
Other receivables 6028955843.98 9604639149.06
Total 6028955843.98 9964613349.06
(1) Dividends receivable
Item 2025.12.31 2024.12.31
Guangdong Haid Pet Co. Ltd. - 24240000.00
Liyang Jiuhe Feed Co. Ltd. - 22256000.00
Shandong Daxin Group Co. Ltd. - 214637700.00
Haid International Group Limited - 98840500.00
Subtotal - 359974200.00
Less: Loss allowance - -
Total - 359974200.00
(2) Other receivables
* Other receivables by aging
Aging 2025.12.31 2024.12.31
Within 1 year 5775584974.62 9145370367.41
1 to 2 years 170045301.89 454146513.35
2 to 3 years 81018090.15 2135000.00
3 to 4 years 1295000.00 2943510.00
4 to 5 years 1358510.00 354640.00
Subtotal 6029301876.66 9604950030.76
Less: Loss allowance 346032.68 310881.70
Total 6028955843.98 9604639149.06
303* Other receivables disclosed by nature
Item 2025.12.31 2024.12.31
Security deposits 620990.51 1773473.65
Receivable due from related parties within the scope of
consolidation 6008911687.51 9585943939.28
Petty cash 1937710.00 100739.66
Others 17831488.64 17131878.17
Total 6029301876.66 9604950030.76
* Additions recoveries or reversals of provision during the current period
The first stage The second stage The third stage
Lifetime expected Lifetime expected
Loss allowance Expected credit
losses over the credit losses (no credit losses (credit
Total
next 12 months credit impairment impairment has occurred) occurred)
Balance as of
December 31 310881.70 - - 310881.70
2024
Movement during
the current period:
- Transfer to the
second stage - - - -
- Transfer to the
third stage - - - -
- Reverse to the
second stage - - - -
- Reverse to the
first stage - - - -
Additions 860293.96 - - 860293.96
Reversals - - - -
Write-offs 825142.98 - - 825142.98
Balance as of
December 31 346032.68 - - 346032.68
2025
There were no significant recoveries or reversals of loss allowance during the current period.* There were no written-off in other receivables during the current period
304* Top five closing balances of other receivables by debtor
Proportion of the
Debtor Nature Other receivables as of Aging total closing balance Loss allowance as of December 31 2025 of other receivables December 31 2025
(%)
Company 6 Receivable due from related parties within the scope of consolidation 344741261.51 Within one year 5.72 -
Company 7 Receivable due from related parties within the scope of consolidation 239644416.66 Within one year 3.97 -
Company 8 Receivable due from related parties within the scope of consolidation 210514861.83 Within one year 3.49 -
Company 9 Receivable due from related parties within the scope of consolidation 187928353.19 Within one year 3.12 -
Company 10 Receivable due from related parties within the scope of consolidation 169945297.93 Within one year 2.82 -
Total 1152774191.12 19.12 -
2. Long-term equity investments
2025.12.312024.12.31
Item
Book value Provision for Provision for impairment Carrying amount Book value impairment Carrying amount
Investment in subsidiaries 14515881706.36 891834588.15 13624047118.21 11192202066.55 78999515.19 11113202551.36
Investment in associates 9859735.05 - 9859735.05 9864033.29 - 9864033.29
Total 14525741441.41 891834588.15 13633906853.26 11202066099.84 78999515.19 11123066584.65
(1) Investment in subsidiaries
2024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Guangzhou Runchuan
Investment Co. Ltd. 1469812949.78 - - - - - 1469812949.78 -
3052024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Guangzhou Yitun Pig
Industry Investment Co. 13081285.78 - - - - 1750613.66 14831899.44 -
Ltd.Enping Fengwo
Agriculture and Animal 962305.66 - - - - 63691.19 1025996.85 -
Husbandry Co. Ltd.Yangxi Fengwo
Ecological Agriculture 1736959.73 - - - - 97203.52 1834163.25 -
Co. Ltd.Yangjiang Yangdong
Fengwo Agriculture and
Animal Husbandry Co. 462493.51 - - - - 125105.33 587598.84 -
Ltd.Enping Yitun Ecological
Agriculture Co. Ltd. 797157.26 - - - - 154461.96 951619.22 -
Gaozhou Sanhe Animal
Husbandry Co. Ltd. 587308.10 - - - - -305407.34 281900.76 -
Yingde Yitun Ecological
Agriculture Co. Ltd. 273007.44 - - - - -90619.54 182387.90 -
Hunan Yitun Ecological
Agriculture Co. Ltd. 1708546.63 - - - - 58850.11 1767396.74 -
Yueyang Yitun
Agriculture and Animal 728595.71 - - - - -123524.83 605070.88 -
Husbandry Co. Ltd.Guigang Tantang Yitun
Ecological Agriculture 12282.92 - - - - - 12282.92 -
Co. Ltd.Pingnan Yitun
Ecological Agriculture 1297701.52 - - - - -194791.55 1102909.97 -
Co. Ltd.Pingguo Yitun
Ecological Agriculture 270847.14 - - - - 31430.32 302277.46 -
Co. Ltd.
3062024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Hengshan Yitun
Ecological Agriculture 1554044.70 - - - - -33544.92 1520499.78 -
Co. Ltd.Guigang Gangbei Yitun
Ecological Agriculture 1053913.93 - - - - 74663.68 1128577.61 -
Co. Ltd.Duyun Yitun Ecological
Agriculture Co. Ltd. 818163.63 - - - - -51782.71 766380.92 -
Rongjiang Yitun
Ecological Agriculture 124591.82 - - - - -204.06 124387.76 -
Co. Ltd.Binyang Yitun
Ecological Agriculture 1126196.68 - - - - -141995.26 984201.42 -
Co. Ltd.Yicheng Yitun
Ecological Agriculture 781013.51 - - - - -14128.33 766885.18 -
Co. Ltd.Zixing Yitun Ecological
Agriculture Co. Ltd. 362219.01 - - - - 75401.14 437620.15 -
Guigang Donghuang
Breeding Co. Ltd. 317786.53 - - - - -6030.15 311756.38 -
Shaoguan Zhenjiang
Yitun Ecological 1546796.39 - - - - -51491.27 1495305.12 -
Agriculture Co. Ltd.Laizhou Zhizhuren
Animal Husbandry Co. 370052.84 - - - - 14060.43 384113.27 -
Ltd.Qinzhou Yitun
Ecological Agriculture 177828.44 - - - - 46536.48 224364.92 -
Co. Ltd.Feicheng Heruifeng
Agricultural Technology 620268.90 - - - - -620268.90 - -
Co. Ltd.
3072024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Weifang Xuheng
Agricultural Technology 164526.50 - - - - -164526.50 - -
Co. Ltd.Guizhou Aikexin Pig
Breeding Co. Ltd. 767112.17 - - - - 200585.93 967698.10 -
Binyang Heji Yitun
Ecological Agriculture 217908.03 - - - - 888.84 218796.87 -
Co. Ltd.Huayuan Yitun
Ecological Agriculture 158375.10 - - - - -1128.91 157246.19 -
Co. Ltd.Yingde Yitun Pig
Breeding Co. Ltd. 32196.87 - - - - -5677.88 26518.99 -
Hengnan Yitun
Ecological Agriculture 187735.04 - - - - 3311.52 191046.56 -
Co. Ltd.Longan Yitun Ecological
Agriculture Co. Ltd. 198481.89 - - - - 34891.93 233373.82 -
Youxian Yitun
Ecological Agriculture 103950.40 - - - - 102469.96 206420.36 -
Co. Ltd.Wengyuan Yitun Pig
Breeding Co. Ltd. 4214.88 - - - - -1510.70 2704.18 -
Fufeng Yitun Ecological
Agriculture Co. Ltd. 687298.93 - - - - -19714.43 667584.50 -
Linyou Yitun Ecological
Agriculture Co. Ltd. 215906.39 - - - - -82619.23 133287.16 -
Yantai Yitun Ecological
Agriculture Co. Ltd. 375981.52 - - - - 36712.25 412693.77 -
Yantai Zhizhuren
Animal Husbandry Co. 166823.49 - - - - -9062.67 157760.82 -
Ltd.
3082024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Hunan Yitun Technology
Co. Ltd. 279672.25 - - - - 68635.92 348308.17 -
Pingnan Haid Feed Co.Ltd. 213353.54 - - - - 248625.55 461979.09 -
Heyuan Yitun
Agricultural 273060.09 - - - - -67304.57 205755.52 -
Development Co. Ltd.Yangjiang Peiqi
Breeding Services Co. 85120.46 - - - - 111866.81 196987.27 -
Ltd.Weifang Yitun
Ecological Agriculture 13196.97 - - - - -12625.51 571.46 -
Co. Ltd.Guilin Yitun Ecological
Agriculture Co. Ltd. 46189.43 - - - - 15749.13 61938.56 -
Hengyang Jisheng
Agriculture and Animal
Husbandry Development 141556.43 - - - - 18215.40 159771.83 -
Co. Ltd.Chuzhou Yitun
Ecological Agriculture 34641.99 - - - - 52033.60 86675.59 -
Co. Ltd.Zhangzhou Yitun
Ecological Agriculture 23754.56 - - - - 32677.69 56432.25 -
Development Co. Ltd.Ji'an Yitun Ecological
Agriculture Co. Ltd. - - - - - 3943.32 3943.32 -
Meizhou Yikang Pig
Breeding Technology - - - - - 5520.64 5520.64 -
Co. Ltd.Qingdao Daxin Yitun
Ecological Agriculture - - - - - 1971.66 1971.66 -
Co. Ltd.
3092024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Ruyuan Yitun Pig
Breeding Co. Ltd. 86281.83 - - - - 62406.53 148688.36 -
Shaoguan Zhenjiang
Yixian Food Co. Ltd. - - - - - 8675.30 8675.30 -
Guangdong Yitun
Supply Chain 2453990.93 - - - - -2453990.93 - -
Management Co. Ltd.Luoding Yitun
Ecological Agriculture 438152.44 - - - - 100741.65 538894.09 -
Co. Ltd.Gaozhou Haiyuan
Agricultural Co. Ltd. 301024.39 - - - - -74203.89 226820.50 -
Sichuan Hailinge
Biopharmaceutical Co. 1952652.15 - - - - -375138.95 1577513.20 -
Ltd.Guangzhou Xitun
Agricultural Investment - - - - - 41050.57 41050.57 -
Co. Ltd.Hunan Xitun Ecological
Agriculture Co. Ltd. - - - - - 10777.43 10777.43 -
Guangdong Xitun
Ecological Agriculture - - - - - 5599.51 5599.51 -
Co. Ltd.Guangxi Xitun
Ecological Agriculture - - - - - 5520.64 5520.64 -
Co. Ltd.Hubei Xitun Ecological
Agriculture Co. Ltd. - - - - - 2365.99 2365.99 -
Binchuan Yitun
Ecological Agriculture - - - - - 3943.32 3943.32 -
Co. Ltd.
3102024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Shicheng Yitun
Ecological Agriculture - - - - - 3470.12 3470.12 -
Co. Ltd.Gaotang Huayu Pig
Farming Co. Ltd. 110436.17 - - - - -89647.76 20788.41 -
Mianyang Yitun
Ecological Agriculture - - - - - 18917.77 18917.77 -
Co. Ltd.Guangzhou Peiqi
Investment Co. Ltd. - - - - - 30284.68 30284.68 -
Qinzhou Peiqi Breeding
Services Co. Ltd. - - - - - 2444.86 2444.86 -
Yantai Peiqi Breeding
Services Co. Ltd. - - - - - 4653.11 4653.11 -
Hunan Haiyue
Ecological Agriculture - - - - - 2365.99 2365.99 -
Co. Ltd.Guangzhou Haiwei Feed
Co. Ltd. 18063234.27 - - - - 161589.99 18224824.26 -
Guangzhou Rongchuan
Feed Co. Ltd. 15450021.72 - - - - -39272.23 15410749.49 -
Foshan Haihang Feed
Co. Ltd. 25667260.30 - - - - 206271.55 25873531.85 -
Maoming Haihang Feed
Co. Ltd. 590763.15 - - - - 49032.45 639795.60 -
Guangzhou Dachuan
Feed Co. Ltd. 19744622.75 - - - - -899754.77 18844867.98 -
Hubei Haid Feed Co.Ltd. 36130690.43 - - - - -533003.26 35597687.17 -
Guangdong Hinter
Biotechnology Group 90195492.42 - - - - -625740.50 89569751.92 -
Co. Ltd.
3112024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Guangzhou
Haishengyuan 11642.38 - - - - - 11642.38 -
Biotechnology Co. Ltd.Guangzhou Mutai Feed
Technology Co. Ltd. 1111646.25 - - - - -1111646.25 - -
Zhuhai Haiyiyuan
Supply Chain 453752.01 - - - - 471469.13 925221.14 -
Management Co. Ltd.Shaanxi Haid
Agriculture and Animal 13610625.50 - - - - -25399.29 13585226.21 -
Husbandry Co. Ltd.Yangling Haid Feed Co.Ltd. 316027.94 - - - - -38672.62 277355.32 -
Gansu Haid Feed Co.Ltd. 409687.15 - - - - 132196.98 541884.13 -
Weinan Haid Feed Co.Ltd. 351597.97 - - - - 121430.44 473028.41 -
Wuwei Haid Feed Co.Ltd. 38100.09 - - - - 9445.98 47546.07 -
Baoji Haid Agriculture
and Animal Husbandry 140548.27 - - - - 94283.64 234831.91 -
Co. Ltd.Hunan Haid Biological
Feed Co. Ltd. 21672336.78 - - - - -246183.67 21426153.11 -
Guangzhou Haihe Feed
Co. Ltd. 107692400.00 - - - - - 107692400.00 -
Anyang Haiyue Feed
Technology Co. Ltd. 90542.17 - - - - -58888.97 31653.20 -
Lanzhou Haid Feed Co.Ltd. 25785.02 - - - - - 25785.02 -
Yichang Haid Feed Co.Ltd. 785058.85 - - - - 138469.69 923528.54 -
3122024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Foshan Haipu Feed Co.Ltd. 7821924.92 - - - - -91530.24 7730394.68 -
Qingyuan Haibei
Biotechnology Co. Ltd. 23259696.31 - 390000000.00 - - 158765.70 413418462.01 -
Zhanjiang Haid Feed
Co. Ltd. 26167233.00 - - - - -532341.67 25634891.33 -
Jiangmen Haid Feed
Co. Ltd. 87598911.63 - - - - -295649.62 87303262.01 -
Chengdu Haid
Biotechnology Co. Ltd. 20271256.01 - - - - -60038.40 20211217.61 -
Taizhou Haid Biological
Feed Co. Ltd. 24936412.17 - - - - 42762.75 24979174.92 -
Jingzhou Haid Feed Co.Ltd. 18879928.58 - - - - -255741.79 18624186.79 -
Ezhou Haid Feed Co.Ltd. 6292873.11 - - - - 861.98 6293735.09 -
Dongguan Haid Feed
Co. Ltd. 24741358.89 - - - - -110515.65 24630843.24 -
Fujian Haid Feed Co.Ltd. 16173131.88 - - - - 274056.33 16447188.21 -
Zhejiang Haid Feed Co.Ltd. 13804152.44 - - - - -266289.76 13537862.68 -
Guangxi Haid Feed Co.Ltd. 21483206.97 - - - - -255083.14 21228123.83 -
KINGHILL
HOLDINGS PTE.LTD. 965763140.32 - 254770689.80 - - - 1220533830.12 -
Haid Egypt Co. Ltd. 350268.87 - - - - -134411.12 215857.75 -
PT.HAIDA
AGRICULTURE 989324.94 - - - - - 989324.94 -
INDONESIA
PT.HAIDA SURABAYA
TRADING 71468.91 - - - - - 71468.91 -
3132024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
PT HISENOR
TECHNOLOGY 135306.68 - - - - - 135306.68 -
INDONESIA
Jiangxi Haid Feed Co.Ltd. 76969655.44 - - - - -394569.03 76575086.41 -
Guangzhou Haid Feed
Co. Ltd. 14219054.97 - - - - -112127.20 14106927.77 -
Guangdong Hisenor
Group Co. Ltd. 9302745.51 - - - - -308932.54 8993812.97 -
Zhanjiang Hisenor
Marine Biotechnology 1365867.84 - - - - -249346.49 1116521.35 -
Co. Ltd.Zhanjiang Haijingzhou
Marine Biotechnology 327538.66 - - - - -67127.10 260411.56 -
Co. Ltd.Hainan Hisenor Marine
Biotechnology Co. Ltd. 3378630.25 - - - - -693332.28 2685297.97 -
Zhangzhou Haijingzhou
Marine Biotechnology 664403.03 - - - - -69308.88 595094.15 -
Co. Ltd.Nantong Haijingzhou
Biotechnology Co. Ltd. 209357.29 - - - - -7978.44 201378.85 -
Shanwei Haijingzhou
Marine Biotechnology 584544.86 - - - - -65145.58 519399.28 -
Co. Ltd.Guangzhou Hailingxian
Food Co. Ltd. 61838.87 - - - - 14353.45 76192.32 -
Dongying Haijingzhou
Biotechnology Co. Ltd. 160202.47 - - - - -25899.99 134302.48 -
Zhuhai Hisenor Aquatic
Seed Industry 17456629.77 - - - - 3713679.83 21170309.60 -
Technology Co. Ltd.
3142024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Tangshan Haijingzhou
Biotechnology Co. Ltd. 46705.54 - - - - -6909.71 39795.83 -
Yancheng Haize Seed
Industry Technology 26393.96 - - - - 37132.26 63526.22 -
Co. Ltd.Huizhou Haizenong
Marine Biotechnology 29033.35 - - - - 38156.14 67189.49 -
Co. Ltd.Zhaoqing Haizehui
Fishery Development 46068.77 - - - - -2163.61 43905.16 -
Co. Ltd.Guangzhou Nansha
Haishengyuan
Aquaculture Technology - - - - - 8607.16 8607.16 -
Co. Ltd.Guangzhou Haizexin
Marine Biotechnology - - - - - 17506.07 17506.07 -
Co. Ltd.Shanwei Haizenong
Marine Biotechnology 44973.57 - - - - -44973.54 0.03 -
Co. Ltd.Yongji Haijingzhou
Fishery Technology Co. 149894.45 - - - - -46157.99 103736.46 -
Ltd.Jingtai Haijingzhou
Fishery Technology Co. 122296.76 - - - - -47039.68 75257.08 -
Ltd.Shanwei Haizexin
Marine Biotechnology - - - - - 2839.19 2839.19 -
Co. Ltd.Qingyuan Haizehui
Fishery Technology Co. 77431.18 - - - - -14201.25 63229.93 -
Ltd.
3152024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Raoping Haizexin
Marine Biotechnology 8266.91 - - - - 3430.69 11697.60 -
Co. Ltd.Jiangmen Haizenong
Marine Biotechnology - - - - - 7358.93 7358.93 -
Co. Ltd.Zhuhai Haizexin Marine
Biotechnology Co. Ltd. 20455.35 - - - - -10499.86 9955.49 -
Zahnjiang Haizexin
Marine Biotechnology - - - - - 5599.51 5599.51 -
Co. Ltd.Guangdong Bairong
Aquatic Breeding Group 2570261.37 - - - - -215949.59 2354311.78 -
Co. Ltd.Yangxin Bairong
Aquatic Seed Co. Ltd. 816683.80 - - - - -112334.89 704348.91 -
Jingzhou Bairong
Aquatic Seed Co. Ltd. 371076.17 - - - - -68896.22 302179.95 -
Shandong Bairong
Aquatic Seed Co. Ltd. 749604.09 - - - - -147577.76 602026.33 -
Hainan Bairong Aquatic
Seed Co. Ltd. 602319.69 - - - - -107521.81 494797.88 -
Zhaoqing Baishengyuan
Aquatic Seed Co. Ltd. 221174.17 - - - - 17646.03 238820.20 -
Guangdong
Baishengyuan Aquatic 219865.74 - - - - 65705.77 285571.51 -
Seed Co. Ltd.Rongcheng Rongchuan
Biotechnology Co. Ltd. 474124.60 - - - - 199958.99 674083.59 -
Zhenyuan Haisheng
Protein Feed Co. Ltd. 23094.76 - - - - 33111.85 56206.61 -
Guangze Haisheng
Biotechnology Co. Ltd. 46189.52 - - - - 66223.70 112413.22 -
3162024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Haid Supply Chain
Management (Zhuhai) 27012492.52 - - - - 4015249.27 31027741.79 -
Co. Ltd.Sanya Fengmu
Agricultural 40873.75 - - - - 17351.95 58225.70 -
Development Co. Ltd.Guangzhou Anan
Logistics Co. Ltd. 328934.69 - - - - 8159.02 337093.71 -
Xiyu Haisheng
(Guangzhou) Supply 146963.14 - - - - 77976.17 224939.31 -
Chain Co. Ltd.Sihui Haifeng
Ecological Agriculture 628584.46 - - - - 102584.85 731169.31 -
Co. Ltd.Ezhou Haifeng
Ecological Agriculture 236610.02 - - - - 40041.89 276651.91 -
Co. Ltd.Sichuan Haimufeng
Agriculture Co. Ltd. 127998.91 - - - - 12215.34 140214.25 -
Hailet (Zhengzhou)
Biotechnology Co. Ltd. - - - - - 82816.23 82816.23 -
Rongcheng Haituo
Biotechnology Co. Ltd. - - - - - 2444.86 2444.86 -
Maoming Hailong Feed
Co. Ltd. 13451937.68 - - - - 144896.46 13596834.14 -
Nanchang Haid
Biotechnology Co. Ltd. 7045141.83 - - - - -191573.09 6853568.74 -
Zhuhai Rongchuan Feed
Co. Ltd. 44006303.84 - - - - -964229.24 43042074.60 -
Jieyang Haid Feed Co.Ltd. 5078194.08 - - - - -373402.97 4704791.11 -
3172024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Zhuhai Ronghai
Breeding Technology 200187.85 - - - - -27337.37 172850.48 -
Co. Ltd.Foshan Sanshui Fanling
Feed Co. Ltd. 16731675.00 - - - - 67320.94 16798995.94 -
Dalian Haid Rongchuan
Trading Co. Ltd. 50591641.39 - - - -32178.11 -3413.04 50556050.24 32178.11
Haid International
Group Limited 244673774.32 - - - - -55575.75 244618198.57 -
HAID FEED
COMPANY LIMITED 726642.02 - - - - -178002.23 548639.79 -
DONG NAI HAID
FARM COMPANY 58310.36 - - - - -31055.68 27254.68 -
LIMITED
SHENG LONG
INTERNATIONAL 262308.02 - - - - - 262308.02 -
LTD.SHENG LONG BIO-
TECH
INTERNATIONAL 3242604.22 - - - - 473488.12 3716092.34 -
CO. LTD
SHENG LONG
BIOTECH (HAI
DUONG) 50808.40 - - - - 75882.36 126690.76 -
INTERNATIONAL
CO. LTD
LONG SHENG
INTERNATIONAL 213973.95 - - - - -8833.27 205140.68 -
CO. LTD.THANG LONG(VINH
LONG)BIOTECH CO. 205303.66 - - - - 31860.87 237164.53 -
LTD.
3182024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Changzhou Haid
Biological Feed Co. 31479370.35 - - - - -299244.68 31180125.67 -
Ltd.Tianjin Haid Feed Co.Ltd. 152344872.36 - - - - -68506.19 152276366.17 -
Jiangmen Xinhui Aote
Animal Feed Co. Ltd. 26348419.03 - - - - -139068.85 26209350.18 -
Tianmen Haid Feed Co.Ltd. 10305837.32 - - - - -25122.23 10280715.09 -
Zhuhai Hailong
Biotechnology Co. Ltd. 21046314.57 - - - - -862018.42 20184296.15 -
Yangjiang Haid Feed
Co. Ltd. 10107356.68 - - - - -867375.20 9239981.48 -
Hengyang Yunyi
Biotechnology Co. Ltd. 173460.56 - - - - 226202.88 399663.44 -
Sanming Haid Feed Co.Ltd. 36252260.06 - - -35000000.00 - 14765.90 1267025.96 -
Guigang Haid Feed Co.Ltd. 8766834.94 - - - - -423436.63 8343398.31 -
Yiyang Haid Feed Co.Ltd. 14135965.96 - - - - 332526.63 14468492.59 -
Yiyang Dachuan Feed
Co. Ltd. 74811.45 - - - - -74811.45 - -
Nantong Haid
Biotechnology Co. Ltd. 107790602.01 - - - - 127750.68 107918352.69 -
Yunnan Haid
Biotechnology Co. Ltd. 9733943.23 - - - - -361603.22 9372340.01 -
Guangdong Mutai
Biotechnology Co. Ltd. 13989181.94 - - - - 1305648.62 15294830.56 -
Zhaoqing Haid Feed
Co. Ltd. 5877470.15 - - - - -24687.78 5852782.37 -
Wuhan Shuijiyuan
Biotechnology Co. Ltd. 5615105.56 - - - - -30707.48 5584398.08 -
3192024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Shenzhen Longreat
Trading Co. Ltd. 1582218.69 - - - - 56972.00 1639190.69 -
LANKING PTE.LTD. 726198089.14 - 173104079.00 - - - 899302168.14 -
Haid Lanking
International Trading 134228.04 - - - - -101049.65 33178.39 -
Inc.SHENGLONG BIO-
TECH(INDIA)PRIVATE 905752.94 - - - - -36931.72 868821.22 -
LIMITED
HAI DUONG HAID
COMPANY LIMITED 1015307.91 - - - - -333913.90 681394.01 -
HAI DAI COMPANY
LIMITED 30280.95 - - - - -839.91 29441.04 -
VINH LONG HAI DAI
CO. LTD. 399268.33 - - - - -248881.88 150386.45 -
BINH DINH HAI
LONG CO. LTD. 37368.15 - - - - 40039.83 77407.98 -
Hunan Dongting Haid
Feed Co. Ltd. 22745284.01 - - - - -261607.84 22483676.17 -
Zhangzhou Haid Feed
Co. Ltd. 18726419.61 - - - - -105267.57 18621152.04 -
Anhui Haid Feed Co.Ltd. 12829623.22 - - - - 94363.76 12923986.98 -
Xiangtan Haid Feed Co.Ltd. 22140494.46 - - - - -90634.52 22049859.94 -
Guangzhou Changsheng
Logistics Co. Ltd. 10674540.93 - - - - 25794.67 10700335.60 -
Guangdong Haid Pet
Co. Ltd. 500000.00 - 9500000.00 - - - 10000000.00 -
Haid Pet Food (Weihai)
Co. Ltd. 259721.09 - - - - -41306.33 218414.76 -
3202024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Shandong Haiding
Agriculture and Animal 60059410.19 - - - - 356138.74 60415548.93 -
Husbandry Co. Ltd.Suixian Yuliang Haiding
Feed Co. Ltd. 358810.23 - - - - 163764.00 522574.23 -
Yuncheng Haiding
Hongda Feed Co. Ltd. 530419.85 - - - - -19281.83 511138.02 -
Jinan Haiding
Agriculture and Animal 82307.81 - - - - 5472.79 87780.60 -
Husbandry Co. Ltd.Liaocheng Haiding Feed
Co. Ltd. 571246.21 - - - - 87918.64 659164.85 -
Yucheng Haiding
Agriculture and Animal - - - - - 3154.65 3154.65 -
Husbandry Co. Ltd.Shanxian Zhongyi
Haiding Feed Co. Ltd. 1323453.13 - - - - 165324.20 1488777.33 -
Xinxiang Haiding Feed
Co. Ltd. 157667.21 - - - - 99877.44 257544.65 -
Xinxiang Hairuida Feed
Co. Ltd. 138060.45 - - - - 27377.95 165438.40 -
Heze Haiding Feed
Technology Co. Ltd. 1385855.59 - - - - 105408.78 1491264.37 -
Jining Haiding Feed Co.Ltd. 775977.00 - - - - 293252.46 1069229.46 -
Feixian Hairuida Feed
Co. Ltd. 883651.16 - - - - 62552.43 946203.59 -
Yinan Haiding Feed Co.Ltd. 711294.05 - - - - 202786.25 914080.30 -
Tengzhou Fengcheng
Feed Co. Ltd. 280731.52 - - - - -53653.01 227078.51 -
Binzhou Haiding Feed
Co. Ltd. 479772.63 - - - - 63439.17 543211.80 -
3212024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Linyi Haiding Feed
Technology Co. Ltd. 452321.55 - - - - 7395.87 459717.42 -
Linyi Hedong Haiding
Agriculture and Animal
Husbandry Development 461495.74 - - - - 187891.28 649387.02 -
Co. Ltd.Junan Haiding Feed Co.Ltd. 260904.55 - - - - -39200.75 221703.80 -
Sihong Haiding Feed
Co. Ltd. 150082.34 - - - - 11664.34 161746.68 -
Linyi Dingxin Breeding
Co. Ltd. 184691.96 - - - - -130487.49 54204.47 -
Henan Haiding Feed
Co. Ltd. 337992.32 - - - - 240949.94 578942.26 -
Qingzhou Haidinghe
Xinsheng Feed Co. Ltd. 479668.91 - - - - 63607.60 543276.51 -
Linyi Haiding Lusheng
Feed Co. Ltd. 109144.21 - - - - 18258.55 127402.76 -
Qinggang Fengcheng
Baizun Feed Co. Ltd. 26393.96 - - - - 37842.05 64236.01 -
Chengwu Fengcheng
Feed Co. Ltd. 34939.42 - - - - 44827.64 79767.06 -
Weifang Binhai Haiding
Feed Co. Ltd. 4355.43 - - - - -839.91 3515.52 -
Linyi Dinghao Breeding
Co. Ltd. 68061.08 - - - - -31769.05 36292.03 -
Xuzhou Hairuida Feed
Co. Ltd. 41647.75 - - - - 22062.46 63710.21 -
Xuzhou Zhongyi
Haiding Agriculture and
Animal Husbandry Co. 74546.00 - - - - 70617.31 145163.31 -
Ltd.
3222024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Lanling Haiding
Hekangyuan Agriculture
and Animal Husbandry 125818.24 - - - - -10662.78 115155.46 -
Co. Ltd.Linyi Haiding Biological
Feed Co. Ltd. 76927.13 - - - - - 76927.13 -
Gaotang Haiding
Agriculture and Animal 165713.76 - - - - 56245.01 221958.77 -
Husbandry Co. Ltd.Qingdao Dinghao
Fengying International 27367.49 - - - - 0.00 27367.49 -
Trade Co. Ltd.Juxian Haiding Feed
Co. Ltd. 215603.47 - - - - 161087.32 376690.79 -
Liaocheng Fengcheng
Feed Co. Ltd. - - - - - 4073.79 4073.79 -
Zhuhai Fengcheng
Supply Chain - - - - - 40845.22 40845.22 -
Management Co. Ltd.Dalian Haiding
Jinyifeng Feed Co. Ltd. - - - - - 23473.07 23473.07 -
Yingkou Dachuan Feed
Technology Co. Ltd. 12825935.88 - - -12000000.00 - -154835.18 671100.70 -
Shandong Fengying
Food Co. Ltd. 518834.46 - - - - 67061.55 585896.01 -
Jiaxiang Haiying Food
Co. Ltd. 92572.09 - - - - -21304.78 71267.31 -
Linxi Haiying Food Co.Ltd. 114968.67 - - - - 14720.53 129689.20 -
Yiyuan Haiying Food
Co. Ltd. 124197.66 - - - - -25801.66 98396.00 -
Zouping Haiying Food
Co. Ltd. 158354.52 - - - - -2652.51 155702.01 -
3232024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Xishui Haid Feed Co.Ltd. 5739477.00 - - - - 192572.72 5932049.72 -
Yancheng Haid
Biological Feed Co. 31685299.33 - - - - -204568.17 31480731.16 -
Ltd.Honghu Haid Feed Co.Ltd. 9042293.93 - - - - -155325.46 8886968.47 -
Kaifeng Haid Feed Co.Ltd. 31822368.39 - - - - -51356.35 31771012.04 -
Guangzhou Heshengtang
Biotechnology Co. Ltd. 3330000.00 - - - -127116.22 - 3202883.78 127116.22
Guangzhou Heshengtang
Animals Pharmaceutical 22315164.73 - - - - -642272.87 21672891.86 -
Co. Ltd.Guangdong Hairui
Biotechnology Co. Ltd. 78152643.87 5809578.76 40000000.00 - - -599945.81 117552698.06 5809578.76
Henan Haihe Agriculture
and Animal Husbandry 6822139.46 - - - - -39816.08 6782323.38 -
Technology Co. Ltd.Anyang Haihe
Agriculture and Animal
Husbandry Technology 340456.55 - - - - 35424.84 375881.39 -
Co. Ltd.Henan Mugaole Feed
Co. Ltd. 537544.29 - - - - 130829.03 668373.32 -
Hexin Technology
(Henan) Co. Ltd. - - - - - 25623.10 25623.10 -
Suqian Haid Feed Co.Ltd. 22769264.61 - - - - -136760.75 22632503.86 -
Huaihua Haid Feed Co.Ltd. 15341427.60 - - - - -158831.29 15182596.31 -
3242024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Guangzhou Meinong
Investment Management 7878629.33 - - -7878629.33 - - - -
Co. Ltd.Guangdong Hairuite
Supply Chain 24145921.75 - - - - 2750518.47 26896440.22 -
Management Co. Ltd.Guangzhou Haijian
Investment Co. Ltd. 121500000.00 - - -121500000.00 - - - -
Hunan Innovation
Biotechnology Co. Ltd. 71235562.22 - - - -4075623.47 -106372.39 67053566.36 4075623.47
Qingyuan Haid
Biotechnology Co. Ltd. 13962339.80 - - - - -865462.16 13096877.64 -
Xuancheng Haid
Biotechnology Co. Ltd. 5778794.01 - - - - 21472.94 5800266.95 -
Guangdong Shunde
Haid Biotechnology Co. 5676151.24 - - -5000000.00 - -676151.24 - -
Ltd.Jiaxing Haid Yongwang
Biological Feed Co. 15314576.83 - - - - 25043.21 15339620.04 -
Ltd.Shijiazhuang Vike
Biotechnology Co. Ltd. 51078462.99 - - - - -224250.96 50854212.03 -
Chongqing Haid Feed
Co. Ltd. 27006056.42 - - - - -135146.85 26870909.57 -
Shenyang Haid Feed
Co. Ltd. 3338273.11 - - - - -34181.80 3304091.31 -
Jiangsu Haihe
Agriculture and Animal 7203746.72 - - - - 136175.71 7339922.43 -
Husbandry Co. Ltd.Xuzhou Haihe Feed Co.Ltd. 224450.34 - - - - -52284.16 172166.18 -
Lianyungang Haihe
Feed Co. Ltd. 780739.26 - - - - 100858.48 881597.74 -
3252024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Xuzhou Haid Hexin
Feed Co. Ltd. 404443.40 - - - - 52318.80 456762.20 -
Anshan Dachuan Feed
Technology Co. Ltd. 3113130.03 - - - - - 3113130.03 -
Guangzhou Haiyuan
Commercial Factoring 150163792.77 - - - - -10400.32 150153392.45 -
Co. Ltd.Haid Pet Food Co. Ltd. 180950417.56 - - - -115365236.34 -221027.26 65364153.96 115365236.34
Ganzhou Haid
Biotechnology Co. Ltd. 52720524.09 - - - - -72588.39 52647935.70 -
Guangzhou Punong
Investment Management 4600000.00 - - - - - 4600000.00 -
Co. Ltd.Guangzhou Yuannong
Investment Management 19758109.00 - - - - - 19758109.00 -
Co. Ltd.Zhongshan Yugezi Food
Co. Ltd. 258489.78 - - - - -114860.83 143628.95 -
Foshan Rongda Aquatic
Seed Co. Ltd. 61366.05 - - - - 87982.94 149348.99 -
Guangzhou Rongda
Aquatic Technology Co. 758030.47 - - - - 22051.63 780082.10 -
Ltd.Zhongshan Ronghai
Aquaculture Co. Ltd. 1822380.46 - - - - 48958.73 1871339.19 -
Guangxi Ronghai
Fishery Co. Ltd. 498656.49 - - - - 128787.25 627443.74 -
Liyang Jiuhe Feed Co.Ltd. 66598334.31 - - - - 72405.20 66670739.51 -
Shaoguan Haid
Biotechnology Co. Ltd. 16194127.70 - - - - 31131.71 16225259.41 -
Shandong Daxin Group
Co. Ltd. 299551292.68 39459654.06 29693750.81 - - -54253.09 329190790.40 39459654.06
3262024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Weifang Daxin Feed
Co. Ltd. 265976.08 - - - - 97068.54 363044.62 -
Yantai Daxin Feed Co.Ltd. 393318.57 - - - - 3993.79 397312.36 -
Linyi Yihe Feed Co.Ltd. 947488.92 - - - - 183997.19 1131486.11 -
Jiangsu Daxin Feed Co.Ltd. 324883.70 - - - - 50487.68 375371.38 -
Shandong Daxin
Agriculture and Animal
Husbandry Technology 244559.29 - - - - 71847.18 316406.47 -
Co. Ltd.Laiyang Haihe
Agriculture and Animal
Husbandry Technology 210300.07 - - - - 136715.77 347015.84 -
Co. Ltd.Qingdao Haihe
Agriculture and Animal
Husbandry Technology 84764.83 - - - - 19400.43 104165.26 -
Co. Ltd.Linyi Haihe Agriculture
and Animal Husbandry 45590.79 - - - - -45590.79 - -
Technology Co. Ltd.Gaomi Haihe
Agriculture and Animal
Husbandry Technology 127349.08 - - - - 71928.87 199277.95 -
Co. Ltd.Qingdao Huaxin Feed
Co. Ltd. 163767.18 - - - - 76051.83 239819.01 -
Linyi Zhizhuxia
Breeding Technology 52431.54 - - - - -52431.54 - -
Services Co. Ltd.
3272024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Huai’an Hailong Feed
Co. Ltd. 51961038.33 - - - - -71365.12 51889673.21 -
Hunan Jinhuilong
Technology Co. Ltd. 51901888.28 - - - -959755.34 302111.14 51244244.08 959755.34
Shijiazhuang Huilong
Feed Co. Ltd. 84458.21 - - - - -76114.10 8344.11 -
Handan Huilong Feed
Co. Ltd. 206791.60 - - - - -29034.39 177757.21 -
Huai'an Huilong Feed
Co. Ltd. 110030.92 - - - - 25267.22 135298.14 -
Fuzhou Haid Feed Co.Ltd. 86345721.64 - 70000000.00 - - 27774.88 156373496.52 -
Zhaoqing Gaoyao Haid
Biotechnology Co. Ltd. 82877028.48 - - - - 231441.14 83108469.62 -
Nanning Haid
Biotechnology Co. Ltd. 124197658.00 - - - - 1142253.05 125339911.05 -
Guangzhou Haiyuan
Microfinance Co. Ltd. 202645069.45 - - - - -679071.92 201965997.53 -
Jiangmen Rongchuan
Feed Co. Ltd. 187021921.03 - 190000000.00 - - 561398.95 377583319.98 -
Chongqing Kaizhou
Haid Biotechnology Co. 35370883.62 - - - - 160261.85 35531145.47 -
Ltd.Meizhou Haid
Biotechnology Co. Ltd. 63587268.14 - - - - -21286.30 63565981.84 -
Yicheng Haid
Biotechnology Co. Ltd. 45719096.74 - - - - 102073.10 45821169.84 -
Zhuhai Dachuan
Biotechnology Co. Ltd. 48569403.78 - - - - -134468.36 48434935.42 -
Hexian Haid
Biotechnology Co. Ltd. 161240572.92 - 100000000.00 - - 295242.51 261535815.43 -
Guangzhou Nansha Haid
Technology Co. Ltd. 50000000.00 - - - - - 50000000.00 -
3282024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Tianjin Rongchuan Feed
Co. Ltd. 164758178.10 - - - - -369399.40 164388778.70 -
Zhanjiang Rongda Feed
Co. Ltd. 41235294.72 - - - - -229253.27 41006041.45 -
Huainan Haid Biological
Feed Co. Ltd. 85348881.81 - 45000000.00 - - 153727.65 130502609.46 -
Maoming Haid
Biotechnology Co. Ltd. 61664189.97 - - - - -19398.51 61644791.46 -
Guangzhou Ronghai
Breeding Technology 24410255.89 - 761000000.00 - -695275367.16 -225976.32 89908912.41 695275367.16
Co. Ltd.Sichuan Rongchuan
Feed Co. Ltd. 91318835.65 - 30000000.00 - - -278152.18 121040683.47 -
Yulin Haid Feed Co.Ltd. 45605368.91 - 50000000.00 - - -40267.56 95565101.35 -
Sichuan Haile
Agriculture and Animal 16565283.34 - - - - 87542.87 16652826.21 -
Husbandry Co. Ltd.Yichang Zhihai
Agriculture and Animal 77494.63 - - - - 14936.77 92431.40 -
Husbandry Co. Ltd.Mianyang Zhonggui
Feed Co. Ltd. 119299.90 - - - - 27934.52 147234.42 -
Dali Haiwang Feed Co.Ltd. 211812.36 - - - - 20258.58 232070.94 -
Yunnan Zhonggui Feed
Co. Ltd. 235247.80 - - - - -18881.46 216366.34 -
Chongqing Zhihai Feed
Co. Ltd. 129944.27 - - - - -44199.63 85744.64 -
Guiyang Haid Zhihai
Feed Co. Ltd. 813299.86 - - - - -79898.74 733401.12 -
Qujing Zhihai Feed Co.Ltd. 232078.57 - - - - 29764.55 261843.12 -
3292024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Yibin Zhihai Feed Co.Ltd. 523509.76 - - - - -27627.42 495882.34 -
Guangzhou Xingnong
Ecological Agriculture
and Animal Husbandry 29825119.61 - - -29000000.00 - -825119.61 - -
Development Co. Ltd.Qingyuan Ronghai Food
Technology Co. Ltd. 70768986.10 - - - - 43986.17 70812972.27 -
Guangzhou Haiyin
Financing Guarantee 252234263.51 - - - - 1015352.52 253249616.03 -
Co. Ltd.Qinzhou Hailong Feed
Co. Ltd. 40501193.34 - - - - 82436.39 40583629.73 -
Hainan Haid
Biotechnology Co. Ltd. 60368077.59 - 90000000.00 - - 242726.95 150610804.54 -
Jiangsu Haixin
Biotechnology Co. Ltd. 24839575.17 - - - - 2604.44 24842179.61 -
Gaoan Haid
Biotechnology Co. Ltd. 42385068.59 - - - - 10919.31 42395987.90 -
Shanggao Haid
Biotechnology Co. Ltd. 25752555.93 - - - - -71997.58 25680558.35 -
Qingyuan Hailong
Biotechnology Co. Ltd. 132595926.41 - - - - -164283.16 132431643.25 -
Guangdong Haid
International Trade Co. 100000000.00 - - - - - 100000000.00 -
Ltd.Guangzhou Nansha Haid
Biotechnology Co. Ltd. 9587437.39 - - - - 923419.44 10510856.83 -
Yancheng Haiwei
Biotechnology Co. Ltd. 60853972.46 - - - - 529781.96 61383754.42 -
Hainan Haid Aquatic
Seed Industry 45450791.93 - - - - -196104.44 45254687.49 -
Development Co. Ltd.
3302024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Wuzhou Haid
Biotechnology Co. Ltd. 25681950.11 - - - - -163904.60 25518045.51 -
Zhangzhou Haiheng
Feed Co. Ltd. 2686215.27 - - - - 42184.51 2728399.78 -
Deyang Dachuan
Agriculture and Animal
Husbandry Technology 41419605.21 - 70000000.00 - - 75987.00 111495592.21 -
Co. Ltd.Mianyang Hailong Feed
Co. Ltd. 4087602.68 - - - - -958.33 4086644.35 -
Guangzhou Nongzhidao
Feed Co. Ltd. 6380632.84 - - - - -187725.93 6192906.91 -
Jiesou Haid Feed Co.Ltd. 16252210.75 - - - - -145038.27 16107172.48 -
Anlu Haid Feed Co.Ltd. 20677627.76 - - - - 94974.32 20772602.08 -
Jingzhou Haihe
Biotechnology Co. Ltd. 41001757.93 - - - - 103602.24 41105360.17 -
Hainan Zhuangmei
Agriculture and Animal 42024597.59 - - - -1999796.32 -453553.90 39571247.37 1999796.32
Husbandry Co. Ltd.Yancheng Runchuan
Agricultural Technology 163540.70 - - - - -20958.88 142581.82 -
Co. Ltd.Zigong Hailong
Biotechnology Co. Ltd. 31446252.00 - 60000000.00 - - 417582.96 91863834.96 -
Jiangxi Jiabo Biological
Engineering Co. Ltd. 22947534.96 17826753.49 - - - 495361.17 23442896.13 17826753.49
Guangxi Rongchuan
Feed Co. Ltd. 242768.29 - - - - -111878.03 130890.26 -
Dali Haid Biotechnology
Co. Ltd. 40214317.59 - 50000000.00 - - 77896.54 90292214.13 -
3312024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Guangzhou Haid
Technology 14211186.58 - - - - -52383.29 14158803.29 -
Development Co. Ltd.Heshan Haiwei Feed
Co. Ltd. 7094710.68 5000000.00 - -7050000.00 - -44710.68 - -
Ganzhou Lianduoli Feed
Technology Co. Ltd. 19229888.06 - - - - 12039.21 19241927.27 -
Maoming Haiwei Feed
Co. Ltd. 7888082.14 - - - - -92256.79 7795825.35 -
Sichuan Hailong
Biotechnology Co. Ltd. 208685.52 - 9000000.00 -9000000.00 - -208685.52 - -
Qinzhou Haiwei Feed
Co. Ltd. 35211465.18 - - - - 134352.16 35345817.34 -
Yancheng Rongchuan
Biotechnology Co. Ltd. 61168339.05 - 135000000.00 - - 498801.10 196667140.15 -
Nanning Dachuan
Biotechnology Co. Ltd. 9126376.18 - - - - -62894.81 9063481.37 -
Yongzhou Haid
Biotechnology Co. Ltd. 5000000.00 - - - - 2444.86 5002444.86 -
Guiyang Haid
Biotechnology Co. Ltd. 30000000.00 - 20000000.00 - - - 50000000.00 -
Wuwei Haimu
Biotechnology Co. Ltd. 25586863.39 - 60000000.00 - - -149021.93 85437841.46 -
Guilin Haid
Biotechnology Co. Ltd. 5029033.35 - - - - 41626.26 5070659.61 -
Inner Mongolia Haid
Feed Co. Ltd. 25826033.21 - 45000000.00 - - 218193.91 71044227.12 -
Guiyang Dachuan
Biotechnology Co. Ltd. 5327706.60 - - - - 88493.99 5416200.59 -
Xingtai Haid
Biotechnology Co. Ltd. 30206561.03 - 70000000.00 - - 32139.74 100238700.77 -
Guangdong Haifulai
Biotechnology Co. Ltd. 21106843.22 - 29000000.00 - - -22398.57 50084444.65 -
3322024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Qingyuan Hailier
Biotechnology Co. Ltd. 258725.91 - - - - 88517.54 347243.45 -
Liupanshui Haid
Biotechnology Co. Ltd. 40207441.19 - - - - 291990.30 40499431.49 -
Guangdong Haiqi
Investment Co. Ltd. 30000000.00 - 40000000.00 - - - 70000000.00 -
Hubei Haiqi Technical
Services Co. Ltd. 390010.10 - - - - -187069.68 202940.42 -
Guangzhou Haiqi
Technology Co. Ltd. 1998610.24 - - - - -79911.03 1918699.21 -
Guangzhou Haifeng
Breeding Services Co. 53031.23 - - - - -28533.22 24498.01 -
Ltd.Nanning Haililai
Biotechnology Co. Ltd. 7507562.12 - - - - 108205.50 7615767.62 -
Shaoyang Haid Feed
Co. Ltd. 10447870.69 - - - - 46080.21 10493950.90 -
Foshan Debao
Biological Group Co. 114113712.03 10903528.88 - - - 438611.15 114552323.18 10903528.88
Ltd.Guangzhou Denong
Feed Co. Ltd. 338222.52 - - - - 17820.22 356042.74 -
Foshan Dazhi
Biotechnology Co. Ltd. 594970.33 - - - - -187949.86 407020.47 -
Taishan Debao Feed Co.Ltd. 287730.15 - - - - 59107.81 346837.96 -
Maoming Debao
Agriculture and Animal 178819.45 - - - - -178819.45 - -
Husbandry Co. Ltd.Shaoguan Dachuan
Biotechnology Co. Ltd. 5000000.00 - - - - - 5000000.00 -
Liaoning Haid
Biotechnology Co. Ltd. 20745048.18 - 45000000.00 - - 114945.38 65859993.56 -
3332024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Guizhou Hailongwang
Biotechnology Co. Ltd. 358124.48 - - - - 126007.40 484131.88 -
Guangdong Huashite
Testing Technology Co. 2027600.26 - - - - 22182.76 2049783.02 -
Ltd.Tianjin Haid
Biotechnology Co. Ltd. 754862.38 - - - - 21381.57 776243.95 -
Dali Dachuan
Biotechnology Co. Ltd. 25593201.49 - 55000000.00 - - 4197.22 80597398.71 -
Yunnan Hairui
Biotechnology Co. Ltd. 38202794.93 - - - - 41502.03 38244296.96 -
Henan Haid Jiuzhou
Biotechnology Co. Ltd. 7896816.39 - - - - 16528.19 7913344.58 -
Enshi Haid
Biotechnology Co. Ltd. 50126366.15 - - - - 174080.18 50300446.33 -
Ningguo Haid
Biotechnology Co. Ltd. 15808102.44 - 3900000.00 - - 43479.62 19751582.06 -
Chaozhou Haid
Biotechnology Co. Ltd. 10000000.00 - - - - - 10000000.00 -
Haixin (Tianjin)
Biotechnology Co. Ltd. 30490554.10 - - - - 207907.07 30698461.17 -
Haid Biological
(Beijing) Technology 455595.36 - - - - 526699.92 982295.28 -
Co. Ltd.Dalian Haid
Biotechnology Co. Ltd. 495654.61 - - - - 535273.58 1030928.19 -
Shenzhen Xinlingke
Biotechnology Co. Ltd. 187958.96 - - - - 138388.26 326347.22 -
Haid Nanshan
Biotechnology (Jinhu) 35732776.45 - - - - 40243.89 35773020.34 -
Co. Ltd.
3342024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Guangdong Haizhihui
Aquaculture Technology 53020455.35 - - - - 29327.65 53049783.00 -
Co. Ltd.Leizhou Yuexiu
Haishengyuan Shrimp
Farming Technology 82979.35 - - - - 38929.57 121908.92 -
Co. Ltd.Dongying Haishengyuan
Aquaculture Co. Ltd. 61366.05 - - - - 102924.92 164290.97 -
Wudi Haishengyuan
Aquaculture Co. Ltd. 20455.35 - - - - 32876.63 53331.98 -
Changyi Haijingzhou
Biotechnology Co. Ltd. 904482.08 - - - - 135946.99 1040429.07 -
Yuncheng Haishengyuan
Fishery Technology Co. 72347.78 - - - - -22564.75 49783.03 -
Ltd.Jiangsu Haiwei Feed
Co. Ltd. 25203252.77 - 40000000.00 - - 79116.97 65282369.74 -
Hubei Haid Seed
Industry Technology 25041363.90 - 5000000.00 - - 8419.03 30049782.93 -
Co. Ltd.Qianjiang Hailong
Biotechnology Co. Ltd. 70505484.49 - - - - 198682.20 70704166.69 -
Yueyang Haid
Biotechnology Co. Ltd. 15280280.73 - - - - -31956.07 15248324.66 -
Guiyang Haiyue Feed
Technology Co. Ltd. 10104915.95 - - - - 43242.74 10148158.69 -
Chifeng Haid
Biotechnology Co. Ltd. 1800000.00 - 1257243.00 - - - 3057243.00 -
Huizhou Haid
Biotechnology Co. Ltd. 32281222.21 - - - - -81982.66 32199239.55 -
3352024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Guangzhou Hualaike
Testing Technology Co. 2176807.11 - - - - 252302.75 2429109.86 -
Ltd.Huaibei Haid Biological
Feed Co. Ltd. 3093200.81 - 7000000.00 - - 84599.71 10177800.52 -
Guigang Hailong
Biotechnology Co. Ltd. 72660.07 - 5000000.00 - - 76630.10 5149290.17 -
Guizhou Haid Feed Co.Ltd. 5153571.29 - - - - 111819.62 5265390.91 -
Pizhou Haid Ruminant
Feed Co. Ltd. 5113494.16 - - - - 174823.85 5288318.01 -
Nanping Haid
Biotechnology Co. Ltd. 14584473.32 - 4028871.77 - - - 18613345.09 -
Xishui Chenke Feed
Technology Co. Ltd. 121380975.55 - - - - 198064.09 121579039.64 -
Tuanfeng Source Feed
Technology Co. Ltd. 23094.76 - - - - 35872.17 58966.93 -
Huangshi Haid Feed
Co. Ltd. 120092.57 - - - - 19180.73 139273.30 -
Qichun Sifang
Technology Feed Co. 87100.22 - - - - 134874.58 221974.80 -
Ltd
Huangmei Haid Feed
Co. Ltd. 83141.04 - - - - 116915.46 200056.50 -
Quzhou Haid Huilong
Biological Feed Co. Ltd 10023094.76 - - - - 36266.51 10059361.27 -
HAID (ECUADOR)
FEED CIA.LTDA. 499931951.27 - - - - -244502.36 499687448.91 -
Xinyu Haihe
Biotechnology Co. Ltd 20033949.66 - - - - 67980.39 20101930.05 -
Zhuhai Haiyue
Agriculture and Animal 20226499.58 - - - - 309297.49 20535797.07 -
Husbandry Co. Ltd.
3362024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Qingyuan Haifulai
Biotechnology Co. Ltd. 30000000.00 - - - - - 30000000.00 -
Guangdong Konong
Culture Co. Ltd 32992.44 - - - - 44936.58 77929.02 -
Fuzhou Hailong
Biotechnology Co. Ltd. 30129100.00 - 35955172.50 - - 436259.02 66520531.52 -
Guangzhou Haiying
Commercial 1500000.00 - - - - - 1500000.00 -
Management Co. Ltd.Lishui Haid Huatong
Biotechnology Co. Ltd. 18000000.00 - - - - 13352.77 18013352.77 -
Ningdu Haid
Biotechnology Co. Ltd. 3600000.00 - 3600000.00 - - 5520.64 7205520.64 -
Huai'an Dachuan Feed
Co. Ltd. - - - - - 16981.49 16981.49 -
Zhuhai Haibei Supply
Chain Management Co. 16685896.20 - 5000000.00 - - 3188043.31 24873939.51 -
Ltd.Dangshan Shengfeng
Haid Feed Co. Ltd. - - 5500000.00 - - - 5500000.00 -
Shanxi Haid Agriculture
and Animal Husbandry - - 3000000.00 - - - 3000000.00 -
Technology Co. Ltd.Zhuhai Dehai Biological
Technology Co. Ltd. - - 500000000.00 - - 2760.32 500002760.32 -
Yangjiang Dehai
Biotechnology Co. Ltd. - - - - - 2444.86 2444.86 -
Jiangmen Ronghai
Breeding Technology 356627.67 - 3415362.81 - - 83749.45 3855739.93 -
Co. Ltd.Dezhou Haiying Animal
Husbandry and - - 510000.00 - - - 510000.00 -
Technology Co. Ltd.
3372024.12.31 2024.12.31 Movements during the period 2025.12.31 2025.12.31
Investee Carrying Provision for Increase in Decrease in Provision for Carrying Provision for
amount impairment investment investment impairment Others amount impairment
Total 11113202551.36 78999515.19 3544235169.69 -226428629.33 -817835072.96 10873099.45 13624047118.21 891834588.15
Note: Other movements represent the change amount related to share-based payments during the current period.
(2) Investment in associate and joint ventures
Movements during the year
Investment
2024.12.31 2024.12.31 gains or 2025.12.31 Adjustment in Cash 2025.12.31
Investee Carrying Provision for Provision Increase in Decrease losses other Changes dividends or Provision Others Carrying
amount impairment for investment in recognized in other for amount investment under comprehensive equity profits impairment impairment
equity income declared
method
Associate
Bangpu Seed -
Industry
Technology 9864033.29 - - -4298.24 - - - - - 9859735.05 -
Co. Ltd
Total 9864033.29 - - - -4298.24 - - - - - 9859735.05 -
3. Operating income and operating cost
20252024
Item
Income Cost Income Cost
Principal activities 3324143498.26 1390910887.01 3170389684.44 1327894322.77
Other operating activities 35677382.00 10555391.19 44806888.79 2598724.48
Total 3359820880.26 1401466278.20 3215196573.23 1330493047.25
3384. Investment income
Item 2025 2024
Income from long-term equity investments under cost
method 832110806.57 706114524.65
Income from long-term equity investments under the equity
method -4298.24 -296743.27
Investment income from disposal of long-term equity
investments -131932623.52 -245676680.43
Investment income earned from held-for-trading financial
assets during the holding period 48253671.35 28305495.90
Investment income earned from other non-current financial
assets during the holding period 362476.50 83574.61
Investment income from disposal of held-for-trading
financial assets - -368422.81
Investment income from disposal of non-current financial
assets - -1325686.53
Others -1241755.54 -
Total 747548277.12 486836062.12
XVII. Supplementary Information
1. Details of non-recurring gain or loss during the current period
Item 2025 Note
Gain or loss on disposal of non-current assets including the write-
off of previously accrued impairment provisions -36158599.44
Government grants recognized in current profit or loss other than
those that are closely related to the company’s ordinary business
activities in accordance with national policies are determined 70422837.99
based on predetermined criteria and have a continuous impact on
the company’s profit or loss
Gains or losses arising from changes in fair value changes of
financial assets and financial liabilities held by non-financial
enterprises gains or losses on financial assets and financial -126235785.00
liabilities excluding effective hedging activities that are related to
the company's ordinary course of business
Reversal of impairment allowance on accounts receivable
individually assessed for impairment 49219466.84
Other non-operating incomes and expenses not listed above 2661719.15
Other items meeting the definition of non-recurring gain or loss -
Total non-recurring gain or loss -40090360.46
Less: Income tax impact of non-recurring items -43336092.77
Net non-recurring gain or loss 3245732.31
Less: non-recurring item attributable to non-controlling interests
net of tax 2315455.83
Non-recurring gain or loss attributable to the ordinary
shareholders of the company 930276.48
3392. Return on equity (ROE) and earnings per share (EPS)
Earnings per share
Profit for the reporting period Weighted average ROE Basic EPS Diluted EPS
Net profit attributable to ordinary
shareholders of the company 17.42% 2.58 2.57
Net profit attributable to ordinary
shareholders of the company after deducting 17.42% 2.58 2.57
non-recurring gain or loss
340



